Quarterlytics / Industrials / Electrical Equipment & Parts / CBAK Energy Technology, Inc. / FY2020 Annual Report

CBAK Energy Technology, Inc.
Annual Report 2020

CBAT · NASDAQ Industrials
Claim this profile
Ticker CBAT
Exchange NASDAQ
Sector Industrials
Industry Electrical Equipment & Parts
Employees 1463
← All annual reports
FY2020 Annual Report · CBAK Energy Technology, Inc.
Loading PDF…
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

(Mark One)
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: December 31, 2020

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________to _____________

Commission File No. 001-32898

CBAK ENERGY TECHNOLOGY, INC. 
(Exact Name of Registrant as Specified in Its Charter)

Nevada
(State or Other Jurisdiction of
Incorporation or Organization)

88-0442833
(I.R.S. Employer
Identification No.)

CBAK Industrial Park, Meigui Street
Huayuankou Economic Zone
Dalian City, Liaoning Province,
People’s Republic of China, 116450
(Address of Principal Executive Offices)

(86) (411)-3918-5985
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Common Stock, $0.001 par value

Trading Symbol(s)
CBAT

Name of each exchange on which registered
Nasdaq Capital Market

Securities registered pursuant to Section 12(g) of the Exchange Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒ 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an
emerging  growth  company.  See  the  definitions  of  “large  accelerated  filer,”  “accelerated  filer,”  “smaller  reporting  company,”  and  “emerging  growth
company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer
Non-Accelerated Filer

☐
☒

Accelerated Filer
Smaller reporting company
Emerging growth company

☐
☒
☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control
over  financial  reporting  under  Section  404(b)  of  the  Sarbanes-Oxley  Act  (15  U.S.C.  7262(b))  by  the  registered  public  accounting  firm  that  prepared  or
issued its audit report. ☐

Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Act) Yes ☐ No ☒ 

As of June 30, 2020 (the last business day of the registrant’s most recently completed second fiscal quarter), the aggregate market value of the shares of the
registrant’s  common  stock  held  by  non-affiliates  (based  upon  the  closing  sale  price  of  $0.76  per  share)  was  approximately  $21  million.  Shares  of  the
registrant’s common stock held by each executive officer and director and by each person who owns 10% or more of the outstanding common stock have
been  excluded  from  the  calculation  in  that  such  persons  may  be  deemed  to  be  affiliates  of  the  registrant.  This  determination  of  affiliate  status  is  not
necessarily a conclusive determination for other purposes.

There was a total of 88,106,019 shares of the registrant’s common stock outstanding as of April 9, 2021.

DOCUMENTS INCORPORATED BY REFERENCE

None.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CBAK ENERGY TECHNOLOGY, INC.

Annual Report on Form 10-K

TABLE OF CONTENTS

PART I

Item 1.
Item 1A.
Item 1B.
Item 2.
Item 3.
Item 4.

Business
Risk Factors
Unresolved Staff Comments
Properties
Legal Proceedings
Mine Safety Disclosures

PART II

Item 5.
Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Selected Financial Data
Management’s Discussion And Analysis Of Financial Condition And Results Of Operations
Quantitative And Qualitative Disclosures About Market Risk
Financial Statements And Supplementary Data
Changes In And Disagreements With Accountants On Accounting And Financial Disclosure
Controls And Procedures
Other Information

PART III

Item 10.
Item 11.
Item 12.
Item 13.
Item 14.

Directors, Executive Officers And Corporate Governance
Executive Compensation
Security Ownership Of Certain Beneficial Owners And Management And Related Stockholder Matters
Certain Relationships And Related Transactions, And Director Independence
Principal Accounting Fees And Services

Item 15.
Item 16.

Exhibits, Financial Statement Schedules
Form 10-K Summary

PART IV

i

1
10
28
28
28
28

29
29
30
43
F-1
44
44
45

46
51
54
57
57

58
59

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Use of Terms

Except as otherwise indicated by the context and for the purposes of this report only, references in this report to:

 INTRODUCTORY NOTE

● “Company”, “we”, “us” and “our” are to the combined business of CBAK Energy Technology, Inc., a Nevada corporation, and its consolidated

subsidiaries;

● “BAK Asia” are to our Hong Kong subsidiary, China BAK Asia Holdings Limited;

● “CBAK Trading” are to our PRC subsidiary, Dalian CBAK Trading Co., Ltd.;

● “CBAK Power” are to our PRC subsidiary, Dalian CBAK Power Battery Co., Ltd.;

● “CBAK Suzhou” are to our PRC subsidiary, CBAK New Energy (Suzhou) Co., Ltd.;

● “CBAK Energy” are to our PRC subsidiary, Dalian CBAK Energy Technology Co., Ltd.;

● “BAK Investments” are to our Hong Kong subsidiary, BAK Asia Investments Limited;

● “CBAK Nanjing” are to our PRC subsidiary, CBAK New Energy (Nanjing) Co., Ltd;

● “Nanjing CBAK” are to our PRC subsidiary, Nanjing CBAK New Energy Technology Co., Ltd.;

● “Nanjing Daxin” are to our PRC subsidiary, Nanjing Daxin New Energy Automobile Industry Co., Ltd.;

● “China” and “PRC” are to the People’s Republic of China;

● “RMB” are to Renminbi, the legal currency of China;

● “U.S. dollar”, “$” and “US$” are to the legal currency of the United States;

● “SEC” are to the United States Securities and Exchange Commission;

● “Securities Act” is to the Securities Act of 1933, as amended; and

● “Exchange Act” are to the Securities Exchange Act of 1934, as amended.

Special Note Regarding Forward Looking Statements and Summary of Risk Factors

Statements contained in this report include “forward-looking statements” within the meaning of such term in Section 27A of the Securities Act and Section
21E of the Exchange Act. Forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause actual financial
or operating results, performances or achievements expressed or implied by such forward-looking statements not to occur or be realized. Forward-looking
statements made in this report generally are based on our best estimates of future results, performances or achievements, predicated upon current conditions
and the most recent results of the companies involved and their respective industries. Forward-looking statements may be identified by the use of forward-
looking terminology such as “may,” “will,” “could,” “should,” “project,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue,” “potential,”
“opportunity”  or  similar  terms,  variations  of  those  terms  or  the  negative  of  those  terms  or  other  variations  of  those  terms  or  comparable  words  or
expressions. Potential risks and uncertainties include, among other things, such factors as:

● Our independent auditors have expressed substantial doubt about our ability to continue as a going concern.   

● There are inherent risks associated with new product development and our efforts to develop and market new products could fail.

● Our failure, if any, to keep up with rapid technological changes and evolving industry standards may cause our products to become obsolete and

less marketable, resulting in loss of market share to our competitors.

● Our efforts to enter into the light electric vehicle business could fail.

● Maintaining our R&D activities and manufacturing operations require significant capital expenditures, and our inability or failure to maintain our

operations could have a material adverse impact on our market share and ability to generate revenue.

● We face intense competition from other battery manufacturers, many of which have significantly greater resources.

● We are dependent on a limited number of customers for a significant portion of our revenues and this dependence is likely to continue.

ii

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
● Our business depends on the growth in demand for light electric vehicles, electric vehicles, electric tools, energy storage including but not limited

to UPS application, and other high-power electric devices.

● Our success, in part, depends on the success of manufacturers of the end applications that use our products, and our failure to gain acceptance of

our products from such manufacturers could materially and adversely affect our results of operations and profitability.

● We do not have insurance coverage against damages or losses of our products. Defects in our products could result in a loss of customers and

decrease in revenue, unexpected expenses and a loss of market share.

● We do not have long-term purchase commitments from our customers, which may result in significant uncertainties and volatility with respect to

our revenue from period to period.

● We have identified material weaknesses in our internal control over financial reporting. If we fail to remediate the material weaknesses or maintain
an effective system of internal control over financial reporting, we may be unable to accurately report our financial results or prevent fraud, and
investor confidence and the market price of our shares may be adversely affected.

● Our auditors,  based  in  Hong  Kong,  China,  like  other  independent  registered  public  accounting  firms  operating  in  China  and  to  the  extent  their
audit clients have operations in China, is not permitted to be subject to full inspection by the Public Company Accounting Oversight Board and, as
such,  you  may  be  deprived  of  the  benefits  of  such  inspection.  In  addition,  as  a  result  of  the  enactment  of  the  Holding  Foreign  Companies
Accountable Act, we could be delisted if we were unable to cure the situation to meet the PCAOB inspection requirement in time.

● We may be adversely affected by the outcome of litigation against us in China.

● Numerous factors, many of which are beyond our control, may cause the market price of our common stock to fluctuate significantly.

● Techniques employed by short sellers may drive down the market price of our common stock.

● Other risks identified in this report and in our other reports filed with the SEC, including those identified in “Item 1A. Risk Factors” below.

Readers  are  urged  to  carefully  review  and  consider  the  various  disclosures  made  by  us  in  this  report  and  our  other  filings  with  the  SEC.  These  reports
attempt to advise interested parties of the risks and factors that may affect our business, financial condition and results of operations and prospects. New
risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the
extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements
we may make. The forward-looking statements made in this report speak only as of the date hereof and we disclaim any obligation to provide updates,
revisions or amendments to any forward-looking statements to reflect changes in our expectations or future events.

iii

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 1. BUSINESS.

Overview of Our Business

PART I

We are a manufacturer of new energy high power lithium batteries that are mainly used in light electric vehicles, electric vehicles, electric tools, energy
storage  including  but  not  limited  to  uninterruptible  power  supply  (UPS)  application,  and  other  high-power  applications.  Our  primary  product  offering
consists of new energy high power lithium batteries, but we are also seeking to expand into the production and sale of light electric vehicles.

We  acquired  most  of  our  operating  assets,  including  customers,  employees,  patents  and  technologies  from  our  former  subsidiary  BAK  International
(Tianjin)  Ltd.  (“BAK  Tianjin”).  We  acquired  these  assets  in  exchange  for  a  reduction  in  accounts  receivable  from  our  former  subsidiaries  that  were
disposed of in June 2014.

As of December 31, 2020, we report financial and operational information in one segment, producing high-power lithium battery cells.

Although the COVID-19 pandemic has caused disruptions to our operations, it has had limited adverse impacts on our operating results for the fiscal year
ended December 31, 2020. We generated revenues of $37.6 million and $22.2 million for the fiscal years ended December 31, 2020 and 2019, respectively.
We had a net loss of $7.8 million and $10.9 million in the fiscal years ended December 31, 2020 and 2019, respectively. As of December 31, 2020, we had
an accumulated deficit of $184.0 million and net assets of $52.4 million. We had a working capital deficiency, accumulated deficit from recurring net losses
from operations and short-term debt obligations maturing in less than one year as of December 31, 2020.

In the second half of 2020, we commenced capital intensive construction undertakings to expand the Company’s manufacturing capabilities. In addition,
we have been expanding our business by developing new products, fostering new partnerships and launching the light electric vehicle business.

Due to the growing environmental pollution problem, the Chinese government has been providing support to the development of new energy facilities and
vehicles for several years. It is expected that we will be able to secure more potential orders from the new energy market. We believe that with the booming
market demand in high power lithium-iron products, we can continue as a going concern and return to profitability.

In  2015,  to  promote  the  development  of  electric  vehicles  industry,  the  Chinese  government  issued  a  subsidy  policy  named  Notice  of  2016-2020  New
Energy Vehicles Promotion with Financial Support, which regulated subsidies for consumers in purchase of electric vehicles from the central government
and local governments. The policy sets forth subsidy standards for various types of electric vehicles based upon the endurance mileage, battery pack energy
density,  energy  consumption  level  and  others,  which  means  new  energy  vehicles  providing  long  driving  range  and  high  technical  performance  will  get
higher subsidies. From 2017 to 2020, the Chinese government has gradually reduced the subsidy standards for electric vehicles year by year. On April 23,
2020, the Chinese government extended the subsidy for another two years and the subsidy standards will continue to fall by 10%, 20% and 30% in 2020,
2021 and 2022, respectively.

In addition, for the purposes of establishing a long-term mechanism for the administration of energy conservation and new energy vehicles, and promoting
the development of the automobile industry, the Chinese government has implemented several policies to stimulate the increase of new energy vehicles. On
December  26,  2017,  the  Chinese  government  issued  a  policy  for  exemption  of  purchase  tax  for  electric  vehicles  for  another  three  years  until  2020.  In
March 2020, the Chinese government extended the purchase tax exemption from 2020 to 2022.

On September 28, 2017, the Chinese Ministry of Industry and Information Technology issued a new policy named Measures for Parallel Administration of
the Average Fuel Consumption and New Energy Vehicle Credits of Passenger Vehicle Enterprises (“Measures for Parallel Administration”). According to
the  Measures  for  Parallel  Administration,  the  Chinese  government  will  calculate  and  examine  the  Average  Fuel  Consumption  Credits  and  New  Energy
Vehicle Credits of enterprises manufacturing passenger vehicles. If the enterprises get negative credits on the declaration day, their production of high-fuel
consumption  vehicles  will  be  suspended.  The  positive  credits  of  average  fuel  consumption  of  passenger  vehicle  makers  may  be  carried  forward  or
transferred  among  affiliated  enterprises.  A  passenger  vehicle  manufacturer’s  negative  credits  with  respect  to  new  energy  vehicles  shall  subject  the
manufacturer to compensation obligations and need to be zeroing through purchasing positive credits of new energy vehicles. Accordingly, the automobile
makers  are  required  to  produce  more  new  energy  vehicles  or  pay  money  to  other  enterprises  to  get  positive  credits  if  their  credits  are  negative.  The
Measures for Parallel Administration became effective on April 1, 2018.

1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
On October 20, 2020, the State Council of PRC issued a new round of “Development Plan for New Energy Vehicles Industry (2021-2035)” (“Plan”), which
is a successor to the previously published “Development Plan for Energy Conservation and New Energy Vehicles Industry (2012-2020)”. The Plan admits
several key problems facing Chinese new energy vehicle manufacturers and stresses that these manufacturers should be committed to improving their R&D
ability, building more infrastructure and promoting the integration of the whole industry. The Plan further outlined the policy and administrative supports
that would be given to the industry, and again certified the importance of the development of new energy vehicles for China.

We believe these energy efficiency policies in the long term will result in a healthy development of the new energy vehicles market as a whole. In the short
term, the extension of subsidies, to some extent, helps ease the pressure on electric vehicle manufacturers and as a result, will be beneficial to the market of
EV batteries in China. However, the Chinese government has significantly reduced the amount of subsidies available to electric vehicle makers over the
years and we believe this trend will continues in the next two years. Given the changing market environment, we plan to continue to focus our resources on
the existing cylindrical batteries for UPS market, temporarily reduce the sales on EV market. We are also researching new products which have higher
energy  density  for  electric  vehicle  market  to  cater  to  the  EV  market  demand.  We  will  closely  monitor  market  changes  and  adjust  our  operations
accordingly.

Expansion of Manufacturing Capabilities

In  June  2020,  our  wholly-owned  subsidiary,  BAK Asia  entered  into  a  framework  investment  agreement  with  Jiangsu  Gaochun  Economic  Development
Zone Development Group Company (“Gaochun EDZ”), pursuant to which we intend to develop certain lithium battery projects which are expected to have
a  total  production  capacity  of  8  GWh  per  year.  As  of  December  31,  2020,  we  had  received  government  subsidies  in  an  amount  of  RMB20  million
(approximately $3.06 million) from Gaochun EDZ. We plan to attain a total capacity of 8 GWh per year to produce lithium batteries for the light electric
vehicle  (LEV),  electric  vehicle,  and  energy  storage  industries.  The  Company  expects  to  achieve  such  capacity  expansion  through  two  phases  of
construction: Phase I is to be completed by the end of 2022 to reach an annual production capacity of 2 GWh. Phase II is to be completed by the end of
2023 to reach the remaining 6 GWh of the planned annual production capacity expansion. The actual production capacity and construction timelines of
such battery projects are subject to revision and adjustment based on the market acceptance of our new battery products. We are currently in the first phase
construction of facilities, which occupy an area of approximately 10,260 square meters and the second-phase construction is at the design stage. As part of
the first phase, we are constructing the production lines of model 18650 battery and 32140 battery, a new battery model as further described below.

Further, we are constructing a new production line with an annual capacity of 0.4 GWh to produce additional 100,000 model 26650 batteries per day in
Dalian due to increased demands for our model 26650 batteries. We expect that the production line construction will be completed in 2021. At the same
time, the Company continues to renovate its existing facilities, upgrade its equipment, add new equipment, improve its product functionality, and enhance
the raw materials and components used for production.

Development of a New Battery Model

Currently, our primary product offering consists of model 26650 lithium cells which account for approximately 50% of our sales in 2020. Model 26650
batteries can be used in light electric vehicles, electric vehicles, electric tools, energy storage such as uninterruptible power supply (UPS) application, and
other high-power applications.

To maintain our competitive position, we are developing model 32140 large-sized cylindrical “tabless” battery which has passed internal technical and pilot
plant tests. Model 32140 batteries can be used in end applications such as light electric vehicles, electric vehicles, electric tools and energy storage.

2

 
 
 
 
 
 
 
 
 
 
We also announced in February 2021 that we have started the trial production of special 26650 lithium battery, which was designed for application in ultra-
low  temperature.  Capable  of  operating  with  high  efficiency  in  low-temperature  environments,  the  special  26650  battery  has  several  use  cases  in  high-
latitude  and  high-altitude  low  temperature  environments,  such  as  energy  storage  in  ultra-low-temperature  environment,  base  stations,  transportation,
unmanned drones, aviation and aerospace areas, as well as other specific circumstances that require ultra-low-temperature cells.

Launch of the Light Electric Vehicle Business

On September 24, 2020, BAK Asia entered into a framework investment agreement with Gaochun EDZ, under which we intend to develop light electric
vehicle projects. On November 9, 2020, we established our subsidiary, Nanjing Daxin to launch and develop our light electric vehicle business. Nanjing
Daxin is in the process of registering its branch in Tianjin City which has eight employees and has rented a manufacturing facility of approximately 4,800
square  meters  in  Tianjin  in  January,  2021.  Nanjing  Daxin  is  currently  building  a  production  line  at  the  Tianjin  branch  to  produce  electric  bicycles. We
expect that the Tianjin production line construction will be completed in 2021. Upon completion of the construction of the Tianjin production line, we plan
to utilize this facility to manufacture electric bicycles under our own brand and sell them through distributors and sales representatives. We may provide
contract manufacturing services to other electric bicycle producers if we can secure such orders.

Trends in End Applications of Our Products

Our business, financial condition and results of operations depend on whether end-application manufacturers are willing to use our products. We target the
battery  markets  for  light  electric  vehicles,  electric  vehicles,  electric  tools,  energy  storage  including  but  not  limited  to  UPS  application,  and  other  high-
power  electric  devices.  However,  our  revenues  derived  from  a  specific  end-application  have  been  fluctuating  depending  on  various  factors  such  as
governmental policies, technological changes, evolving industry standards and customer needs and preferences.

During the period from 2017 to 2019, our largest electric vehicle customers included Dongfeng Autos, Dayun Motor and Yema Auto. Our battery sales in
the electric vehicle market have decreased significantly during the period of 2018–2020 as a result of changes to the Chinese government’s new energy
vehicle subsidy policies. More specifically, under the subsidy policies, new energy vehicles receive different subsidies based on their driving range and
technical  performance.  New  energy  vehicles  providing  long  driving  range  and  high  technical  performance  qualify  for  higher  subsidies  and  the  Chinese
government  has  gradually  raised  the  performance  thresholds  for  electric  vehicles  to  receive  subsidies  over  the  years.  Since  2019,  as  the  battery  packs
comprising  our  primary  model  26650  batteries  were  only  able  to  support  energy  vehicles  that  qualify  for  the  lowest  level  of  subsidies,  electric  vehicle
producers do not have the incentive to purchase batteries from us. As a result, we had only generated approximately $0.3 million in revenues from electric
vehicle customers in 2020. The market where we mainly sell now is the energy storage market. However, we have been looking for opportunities to re-
enter  the  electric  vehicle  battery  market  by  continuing  to  develop  batteries  suitable  for  electric  vehicles  and  actively  cooperating  with  previous  electric
vehicle customers in battery pack after-sales service and technical support.

3

 
 
 
 
 
 
 
 
Our Corporate History and Structure

The Company was incorporated in the State of Nevada on October 4, 1999. The shares of the Company traded in the over-the-counter market through the
Over-the-Counter Bulletin Board from 2005 until May 31, 2006, the date when the Company obtained approval to list its common stock on the Nasdaq
Global Market, and trading commenced that same date under the symbol “CBAK.” Effective January 16, 2017, the Company changed its name to CBAK
Energy Technology, Inc. Effective November 30, 2018, the trading symbol for the common stock of the Company was changed from CBAK to CBAT.
Effective June 21, 2019, the Company’s common stock started trading on the Nasdaq Capital Market.

We currently conduct our business through (i) three wholly-owned operating subsidiaries in China that we own through BAK Asia, an investment holding
company formed under the laws of Hong Kong on July 9, 2013; (ii) CBAK Nanjing, a wholly-owned operating subsidiary in China that we own through
BAK  Investments,  an  investment  holding  company  formed  under  the  laws  of  Hong  Kong  and  acquired  by  us  on  July  14,  2020;  (iii)  Nanjing  CBAK,  a
100% owned subsidiary of CBAK Nanjing; and (iv) Nanjing Daxin, a 100% owned subsidiary of CBAK Nanjing:

● CBAK Trading,  wholly-owned  by  BAK  Asia,  located  in  Dalian,  China,  incorporated  on  August  14,  2013,  focuses  on  the  wholesale  of  lithium

batteries and lithium batteries’ materials, import & export business and related technology consulting service.

● CBAK Power,  wholly-owned  by  BAK  Asia,  located  in  Dalian,  China,  incorporated  on  December  27,  2013,  focuses  on  the  development  and

manufacture of high-power lithium batteries.

● CBAK Suzhou, 90% owned by CBAK Power, located in Suzhou, China, incorporated on May 4, 2018, used to focus on the development and
manufacture of  new  energy  high  power  battery  packs.  CBAK  Suzhou  currently  does  not  have  any  employees  working  locally.  Since  its  lease
expired in October 2019, CBAK Suzhou has stopped using the facilities located at its registered address. Some of its business has been transferred
to our subsidiaries in Dalian and CBAK Suzhou’s remaining assets are temporarily stored in our facilities in Dalian. We plan to dissolve CBAK
Suzhou in 2021.

● CBAK Energy,  wholly-owned  by  BAK  Asia,  located  in  Dalian,  China,  incorporated  on  November  21,  2019,  focuses  on  the  development  and
manufacture of lithium batteries, wholesale of lithium batteries and lithium batteries’ materials, import & export business and related technology
consulting service. 

● CBAK Nanjing, wholly-owned by BAK Investments located in Nanjing, China, incorporated on July 31, 2020, focuses on the development and
manufacture of lithium batteries, wholesale of lithium batteries and lithium batteries’ materials, import & export business and related technology
consulting service. 

● Nanjing CBAK, wholly owned by CBAK Nanjing, located in Nanjing, China, incorporated on August 6, 2020, focuses on the development and
manufacture of lithium batteries, wholesale of lithium batteries and lithium batteries’ materials, import & export business and related technology
consulting service. 

● Nanjing Daxin, wholly-owned by CBAK Nanjing, incorporated on November 9, 2020, focuses on the development and manufacture of electric

bicycle, motorcycle and automobile spare parts, import & export business and related technology consulting service.

4

 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Almost all of our business operations are conducted primarily through our Chinese subsidiaries. The chart below presents our current corporate structure:

Our Products

The use of new materials has enabled the configuration of high-power lithium battery cells to contain much higher energy density and higher voltage and
have a longer life cycle and shorter charge time than other types of lithium-based batteries. These special attributes, coupled with intrinsic safety features,
are suitable for batteries used for high-power applications, such as electric cars, electric bicycles, electric tools, and energy storage such as uninterruptible
power supply, or UPS application.

We currently are manufacturing the following high power lithium batteries, which can be used for various applications:

Battery Cell Type
High-power lithium battery

  End applications*
  Electric bus [6,000-20,000]
  Electric car [1,500-3,5000]
  Hybrid electric vehicle [500-2000]
  Light electric vehicle [10-150]
  Cordless power tool [10-30]
  Energy Storage including UPS [>30]

* Bracketed numbers denote number of cells per particular battery.

Key High Power Lithium Battery Applications

End-product applications that are driving the demand for high power lithium batteries include electric vehicles, such as electric cars, electric buses, hybrid
electric cars and buses; light electric vehicles, such as electric bicycles, electric motors, sight-seeing cars; and electric tools, energy storage including but
not limited to uninterruptible power supply application, and other high-power applications.

Electric Vehicles

An electric vehicle, sometimes referred to as an electric drive vehicle, uses one or more electric motors for propulsion. Electric vehicles include electric
cars, electric buses, electric trains, electric lorries, electric airplanes, electric boats, and hybrid electric vehicles, plug in hybrid electric vehicles and electric
spacecraft. Electric cars and electric buses are propelled by one or more electric motors powered by rechargeable battery packs. Electric cars and buses
have  the  potential  to  significantly  reduce  city  pollution  by  having  zero  tail  pipe  emissions.  Electric  cars  and  buses  are  also  expected  to  have  less
dependence on oil. World governments are pledging significant funds to fund the development of electric vehicles and their components due in part to these
advantages. Due to these factors and a lithium battery’s relatively environmentally-friendly, light-weight and high-capacity features, the demand for lithium
batteries in the field of electric cars and buses is increasing.

5

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Due to such recent trends as renewed concerns relating to the availability and price of oil, increased legal fuel-efficiency requirements and incentives, and
heightened interest in environmentally-friendly or “green” technologies, hybrid electric vehicles are likely to continue to attract substantial interest from
vehicle  manufacturers  and  consumers.  Hybrid  electric  vehicles  include  automobiles,  trucks,  buses,  and  other  vehicles  that  combine  a  conventional
propulsion system with a rechargeable energy storage system to achieve better fuel economy than conventional vehicles. As these vehicles tend to be large
and heavy, their rechargeable energy storage system generally consists of a large quantity of rechargeable high-power lithium cells.

The year 2014 was seen as the first real year for the development of China’s new energy vehicle industry by many industry insiders. After explosive growth
in  2017,  the  production  and  sales  of  new  energy  vehicles  continued  to  grow  tremendously  in  2018  and  in  2020,  despite  of  a  slightly  decline  in  2019.
According to Ministry of Industry and Information Technology of China (“MIIT”), from January to December 2018, the production of new energy vehicles
in China reached 1,270,000 units - up 43.4 percent year-on-year; and sales in China reached 1,256,000 units - up 61.7 percent year-on-year. In 2019, the
production and sales of new energy vehicles reached 1,242,000 units and 1,206,000 units, down 2.3 percent and 4.0 percent year-on-year, respectively. In
2020,  the  production  and  sales  of  new  energy  vehicles  reached  a  record  high  of  1,366,000  units  and  1,267,000  units,  up  10.0  percent  and  5.1  percent,
respectively, from last year. We believe that Chinese electric vehicle market is adversely impacted by the gradually decreasing subsidy in the short term. In
the long term, we believe that the Chinese government will extend the subsidy and more diversity policies will drive a healthy development in the new
energy vehicles market.

Light Electric Vehicles

Light electric vehicles include bicycles, scooters, and motorcycles, with rechargeable electric motors. Due to their relatively small size and light design,
approximately 10-150 high-power lithium cells can be used to power light electric vehicles. We believe that he electric bicycle market in China is very
large.

Energy Storage & Uninterruptible Power Supplies (“UPS”)

Energy storage mainly means storage of electric energy by battery, inductor, and capacitor. Battery energy storage is mainly used for storage of emergency
supply,  battery  car,  and  redundant  energy  of  power  plants.  A  UPS  is  a  form  of  energy  storage  application.  A  UPS  provides  emergency  power  from  a
separate  source  when  utility  power  is  not  available.  The  most  common  type  of  battery  used  in  UPS  is  Sealed  Lead-Acid,  however,  due  to  the  lithium
battery’s relatively small size, light design and environmentally friendly features, the demand for lithium batteries in this industry is increasing.

Electric Tools

Electric tools such as drills, saws and grinders are used for both commercial and personal use. Due to high power requirements, many electric tools have
historically used small combustion engines, used heavier nickel metal hydride batteries or relied on external power sources. Manufacturers of electric tools,
such as Milwaukee Electric Tool Corporation, Stanley Black & Decker, Inc., the Bosch Group, Metabowerke GmbH and Rigid Tool Company have begun
to use lithium-ion technology. The market for portable high-powered electric tools is rapidly growing and has prompted many users, both commercial and
personal, to replace or upgrade their current power tools.

Sales and Marketing

We  plan  to  build  an  extensive  sales  and  service  network  in  China,  highlighted  by  our  presence  in  the  regions  where  China’s  main  lithium  battery
productions located, such as Tianjin, Shandong Province, Guangdong Province and Jiangsu Province. We intend to gradually establish post-sales service
offices  in  these  areas  to  serve  brand  owners  and  pack  manufacturers  in  each  designated  area  as  currently  our  marketing  department  at  headquarters  is
responsible for our promoting efforts. In doing so, our sales staff works closely with our customers to understand their needs and provide feedback to us so
that we can better address their needs and improve the quality and features of our products.

6

 
 
 
  
 
 
 
 
 
 
 
 
We  also  engage  in  marketing  activities  such  as  attending  industry-specific  conferences  and  exhibitions  to  promote  our  products  and  brand  name.  We
believe these activities are conducive in promoting our products and brand name among key industry participants.

Suppliers

The primary raw materials used in the manufacture of lithium-ion batteries include electrode materials, cases and caps, foils, electrolyte and separators.
Cost of these raw materials is a key factor in pricing our products. We believe that there is an ample supply of most of the raw materials we need in China.
We are seeking to identify alternative raw material suppliers to the extent there are viable alternatives and to expand our use of alternative raw materials.

We aim to maintain multiple supply sources for each of our key raw materials to ensure that supply problems with any one supplier will not materially
disrupt  our  operations.  In  addition,  we  strive  to  develop  strategic  relationships  with  new  suppliers  to  secure  a  stable  supply  of  materials  and  introduce
competition in our supply chain, thereby increasing our ability to negotiate better pricing and reducing our exposure to possible price fluctuations.

For the fiscal year ended December 31, 2020, our key raw material suppliers for battery cells were as follows:

Materials
Anode materials
Cathode materials
Copper foil
Battery separator paper
Electrolyte
Cases and caps
Steel-can
Solvent NMP

  Main Suppliers
  Hubei Wanrun New Energy Technology Development Co., Ltd
  Luoyang Yuexing New Energy Technology Co., Ltd
  Wason Copper Foil Co., Ltd
  Shenzhen Huatengda Electronic Co., Ltd
  Xianghe Kunlun Chemicals Co., Ltd
  Taixin Zhengxing Electrom Co., Ltd
  Xinxiang Zhengyuan Electronic Material Co., Ltd
  MYJ Chemical Co., Ltd

We source our manufacturing equipment both locally and from overseas, based on their respective cost and function. Our key equipment as of December
31, 2020 was purchased from the following suppliers:  

Instruments
Charge and Discharge Equipment
Electrode Preparing Machine
Infusing Machine
Laser welding machine
Coating Machine
Vacuum Oven
Automatic Line Machine
Dehumidifier
Automatic Feeding System
Rolling

Intellectual Property

  Main Suppliers
  Zhejiang Hangke Technologies Co., Ltd
  Zhuhai Higrand Electronic Technology Inc.
  Kinlo Technology & System (Shenzhen) Co. Ltd
  United Winners Laser Co., Ltd
  Shenzhen Haoneng Technology Co., Ltd
  Wujiang Jiangling Equipment Co., Ltd
  Shenzhen Zhongji Automation Co., Ltd
  Hangzhou Dry Air Treatment Equipment Co., Ltd
  Shenzhen Jiewei Industrial Equipment Co., Ltd
  Xingtai HYLN Battery Equipment Co., Ltd

On August  25,  2014,  we  entered  into  an  intellectual  property  rights  use  agreement  with  Shenzhen  BAK,  pursuant  to  which  we  are  authorized  to  use
Shenzhen BAK’s registered logo, trademarks and patents obtained as of June 30, 2014 for a period of 5 years for free from June 30, 2014. As of June 30,
2014,  Shenzhen  BAK  had  registered  80  trademarks  in  the  PRC,  including  BAK  in  both  English  and  in  Chinese  characters  as  well  as  its  logo,  and  had
registered 49 trademarks in the United States, European Union, Korea, Russia, Taiwan, India, Canada and Hong Kong. As of June 30, 2014, Shenzhen
BAK had registered 522 patents in the PRC and other countries relating to battery cell materials, design and manufacturing processes. As of December 31,
2019, our intellectual property rights use agreement with Shenzhen BAK had expired, and we no longer have rights to use the foregoing trademarks and
patents of Shenzhen BAK. We believe that our proprietary patents, trademarks and other intellectual property rights are adequate to fulfill our operational
needs.

7

 
 
 
 
 
 
 
  
 
 
 
 
As of December 31, 2020, CBAK Power has 48 patents in the PRC, 20 of which will expire before 2025 while the remaining 28 will expire between 2026
to 2036. Two of these patents were acquired by BAK Asia, from an unrelated third party at RMB1 and were contributed as paid-in capital of CBAK Power.

We have registered the following Internet and WAP domain name: www.cbak.com.cn.

We  also  have  unpatented  proprietary  technologies  for  our  product  offerings  and  key  stages  of  the  manufacturing  process.  Our  management  and  key
technical personnel have entered into agreements requiring them to keep confidential all information relating to our customers, methods, business and trade
secrets during their terms of employment with us and thereafter and to assign to us their inventions, technologies and designs they develop during their
term of employment with us.

We have institutionalized our efforts to safeguard our intellectual property rights by establishing an internal department that includes professionals such as
attorneys,  engineers,  information  managers  and  archives  managers  responsible  for  handling  matters  relating  to  our  intellectual  property  rights.  We  have
published internally a series of rules to protect our intellectual property rights.

While our intellectual property rights in the aggregate are important to the operation of each of our businesses, we do not believe that our business would
be materially affected by the expiration of any particular intellectual property right.

Seasonality

According to the market demands, we usually experience seasonal peaks during the months of October to December for electric vehicle markets, during the
months of May to December for light electric markets, and March to December for UPS market. Also, at various times during the year, our inventories may
be increased in anticipation of increased demand for consumer electronics.

Customers

Our  current  major  customers  include  Viessmann  Faulquemont  S.A.S,  ShenZhen  ZTS  Technology,  Co.,  Ltd.  and  SolaX  Power.  We  believe  that  we  will
continue to increase our revenue and market share as we gradually increase our high-power batteries production as the demand for these batteries has been
increasing.

Geography of Sales

Before  June  30,  2014,  we  sold  our  products  domestically  and  internationally.  Thereafter,  we  sell  high-power  lithium  battery  primarily  to  customers  in
China. The following table sets forth certain information relating to our total revenues by location of our customers for the last two fiscal years:

Mainland China
Europe
Korea
Israel
USA
Others
Total

Fiscal Years ended

December 31, 2019

December 31, 2020

Amount

% of Net
Revenues

Amount

    % of Net
Revenues

(in thousands of U.S. dollars, except percentages)

21,632     
-     
-     
119     
286     
157     
22,194     

97.47    $
-     
-     
0.54     
1.29     
0.70     
100.00    $

35,464     
1,776     
246     
-     
4     
76     
37,566     

94.40 
4.73 
0.66 
- 
0.01 
0.20 
100.00 

  $

  $

8

 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
   
   
 
 
 
 
   
   
   
 
 
 
 
   
   
   
   
   
 
Competition

We face intense competition from high-power lithium battery makers in China, as well as in Korea and Japan for each of our product types. The following
table sets forth our major competitors for the EV market, LEV market and UPS market as of December 31, 2020:

Product Type
EV battery

LEV battery

UPS battery

Competitors
Japan:
Korea:

  Panasonic Corporation
  Samsung Electronics Co., Ltd

LG Chemical

China:

  Tianjin Lishen Battery Joint-stock Co., Ltd 

Contemporary Amperex Technology Co., Ltd 
Hefei Guoxuan Hi-Tech Power Energy Co., Ltd
China Aviation Lithium Battery Co., Ltd

China:

  Tianneng Power International Limited

Chaowei Power Holdings Limited
Phylion Battery Co., Ltd

China:

  Shandong Goldencell Electronics Technology Co., Ltd

DLG Power Battery (Shanghai) Co., Ltd
Dongguan Power Long Battery Technology Co., Limited

We  believe  that  we  are  able  to  leverage  our  low-cost  advantage  to  compete  favorably  with  our  competitors.  Compared  to  Korean  and  Japanese  battery
makers, we are able to source our needs for skilled labor and raw materials locally and economically. Compared to Chinese battery makers, we believe we
have higher consistency and safety in product quality, which enables us to compete favorably with local competitors.

Research and Development

The R&D of next-generation advanced lithium battery and its key materials – characterized by high energy density, high security, long-lasting life, and low
cost – as well as the training of related technical talents, have become a major demand in the development of advanced electric vehicles in China.

We have an advanced R&D center in Dalian, receiving almost all the R&D achievements, R&D equipment and staff of BAK Tianjin. BAK Tianjin began
its R&D manufacturing and distribution of high-power lithium battery and battery modules in December 2006, for use in electric cars, electric bicycles,
UPS, and other applications.

Regulatory Compliance

As  we  conduct  our  manufacturing  activities  in  China,  we  are  subject  to  the  requirements  of  PRC  environmental  laws  and  regulations  on  air  emission,
wastewater discharge, solid waste and noise. The major environmental regulations applicable to us include the PRC Environmental Protection Law, the
PRC Law on the Prevention and Control of Water Pollution and its Implementation Rules, the PRC Law on the Prevention and Control of Air Pollution and
its Implementation Rules, the PRC Law on the Prevention and Control of Solid Waste Pollution, and the PRC Law on the Prevention and Control of Noise
Pollution. We aim to comply with environmental laws and regulations. We have built environmental treatment facilities concurrently with the construction
of our manufacturing facilities, where waste air, waste water and waste solids we generate can be treated in accordance with the relevant requirements. We
outsource our disposal of solid waste we generate in the Dalian facility to a third-party contractor. Certain key materials used in manufacturing, such as
cobalt  dioxide,  electrolyte  and  separators,  have  proven  innocuous  to  worker’s  health  and  safety  as  well  as  the  environment.  We  are  not  subject  to  any
admonitions, penalties, investigations or inquiries imposed by the environmental regulators, nor are we subject to any claims or legal proceedings to which
we  are  named  as  a  defendant  for  violation  of  any  environmental  law  or  regulation.  We  do  not  have  any  reasonable  basis  to  believe  that  there  is  any
threatened  claim,  action  or  legal  proceedings  against  us  that  would  have  a  material  adverse  effect  on  our  business,  financial  condition  or  results  of
operations.

9

 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Employees

We had a total of approximately 537 employees as of December 31, 2020, all of whom are full-time employees. The following table sets forth the number
of our employees by function.

Function
Production
Research and development
Sales and marketing
General and administrative
Total

Number

409 
51 
13 
64 
537 

Our employees are not represented by a labor organization or covered by a collective bargaining agreement. We have not experienced any work stoppages.
We believe we maintain good relations with our employees. 

Available Information

We make available free of charge, on or through our website, http://www.cbak.com.cn, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-
Q, Current Reports on Form 8-K, and other filings pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and amendments to such
filings, as soon as reasonably practicable after each is electronically filed with, or furnished to, the SEC. The SEC maintains a website that contains our
reports,  proxy  and  information  statements,  and  our  other  SEC  filings.  The  address  of  the  SEC’s  website  is  www.sec.gov.  Information  appearing  on  our
website is not part of any report that we file with the SEC.

ITEM 1A. RISK FACTORS.

RISKS RELATED TO OUR BUSINESS

If the COVID-19 pandemic is not effectively controlled in a short period of time, our business operation and financial condition in the long-term may
be materially and adversely affected as a result of any slowdown in economic growth, operation disruptions or other factors that we cannot predict.

The spread of the novel coronavirus (“COVID-19”), which was declared a pandemic by the World Health Organization in March 2020, has caused different
countries and cities to mandate curfews, including “shelter-in-place” and closures of most non-essential businesses as well as other measures to mitigate the
spread of the virus. All of our operating subsidiaries are located in China. All of our employees and substantially all of our customers and suppliers are also
located in China. The pandemic caused disruptions to our operations during the first quarter of 2020 and our business and operations fully resumed during
the  second  quarter  of  2020.  Although  the  COVID-19  pandemic  has  caused  disruptions  to  our  operations,  it  has  had  limited  adverse  impacts  on  our
operating  results  for  the  fiscal  year  ended  December  31,  2020.  We  generated  revenues  of  $37.6  million  and  $22.2  million  for  the  fiscal  years  ended
December 31, 2020 and 2019, respectively. We had a net loss of $7.8 million and $10.9 million in the fiscal years ended December 31, 2020 and 2019,
respectively. However, the extent of the long-term adverse impact of COVID-19 on our business and operations is highly uncertain and depends on several
factors,  such  as  the  duration,  severity,  and  geographic  spread  of  the  pandemic,  development  of  the  testing  and  treatment  and  stimulus  measures  of  the
government, all of which are out of our control. 

Given the uncertainty of the outbreak, the spread of COVID-19 may be prolonged and worsened, and we may be forced to scale back or even suspend our
operations. As COVID-19 spreads outside China, the global economy is suffering a noticeable slowdown. As this outbreak persists, commercial activities
throughout the world have been curtailed with decreased consumer spending, business operation disruptions, interrupted supply chain, difficulties in travel
and reduced workforces. The duration and intensity of disruptions resulting from the COVID-19 outbreak is uncertain. It is unclear as to when the outbreak
will be contained, and we also cannot predict if the impact will be short-lived or long-lasting. The extent to which outbreak impacts our long-term financial
results will depend on its future developments. If the COVID-19 pandemic is not effectively controlled in a short period of time, our long-term business
operation and financial condition may be materially and adversely affected as a result of any slowdown in economic growth, operation disruptions or other
factors that we cannot predict.

10

 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
 
 
Our independent auditors have expressed substantial doubt about our ability to continue as a going concern.

Our independent auditors have added an explanatory paragraph to their audit opinion issued in connection with our financial statements included in this
annual report which states that the financial statements were prepared assuming that we would continue as a going concern. As discussed in Note 1 to the
consolidated  financial  statements  included  herein,  we  had  a  working  capital  deficiency,  accumulated  deficit  from  recurring  losses  and  short-term  debt
obligations as of December 31, 2020. These conditions raise substantial doubt about our ability to continue as a going concern. We plan to renew our bank
borrowings upon maturity and raise additional funds through bank borrowings and equity financing to meet our daily cash demands. However, there can be
no assurance that we will be successful in obtaining the financing. The audited consolidated financial statements included in this report do not include any
adjustments that might result from the outcome of this uncertainty.

There are inherent risks associated with new product development and our efforts to develop and market new products could fail.

In June 2020, our wholly-owned subsidiary, BAK Asia entered into a framework investment agreement with Gaochun EDZ, pursuant to which intend to
develop certain lithium battery projects which are expected to have a total production capacity of 8 GWh per year. We are currently developing certain new
products including model 32140 large-sized cylindrical “tabless” batteries and anticipate to complete the construction of a production line of model 32140
battery with the projected production capacity of 0.7 GWh per year in 2021. Model 32140 batteries can be used in light electric vehicles, electric vehicles,
electric tools and energy storage.

However, we cannot provide assurance that market acceptance of this new product will occur due to the highly competitive nature of the business. The
Company competes in the battery industry where there are frequent introductions of new products and line extensions and such product introductions often
require significant investment and support. The ability of the Company to understand end user needs and preferences is key to maintaining and improving
the competitiveness of its product offerings. The development and introduction of new products, as well as the renovation of current products and product
lines,  require  substantial  and  effective  research,  development  and  marketing  expenditures,  which  the  Company  may  be  unable  to  recoup  if  the  new  or
renovated products do not gain widespread market acceptance. There are inherent risks associated with new product development and marketing efforts,
including  product  development  or  launch  delays,  product  performance  issues  during  development,  changing  regulatory  frameworks  that  affect  the  new
products in development and the availability of key raw materials included in such products. These inherent risks could result in the failure of new products
and  product  line  extensions  to  achieve  anticipated  levels  of  market  acceptance,  additional  costs  resulting  from  failed  product  introductions  and  the
Company not being first to market. As the Company continues to focus on innovation and renovation of its products, the Company’s business, financial
condition  or  results  of  operations  could  be  adversely  affected  in  the  event  that  the  Company  is  not  able  to  effectively  develop  and  introduce  new  or
renovated products and line or brand extensions.

Our failure, if any, to keep up with rapid technological changes and evolving industry standards may cause our products to become obsolete and less
marketable, resulting in loss of market share to our competitors.

The lithium-based battery market is characterized by changing technologies and evolving industry standards, which are difficult to predict. This, coupled
with  frequent  introduction  of  new  products  and  models,  has  shortened  product  life  cycles  and  may  render  our  products  obsolete  or  unmarketable.  Our
ability to adapt to evolving industry standards and anticipate future standards will be a significant factor in maintaining and improving our competitive
position and our prospects for growth. To achieve this goal, we have invested and plan to continue investing significant financial resources in our R&D
infrastructure.  Currently,  we  have  a  facility  in  Dalian,  China,  which  has  about  80  engineers  and  over  4,000  square  meters  of  space  dedicated  to  R&D
activities.

R&D activities, however, are inherently uncertain, and we might encounter practical difficulties in commercializing our research results. Accordingly, our
significant investment in our R&D infrastructure may not bear fruit. On the other hand, our competitors may improve their technologies or even achieve
technological  breakthroughs  that  would  render  our  products  obsolete  or  less  marketable.  Therefore,  our  failure  to  effectively  keep  up  with  rapid
technological changes and evolving industry standards by introducing new and enhanced products may cause us to lose our market share and to suffer a
decrease in our revenue.

11

 
 
 
 
 
 
 
 
 
 
Our efforts to enter into the light electric vehicle business could fail.

On September 24, 2020, our wholly-owned Hong Kong subsidiary, BAK Investments entered into a framework investment agreement with Gaochun EDZ,
under which we intended to develop light electric vehicle projects. On November 9, 2020, we established our new subsidiary, Nanjing Daxin to launch and
develop our light electric vehicle business.

There  are  risks  and  uncertainties  associated  with  this  effort,  particularly  given  that  the  light  electric  vehicle  market  is  evolving.  In  developing  and
commercializing  this  new  line  of  business,  we  may  have  to  invest  significant  time  and  resources.  External  factors,  such  as  regulatory  compliance
obligations, competitive alternatives, lack of market acceptance and shifting market preferences, may also affect the successful implementation of this new
line of business. Failure to successfully plan for and manage these risks in the development and implementation of this new line of business could have a
material adverse effect on our business, financial condition and results of operations.

Maintaining our R&D activities and manufacturing operations require significant capital expenditures, and our inability or failure to maintain our
operations could have a material adverse impact on our market share and ability to generate revenue.

We incurred capital expenditures of approximately $2.5 million and $17.5 million for the years ended December 31, 2019 and 2020, respectively. We may
incur significant additional capital expenditures as a result of unanticipated expenses, regulatory changes and other events that impact our business. If we
are unable or fail to timely obtain capital on acceptable terms and adequately maintain our manufacturing capacity, we could lose customers and there could
be a material adverse impact on our market share and our ability to generate revenue.

We face intense competition from other battery manufacturers, many of which have significantly greater resources.

The market for batteries used in electric vehicles and light electric vehicles is intensely competitive and is characterized by frequent technological changes
and evolving industry standards. We expect competition to become more intense. Increased competition may result in declines in average selling prices,
causing a decrease in gross profit margins. We have faced and will continue to face competition from manufacturers of traditional rechargeable batteries,
such as lead-acid batteries other manufacturers of lithium-ion batteries, as well as from companies engaged in the development of batteries incorporating
new technologies. Other manufacturers of high-power lithium batteries currently include Panasonic Corporation, Samsung Electronics Co., Ltd., LG Chem,
Tianjin Lishen Battery Joint Stock Co., Ltd., Contemporary Amperex Technology Co., Limited, BYD Co. Ltd, Hefei Guoxuan Hi-Tech Power Energy Co.,
Ltd and Shandong Goldencell Electronics Technology Co., Ltd.

Many  of  these  existing  competitors  have  greater  financial,  personnel,  technical,  manufacturing,  marketing,  sales  and  other  resources  than  we  do.  As  a
result, these competitors may be in a stronger position to respond quickly to market opportunities, new or emerging technologies and evolving industry
standards. Many of our competitors are developing a variety of battery technologies, such as lithium polymer, prismatic cells and fuel cell batteries, which
are  expected  to  compete  with  our  existing  product  lines.  Other  companies  undertaking  R&D  activities  of  solid-polymer  lithium-ion  batteries  have
developed prototypes and are constructing commercial scale production facilities. It is possible that our competitors will be able to introduce new products
with more desirable features than ours and their new products will gain market acceptance. If our competitors successfully do so, we may not be able to
maintain our competitive position and our future success would be materially and adversely affected.

We are dependent on a limited number of customers for a significant portion of our revenues and this dependence is likely to continue.

We have been dependent on a limited number of customers for a significant portion of our revenue. Our top five customers accounted for approximately
79.45% and 77.59% of our revenues for the years ended December 31, 2020 and 2019, respectively. Dependence on a few customers could make it difficult
to  negotiate  attractive  prices  for  our  products  and  could  expose  us  to  the  risk  of  substantial  losses  if  a  single  dominant  customer  stops  purchasing  our
products.  We  expect  that  a  limited  number  of  customers  will  continue  to  contribute  a  significant  portion  of  our  sales  in  the  near  future.  Our  ability  to
maintain close relationships with these top customers is essential to the growth and profitability of our business. If we fail to sell our products to one or
more of these top customers in any particular period, or if a large customer purchases fewer of our products, defers orders or fails to place additional orders
with us, or if we fail to develop additional major customers, our revenue could decline, and our results of operations could be adversely affected. 

12

 
 
 
 
 
 
 
 
 
 
 
 
In  addition  to  our  own  production,  we  also  rely  on  a  few  battery  suppliers  to  fulfill  our  customers’  orders.  If  we  fail  to  effectively  manage  our
relationships with, or lose the services of these suppliers and we cannot substitute suitable alternative suppliers, our operations would be materially
adversely affected.

We generate part of our revenues by outsourcing some of our customers’ orders to Zhengzhou BAK New Energy Vehicle Co., Ltd (“BAK New Energy”),
Shenzhen  BAK  Battery  Co.,  Ltd  (“Shenzhen  BAK”)  and  a  few  other  suppliers  for  certain  battery  models  that  we  do  not  produce.  If  our  business
relationship  with  BAK  New  Energy,  Shenzhen  BAK  and  other  suppliers  changes  negatively  or  their  financial  condition  deteriorates,  or  their  operating
environment changes, our business may be harmed in many ways. BAK New Energy, Shenzhen BAK and other suppliers may also unilaterally terminate
battery supply to us or increase the prices. As a result, we are not assured of an uninterrupted supply of certain types of high-power lithium batteries of
acceptable quality or at acceptable prices from BAK New Energy, Shenzhen BAK or other suppliers. On the other hand, we may not be able to substitute
them with suitable alternative contract manufacturers in a timely manner on commercially acceptable term or at all. We may be forced to default on the
agreements with our customers. This may negatively impact our revenues and adversely affect our reputation and relationships with our customers, causing
a material adverse effect on our financial condition, results of operations and prospects.

Our business depends on the growth in demand for light electric vehicles, electric vehicles, electric tools, energy storage, such as UPS application, and
other high-power electric devices.

As the demand for our battery products is directly related to the market demand for high-power electric devices, a fast-growing high-power electric devices
market will be critical to the success of our business. In anticipation of an expected increase in the demand for high-power electric devices such as electric
vehicles,  light  electric  vehicles,  electric  tools,  and  energy  storage  including  UPS  application  in  the  next  few  years,  we  are  building  new  manufacturing
facilities in Nanjing. However, the markets we have targeted, primarily those in the PRC, may not achieve the level of growth we expect. If this market
fails  to  achieve  our  expected  level  of  growth,  we  may  have  excess  production  capacity  and  may  not  be  able  to  generate  enough  revenue  to  obtain  our
profitability.

Our success, in part, depends on the success of manufacturers of the end applications that use our products, and our failure to gain acceptance of our
products from such manufacturers could materially and adversely affect our results of operations and profitability.

As we target the battery markets for light electric vehicles, electric vehicles, electric tools, energy storage including but not limited to UPS application, and
other high-power electric devices, our future success in part depends on whether end-application manufacturers are willing to use batteries that incorporate
our products. To secure acceptance of our products, we must constantly develop and introduce more reliable and cost-effective battery cells with enhanced
functionality to meet evolving industry standards. Our failure to gain acceptance of our products from these manufacturers could materially and adversely
affect our future success. From 2017 to 2019, our electric vehicle customers included Dongfeng Autos, Dayun Motor and Yema Auto. Since then, however,
our  sales  to  electric  vehicle  customers  have  decreased  significantly  and  we  only  generated  approximately  $0.3  million  revenues  from  electric  vehicle
customers in 2020.

Even if a manufacturer decides to use batteries that incorporate our products, the manufacturer may not be able to market and sell its products successfully.
The  manufacturer’s  inability  to  market  and  sell  its  products  successfully,  whether  from  lack  of  market  acceptance  or  otherwise,  could  materially  and
adversely affect our business and prospects because this manufacturer may not order new products from us. If we cannot achieve the expected level of
sales, we will not be able to make sufficient profits to offset the expenditures we have incurred to expand our production capacity, nor will we be able to
grow our business. Accordingly, our business, financial condition, results of operations and future success would be materially and adversely affected.

We are subject to declining average selling prices of the end applications that may use our products, which may harm our revenue and gross profits.

The end applications that may incorporate our products such as light electric vehicles, electric vehicles, electric tools, and energy storage including but not
limited  to  UPS  application  are  subject  to  declines  in  average  selling  prices  due  to  rapidly  evolving  technologies,  industry  standards  and  consumer
preferences. As a result, manufacturers of these electronic devices expect us as suppliers to cut our costs and lower the price of our products in order to
mitigate the negative impact on their own margins. We have reduced the price of some of our electric bike batteries in the past in order to meet market
demand and expect to continue to face market-driven downward pricing pressures in the future. Our revenue and profitability will suffer if we are unable to
offset any declines in our average selling prices by developing new or enhanced products with higher selling prices or gross profit margins, increasing our
sales volumes or reducing our costs on a timely basis.

13

 
 
 
 
 
 
 
 
 
 
 
We extend relatively long payment terms to some large customers.

As is customary in our industry in the PRC, we extend relatively long payment terms to some large customers. In 2020, it generally took 90 days for us to
collect payments from our major customers. Due to the large size of many of our orders, these extended terms may adversely affect our cash flow and our
ability to fund our operations out of our operating cash flows.

While our revenue grew by $15.4 million, or 69% for the year ended December 31, 2020 compared to the prior year, our trade accounts and bills receivable
increased by $21.6 million, or 272% as of December 31, 2020 compared to that as of December 31, 2019. Although we attempt to establish appropriate
reserves for our receivables, those reserves may not prove to be adequate in view of large amounts of accounts receivable and actual levels of bad debts.
The failure of our customers to pay us timely would negatively affect our working capital, which could in turn adversely affect our cash flows.

Our customers often place large orders for products, requiring fast delivery, which impacts our working capital. If our customers do not incorporate our
products into their products and sell them in a timely fashion, for example, due to excess inventories, sales slowdowns or other issues, they may not pay us
in a timely fashion, even on our extended terms. Our customers’ failure to pay may force us to defer or delay further product orders, which may adversely
affect our cash flows, sales or income in subsequent periods.

We may not be able to accurately plan our production based on our sales contracts, which may result in excess product inventory or product shortages.

Our sales contracts typically provide for a non-binding, three-month forecast on the quantity of products that our customers may purchase from us. We
typically have only a 15-day to 30-day lead time to manufacture products to meet our customers’ requirements once our customers place orders with us. To
meet the short delivery deadline, we generally make significant decisions on our production level and timing, procurement, facility requirements, personnel
needs and other resources requirements based on our estimate in light of this forecast, our past dealings with such customers, market conditions and other
relevant factors. Our customers’ final purchase orders may not be consistent with our estimates. If the final purchase orders substantially differ from our
estimates,  we  may  have  excess  product  inventory  or  product  shortages.  Excess  product  inventory  could  result  in  unprofitable  sales  or  write-offs  as  our
products are susceptible to obsolescence and price declines. Producing additional products to make up for any product shortages within a short time frame
may be difficult, making us unable to fill out the purchase orders. In either case, our results of operation would fluctuate from period to period.

We may not be able to substantially increase our manufacturing output in order to maintain our cost competitiveness.

We believe that our ability to provide cost-effective products is one of the most significant factors that contributed to our past success and will be essential
for  our  future  growth.  We  believe  this  is  one  of  our  competitive  advantages  over  our  Japanese  and  Korean  competitors.  We  need  to  increase  our
manufacturing output to a level that will enable us to substantially reduce the cost of our products on a per unit basis through economies of scale. However,
our ability to substantially increase our manufacturing output is subject to significant constraints and uncertainties, including:

● the need to raise significant additional funds to purchase and prepay raw materials or to build additional manufacturing facilities, which we may

be unable to obtain on reasonable terms or at all;

● delays and cost overruns as a result of a number of factors, many of which may be beyond our control, such as increases in raw material prices and

problems with equipment vendors;

● delays or denial of required approvals by relevant government authorities;

● diversion of significant management attention and other resources; and

● failure to execute our expansion plan effectively.

14

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If we are unable to increase our manufacturing output because of any of the risks described above, we may be unable to maintain our competitive position
or achieve the growth we expect. Moreover, even if we expand our manufacturing output, we may not be able to generate sufficient customer demand for
our products to support our increased production output.

We may incur significant costs because of the warranties we supply with our products and services.

With respect to the sale of our battery products, we typically offer warranties against any defects due to product malfunction or workmanship for a period
of six months-to-eight years from the date of purchase, including a period of six to twenty-four months for battery cells, and a period of twelve to twenty-
seven months for battery modules for electric bicycles, and a period of three years to eight years (or 120,000 or 200,000 km if reached sooner) for battery
modules for electric vehicles. We provide a reserve for these potential warranty expenses, which is based on an analysis of historical warranty issues. There
is  no  assurance  that  future  warranty  claims  will  be  consistent  with  past  history,  and  in  the  event  that  we  experience  a  significant  increase  in  warranty
claims, there is no assurance that our reserves will be sufficient. This could have a material adverse effect on our business, financial condition and results of
operations.

We do not have insurance coverage against damages or losses of our products. Defects in our products could result in a loss of customers and decrease
in revenue, unexpected expenses and a loss of market share.

We have not purchased product liability insurance to provide against any claims against us based on our product quality. As a result, defects in our products
could result in a loss of customers and decrease in revenue, unexpected expenses and a loss of market share, and any of our products are found to have
reliability, quality or compatibility problems, we will be required to accept returns, provide replacements, provide refunds, or pay damages. We may be
required  to  incur  substantial  amounts  to  indemnify  our  customers  in  respect  of  their  product  quality  claims  against  us,  which  would  materially  and
adversely affect the results of our operations and severely damage our reputation. 

We do not have insurance coverage against all the damages or losses of our facilities.

We  currently  have  insurance  coverage  for  certain  pledged  machinery  and  equipment  and  pledged  buildings  located  at  our  facilities.  We  expect  we  will
purchase related insurance for the remaining buildings when we obtain their property ownership certificates. If we were to suffer any losses or damages to
any of the facilities before the purchase of insurance policies that provide adequate coverage, our business, financial condition and results of operations
may be materially and adversely affected.

We  depend  on  third  parties  to  supply  key  raw  materials  and  components  to  us.  Failure  to  obtain  a  sufficient  supply  of  these  raw  materials  and
components in a timely fashion and at reasonable costs could significantly delay our production and shipments, which would cause us to breach our
sales contracts with our customers.

We purchase from Chinese domestic suppliers for certain key raw materials and components such as electrolytes, electrode materials and separators. We
have purchased raw materials and components on the basis of purchase orders. In the absence of firm and long-term contracts, we may not be able to obtain
a sufficient supply of these raw materials and components from our existing suppliers or alternates in a timely fashion or at a reasonable cost. If we fail to
secure a sufficient supply of key raw materials and components in a timely fashion, it would result in a significant delay in our production and shipments,
which  may  cause  us  to  breach  our  sales  contracts  with  our  customers.  Furthermore,  failure  to  obtain  sufficient  supply  of  these  raw  materials  and
components at a reasonable cost could also harm our revenue and gross profit margins.

Fluctuations  in  prices  and  availability  of  raw  materials,  particularly  Ni,  Co,  Mn,  Li2CO3,  LiPF6  and  LiFePO4,  could  increase  our  costs  or  cause
delays in shipments, which would adversely impact our business and results of operations.

Our  operating  results  could  be  adversely  affected  by  increases  in  the  cost  of  raw  materials,  particularly  Ni,  Co,  Mn,  Li2CO3,  LiPF6  and  LiFePO4,  the
primary cost component of our battery products, or other product parts or components. The price of Ni, Co, Mn, Li2CO3, LiPF6 and LiFePO4 is not stable.
If the price increases, it will negatively impact our financial results in years ahead. We historically have not been able to fully offset the effects of higher
costs of raw materials through price increases to customers or by way of productivity improvements. As a result, a significant increase in the price of one or
more raw materials, parts or components or the inability to successfully implement price increases/ surcharges to mitigate such cost increases could have a
material adverse effect on our results of operations.

15

 
 
 
 
 
 
 
 
 
 
 
 
 
We experience fluctuations in quarterly and annual operating results.

Our quarterly and annual operating results have fluctuated in the past and likely will fluctuate in the future. The demand for our products is driven largely
by  the  demand  for  the  end-product  applications  that  are  powered  by  our  products.  Accordingly,  the  rechargeable  battery  industry  is  affected  by  market
conditions  that  are  often  outside  our  control.  Our  results  of  operations  may  fluctuate  significantly  from  period  to  period  due  to  a  number  of  factors,
including seasonal variations in customers’ demand for batteries and their end applications, capacity ramp up by competitors, industry-wide technological
changes, the loss of a key customer and the postponement, rescheduling or cancellation of large orders by a key customer. As a result of these factors and
other risks discussed in this section, period-to-period comparisons should not be relied upon to predict our future performance.

We do not have long-term purchase commitments from our customers, which may result in significant uncertainties and volatility with respect to our
revenue from period to period.

We do not have long-term purchase commitments from our customers and the term of our sales contracts with our customers is typically one year or less.
Furthermore, these contracts leave certain major terms such as price and quantity of products open to be determined in each purchase order. These contracts
also allow parties to re-adjust the contract price for substantial changes in market conditions. As a result, if our customers hold stronger bargaining power
than us or the market conditions are in their favor, we may not be able to enjoy the price downside protection or upside gain. Furthermore, our customers
may decide not to continue placing purchase orders with us in the future at the same level as in prior periods. As a result, our results of operations may vary
from period to period and may fluctuate significantly in the future.

We  face  risks  associated  with  the  marketing,  distribution  and  sale  of  our  products  internationally,  and  if  we  are  unable  to  effectively  manage  these
risks, they could impair our ability to expand our business abroad.

For the years ended December 31, 2020 and 2019, we derived 5.6% and 2.5%, respectively, of our sales from outside the PRC mainland. We still deem
overseas market as an important revenue source for us, and have been actively exploring overseas customers. The marketing, international distribution and
sale of our products expose us to a number of risks, including:

● fluctuations in currency exchange rates;

● difficulty in engaging and retaining distributors that are knowledgeable about, and can function effectively in, overseas markets;

● increased costs associated with maintaining marketing efforts in various countries;

● difficulty and  cost  relating  to  compliance  with  the  different  commercial  and  legal  requirements  of  the  overseas  markets  in  which  we  offer  our

products;

● inability to obtain, maintain or enforce intellectual property rights; and

● trade barriers such as export requirements, tariffs, taxes and other restrictions and expenses, which could increase the prices of our products and

make us less competitive in some countries.

Our  business  depends  substantially  on  the  continuing  efforts  of  our  senior  executives  and  other  key  personnel,  and  our  business  may  be  severely
disrupted if we lost their services.

Our future success heavily depends on the continued service of our senior executives and other key employees. In particular, we rely on the expertise and
experience of our Chairman, Chief Executive Officer, President Mr. Yunfei Li and our Interim Chief Financial Officer, Ms. Xiangyu Pei. If one or more of
our  other  senior  executives  are  unable  or  unwilling  to  continue  to  work  for  us  in  their  present  positions,  we  may  encounter  similar  problems,  but  on  a
compounded basis. Moreover, if any of our current or former senior executives joins a competitor or forms a competing company, we may lose customers,
suppliers,  know-how  and  key  personnel.  Each  of  our  executive  officers  has  entered  into  an  employment  agreement  with  us,  which  contains  non-
competition and confidentiality clauses. However, if any dispute arises between our current or former executive officers and the Company, it is hard to
predict the extent to which any of these agreements could be enforced in China, where these executive officers reside, in light of the uncertainties with
China’s legal system.

16

 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
We have experienced significant management changes which could increase our control risks and have a material adverse effect on our ability to do
business and our results of operations.

Since 2009, we have had a number of changes in our senior management, including multiple changes in our Chief Financial Officer. The magnitude of
these past and potential changes and the short time interval in which they have occurred or may occur, particularly during a time of economic or financial
crisis,  add  to  the  risks  of  control  failures,  including  a  failure  in  the  effective  operation  of  our  internal  control  over  financial  reporting  or  our  disclosure
controls and procedures. Control failures could result in material adverse effects on our financial condition and results of operations. It may take time for
the new management team to become sufficiently familiar with our business and each other to effectively develop and implement our business strategies.
The turnover of key management positions could further harm our financial performance and results of operations. Management attention may be diverted
from regular business concerns by reorganizations.

We have identified material weaknesses in our internal control over financial reporting. If we fail to remediate the material weaknesses or maintain an
effective system of internal control over financial reporting, we may be unable to accurately report our financial results or prevent fraud, and investor
confidence and the market price of our shares may be adversely affected.

To  implement  Section  404  of  the  Sarbanes-Oxley  Act  of  2002,  or  SOX  404,  the  SEC  adopted  rules  requiring  public  companies  to  include  a  report  of
management  on  the  company’s  internal  control  over  financial  reporting  in  their  annual  reports  on  Form  10-K.  Under  current  law,  we  are  subject  to  the
requirement that we maintain internal controls and that management perform periodic evaluation of the effectiveness of the internal controls, assuming our
filing status remains as a smaller reporting company. A report of our management is included under Item 9A of this annual report. Our management has
identified the following material weakness in our internal control over financial reporting: we did not have appropriate policies and procedures in place to
evaluate the proper accounting and disclosures of key documents and agreements, and there was insufficient accounting personnel with an appropriate level
of technical accounting knowledge and experience in the application of accounting principles generally accepted in the United States of America, or U.S.
GAAP, commensurate with our financial reporting requirements. A “material weakness” is a deficiency, or a combination of deficiencies, in internal control
over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will
not be prevented or detected on a timely basis. We have taken measures and plan to continue to take measures to remedy this material weakness. Since
September  2016,  we  have  regularly  offered  our  financial  personnel  trainings  on  internal  control  and  risk  management.  Since  November  2016,  we  have
regularly provided trainings to our financial personnel on U.S. GAAP accounting guidelines. However, the implementation of these measures may not fully
address the material weakness in our internal control over financial reporting. Our failure to address any control deficiency could result in inaccuracies in
our financial statements and could also impair our ability to comply with applicable financial reporting requirements and related regulatory filings on a
timely basis. Moreover, effective internal control over financial reporting is important to prevent fraud. As a result, our business, financial condition, results
of operations and prospects, as well as the trading price of our shares, may be materially and adversely affected.

Our auditors, based in Hong Kong, China, like other independent registered public accounting firms operating in China and to the extent their audit
clients have operations in China, is not permitted to be subject to full inspection by the Public Company Accounting Oversight Board and, as such, you
may be deprived of the benefits of such inspection. In addition, as a result of the enactment of the Holding Foreign Companies Accountable Act, we
could be delisted if we were unable to cure the situation to meet the PCAOB inspection requirement in time.

Our independent registered public accounting firms that issued the audit reports included in our annual reports filed with the SEC, as auditors of companies
that are traded publicly in the United States and a firm registered with the US Public Company Accounting Oversight Board (United States), or PCAOB,
are required by the laws of the United States to undergo regular inspections by the PCAOB to assess their compliance with the laws of the United States
and professional standards. However, our operations are solely located in the PRC, a jurisdiction where PCAOB is currently unable to conduct inspections
without the approval of the PRC authorities. Our independent registered public accounting firm, like others operating in China (and Hong Kong, to the
extent  their  audit  clients  have  operations  in  China),  is  currently  not  subject  to  inspection  conducted  by  the  PCAOB.  Inspections  of  other  firms  that  the
PCAOB has conducted outside China have identified deficiencies in those firms’ audit procedures and quality control procedures, which may be addressed
as part of the inspection process to improve future audit quality. The inability of the PCAOB to conduct full inspections of auditors operating in China
makes it more difficult to evaluate our auditors’ audit procedures or quality control procedures. As a result, investors may be deprived of the benefits of
PCAOB inspections.

17

 
 
 
 
 
 
 
 
In  December  2012,  the  SEC  instituted  proceedings  under  Rule  102(e)(1)(iii)  of  the  SEC’s  Rules  of  Practice  against  five  PRC-based  accounting  firms,
alleging that these firms had violated U.S. securities laws and the SEC’s rules and regulations thereunder by failing to provide to the SEC the firms’ work
papers  related  to  their  audits  of  certain  PRC-based  companies  that  are  publicly  traded  in  the  United  States.  Rule  102(e)(1)(iii)  grants  to  the  SEC  the
authority to deny to any person, temporarily or permanently, the ability to practice before the SEC who is found by the SEC, after notice and opportunity
for a hearing, to have willfully violated, or willfully aided and abetted the violation of, any such laws or rules and regulations. On January 22, 2014, an
initial administrative law decision was issued, sanctioning four of these accounting firms and suspending them from practicing before the SEC for a period
of  six  months. The  sanction  will  not  take  effect  until  there  is  an  order  of  effectiveness  issued  by  the  SEC.  In  February  2014,  four  of  these  PRC-based
accounting firms filed a petition for review of the initial decision. In February 2015, each of these four accounting firms agreed to a censure and to pay fine
to the SEC to settle the dispute with the SEC. The settlement stays the current proceeding for four years, during which time the firms are required to follow
detailed procedures to seek to provide the SEC with access to Chinese firms’ audit documents via the CSRC. If a firm does not follow the procedures, the
SEC  would  impose  penalties  such  as  suspensions,  or  commence  a  new,  expedited  administrative  proceeding  against  the  non-compliant  firm  or  it  could
restart the administrative proceeding against all four firms. The four-year mark occurred on February 6, 2019.

As  part  of  a  continued  regulatory  focus  in  the  United  States  on  access  to  audit  and  other  information  currently  protected  by  national  law,  in  particular
China’s, on December 18, 2020, the Holding Foreign Companies Accountable Act was signed into law. This act amends the Sarbanes-Oxley Act of 2002 to
direct the SEC to prohibit securities of any registrant from being listed on any of the U.S. securities exchanges or traded “over-the-counter” if the auditor of
the registrant’s financial statements is not subject to PCAOB inspection for three consecutive years after the law becomes effective. On March 24, 2021,
SEC announced it has adopted interim final amendments to implement congressionally mandated submission and disclosure requirements of the Act. The
interim final amendments will apply to registrants that the SEC identifies as having filed an annual report on Forms 10-K, 20-F, 40-F or N-CSR with an
audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that the PCAOB has determined it is unable to inspect
or investigate completely because of a position taken by an authority in that jurisdiction. As a result, we could be delisted if we are unable to cure the
situation to meet the PCAOB inspection requirement in time. 

We may be adversely affected by the outcome of litigation against us in China.

As described in detail under Note 23 (ii) to our audited consolidated financial statements included in this report, in recent years, we have been subject to an
array of lawsuits in China, most of which arose out of failure to make timely payments pursuant to contracts with our suppliers, vendors or contractors. As
a result, we and our Chief Executive Officer, Yunfei Li, are subject to court orders restricting high spending. Such orders, among others, prohibit us from
investing in or building high-end properties but allow us to construct production facilities.

We believe that some of plaintiffs’ claims in the above lawsuits are without merit and we are vigorously defending ourselves. There is no assurance that we
will  be  successful  in  the  lawsuits.  In  the  event  that  plaintiffs  prevail  in  the  lawsuit,  unfavorable  court  judgment  could  have  an  adverse  effect  on  our
business, financial condition and results of operations.

RISKS RELATED TO DOING BUSINESS IN CHINA

Changes in the economic and political policies of the PRC government could have a material and adverse effect on our business and operations.

We conduct substantially all our business operations in China. Accordingly, our results of operations, financial condition and prospects are significantly
dependent  on  economic  and  political  developments  in  China.  China’s  economy  differs  from  the  economies  of  developed  countries  in  many  aspects,
including  the  level  of  development,  growth  rate  and  degree  of  government  control  over  foreign  exchange  and  allocation  of  resources.  While  China’s
economy  has  experienced  significant  growth  in  the  past  30  years,  the  growth  has  been  uneven  across  different  regions  and  periods  and  among  various
economic sectors in China. We cannot assure you that China’s economy will continue to grow, or that if there is growth, such growth will be steady and
uniform, or that if there is a slowdown, such slowdown will not have a negative effect on its business and results of operations.

The  PRC  government  exercises  significant  control  over  China’s  economic  growth  through  the  allocation  of  resources,  control  over  payment  of  foreign
currency-denominated obligations, implementation of monetary policy, and preferential treatment of particular industries or companies. Certain measures
adopted by the PRC government may restrict loans to certain industries, such as changes in the statutory deposit reserve ratio and lending guidelines for
commercial banks by the People’s Bank of China, or PBOC. These current and future government actions could materially affect our liquidity, access to
capital, and ability to operate our business.

18

 
 
 
 
 
 
  
 
 
 
 
The  global  financial  markets  experienced  significant  disruptions  in  2008  and  the  United  States,  Europe  and  other  economies  went  into  recession.  Since
2012,  growth  of  the  Chinese  economy  has  slowed  down.  The  PRC  government  has  implemented  various  measures  to  encourage  economic  growth  and
guide the allocation of resources. Some of these measures may benefit the overall PRC economy but may also have a negative effect on us. Our financial
condition and results of operation could be materially and adversely affected by government control over capital investments or changes in tax regulations
that  are  applicable  to  us.  In  addition,  any  stimulus  measures  designed  to  boost  the  Chinese  economy,  may  contribute  to  higher  inflation,  which  could
adversely affect our results of operations and financial condition.

Uncertainties with respect to the PRC legal system could limit the legal protections available to you and us.

We  conduct  substantially  all  of  our  business  through  our  operating  subsidiaries  in  China.  Our  operating  subsidiaries  are  generally  subject  to  laws  and
regulations applicable to foreign investments in China and, in particular, laws applicable to foreign-invested enterprises, or FIEs. The PRC legal system is
based on written statutes, and prior court decisions may be cited for reference, but have limited precedential value. Since 1979, a series of new PRC laws
and  regulations  have  significantly  enhanced  the  protections  afforded  to  various  forms  of  foreign  investments  in  China.  However,  since  the  PRC  legal
system  continues  to  rapidly  evolve,  the  interpretations  of  many  laws,  regulations  and  rules  are  not  always  uniform  and  enforcement  of  these  laws,
regulations and rules involve uncertainties for you and us. In addition, any litigation in China may be protracted and result in substantial costs and diversion
of resources and management attention. Moreover, most of our executive officers and directors are residents of China and not of the United States, and
substantially all the assets of these persons are located outside the United States. As a result, it could be difficult for investors to affect service of process in
the United States or to enforce a judgment obtained in the United States against our Chinese operations and subsidiaries.

The PRC government exerts substantial influence over the manner in which we must conduct our business activities.

The PRC government has exercised and continues to exercise substantial control over virtually every sector of the Chinese economy through regulation and
state ownership. Our ability to operate in China may be harmed by changes in its laws and regulations, including those relating to taxation, import and
export tariffs, environmental regulations, land use rights, property, and other matters. We believe that our operations in China are in material compliance
with all applicable legal and regulatory requirements. However, the central or local governments of the jurisdictions in which we operate may impose new,
stricter regulations or interpretations of existing regulations that would require additional expenditures and efforts on our part to ensure our compliance
with such regulations or interpretations.

Accordingly, government actions in the future, including any decision not to continue to support recent economic reforms and to return to a more centrally
planned  economy  or  regional  or  local  variations  in  the  implementation  of  economic  policies,  could  have  a  significant  effect  on  economic  conditions  in
China or particular regions thereof and could require us to divest ourselves of any interest we then hold in Chinese properties or joint ventures.

We rely on dividends and other distributions on equity paid by our subsidiaries for our cash needs.

We are a holding company, and we conduct all of our operations through our PRC subsidiaries. We rely on dividends and other distributions on equity paid
by our PRC subsidiaries for our cash needs, including the funds necessary to pay dividends and other cash distributions to our stockholders, to service any
debt  we  may  incur  and  to  pay  our  operating  expenses.  Current  regulations  in  the  PRC  permit  payment  of  dividends  only  out  of  accumulated  profits  as
determined in accordance with PRC accounting standards and regulations. According to the articles of association of our PRC subsidiaries, each of our
PRC subsidiaries is required to set aside at least 10% of its after-tax profit based on the PRC accounting standards and regulations each year to its statutory
general reserve, until the balance in the reserve reaches 50% of the registered capital of the company. Funds in the reserve are not distributable to us in
forms of cash dividends, loans or advances. In addition, if our PRC subsidiaries incur debt on their own behalf in the future, the instruments governing the
debt may restrict their ability to pay dividends or make other distributions to us, which in turn will adversely affect our available cash. Any limitations on
the ability of our PRC subsidiaries to transfer funds to us could materially and adversely limit our ability to grow, make investments or acquisitions that
could be beneficial to our business, pay dividends and otherwise fund and conduct our business.

19

 
 
 
 
 
 
 
 
 
 
Restrictions on currency exchange may limit our ability to receive and use our sales revenue effectively.

The majority of our sales will be settled in RMB, and any future restrictions on currency exchanges may limit our ability to use revenue generated in RMB
to fund any future business activities outside China or to make dividend or other payments in U.S. dollars. Although the Chinese government introduced
regulations in 1996 to allow greater convertibility of the RMB for current account transactions, significant restrictions still remain, including primarily the
restriction that foreign-invested enterprises may only buy, sell or remit foreign currencies after providing valid commercial documents, at those banks in
China authorized to conduct foreign exchange business. In addition, conversion of RMB for capital account items, including direct investment and loans, is
subject to governmental approval in China, and companies are required to open and maintain separate foreign exchange accounts for capital account items.
We cannot be certain that the Chinese regulatory authorities will not impose more stringent restrictions on the convertibility of the RMB in the future.

Fluctuations in exchange rates could adversely affect our business and the value of our securities.

The value of our securities will be indirectly affected by the foreign exchange rate between the U.S. dollar and RMB and between those currencies and
other currencies in which our sales may be denominated. Appreciation or depreciation in the value of the RMB relative to the U.S. dollar would affect our
financial results reported in U.S. dollar terms without giving effect to any underlying change in our business or results of operations. Fluctuations in the
exchange rate will also affect the relative value of any dividend we issue that will be exchanged into U.S. dollars, as well as earnings from, and the value
of, any U.S. dollar-denominated investments we make in the future.

Very  limited  hedging  transactions  are  available  in  China  to  reduce  our  exposure  to  exchange  rate  fluctuations.  To  date,  we  have  not  entered  into  any
hedging transactions. While we may enter into hedging transactions in the future, the availability and effectiveness of these transactions may be limited,
and we may not be able to successfully hedge our exposure at all. In addition, our foreign currency exchange losses may be magnified by PRC exchange
control regulations that restrict our ability to convert RMB into foreign currencies. As a result, fluctuations in exchange rates may have a material adverse
effect on your investment.

Failure  to  comply  with  PRC  regulations  relating  to  the  investment  in  offshore  special  purpose  companies  by  PRC  residents  may  subject  our  PRC
resident  stockholders  to  personal  liability,  limit  our  ability  to  acquire  PRC  companies  or  to  inject  capital  into  our  PRC  subsidiaries,  limit  our  PRC
subsidiaries’ ability to distribute profits to us or otherwise materially adversely affect us.

On  July  14,  2014,  SAFE  issued  the  Circular  on  Relevant  Issues  Relating  to  Domestic  Residents’  Investment  and  Financing  and  Roundtrip  Investment
through Special Purpose Vehicles (“Circular 37”), which replaced the Circular 75, promulgated by SAFE on October 21, 2005. Circular 37 requires PRC
residents to register with local branches of SAFE in connection with their direct establishment or indirect control of an offshore entity, for the purpose of
overseas investment and financing, with such PRC residents’ legally owned assets or equity interests in domestic enterprises or offshore assets or interests,
referred to in Circular 37 as a “special purpose vehicle.”

We have notified substantial beneficial owners of our company who we know are PRC residents to comply with the registration obligation. However, we
may not be aware of the identities of all our beneficial owners who are PRC residents. In addition, we do not have control over our beneficial owners and
cannot assure you that all of our PRC resident beneficial owners will comply with Circular 37. The failure of our beneficial owners who are PRC residents
to register or amend their SAFE registrations in a timely manner pursuant to Circular 37 or the failure of future beneficial owners of our company who are
PRC residents to comply with the registration procedures set forth in Circular 37 may subject such beneficial owners or our PRC subsidiaries to fines and
legal sanctions. Failure to register or amend the registration may also limit our ability to contribute additional capital to our PRC subsidiaries or receive
dividends or other distributions from our PRC subsidiaries or other proceeds from disposal of our PRC subsidiaries, or we may be penalized by SAFE.
These risks may have a material adverse effect on our business, financial condition and results of operations.

20

 
 
 
 
 
 
 
 
 
 
The  M&A  Rule  establishes  more  complex  procedures  for  some  acquisitions  of  Chinese  companies  by  foreign  investors,  which  could  make  it  more
difficult for us to pursue growth through acquisitions in China.

On August 8, 2006, six PRC regulatory agencies, including the China Securities Regulatory Commission, promulgated the Provisions Regarding Mergers
and  Acquisitions  of  Domestic  Enterprises  by  Foreign  Investors,  or  the  M&A  Rule,  which  became  effective  on  September  8,  2006.  The  M&A  Rule
establishes additional procedures and requirements that could make some acquisitions of Chinese companies by foreign investors more time-consuming
and complex, including requirements in some instances that the PRC Ministry of Commerce be notified in advance of any change-of-control transaction
and in some situations, require approval of the PRC Ministry of Commerce when a foreign investor takes control of a Chinese domestic enterprise. The
regulations prohibit a transaction at an acquisition price obviously lower than the appraised value of the PRC business or assets and in certain transaction
structures,  require  that  consideration  must  be  paid  within  defined  periods,  generally  not  in  excess  of  a  year.  The  regulation  also  limits  our  ability  to
negotiate  various  terms  of  the  acquisition,  including  aspects  of  the  initial  consideration,  contingent  consideration,  holdback  provisions,  indemnification
provisions and provisions relating to the assumption and allocation of assets and liabilities. Transaction structures involving trusts, nominees and similar
entities  are  prohibited.  Government  approvals  will  have  expiration  dates  by  which  a  transaction  must  be  completed  and  reported  to  the  government
agencies. In the future, we may grow our business in part by acquiring complementary businesses, although we do not have any plans to do so at this time.
The  M&A  Rule  also  requires  PRC  Ministry  of  Commerce  anti-trust  review  of  any  change-of-control  transactions  involving  certain  types  of  foreign
acquirers. On February 3, 2011, the Circular on Establishing the Security Review System for Merger and Acquisition of Domestic Enterprises by Foreign
Investors  was  promulgated  by  the  General  Office  of  the  State  Council,  which  went  into  effect  on  March  4,  2011.  On  August  25,  2011,  the  Ministry  of
Commerce issued the corresponding implementation rules. According to these rules, a foreign investor’s acquisitions of Chinese companies in the fields of
military, important agricultural products, energy and resources, infrastructure, transport service, key technology and major equipment manufacturing, and
other  restricted  fields  requires  security  review  by  a  ministerial  panel  established  and  governed  under  the  direction  of  the  State  Council  and  led  by  the
National  Development  and  Reform  Commission  and  Ministry  of  Commerce.  Complying  with  the  requirements  of  the  M&A  Rule  to  complete  such
transactions could be time-consuming, and any required approval processes, including obtaining approval from the PRC Ministry of Commerce, may delay
or inhibit our ability to complete such transactions, which could affect our ability to expand our business or maintain our market share.

Investors  may  experience  difficulties  in  effecting  service  of  legal  process,  enforcing  foreign  judgments  or  bringing  original  actions  in  China  based
upon U.S. laws, including the federal securities laws or other foreign laws against us or our management.

All  of  our  current  operations  are  conducted  in  China.  Moreover,  most  of  our  current  directors  and  officers  are  nationals  or  residents  of  China.  All  or  a
substantial portion of the assets of these persons are located outside the United States and in the PRC. As a result, it may not be possible to effect service of
process within the United States or elsewhere outside China upon these persons. In addition, uncertainty exists as to whether the courts of China would
recognize  or  enforce  judgments  of  U.S.  courts  obtained  against  us  or  such  officers  and/or  directors  predicated  upon  the  civil  liability  provisions  of  the
securities laws of the United States or any state thereof, or be competent to hear original actions brought in China against us or such persons predicated
upon the securities laws of the United States or any state thereof.

Under the Enterprise Income Tax Law, we may be classified as a “resident enterprise” of China. Such classification will likely result in unfavorable tax
consequences to us and our non-PRC shareholders.

On March 16, 2007, the National People’s Congress of China passed a new Enterprise Income Tax Law, or the EIT Law, and on November 28, 2007, the
State Council of China passed its implementing rules, which took effect on January 1, 2008. Under the EIT Law, an enterprise established outside of China
with “de facto management bodies” within China is considered a “resident enterprise,” meaning that it can be treated in a manner similar to a Chinese
enterprise for enterprise income tax purposes. The implementing rules of the EIT Law define de facto management as “substantial and overall management
and control over the production and operations, personnel, accounting, and properties” of the enterprise.

21

 
 
 
 
 
 
 
 
On April  22,  2009,  the  State  Administration  of  Taxation  issued  the  Notice  Concerning  Relevant  Issues  Regarding  Cognizance  of  Chinese  Investment
Controlled  Enterprises  Incorporated  Offshore  as  Resident  Enterprises  pursuant  to  Criteria  of  de  facto  Management  Bodies,  or  the  Notice,  further
interpreting the application of the EIT Law and its implementation non-Chinese enterprise or group controlled offshore entities. Pursuant to the Notice, an
enterprise incorporated in an offshore jurisdiction and controlled by a Chinese enterprise or group will be classified as a “non-domestically incorporated
resident enterprise” if (i) its senior management in charge of daily operations reside or perform their duties mainly in China; (ii) its financial or personnel
decisions  are  made  or  approved  by  bodies  or  persons  in  China;  (iii)  its  substantial  assets  and  properties,  accounting  books,  corporate  chops,  board  and
shareholder minutes are kept in China; and (iv) at least half of its directors with voting rights or senior management often resident in China. A resident
enterprise would be subject to an enterprise income tax rate of 25% on its worldwide income and must pay a withholding tax at a rate of 10% when paying
dividends to its non-PRC shareholders. In addition, the SAT issued the Announcement of the State Administration of Taxation on Issues concerning the
Determination  of  Resident  Enterprises  Based  on  the  Standards  of  Actual  Management  Institutions  in  January  2014  to  provide  more  guidance  on  the
implementation of Circular 82. This bulletin further provides that, among other things, an entity that is classified as a “resident enterprise” in accordance
with the circular shall file the application for classifying its status of residential enterprise with the local tax authorities where its main domestic investors
are registered. From the year in which the entity is determined to be a “resident enterprise,” any dividend, profit and other equity investment gains from
other resident enterprises within China in previous years (on or after January 1, 2008) shall be taxed in accordance with the enterprise income tax law and
its implementing rules.

We may be deemed to be a resident enterprise by Chinese tax authorities. If the PRC tax authorities determine that we are a “resident enterprise” for PRC
enterprise income tax purposes, a number of unfavorable PRC tax consequences could follow. First, we may be subject to the enterprise income tax at a rate
of 25% on our worldwide taxable income as well as PRC enterprise income tax reporting obligations. In our case, this would mean that income such as
interest on financing proceeds and non-China source income would be subject to PRC enterprise income tax at a rate of 25%. Second, although under the
EIT Law and its implementing rules dividends paid to us from our PRC subsidiaries would qualify as “tax-exempt income,” we cannot guarantee that such
dividends will not be subject to a 10% withholding tax, as the PRC foreign exchange control authorities, which enforce the withholding tax, have not yet
issued guidance with respect to the processing of outbound remittances to entities that are treated as resident enterprises for PRC enterprise income tax
purposes. Finally, it is possible that future guidance issued with respect to the new “resident enterprise” classification could result in a situation in which a
10% withholding tax is imposed on dividends we pay to our non-PRC shareholders and with respect to gains derived by our non-PRC stockholders from
transferring our shares. If we were treated as a “resident enterprise” by the PRC tax authorities, we would be subject to taxation in both the U.S. and China,
and our PRC tax may not be used as a credit to reduce our U.S. tax.

We and our stockholders face uncertainties with respect to indirect transfers of equity interests in PRC resident enterprises or other assets attributed to
a Chinese establishment of a non-Chinese company, or immovable properties located in China owned by non-Chinese companies.

In October 2017, the State Administration of Taxation issued the Bulletin on Issues Concerning the Withholding of Non-PRC Resident Enterprise Income
Tax  at  Source,  or  Bulletin  37,  which  replaced  the  Notice  on  Strengthening  Administration  of  Enterprise  Income  Tax  for  Share  Transfers  by  Non-PRC
Resident  Enterprises  issued  by  the  State  Administration  of  Taxation  on  December  10,  2009,  and  partially  replaced  and  supplemented  rules  under  the
Bulletin  on  Issues  of  Enterprise  Income  Tax  on  Indirect  Transfers  of  Assets  by  Non-PRC  Resident  Enterprises,  or  Bulletin  7,  issued  by  the  State
Administration of Taxation on February 3, 2015. Pursuant to Bulletin 7, an “indirect transfer” of PRC assets, including a transfer of equity interests in an
unlisted non-PRC holding company of a PRC resident enterprise, by non-PRC resident enterprises may be re-characterized and treated as a direct transfer
of  the  underlying  PRC  assets,  if  such  arrangement  does  not  have  a  reasonable  commercial  purpose  and  was  established  for  the  purpose  of  avoiding
payment of PRC enterprise income tax. As a result, gains derived from such indirect transfer may be subject to PRC enterprise income tax. According to
Bulletin 7, “PRC taxable assets” include assets attributed to an establishment in China, immoveable properties located in China, and equity investments in
PRC resident enterprises and any gains from the transfer of such asset by a direct holder, who is a non-PRC resident enterprise, would be subject to PRC
enterprise income taxes. When determining whether there is a “reasonable commercial purpose” of the transaction arrangement, features to be taken into
consideration include: whether the main value of the equity interest of the relevant offshore enterprise derives from PRC taxable assets; whether the assets
of the relevant offshore enterprise mainly consists of direct or indirect investment in China or if its income mainly derives from China; whether the offshore
enterprise and its subsidiaries directly or indirectly holding PRC taxable assets have real commercial nature which is evidenced by their actual function and
risk exposure; the duration of existence of the business model and organizational structure; the replicability of the transaction by direct transfer of PRC
taxable assets; and the tax situation of such indirect transfer and applicable tax treaties or similar arrangements. In the case of an indirect offshore transfer
of assets of a PRC establishment, the resulting gain is to be included with the enterprise income tax filing of the PRC establishment or place of business
being transferred, and may consequently be subject to PRC enterprise income tax at a rate of 25%. Where the underlying transfer relates to immoveable
properties located in China or to equity investments in a PRC resident enterprise, which is not related to a PRC establishment or place of business of a non-
resident enterprise, a PRC enterprise income tax of 10% would apply, subject to available preferential tax treatment under applicable tax treaties or similar
arrangements, and the party who is obligated to make the transfer payments has the withholding obligation. Pursuant to Bulletin 37, the withholding agent
shall declare and pay the withheld tax to the competent tax authority in the place where such withholding agent is located within 7 days from the date of
occurrence of the withholding obligation, while the transferor is required to declare and pay such tax to the competent tax authority within the statutory
time limit according to Bulletin 7. Late payment of applicable tax will subject the transferor to default interest. Both Bulletin 37 and Bulletin 7 do not apply
to transactions of sale of shares by investors through a public stock exchange where such shares were acquired from a transaction through a public stock
exchange.

22

 
 
 
 
 
 
There is uncertainty as to the application of Bulletin 37 or previous rules under Bulletin 7. We face uncertainties as to the reporting and other implications
of certain past and future transactions where PRC taxable assets are involved, such as offshore restructuring, sale of the shares in our offshore subsidiaries
or  investments.  Our  company  may  be  subject  to  filing  obligations  or  taxes  if  our  company  is  transferor  in  such  transactions,  and  may  be  subject  to
withholding  obligations  if  our  company  is  transferee  in  such  transactions,  under  Bulletin  37  and  Bulletin  7.  For  transfer  of  shares  in  our  company  by
investors that are non-PRC resident enterprises, our PRC subsidiary may be requested to assist in the filing under Bulletin 37 and Bulletin 7. As a result, we
may be required to expend valuable resources to comply with Bulletin 37 and Bulletin 7 or to request the relevant transferors from whom we purchase
taxable assets to comply with these circulars, or to establish that our company should not be taxed under these circulars, which may have a material adverse
effect on our financial condition and results of operations.

We may be exposed to liabilities under the Foreign Corrupt Practices Act and Chinese anti-corruption laws, and any determination that we violated
these laws could have a material adverse effect on our business.

We are subject to the Foreign Corrupt Practice Act (“FCPA”), and other laws that prohibit improper payments or offers of payments to foreign governments
and their officials and political parties by U.S. persons and issuers as defined by the statute, for the purpose of obtaining or retaining business. We have
operations, have agreements with third parties, and make most of our sales in China. The PRC also strictly prohibits bribery of government officials. Our
activities  in  China  create  the  risk  of  unauthorized  payments  or  offers  of  payments  by  the  employees,  consultants,  sales  agents,  or  distributors  of  our
subsidiaries,  even  though  they  may  not  always  be  subject  to  our  control.  It  is  our  policy  to  implement  safeguards  to  discourage  these  practices  by  our
employees.  However,  our  existing  safeguards  and  any  future  improvements  may  prove  to  be  less  than  effective,  and  the  employees,  consultants,  sales
agents,  or  distributors  of  our  subsidiaries  may  engage  in  conduct  for  which  we  might  be  held  responsible.  Violations  of  the  FCPA  or  Chinese  anti-
corruption  laws  may  result  in  severe  criminal  or  civil  sanctions,  and  we  may  be  subject  to  other  liabilities,  which  could  negatively  affect  our  business,
operating results and financial condition. In addition, the U.S. government may seek to hold our subsidiaries liable for successor liability FCPA violations
committed by companies in which we invest or that we acquire.

RISKS RELATED TO OUR COMMON STOCK

Numerous factors, many of which are beyond our control, may cause the market price of our common stock to fluctuate significantly.

There  are  numerous  factors,  many  of  which  are  beyond  our  control,  may  cause  the  market  price  of  our  common  stock  to  fluctuate  significantly. These
factors include:

● our earnings releases, actual or anticipated changes in our earnings, fluctuations in our operating results or our failure to meet the expectations of

financial market analysts and investors;

● changes in financial estimates by us or by any securities analysts who might cover our shares;

● speculation about our business in the press or the investment community;

● significant developments relating to our relationships with our customers or suppliers;

● stock market price and volume fluctuations of other publicly traded companies and, in particular, those that are in our industries;

● customer demand for our products;

● investor perceptions of our industry in general and our company in particular;

● the operating and stock performance of comparable companies;

● general economic conditions and trends;

● major catastrophic events;

● announcements by us or our competitors of new products, significant acquisitions, strategic partnerships or divestitures;

● changes in accounting standards, policies, guidance, interpretation or principles;

● loss of external funding sources;

● sales of our shares, including sales by our directors, officers or significant shareholders; and

● additions or departures of key personnel.

23

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securities class action litigation is often instituted against companies following periods of volatility in their share price. This type of litigation could result
in substantial costs to us and divert our management’s attention and resources. Moreover, securities markets may from time to time experience significant
price  and  volume  fluctuations  for  reasons  unrelated  to  operating  performance  of  particular  companies.  For  example,  from  September  1,  2020  through
December 31, 2020 the closing price of our common stock on the NASDAQ Capital Market has ranged from a high of $11.30 to a low of $0.66. These
market fluctuations may adversely affect the price of our shares and other interests in our company at a time when you want to sell your interest in us.

Techniques employed by short sellers may drive down the market price of our common stock.

Short selling is the practice of selling securities that the seller does not own but rather has borrowed from a third party with the intention of buying identical
securities back at a later date to return to the lender. The short seller hopes to profit from a decline in the value of the securities between the sale of the
borrowed securities and the purchase of the replacement shares, as the short seller expects to pay less in that purchase than it received in the sale. As it is in
the short seller’s interest for the price of the security to decline, many short sellers publish, or arrange for the publication of, negative opinions regarding
the relevant issuer and its business prospects in order to create negative market momentum and generate profits for themselves after selling a security short.
These short attacks have, in the past, led to selling of shares in the market.

Public companies that have substantially all of their operations in China have been the subject of short selling. Much of the scrutiny and negative publicity
has centered on allegations of a lack of effective internal control over financial reporting resulting in financial and accounting irregularities and mistakes,
inadequate corporate governance policies or a lack of adherence thereto and, in many cases, allegations of fraud. As a result, a number of targets of such
efforts  are  now  conducting  internal  and  external  investigations  into  the  allegations  and,  in  the  interim,  are  subject  to  shareholder  lawsuits  and/or  SEC
enforcement actions.

We have become the subject of certain unfavorable allegations. Although we believe such allegations are untrue, inaccurate or inflated, we have expended
resources to investigate such allegations and defend ourselves and we may need to expend more resources in connection with these allegations in the future,
which could be costly and time-consuming and could distract our management from growing our business. The allegations against us may severely impact
our stock price and disrupt our business operations. Any investment in our common stock could be greatly reduced or even rendered worthless due to such
allegations.

If  we  fail  to  comply  with  the  continued  listing  requirements  of  NASDAQ,  we  would  face  possible  delisting,  which  would  result  in  a  limited  public
market for our shares and make obtaining future debt or equity financing more difficult for us.

Our common stock is traded and listed on the NASDAQ Capital Market under the symbol “CBAT”, which was changed from “CBAK” on November 30,
2018. The common stock may be delisted if we fail to maintain certain NASDAQ listing requirements.

On February 20, 2020, we received notice from the Listing Qualifications Department of The NASDAQ Stock Market (“Nasdaq”) indicating that, for the
last  30  consecutive  business  days,  the  bid  price  for  the  Company’s  common  stock  had  closed  below  the  minimum  $1.00  per  share  and  as  a  result,  the
Company was no longer in compliance with the NASDAQ Listing Rule 5550(a)(2). We regained compliance with the minimum bid price rule on October
2, 2020.

We cannot assure you that the Company will continue to comply with the requirements for continued listing on the NASDAQ Capital Market in the future.
If our common stock loses its status on the NASDAQ Capital Market, our common stock would likely trade in the over-the-counter market. If our shares
were to trade on the over-the-counter market, selling our common stock could be more difficult because smaller quantities of shares would likely be bought
and  sold,  transactions  could  be  delayed,  and  security  analysts’  coverage  of  us  may  be  reduced.  In  addition,  in  the  event  our  common  stock  is  delisted,
broker-dealers have certain regulatory burdens imposed upon them, which may discourage broker-dealers from effecting transactions in our common stock,
further limiting the liquidity of our common stock. These factors could result in lower prices and larger spreads in the bid and ask prices for our common
stock. Such delisting from the NASDAQ Capital Market and continued or further declines in our share price could also greatly impair our ability to raise
additional necessary capital through equity or debt financing and could significantly increase the ownership dilution to shareholders caused by our issuing
equity in financing or other transactions.

24

 
 
 
 
 
 
 
 
 
 
 
You may experience dilution to the extent that shares of our common stock are issued upon the exercise of outstanding warrants or other securities that
we may issue in the future.

You may experience dilution to the extent that shares of our common stock are issued upon the exercise of outstanding warrants of the Company, and if we
issue additional equity securities, or there are any issuances and subsequent exercises of stock options issued in the future. On February 10, 2021, pursuant
to  a  certain  Securities  Purchase  Agreement,  dated  February  8,  2021,  we  issued  to  certain  investors  (i)  in  a  private  placement,  Series  A-1  warrants  to
purchase a total of 4,469,988 shares of common stock, at a per share exercise price of $7.67 and exercisable for 42 months from the date of issuance; (ii) in
a registered direct offering, certain Series B warrants to purchase a total of 4,469,988 shares of common stock, at a per share exercise price of $7.83 and
exercisable for 90 days from the date of issuance; and (iii) in the registered direct offering, certain Series A-2 warrants to purchase up to 2,234,992 shares
of common stock, at a per share exercise price of $7.67 and exercisable for 45 months from the date of issuance. Prior to that, in December 2020, we issued
to the same investors warrants to purchase an aggregate of 3,795,920 shares of common stock at an exercise price of $6.46 per share. These warrants are
exercisable until 36 months after the date of issuance. The exercise prices of all of the above warrants are subject to full-ratchet anti-dilution adjustment in
the  case  of  future  issuances  or  deemed  issuances  of  shares  of  common  stock  below  the  warrants’  exercise  price  then  in  effect,  as  well  as  customary
adjustment  in  case  of  stock  splits,  stock  dividends,  stock  combinations  and  similar  recapitalization  transactions.  In  addition,  we  issued  to  Mr.  Jian  Ke
placement agent warrants to purchase up to 379,592 shares of common stock at an exercise price of $6.475 per share in December 2020 and the placement
agent  warrant  to  purchase  up  to  446,999  shares  of  common  stock  at  an  exercise  price  of  $9.204  per  share  in  February  2021.  These  warrants  also  bear
customary anti-dilution protections in the event of stock dividends or splits, business combination, sale of assets, similar recapitalization transactions, or
other similar transactions.

Our directors and executive officers, collectively, own approximately 12.79% of our outstanding common stock and may possess significant influence
in or control over our management and affairs.

Mr. Yunfei Li, our president and chief executive officer and chairman of our board, and our other executive officers and directors beneficially owns an
aggregate of 12.79% of our outstanding common stock as of April 9, 2021. As a result, our directors and executive officers, acting together, may have
significant influence in or control over our management and affairs, including the election of directors and approval of significant corporate transactions,
such  as  mergers,  consolidation,  and  sale  of  all  or  substantially  all  of  our  assets.  Consequently,  this  concentration  of  ownership  may  have  the  effect  of
delaying or preventing a change of control, including a merger, consolidation or other business combination involving us, even if such a change of control
would benefit our stockholders. 

GENERAL RISK FACTORS

If we cannot continue to develop new products in a timely manner, and at favorable margins, we may not be able to compete effectively.

The battery industry has been notable for the pace of innovations in product life, product design and applied technology. We have made, and will continue
to make, investments in research and development with the goal of further innovation. The successful development and introduction of new products and
line  extensions  face  the  uncertainty  of  customer  acceptance  and  reaction  from  competitors,  as  well  as  the  possibility  of  cannibalization  of  sales  of  our
existing products. In addition, our ability to create new products and line extensions and to sustain existing products is affected by whether we can:

● develop and fund research and technological innovations;

● receive and maintain necessary intellectual property protections;

● obtain governmental approvals and registrations;

● comply with governmental regulations; and

● anticipate customer needs and preferences successfully.

25

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The failure to develop and launch successful new products could hinder the growth of our business and any delay in the development or launch of a new
product could also compromise our competitive position. If competitors introduce new or enhanced products that significantly outperform ours, or if they
develop or apply manufacturing technology which permits them to manufacture at a significantly lower cost relative to ours, we may be unable to compete
successfully in the market segments affected by these changes.

A change in our product mix may cause our results of operations to differ substantially from the anticipated results in any particular period.

Our overall profitability may not meet expectations if our products, customers or geographic mix are substantially different than anticipated. Our profit
margins  vary  among  products,  customers  and  geographic  markets.  Consequently,  if  our  mix  of  any  of  these  is  substantially  different  from  what  is
anticipated in any particular period, our profitability could be lower than anticipated.

Manufacturing or use of our products may cause accidents, which could result in significant production interruption, delay or claims for substantial
damages.

Due  to  the  high  energy  density  inherent  in  lithium-based  batteries,  our  batteries  can  pose  certain  safety  risks,  including  the  risk  of  fire. Although  we
incorporate  safety  procedures  in  the  research,  development,  manufacture  and  transportation  of  batteries  that  are  designed  to  minimize  safety  risks,  the
manufacture  or  use  of  our  products  may  still  cause  accidents.  Any  accident,  whether  occurring  at  the  manufacturing  facilities  or  from  the  use  of  our
products, may result in significant production interruption, delays or claims for substantial damages caused by personal injuries or property damages. 

We may face impairment charges if economic environments in which our businesses operate and key economic and business assumptions substantially
change.

Assessment of the potential impairment of property, plant and equipment and other identifiable intangible assets is an integral part of our normal ongoing
review  of  operations.  Testing  for  potential  impairment  of  long-lived  assets  is  dependent  on  numerous  assumptions  and  reflects  our  best  estimates  at  a
particular point in time, which may vary from testing date to testing date. The economic environments in which our businesses operate and key economic
and business assumptions with respect to projected product selling prices and materials costs, market growth and inflation rates, can significantly affect the
outcome of impairment tests. Estimates based on these assumptions may differ significantly from actual results. Changes in factors and assumptions used in
assessing  potential  impairments  can  have  a  significant  impact  on  both  the  existence  and  magnitude  of  impairments,  as  well  as  the  time  at  which  such
impairments  are  recognized.  Future  changes  in  the  economic  environment  and  the  economic  outlook  for  the  assets  being  evaluated  could  also  result  in
impairment charges. Any significant asset impairments would adversely impact our financial results.

We may be exposed to infringement or misappropriation claims by third parties, which, if determined adversely to us, could cause our loss of significant
rights and inability to continue providing our existing product offerings.

Our success also depends largely on our ability to use and develop our technology and know-how without infringing the intellectual property rights of third
parties.  The  validity  and  scope  of  claims  relating  to  lithium-ion  battery  technology  patents  involve  complex  scientific,  legal  and  factual  questions  and
analysis and, therefore, may be highly expensive and time-consuming. If there is a successful claim of infringement against us, we may be required to pay
substantial damages to the party claiming infringement, develop non-infringing technologies or enter into royalty or license agreements that may not be
available on acceptable terms, if at all. Our failure to develop non-infringing technologies or license the proprietary rights on a timely basis would harm our
business.  Protracted  litigation  could  result  in  our  customers,  or  potential  customers,  deferring  or  limiting  their  purchase  or  use  of  our  products  until
resolution of such litigation. Parties making the infringement claim may also obtain an injunction that can prevent us from selling our products or using
technology that contains the allegedly infringing contents. Any intellectual property litigation could have a material adverse effect on our business, results
of operation and financial condition.

26

 
 
 
 
 
 
 
 
 
 
 
Compliance with environmental regulations can be expensive, and our failure to comply with these regulations may result in adverse publicity and a
material adverse effect on our business.

As  a  manufacturer,  we  are  subject  to  various  PRC  environmental  laws  and  regulations  on  air  emission,  wastewater  discharge,  solid  waste  and  noise.
Although we believe that our operations are in substantial compliance with current environmental laws and regulations, we may not be able to comply with
these regulations at all times as the PRC environmental legal regime is evolving and becoming more stringent. Therefore, if the PRC government imposes
more stringent regulations in the future, we will have to incur additional substantial costs and expenses in order to comply with new regulations, which may
negatively affect our results of operations. If we fail to comply with any of the present or future environmental regulations in material aspects, we may
suffer from negative publicity and may be required to pay substantial fines, suspend or even cease operations. Failure to comply with PRC environmental
laws and regulations may materially and adversely affect our business, financial condition and results of operations.

The success of our business depends on our ability to attract, train and retain highly skilled employees and key personnel.

Because  of  the  highly  specialized,  technical  nature  of  our  business,  we  must  attract,  train  and  retain  a  sizable  workforce  comprising  highly  skilled
employees and other key personnel. Since our industry is characterized by high demand and intense competition for talent, we may have to pay higher
salaries and wages and provide greater benefits in order to attract and retain highly skilled employees or other key personnel that we will need to achieve
our strategic objectives. Our ability to train and integrate new employees into our operations may not meet the requirements of our growing business. Our
failure to attract, train or retain highly skilled employees and other key personnel in numbers that are sufficient to satisfy our needs would materially and
adversely affect our business.

If  we  become  directly  subject  to  the  scrutiny,  criticism  and  negative  publicity  involving  U.S.-listed  Chinese  companies,  we  may  have  to  expend
significant resources to investigate and resolve the matter which could harm our business operations, stock price and reputation and could result in a
loss of your investment in our stock, especially if such matter cannot be addressed and resolved favorably.

U.S.  public  companies  that  have  substantially  all  of  their  operations  in  China,  particularly  companies  like  us  which  have  completed  so-called  reverse
merger  transactions,  have  been  the  subject  of  intense  scrutiny,  criticism  and  negative  publicity  by  investors,  financial  commentators  and  regulatory
agencies, such as the SEC. Much of the scrutiny, criticism and negative publicity has centered around financial and accounting irregularities and mistakes, a
lack of effective internal controls over financial accounting, inadequate corporate governance policies or a lack of adherence thereto and, in many cases,
allegations  of  fraud.  As  a  result  of  the  scrutiny,  criticism  and  negative  publicity,  the  publicly  traded  stock  of  many  U.S.  listed  Chinese  companies  has
sharply decreased in value and, in some cases, has become virtually worthless. Many of these companies have also been subject to shareholder lawsuits and
SEC enforcement actions, and have been conducting internal and external investigations into the allegations. If we become the subject of any unfavorable
allegations, whether such allegations are proven to be true or untrue, we will have to expend significant resources to investigate such allegations and/or
defend our company. This situation will be costly and time consuming and distract our management from growing our company. If such allegations are not
proven to be groundless, our company and business operations will be severely and your investment in our stock could be rendered worthless.

The disclosures in our reports and other filings with the SEC and our other public pronouncements are not subject to the scrutiny of any regulatory
bodies  in  the  PRC.  Accordingly,  our  public  disclosure  should  be  reviewed  in  light  of  the  fact  that  no  governmental  agency  that  is  located  in  China
where substantially all of our operations and business are located have conducted any due diligence on our operations or reviewed or cleared any of
our disclosures.

We  are  regulated  by  the  SEC  and  our  reports  and  other  filings  with  the  SEC  are  subject  to  SEC  review  in  accordance  with  the  rules  and  regulations
promulgated by the SEC under the Securities Act and the Exchange Act. Unlike public reporting companies whose operations are located primarily in the
United States, however, substantially all of our operations are located in China. Since substantially all of our operations and business take place in China, it
may be more difficult for the Staff of the SEC to overcome the geographic and cultural obstacles that are present when reviewing our disclosures. These
same obstacles are not present for similar companies whose operations or business take place entirely or primarily in the United States. Furthermore, our
SEC reports and other disclosures and public pronouncements are not subject to the review or scrutiny of any PRC regulatory authority. For example, the
disclosure in our SEC reports and other filings are not subject to the review of China Securities Regulatory Commission, a PRC regulator that is tasked
with  oversight  of  the  capital  markets  in  China.  Accordingly,  you  should  review  our  SEC  reports,  filings  and  our  other  public  pronouncements  with  the
understanding that no local regulator has done any due diligence on our company and with the understanding that none of our SEC reports, other filings or
any of our other public pronouncements has been reviewed or otherwise been scrutinized by any local regulator.

27

 
 
 
 
 
 
 
 
 
 
ITEM 1B. UNRESOLVED STAFF COMMENTS.

Not applicable.

ITEM 2. PROPERTIES.

We  have  completed  the  construction  of  the  facilities  in  our  Dalian  site  with  a  total  area  of  44,928  square  meters  comprising  manufacturing  facilities,
warehousing and packaging facilities and administrative offices at the BAK Industrial Park in Dalian. Of that space, approximately 33,138 square meters
are manufacturing facilities. We have completed the construction of a power battery manufacturing plant and a power battery packing plant in Dalian which
started commercial production in July 2015.

We are constructing the facilities of our Phase One Nanjing site, which occupies an area of 10,268 square meters.

Nanjing  Daxin  has  rented  facilities  in  Nanjing,  including  administrative  offices,  manufacturing  and  warehousing  facilities  occupying  an  area  of  6,615
square meters.

We believe that these facilities will meet our recent business needs as well as the needs of our expanded operations in the future.

The following table sets forth the breakdown of our facilities as of December 31, 2020 based on use:

Facility
Constructions completed

Constructions in progress

Facilities rented

Dalian CBAK Power facilities site area

Nanjing Daxin facility site area

Nanjing CBAK facilities site area

  Usage
  Manufacturing
  R&D and administrative
  Warehousing
  Other facilities
  Subtotal

  Manufacturing
  Warehousing
  Subtotal

  Manufacturing
  Warehousing
  Administrative
  Other facilities
  Subtotal

  Total

  Total

  Total

  Area (m2 )

33,138 
4,276 
3,197 
4,317 
44,928 

16,908 
12,421 
29,329 

10,598.2 
1,364.8 
4,140 
780 
16,883 

74,257 
6,615 
10,268 

See Item 1 Business – Overview of Our Business – Expansion of Manufacturing Capabilities for information related to the construction of our Nanjing
facilities. 

We currently have insurance coverage for certain pledged machinery and equipment and pledged buildings located at our owned facilities. We expect we
will  purchase  related  insurance  for  the  remaining  buildings  when  we  obtain  their  property  ownership  certificates.  If  we  were  to  suffer  any  losses  or
damages to any of the facilities before the purchase of insurance policies that provide adequate coverage, our business, financial condition and results of
operations may be materially and adversely affected.

ITEM 3. LEGAL PROCEEDINGS.

See Note 23 (ii) to our audited consolidated financial statements included in this report.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable. 

28

 
 
 
 
 
 
 
 
 
 
 
   
 
   
 
   
 
   
 
   
 
   
   
  
   
 
   
 
   
 
   
   
  
   
 
   
 
   
 
   
 
   
 
   
   
  
   
   
   
 
 
 
 
 
 
 
ITEM  5.  MARKET  FOR  REGISTRANT’S  COMMON  EQUITY,  RELATED  STOCKHOLDER  MATTERS  AND  ISSUER  PURCHASES  OF
EQUITY SECURITIES.

PART II

Market Information

Effective June 21, 2019, the Company’s Common Stock started trading on the Nasdaq Capital Market under the symbol “CBAT.”

Approximate Number of Holders of Our Common Stock

As  of  April  9,  2021,  there  were  approximately  51  holders  of  record  of  our  common  stock,  which  does  not  include  the  number  of  stockholders  holding
shares of our common stock in “street name.”

Dividend Policy

We have never declared or paid any dividends, nor do we have any present plan to pay any cash dividends on our common stock in the foreseeable future.
We currently intend to retain most, if not all, of our available funds and any future earnings to operate and expand our business.

As we are a holding company, we rely on dividends paid to us by our subsidiaries in the PRC through our Hong Kong subsidiary, BAK Asia. In accordance
with its articles of association, each of our subsidiaries in the PRC is required to allocate to its statutory general reserve at least 10% of its respective after-
tax profits determined in accordance with the PRC accounting standards and regulations. Each of our subsidiaries in the PRC may stop allocations to its
general  reserve  if  such  reserve  has  reached  50%  of  its  registered  capital. Allocations  to  the  reserve  can  only  be  used  for  making  up  losses  and  other
specified purposes and may not be paid to us in the form of loans, advances, or cash dividends. Dividends paid by our PRC subsidiaries to BAK Asia, our
Hong Kong subsidiary, will not be subject to Hong Kong capital gains or other income tax under current Hong Kong laws and regulations because they will
not be deemed to be assessable income derived from or arising in Hong Kong. Such dividends, however, may be subject to a 10% withholding tax in the
PRC.

Our board of directors has discretion on whether to pay dividends unless the distribution would render us unable to repay our debts as they become due, as
provided in Chapter 78.288 of the Nevada Revised Statutes. Even if our board of directors decides to pay dividends, the form, frequency and amount will
depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions and other factors that
the board of directors may deem relevant.

Securities Authorized for Issuance Under Equity Compensation Plans

See Item 12, “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters — Securities Authorized for Issuance
Under Equity Compensation Plans.”

Recent Sales of Unregistered Securities

We have not sold any equity securities during the 2020 fiscal year that were not previously disclosed in a quarterly report on Form 10-Q or a current report
on Form 8-K that was filed during the 2020 fiscal year.

Purchases of Equity Securities

No repurchases of our common stock were made during the fiscal year of 2020.

ITEM 6. SELECTED FINANCIAL DATA.

Not applicable.

29

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The  following  management’s  discussion  and  analysis  should  be  read  in  conjunction  with  our  financial  statements  and  the  notes  thereto  and  the  other
financial information appearing elsewhere in this report. In addition to historical information, the following discussion contains certain forward-looking
information. See “Special Note Regarding Forward Looking Statements” above for certain information concerning those forward-looking statements. Our
financial statements are prepared in U.S. dollars and in accordance with U.S. GAAP.

Overview

We are engaged in developing, manufacturing and selling new energy high power lithium batteries, which are mainly used in the following applications:

● Electric vehicles (“EV”), such as electric cars, electric buses, hybrid electric cars and buses;

● Light electric vehicles (“LEV”), such as electric bicycles, electric motors, sight-seeing cars; and

● Electric tools, energy storage including but not limited to uninterruptible power supply application, and other high-power applications.

We generated revenues from the manufacture and sale of high-power lithium batteries and raw materials for lithium batteries of $37.6 million and $22.2
million for the fiscal years ended December 31, 2020 and 2019, respectively. We incurred a net loss of $7.8 million and $10.9 million during the fiscal
years  ended  December  31,  2020  and  2019,  respectively.  Our  revenues  in  relation  to  electric  vehicles  are,  to  some  extent,  adversely  impacted  by  the
reduction of government subsidies to new energy vehicles. However, new revenues driven from the trading of raw materials for lithium batteries, as well as
the continuous climb of sales in uninterruptible supplies and light-electric-vehicle related products, contributed to the increase. For more details, see “Item
1. Business—Overview of Our Business.” Accordingly, net revenues from sales of batteries for uninterruptable supplies was $22.7 million for the fiscal
year ended December 31, 2020, as compared to $17.7 million for fiscal year ended December 31, 2019, an increase of $5 million, or 28.2%. Net revenues
from raw materials for lithium batteries was $14.5 million for the fiscal year ended December 31, 2020, as compared to nil for fiscal year ended December
31, 2019, an increase of $14.5 million, or 100%. With the announced ultra-low-temperature battery technology, we believe that our revenues in the energy
storage  market  will  continue  to  grow.  In  addition,  net  revenues  from  sales  of  batteries  for  light  electric  vehicles  was  $39,428  for  the  fiscal  year  ended
December 31, 2020, as compared to $16,147 for fiscal year ended December 31, 2019, an increase of $23,281, or 144.0%. We believe the government
policies relating to new energy will in the long term encourage the production of new energy vehicles, optimize the structure of the new energy vehicles
industry, enhance technical standards of the industry and strengthen its core competitiveness, which ultimately would foster strategic development of the
new energy vehicles. In addition, our latest development of 32140 batteries and our planned investment in the R&D of 46800 batteries will help us regain
competitiveness in both LEV/EV markets with the appropriate products. Therefore, the demand for new energy likely will grow in the future and we will
be able to secure more potential orders from the new energy market.

We have completed the construction of a cylindrical power battery manufacturing plant and a power battery packing plant of our Dalian facilities which
started commercial production in July 2015. We have received and been utilizing most of BAK Tianjin’s operating assets relocated to our Dalian facilities,
including its machinery and equipment for battery production and battery pack production, customers, management team and technical staff, patents and
technologies. We also started the investments in and construction of our Nanjing facilities, which is designed to comprise of two phases. The first phase is
in the process of interior renovation and equipment purchase. Phase One has an area of approximately 10,000 square meters at nearly no cost due to the
government’s  low  rentals.  Phase  Two  is  currently  under  construction  design  process. The  Nanjing  facilities,  once  built,  are  expected  to  provide  at  least
8GWh capacity to support our demand. We have also purchased machinery and equipment to expand our manufacturing capabilities. Moreover, given the
equity and debt financings we have obtained recently, we believe that with the booming future market demand for high power lithium-ion products, we can
continue as a going concern and return to profitability.

The consolidated financial statements contained in this annual report have been prepared assuming we will continue to operate as a going concern, which
contemplates the realization of assets and the settlement of liabilities in the normal course of business. The consolidated financial statements do not include
any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that
may result from the outcome of this uncertainty related to our ability to continue as a going concern.

30

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial Statement Presentation

Net  revenues.  The  Company  recognizes  revenues  when  its  customer  obtains  control  of  promised  goods  or  services,  in  an  amount  that  reflects  the
consideration which it expects to receive in exchange for those goods. The Company recognizes revenues following the five-step model prescribed under
ASU No. 2014-09: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price;
(iv)  allocate  the  transaction  price  to  the  performance  obligations  in  the  contract;  and  (v)  recognize  revenues  when  (or  as)  we  satisfy  the  performance
obligation.

Revenues from product sales are recognized when the customer obtains control of our product, which occurs at a point in time, typically upon delivery to
the customer. We expense incremental costs of obtaining a contract as and when incurred it the expected amortization period of the asset that it would have
recognized is on year or less or the amount is immaterial.

Revenue  from  product  sales  is  recorded  net  of  reserves  established  for  applicable  discounts  and  allowances  that  are  offered  within  contracts  with  our
customers.

Product revenue reserves, which are classified as a reduction in product revenues, are generally characterized in the categories: discounts and returns. These
reserves are based on estimates of the amounts earned or to be claimed on the related sales and are classified as reductions of accounts receivable as the
amount is payable to the Company’s customer.

Cost  of  revenues.  Cost  of  revenues  consists  primarily  of  material  costs,  employee  remuneration  for  staff  engaged  in  production  activity,  share-based
compensation, depreciation and related expenses that are directly attributable to the production of products. Cost of revenues also includes write-downs of
inventory to lower of cost and net realizable value.

Research and development expenses. Research and development expenses primarily consist of remuneration for R&D staff, share-based compensation,
depreciation and maintenance expenses relating to R&D equipment, and R&D material costs.

Sales  and  marketing  expenses.  Sales  and  marketing  expenses  consist  primarily  of  remuneration  for  staff  involved  in  selling  and  marketing  efforts,
including staff engaged in the packaging of goods for shipment, warranty expenses, advertising cost, depreciation, share-based compensation and travel and
entertainment  expenses.  We  do  not  pay  slotting  fees  to  retail  companies  for  displaying  our  products,  engage  in  cooperative  advertising  programs,
participate in buy-down programs or similar arrangements.

General  and  administrative  expenses.  General  and  administrative  expenses  consist  primarily  of  employee  remuneration,  share-based  compensation,
professional fees, insurance, benefits, general office expenses, depreciation, liquidated damage charges and bad debt expenses.

Finance costs, net. Finance costs consist primarily of interest income and interest on bank loans, net of capitalized interest.

Income tax expenses. Our subsidiaries in PRC are subject to an income tax rate of 25%. Our Hong Kong subsidiary BAK Asia is subject to profits tax at a
rate of 16.5%. However, because we did not have any assessable income derived from or arising in Hong Kong, BAK Asia had not paid any such tax.

31

 
 
 
 
 
 
 
 
 
 
 
 
 
Results of Operations

Comparison of Years Ended December 31, 2019 and December 31, 2020

The following table sets forth key components of our results of operations for the years indicated, both in dollars and as a percentage of our revenue.

(All amounts, other than percentages, in thousands of U.S. dollars)

Net revenues
Cost of revenues
Gross profit

Years Ended

Change

December 31, 
2019

December 31, 
2020

$

%

  $

22,194    $
(21,572)    
622     

37,566     
(34,852)    
2,714     

15,372     
(13,280)    
2,092     

Operating expenses:
Research and development expenses
Sales and marketing expenses
General and administrative expenses
Impairment charge on property, plant and equipment
Provision for doubtful accounts
Total operating expenses
Operating loss
Finance expense, net
Other income (expense), net
Change in fair value of warrants liability
Loss before income tax
Income tax expenses
Net loss
Less: Net loss attributable to non-controlling interests
Net loss attributable to shareholders of CBAK Energy Technology, Inc.

(1,906)    
(1,021)    
(4,412)    
(2,326)    
(1,046)    
(10,711)    
(10,089)    
(1,385)    
620     
-     
(10,854)    
-     
(10,854)    
86     
(10,768)   $

(1,679)    
(701)    
(3,746)    
(4,346)    
(722)    
(11,194)    
(8,480)    
(1,399)    
(40)    
2,072     
(7,847)    
-     
(7,847)    
40     
(7,807)    

227     
320     
666     
(2,020)    
324     
(483)    
1,609     
(14)    
(660)    
2,072     
3,007     
-     
3,007     
(46)    
2,961     

  $

69 
62 
336 

(12)
(31)
(15)
87 
(31)
5 
(16)
1 
(106)
100 
(28)
- 
(28)
(53)
(27)

Net revenues.  Net  revenues  were  $37.6  million  for  the  fiscal  year  ended  December  31,  2020,  as  compared  to  $22.2  million  for  the  fiscal  year  ended
December 31, 2019, an increase of $15.4 million, or 69%.

The following table sets forth the breakdown of our net revenues by end-product applications derived from high-power lithium batteries.

(All amounts, other than percentage, in thousands of U.S. dollars)

High-power lithium batteries used in:
Electric vehicles
Light electric vehicles
Uninterruptable supplies

Raw materials used in lithium batteries
Total

Years Ended

Change

December 31, 
2019

December 31, 
2020

$

%

  $

  $

4,509    $
16     
17,669     
22,194     
-     
22,194    $

260     
39     
22,749     
23,048     
14,518     
37,566     

(4,249)    
23     
5,080     
854     
14,518     
15,372     

(94)
144 
29 
4 
100 
69 

Net revenues from sales of batteries for electric vehicles were $259,955 for the fiscal year ended December 31, 2020, as compared to $4.5 million for 2019,
a decrease of approximately $4.2 million, or 94%.

Net  revenues  from  sales  of  batteries  for  light  electric  vehicles  was  approximately  $39,428  for  the  fiscal  year  ended  December  31,  2020,  as  compared
$16,147 for 2019, representing an increase of $23,281, or 144%.

32

 
 
 
 
 
 
 
 
   
 
 
 
   
   
   
 
   
   
 
   
      
      
      
  
   
      
      
      
  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
 
 
 
 
 
 
 
   
 
 
 
   
   
   
 
   
     
     
     
 
   
   
 
   
   
 
 
 
Net revenues from sales of batteries for uninterruptable supplies was $22.7 million for the fiscal year ended December 31, 2020, as compared to $17.7
million  for  fiscal  year  ended  December  31,  2019,  an  increase  of  $5  million,  or  29%.  As  we  focused  more  on  this  market  in  2020,  sale  of  batteries  for
uninterruptable power supplies increased significantly.

Net revenues from sales of raw materials used in lithium batteries were $14.5 million for the fiscal year ended December 31, 2020, as compared with nil in
the same period in 2019, representing an increase of $14.5 million. We obtained favorable prices on bulk purchase of raw materials from certain suppliers,
and generated gross profit in the fiscal year ended December 31, 2020.

Cost of revenues. Cost of revenues increased to $34.9 million for the fiscal year ended December 31, 2020, as compared to $21.6 million for 2019, an
increase of $13.3 million, or 62%. The increase in cost of revenues was mainly due to increased net revenues. Included in cost of revenues were write down
of obsolete and slow-moving inventories of $0.8 million for the year ended December 31, 2019, while it was $1.5 million for the year ended 2020. We
write down the inventory value whenever there is an indication that it is impaired. The increase in write down of inventory is mainly due to the increase of
slow-moving inventory. Further write-down may be necessary if market conditions continue to deteriorate.

Gross profit. Gross profit for the year ended December 31, 2020 was $2.7 million, or 7.2% of net revenues as compared to gross profit of $0.6 million, or
2.8% of net revenues, for the fiscal year ended December 31, 2019. Our new Dalian facilities commenced manufacturing activities in July 2015. With our
sustained effort, the quality passing rate of our product has improved due to cost control and enhancement works on production line.

Research and development expenses. Research and development expenses decreased to $1.7 million for the year ended December 31, 2020, as compared
to  $1.9  million  for  2019,  a  decrease  of  $0.2  million,  or  12%.  The  decrease  was  primarily  resulted  from  the  decrease  of  salaries  and  social  insurance
expenses by approximately $0.3 million due to the suspension of our operations in the first quarter of 2020 and the Chinese government’s social security
relief for enterprises, in response to COVID-19.

Sales  and  marketing  expenses.  Sales  and  marketing  expenses  decreased  to  $0.7  million  for  the  year  ended  December  31,  2020,  as  compared  to  $1.0
million  for  2019,  a  decrease  of  $0.3  million,  or  31%.  The  decrease  was  resulted  from  the  decrease  of  salaries  and  social  insurance  expenses  by
approximately  $0.2  million  due  to  the  suspension  of  our  operations  in  the  first  quarter  of  2020  and  the  Chinese  government’s  social  security  relief  for
enterprises, in response to COVID-19 and decrease of $0.1 million in provision for warranty expenses.

General and administrative expenses. General and administrative expenses decreased to $3.7 million for the year ended December 31, 2020, as compared
to  $4.4  million  for  2019,  a  decrease  of  $0.7  million,  or  15%.  The  decrease  was  primarily  resulted  from  the  decrease  of  salaries  and  social  insurance
expenses by approximately $0.6 million due to the suspension of our operations in the first quarter of 2020 and the Chinese government’s social security
relief for enterprises, in response to COVID-19. We also continued to tighten cost control in order to improve profitability.

Property,  plant  and  equipment  impairment  charge.  During  the  course  of  our  strategic  review  of  our  operations,  we  assessed  the  recoverability  of  the
carrying value of certain property, plant and equipment which resulted in impairment losses of $2.3 million and $4.3 million, respectively.

Provision for doubtful accounts. Provision for doubtful accounts decreased to $0.7 million for the year ended December 31, 2020, as compared to $1.0
million for 2019. We determine the allowance based on historical write-off experience, customer specific facts and economic conditions.

Operating loss. As a result of the above, our operating loss totaled $8.5 million for the year ended December 31, 2020, as compared to $10.1 million for
2019, a decrease of $1.6 million or 16%.

Finance expense, net. Finance expense, net was $1.40 million for the year ended December 31, 2020, as compared to $1.39 million for 2019, an increase
of $0.01 million or 1%. 

33

 
 
 
 
 
 
 
 
 
 
 
 
 
Other income (expenses), net. Other expenses were $0.04 million for the year ended December 31, 2020, as compared to other income of approximately
$0.6 million for 2019.

Net loss. As a result of the foregoing, we had a net loss of $7.8 million for the year ended December 31, 2020, compared to a net loss of $10.9 million for
2019.

Liquidity and Capital Resources

We had financed our liquidity requirements from a variety of sources, including short-term bank loans, other short-term loans and bills payable under bank
credit agreements, advance from our related and unrelated parties, investors and issuance of capital stock.

We  incurred  a  net  loss  of  $7.8  million  in  the  fiscal  year  ended  December  31,  2020.  As  of  December  31,  2020,  we  had  cash  and  cash  equivalents  and
restricted cash of $20.7 million. Our total current assets were $63.3 million and our total current liabilities were $73.7 million, resulting in a net working
capital deficiency of $10.5 million. These factors raise substantial doubts about our ability to continue as a going concern. 

On June 4, 2018, we obtained banking facilities from China Everbright Bank Dalian Branch with a maximum amount of RMB200 million (approximately
$30.63 million) with the term from June 12, 2018 to June 10, 2021, bearing interest at 130% of benchmark rate of the People’s Bank of China (“PBOC”)
for  three-year  long-term  loans,  which  is  currently  6.175%  per  annum.  Under  the  facilities,  we  borrowed  RMB126.0  million  ($18.1  million),  RMB23.3
million  ($3.3  million),  RMB9.0  million  ($1.3  million)  and  RMB9.5  million  ($1.4  million)  on  June  12,  June  20,  September  20,  and  October  19,  2018,
respectively. The loans are repayable in six installments of RMB0.8 million ($0.12 million) on December 10, 2018, RMB24.3 million ($3.50 million) on
June  10,  2019,  RMB0.8  million  ($0.12  million)  on  December  10,  2019,  RMB74.7  million  ($10.7  million)  on  June  10,  2020,  RMB0.8  million  ($0.12
million)  on  December  10,  2020  and  RMB66.3  million  ($9.6  million)  on  June  10,  2021.  We  repaid  the  bank  loan  of  RMB0.8  million  ($0.12  million),
RMB24.3 million ($3.72 million) and RMB0.8 million ($0.12 million) in December 2018, June 2019 and December 2019, respectively.

On June 28, 2020, we entered into a supplemental agreement with China Everbright Bank Dalian Branch to change the repayment schedule. According to
the  modification  agreement,  the  remaining  RMB141.8  million  (approximately  $21.72  million)  loans  are  repayable  in  eight  instalments  consisting  of
RMB1.09 million ($0.17 million) on June 10, 2020, RMB1 million ($0.15 million) on December 10, 2020, RMB2 million ($0.31 million) on January 10,
2021, RMB2 million ($0.31 million) on February 10, 2021, RMB2 million ($0.31 million) on March 10, 2021, RMB2 million ($0.31 million) on April 10,
2021, RMB2 million ($0.31 million) on May 10, 2021, and RMB129.7 million ($19.9 million) on June 10, 2021, respectively. We repaid the bank loan of
RMB1.09 million ($0.17 million) and RMB51 million ($7.8 million) in June and December 2020, respectively.

34

 
 
 
 
 
 
 
 
 
As  a  result,  the  balance  of  loan  that  we  borrowed  from  China  Everbright  Bank  Dalian  Branch  as  of  December  31,  2020  was  RMB89.7  million  ($13.7
million). The facilities were secured by our Dalian site’s land use rights and part of our Dalian site’s buildings, machinery and equipment. 

Further, in August 2018, we borrowed a total of RMB60 million (approximately $8.6 million) in the form of bills payable from China Everbright Bank
Dalian Branch for a term until August 14, 2019, which was secured by our cash totaled $8.6 million. We discounted these two bills payable of even date to
China Everbright Bank at a rate of 4.0%. We repaid these bills payable in August 2019.

On August  22,  2018,  we  obtained  one-year  term  facilities  from  China  Everbright  Bank  Dalian  Branch  with  a  maximum  amount  of  RMB100  million
(approximately $14.4 million) including revolving loans, trade finance, notes discount, and acceptance of commercial bills etc. Any amount drawn under
the facilities requires security in the form of cash or banking acceptance bills receivables of at least the same amount. Under the facilities as of December
31, 2018, we borrowed a series of bank acceptance bills totaled RMB28.8 million (approximately $4.1 million) for a term until March 7, 2019, which was
secured by bills receivables of $4.1 million. We repaid the bank acceptance bills on March 7, 2019.

In November 2018, we borrowed a total of RMB100 million (approximately $14.4 million) in the form of bills payable from China Everbright Bank Dalian
Branch for a term until November 12, 2019, which was secured by our cash totaled RMB50 million (approximately $7.2 million) and the 100% equity in
CBAK Power held by BAK Asia. We discounted these five bills payable of even date to China Everbright Bank at a rate of 4.0%. We repaid these bills
payable in November 2019.

We  also  borrowed  a  series  of  acceptance  bill  from  Industrial  Bank  Co.,  Ltd.  Dalian  Branch  totaled  RMB1.5  million  (approximately  $0.2  million)  for
various  terms  through  May  21,  2019,  which  was  secured  by  bills  receivable  of  RMB1.5  million  (approximately  $0.2  million).  We  repaid  the  bank
acceptance bills on May 21, 2019.

In October 2019, we borrowed a total of RMB28 million (approximately $4.12 million) in the form of bills payable from China Everbright Bank Dalian
Branch for a term until October 15, 2020, which was secured by the Company’s cash totaled RMB28 million (approximately $4.12 million. We discounted
these bills payable of even date to China Everbright Bank at a rate of 3.30%. We repaid the bills on October 15, 2020.

In December 2019, we obtained banking facilities from China Everbright Bank Dalian Branch totaled RMB39.9 million (approximately $6.1 million) for a
term until November 6, 2020, bearing interest at 5.655% per annum. The facility was secured by 100% equity in CBAK Power held by BAK Asia and
buildings of Hubei BAK Real Estate Co., Ltd., which our CEO Mr. Yunfei Li holding 15% equity interest. Under the facilities, we borrowed RMB39.9
million  (approximately  $6.1  million)  on  December  30,  2019.  We  repaid  the  bank  loan  of  RMB39.9  million  (approximately  $6.1  million)  in  December
2020.

From  July  to  December  2020,  we  borrowed  a  series  of  acceptance  bills  from  China  Merchants  Bank  totaled  RMB24.9  million  (approximately  $3.82
million) for various terms through January to June 2021, which was secured by our cash totaled RMB24.9 million (approximately $3.82 million).

In December 2020, we borrowed a series of acceptance bills from Agricultural Bank of China totaled RMB32.5 million (approximately $4.97 million) for
various terms through January to June 2021, which was secured by our cash totaled RMB32.5 million (approximately $4.97 million).

In January 2019, we obtained one-year term facilities from Jilin Province Trust Co. Ltd. with a maximum amount of RMB40.0 million (approximately $5.8
million), which was secured by land use rights and buildings of Eodos Liga Energy Co., Ltd. Under the facilities, we borrowed RMB16.4 million ($2.4
million),  RMB15.4  million  ($2.2  million),  RMB6.6  million  ($0.9  million)  and  RMB1.2  million  ($0.2  million)  on  February  1,  2019,  February  22,  2019,
March 8, 2019 and March 21, 2019 respectively. Subsequent to December 31, 2019, we fully repaid the loan principal and accrued interest.

35

 
 
 
 
 
 
 
 
 
 
 
 
In  March  2020,  we  obtained  additional  one-year  term  facilities  from  Jilin  Province  Trust  Co.  Ltd.  with  a  maximum  amount  of  RMB40.0  million
(approximately  $5.9  million),  which  was  secured  by  land  use  rights  and  buildings  of  Eodos  Liga  Energy  Co.,  Ltd.  Under  the  facilities,  we  borrowed
RMB24.2 million ($3.5 million) on March 13, 2020, bearing annual interest of 13.5%. We fully repaid the loan principal and accrued interests in December
2020.

As of December 31, 2020, we had unutilized committed banking facilities of $4.9 million. We plan to renew these loans upon maturity and intend to raise
additional funds through bank borrowings in the future to meet our daily cash demands, if required.

In addition, we have obtained funds through private placements, registered direct offerings and other equity and note financings:

On  July  28,  2016,  the  Company  entered  into  securities  purchase  agreements  with  Mr.  Jiping  Zhou  and  Mr.  Dawei  Li  to  issue  and  sell  an  aggregate  of
2,206,640 shares of common stock of the Company, at $2.5 per share, for an aggregate consideration of approximately $5.52 million. On August 17, 2016,
the Company issued the foregoing shares to the two investors.

On  February  17,  2017,  we  signed  a  letter  of  understanding  with  each  of  eight  individual  investors,  including  our  CEO,  Mr.  Yunfei  Li,  whereby  these
shareholders agreed in principle to subscribe for new shares of our common stock totaling $10 million. The issue price was determined with reference to
the market price prior to the issuance of new shares. In January 2017, the shareholders paid us a total of $2.1 million as refundable earnest money, among
which, Mr. Yunfei Li agreed to subscribe new shares totaling $1.12 million and pay a refundable earnest money of $0.2 million. In April and May 2017, we
received cash of $9.6 million from these shareholders. On May 31, 2017, we entered into a securities purchase agreement with these investors, pursuant to
which we agreed to issue an aggregate of 6,403,518 shares of common stock to these investors, at a purchase price of $1.50 per share, for an aggregate
price of $9.6 million, including 764,018 shares issued to Mr. Yunfei Li. On June 22, 2017, we issued the shares to the investors. The issuance of the shares
to the investors was made in reliance on the exemption provided by Section 4(a)(2) of the Securities Act. In 2019, according to the securities purchase
agreement and agreed by the investors, we returned partial earnest money of $966,579 (approximately RMB6.7 million) to these investors.

On January 7, 2019, each of Mr. Dawei Li and Mr. Yunfei Li entered into an agreement with CBAK Power and Tianjin New Energy whereby Tianjin New
Energy  assigned  its  rights  to  loans  to  CBAK  Power  of  approximately  $3.4  million  (RMB23,980,950)  and  $1.7  million  (RMB11,647,890)  (totaled  $5.1
million, the “First Debt”) to Mr. Dawei Li and Mr. Yunfei Li, respectively. On the same date, the Company entered into a cancellation agreement with Mr.
Dawei  Li  and  Mr.  Yunfei  Li.  Pursuant  to  the  terms  of  the  cancellation  agreement,  Mr.  Dawei  Li  and  Mr.  Yunfei  Li  agreed  to  cancel  the  First  Debt  in
exchange for 3,431,373 and 1,666,667 shares of common stock of the Company, respectively, at an exchange price of $1.02 per share. Upon receipt of the
shares, the creditors released the Company from any claims, demands and other obligations relating to the First Debt.

On April 26, 2019, each of Mr. Jun Lang, Ms. Jing Shi and Asia EVK Energy Auto Limited (“Asia EVK”) entered into an agreement with CBAK Power
and Tianjin New Energy whereby Tianjin New Energy assigned its rights to loans to CBAK Power of approximately $0.3 million (RMB2,225,082), $0.1
million (RMB 912,204) and $5.2 million (RMB35,406,036) (collectively $5.7 million, the “Second Debt”) to Mr. Jun Lang, Ms. Jing Shi and Asia EVK,
respectively. On the same date, the Company entered into a cancellation agreement with Mr. Jun Lang, Ms. Jing Shi and Asia EVK (the creditors). Pursuant
to  the  terms  of  the  Cancellation  Agreement,  the  creditors  agreed  to  cancel  the  Second  Debt  in  exchange  for  300,534,  123,208  and  4,782,163  shares  of
common stock of the Company, respectively, at an exchange price of $1.1 per share. Upon receipt of the shares, the creditors released the Company from
any claims, demands and other obligations relating to the Second Debt.

On  June  28,  2019,  each  of  Mr.  Dawei  Li  and  Mr.Yunfei  Li  entered  into  an  agreement  with  CBAK  Power  to  loan  approximately  $1.4  million
(RMB10,000,000)  and  $2.5  million  (RMB18,000,000),  respectively,  to  CBAK  Power  for  a  terms  of  six  months  (collectively  $3.9  million,  the  “Third
Debt”). The loan was unsecured, non-interest bearing and repayable on demand. On July 16, 2019, each of Asia EVK and Mr. Yunfei Li entered into an
agreement  with  CBAK  Power  and  Dalian  Zhenghong  Architectural  Decoration  and  Installation  Engineering  Co.  Ltd.  (the  Company’s  construction
contractor) whereby Dalian Zhenghong Architectural Decoration and Installation Engineering Co. Ltd. assigned its rights to the unpaid construction fees
owed by CBAK Power of approximately $2.8 million (RMB20,000,000) and $0.4 million (RMB2,813,810) (collectively $3.2 million, the “Fourth Debt”)
to Asia EVK and Mr. Yunfei Li, respectively. On July 26, 2019, we entered into a cancellation agreement with Mr. Dawei Li, Mr. Yunfei Li and Asia EVK
(the creditors). Pursuant to the terms of the cancellation agreement, Mr. Dawei Li, Mr. Yunfei Li and Asia EVK agreed to cancel the Third Debt and Fourth
Debt in exchange for 1,384,717, 2,938,067 and 2,769,435 shares of common stock of the Company, respectively, at an exchange price of $1.05 per share.
Upon receipt of the shares, the creditors released the Company from any claims, demands and other obligations relating to the Third Debt and Fourth Debt.

36

 
 
 
 
 
 
 
 
 
 
On October 10, 2019, each of Mr. Shibin Mao, Ms. Lijuan Wang and Mr. Ping Shen entered into an agreement with CBAK Power and Zhengzhou BAK
New  Energy  Vehicle  Co.,  Ltd.  (the  Company’s  supplier)  whereby  Zhengzhou  BAK  New  Energy  Vehicle  Co.,  Ltd.  assigned  its  rights  to  the  unpaid
inventories cost owed by CBAK Power of approximately $2.1 million (RMB15,000,000), $1.0 million (RMB7,380,000) and $1.0 million (RMB7,380,000)
(collectively $4.2 million, the “Fifth Debt”) to Mr. Shibin Mao, Ms. Lijuan Wang and Mr. Ping Shen, respectively.

On  October  14,  2019,  we  entered  into  a  cancellation  agreement  with  Mr.  Shangdong  Liu,  Mr.  Shibin  Mao,  Ms.  Lijuan  Wang  and  Mr.  Ping  Shen  (the
creditors). Pursuant to the terms of the cancellation agreement, Mr. Shangdong Liu, Mr. Shibin Mao, Ms. Lijuan Wang and Mr. Ping Shen agreed to cancel
and convert the Fifth Debt and the unpaid earnest money in exchange for 528,053, 3,536,068, 2,267,798 and 2,267,798 shares of common stock of the
Company, respectively, at an exchange price of $0.6 per share. Upon receipt of the shares, the creditors released the Company from any claims, demands
and other obligations relating to the Fifth Debt and the unpaid earnest money.

On April 27, 2020, we entered into a cancellation agreement with Mr. Yunfei Li, Asia EVK and Mr. Ping Shen, who loaned an aggregate of approximately
$4.3  million  to  CBAK  Power  (the  “Sixth  Debt”).  Pursuant  to  the  terms  of  the  cancellation  agreement,  the  creditors  agreed  to  cancel  the  Sixth  Debt  in
exchange for an aggregate of 8,928,193 shares of common stock of the Company at an exchange price of $0.48 per share. According to the amount of loan,
2,062,619,  2,151,017  and  4,714,557  shares  were  issued  to  Mr.  Yunfei  Li,  Asia  EVK  and  Mr.  Pin  Shen,  respectively.  Upon  receipt  of  the  shares,  the
creditors released the Company from any claims, demands and other obligations relating to the Sixth Debt.

On July 24, 2019, we entered into a securities purchase agreement with Atlas Sciences, LLC (the “Lender”), pursuant to which we issued a promissory note
(the “Note I”) to the Lender. The Note I has an original principal amount of $1,395,000, bears interest at a rate of 10% per annum and will mature 12
months after the issuance, unless earlier paid or redeemed in accordance with its terms. The Company received proceeds of $1,250,000 after an original
issue discount of $125,000 and payment of Lender’s expenses of $20,000.

On  December  30,  2019,  we  entered  into  a  second  securities  purchase  agreement  with  Atlas  Sciences,  LLC,  pursuant  to  which  the  Company  issued  a
promissory note (the “Note II”) to the Lender. The Note II has an original principal amount of $1,670,000, bears interest at a rate of 10% per annum and
will mature 12 months after the issuance, unless earlier paid or redeemed in accordance with its terms. We received proceeds of $1,500,000 after an original
issue discount of $150,000 and payment of Lender’s expenses of $20,000.

On January 27, 2020, we entered into an exchange agreement (the “First Exchange Agreement”) with the Lender, pursuant to which we and the Lender
agreed to (i) partition a new promissory note in the original principal amount equal to $100,000 (the “Partitioned Promissory Note) from the outstanding
balance of certain promissory note that the Company issued to the Lender on July 24, 2019, which has an original principal amount of $1,395,000, and (ii)
exchange the Partitioned Promissory Note for the issuance of 160,256 shares of the Company’s common stock, par value $0.001 per share, to the Lender.

On February 20, 2020, we entered into another exchange agreement (the “Second Exchange Agreement”) with the Lender, pursuant to which the Company
and the Lender agreed to (i) partition a new promissory note in the original principal amount equal to $100,000 (the “Partitioned Promissory Note”) from
the outstanding balance of certain promissory note that the Company issued to the Lender on July 24, 2019, which has an original principal amount of
$1,395,000, and (ii) exchange the Partitioned Promissory Note for the issuance of 207,641 shares of the Company’s common stock, par value $0.001 per
share, to the Lender.

On April 28, 2020, we entered into a third exchange agreement (the “Third Exchange Agreement”) with the Lender, pursuant to which the Company and
the Lender agreed to (i) partition a new promissory note in the original principal amount equal to $100,000 (the “Partitioned Promissory Note”) from the
outstanding  balance  of  certain  promissory  note  that  the  Company  issued  to  the  Lender  on  July  24,  2019,  which  has  an  original  principal  amount  of
$1,395,000, and (ii) exchange the Partitioned Promissory Note for the issuance of 312,500 shares of the Company’s common stock, par value $0.001 per
share, to the Lender.

37

 
 
 
 
 
 
 
 
 
 
On June 8, 2020, we entered into a fourth exchange agreement (the “Fourth Exchange Agreement”) with the Lender, pursuant to which the Company and
the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to  $100,000  from  the  outstanding  balance  of  certain
promissory note that the Company issued to the Lender on July 24, 2019, which has an original principal amount of $1,395,000, and (ii) exchange the
partitioned promissory note for the issuance of 271,739 shares of the Company’s common stock, par value $0.001 per share to the Lender.

On June 10, 2020, we entered into a fifth exchange agreement (the “Fifth Exchange Agreement”) with the Lender, pursuant to which the Company and the
Lender agreed to (i) partition a new promissory note in the original principal amount equal to $150,000 from the outstanding balance of certain promissory
note  that  the  Company  issued  to  the  Lender  on  July  24,  2019,  which  has  an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  partitioned
promissory note for the issuance of 407,609 shares of the Company’s common stock, par value $0.001 per share to the Lender.

On July 6, 2020, we entered into a sixth exchange agreement (the “Sixth Exchange Agreement”) with the Lender, pursuant to which the Company and the
Lender agreed to (i) partition a new promissory note in the original principal amount equal to $250,000 from the outstanding balance of certain promissory
note  that  the  Company  issued  to  the  Lender  on  July  24,  2019,  which  has  an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  partitioned
promissory note for the issuance of 461,595 shares of the Company’s common stock, par value $0.001 per share to the Lender.

On July 8, 2020, we entered into certain exchange agreement with the Lender, pursuant to which the Company and the Lender agreed to (i) partition a new
promissory note in the original principal amount equal to $250,000 from the outstanding balance of certain promissory note that the Company issued to the
Lender on December 30, 2019, which has an original principal amount of $1,670,000, and (ii) exchange the partitioned promissory note for the issuance of
453,161 shares of the Company’s common stock, par value $0.001 per share to the Lender.

On July 29, 2020, we entered into a seventh exchange agreement (the “Seventh Exchange Agreement”) with the Lender, pursuant to which the Company
and the Lender agreed to (i) partition a new promissory note in the original principal amount equal to $365,000 from the outstanding balance of certain
promissory note that the Company issued to the Lender on July 24, 2019, which has an original principal amount of $1,395,000, and (ii) exchange the
partitioned promissory note for the issuance of 576,802 shares of the Company’s common stock, par value $0.001 per share to the Lender.

On October 12, 2020, we entered into an amendment to promissory notes (the “Amendment”) with the Lender, pursuant to which the Lender has the right
at any time until the outstanding balance of the notes has been paid in full, at its election, to convert all or any portion of the outstanding balance of the
notes into shares of common stock of the Company. The conversion price for each conversion will be calculated pursuant to the following formula: 80%
multiplied by the lowest closing price of the Company common stock during the ten (10) trading days immediately preceding the applicable conversion.
Notwithstanding the foregoing, in no event will the conversion price be less than $1.00.

According to the Amendment, on October 13, 2020, we exchanged part of the outstanding balances of the notes for the issuance of 709,329 shares of the
Company’s common stock, par value $0.001 per share to the Lender.

On October 20, 2020, the Company exchanged the remaining balance of $778,252 under the notes for the issuance of 329,768 shares of common stock, par
value $0.001 per share to the Lender.

On November 5, 2020, Tillicum Investment Company Limited entered into an agreement with CBAK Nanjing and Shenzhen ESTAR Industrial Company
Limited  (the  Company’s  equipment  supplier)  whereby  Shenzhen  ESTAR  Industrial  Company  Limited  assigned  its  rights  to  the  unpaid  equipment  cost
owed by CBAK Power of approximately $$11.17 million (RMB75,000,000) (the “Seventh Debt”) to Tillicum Investment Company Limited.

38

 
 
 
 
 
 
 
 
 
 
 
On November 11, 2020, we entered into a cancellation agreement with Tillicum Investment Company Limited. Pursuant to the terms of the cancellation
agreement, Tillicum Investment Company Limited agreed to cancel the Seventh Debt in exchange for 3,192,291 shares of common stock of the Company,
at  an  exchange  price  of  $3.5  per  share.  Upon  receipt  of  the  shares,  the  creditor  released  the  Company  from  any  claims,  demands  and  other  obligations
relating to the Seventh Debt.

On  December  8,  2020,  we  entered  into  a  securities  purchase  agreement  with  certain  institutional  investors,  pursuant  to  which  we  issued  in  a  registered
direct offering, an aggregate of 9,489,800 shares of common stock of the Company at a per share purchase price of $5.18, and warrants to purchase an
aggregate of 3,795,920 shares of common stock of the Company at an exercise price of $6.46 per share exercisable for 36 months from the date of issuance,
for gross proceeds of approximately $49.16 million, before deducting fees to the placement agent and other estimated offering expenses payable by the
Company.

On February 8, 2021, we entered into another securities purchase agreement with the same investors, pursuant to which we issued in a registered direct
offering, an aggregate of 8,939,976 shares of common stock of the Company at a per share purchase price of $7.83. In addition, we issued to the investors
(i) in a concurrent private placement, the Series A-1 warrants to purchase a total of 4,469,988 shares of common stock, at a per share exercise price of
$7.67 and exercisable for 42 months from the date of issuance; (ii) in the registered direct offering, the Series B warrants to purchase a total of 4,469,988
shares  of  common  stock,  at  a  per  share  exercise  price  of  $7.83  and  exercisable  for  90  days  from  the  date  of  issuance;  and  (iii)  in  the  registered  direct
offering, the Series A-2 warrants to purchase up to 2,234,992 shares of common stock, at a per share exercise price of $7.67 and exercisable for 45 months
from  the  date  of  issuance.  We  received  gross  proceeds  of  approximately  $70  million  from  the  registered  direct  offering  and  the  concurrent  private
placement, before deducting fees to the placement agent and other estimated offering expenses payable by the Company.

We  currently  are  expanding  our  product  lines  and  manufacturing  capacity  in  our  Dalian  and  Nanjing  plants,  which  require  more  funding  to  finance  the
expansion.  We  may  also  require  additional  cash  due  to  changing  business  conditions  or  other  future  developments,  including  any  investments  or
acquisitions we may decide to pursue. We plan to renew these loans upon maturity, if required, and plan to raise additional funds through bank borrowings
and equity financing in the future to meet our daily cash demands, if required. However, there can be no assurance that we will be successful in obtaining
this financing. If our existing cash and bank borrowing are insufficient to meet our requirements, we may seek to sell equity securities, debt securities or
borrow from lending institutions. We can make no assurance that financing will be available in the amounts we need or on terms acceptable to us, if at all.
The  sale  of  equity  securities,  including  convertible  debt  securities,  would  dilute  the  interests  of  our  current  shareholders.  The  incurrence  of  debt  would
divert cash for working capital and capital expenditures to service debt obligations and could result in operating and financial covenants that restrict our
operations and our ability to pay dividends to our shareholders. If we are unable to obtain additional equity or debt financing as required, our business
operations and prospects may suffer.

The following table sets forth a summary of our cash flows for the periods indicated:

(All amounts in thousands of U.S. dollars)

Net cash used in operating activities
Net cash used in investing activities
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents and restricted cash
Net increase (decrease) in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash at the beginning of the year
Cash and cash equivalents and restricted cash at the end of the year

39

Year Ended
  December 31,     December 31,  

2019

2020

  $

  $

(21,222)   $
(2,420)    
13,550     
(463)    
(10,555)    
17,689     
7,134    $

(5,097)
(5,710)
25,827 
(1,482)
13,538 
7,134 
20,672 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
   
   
   
   
   
 
Operating Activities

Net cash used in operating activities was $5.1 million in the year ended December 31, 2020, as compared to net cash used in operating activities of $21.2
million in 2019. The net cash used in operating activities in 2020 was mainly attributable to our net loss (before loss on disposal of property, plant and
equipment,  impairment  charge  of  property,  plant  and  equipment  and  excluding  non-cash  depreciation  and  amortization  and  changes  in  fair  value  of
warrants liability) of $2.9 million, an increase of $20.8 million for trade accounts and bills receivable partially offset by an increase of $11.1 million on
trade accounts and bills payables, an increase of $3.4 million payable to former subsidiary and $2.9 million government grants received.

The  net  cash  used  in  operating  activities  in  2019  was  mainly  attributable  to  our  net  loss  (before  loss  on  disposal  of  property,  plant  and  equipment,
impairment charge of property, plant and equipment and excluding non-cash depreciation and amortization) of $5.8 million, $30.5 million on settlement of
trade accounts and bills payable and $2.0 million on settlement paid to our former subsidiaries, partially offset by a decrease of $10.3 million for trade
accounts and bills receivable, a decrease of $2.8 million in prepayments and other receivables and an increase of $1.1 million of accrued expenses and
other payables and product warranty provision.

Investing Activities

Net cash used in investing activities increased to $5.7 million in the fiscal year ended December 31, 2020, from $2.4 million in 2019. The net cash used in
investing activities in 2020 and 2019 mainly included purchases of property, plant and equipment and construction in progress.

Financing Activities

Net cash provided by financing activities was $25.8 million in the fiscal year ended December 31, 2020, compared with $13.6 million in 2019. The net
cash provided by financing activities for the year ended December 31, 2020 mainly comprised of $45.3 million net proceeds from issuance of shares to
institutional investors, $3.5 million borrowings from unrelated parties, partially offset by repayment of bank borrowings of $13.3 million and repayment of
borrowings from unrelated parties of $9.8 million.

The  net  cash  provided  by  financing  activities  for  the  year  ended  December  31,  2019  mainly  comprised  of  borrowings  from  banks  of  $5.8  million,
borrowings from unrelated parties of $6.3 million, $4.1 million advances from shareholders and proceeds from issue of promissory note of $2.8 million,
partially offset by repayment of bank borrowings of $3.6 million, repayment of earnest money to shareholders of $1.0 million and repayment to related
parties totaled $1.4 million.

As of December 31, 2020, the principal amounts outstanding under our credit facilities and lines of credit were as follows:

(All amounts in thousands of U.S. dollars)

Long-term credit facilities:
China Everbright Bank

Other line of credit:
China Merchants Bank
Agricultural Bank of China

Other short-term loan:
Jilin Province Trust Co., Ltd
Total

40

Maximum
amount
available

Amount
borrowed

  $

18,672    $

13,740 

3,819     
4,972     
8,791     

3,819 
4,972 
8,791 

  $
  $

2,420    $
29,883    $

- 
22,531 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
    
  
 
   
      
  
   
      
  
   
   
 
   
 
   
      
  
   
      
  
 
Capital Expenditures

We incurred capital expenditures of $17.5 million and $2.5 million in fiscal years ended December 31, 2020 and December 31, 2019, respectively. Our
capital  expenditures  in  2020  were  used  primarily  to  construct  our  Dalian  facility  and  Nanjing  facility.  The  table  below  sets  forth  the  breakdown  of  our
capital expenditures by use for the periods indicated.

(All amounts in thousands of U.S. dollars)

Purchase of property, plant and equipment and construction in progress

Year Ended

December 31, 
2019

December 31, 
2020

  $

2,453    $

17,528

We estimate that our total capital expenditures in fiscal year 2021 will reach approximately $15.2 million. Such funds will be used to renovate the current
product lines and construct new plant with new product lines and battery module packing lines.

Contractual Obligations and Commercial Commitments

The following table sets forth our contractual obligations and commercial commitments as of December 31, 2020:

(All amounts in thousands of U.S. dollars)

Contractual Obligations
Current maturities of long-term bank loans
Bills payables
Payable to former subsidiaries
Other short-term loans
Capital injection to CBAK Trading
Capital injection to CBAK Power
Capital injection to CBAK Energy
Capital injection to CBAK Nanjing
Capital injection to Nanjing CBAK
Capital injection to Nanjing Daxin
Capital commitments for construction of buildings
Capital commitments for purchase of equipment
Future interest payment on bank loans
Total

Payments Due by Period
Less than
1 year

1 - 3 years

More than 
3 years

Total

  $

  $

13,740    $
8,791     
627     
1,254     
2,565     
30,000     
45,600     
64,710     
77,582     
7,659     
2,465     
10,308     
379     
265,680    $

13,740    $
8,791     
627     
1,254     
2,565     
30,000     
45,600     
64,710     
77,582     
7,659     
2,465     
10,308     
379     
265,680    $

     -    $
-     
-     
-     
-     
-     
-     
-     
-     
-     
-     
-     
-     
-    $

     - 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 

Other than the contractual obligations and commercial commitments set forth above, we did not have any other long-term debt obligations, operating lease
obligations, capital commitments, purchase obligations or other long-term liabilities as of December 31, 2020.

Off-Balance Sheet Transactions

We have not entered into any transactions, agreements or other contractual arrangements to which an entity unconsolidated with us is a party and under
which we have (i) any obligation under a guarantee, (ii) any retained or contingent interest in assets transferred to an unconsolidated entity that serves as
credit,  liquidity  or  market  risk  support  to  such  entity,  (iii)  any  obligation  under  derivative  instruments  that  are  indexed  to  our  shares  and  classified  as
shareholders’ equity in our consolidated balance sheets, or (iv) any obligation arising out of a variable interest in any unconsolidated entity that provides
financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.

Critical Accounting Policies

Our consolidated financial information has been prepared in accordance with U.S. GAAP, which requires us to make judgments, estimates and assumptions
that affect (1) the reported amounts of our assets and liabilities, (2) the disclosure of our contingent assets and liabilities at the end of each fiscal period and
(3)  the  reported  amounts  of  revenues  and  expenses  during  each  fiscal  period.  We  continually  evaluate  these  estimates  based  on  our  own  historical
experience, knowledge and assessment of current business and other conditions, our expectations regarding the future based on available information and
reasonable assumptions, which together form our basis for making judgments about matters that are not readily apparent from other sources. Since the use
of  estimates  is  an  integral  component  of  the  financial  reporting  process,  our  actual  results  could  differ  from  those  estimates.  Some  of  our  accounting
policies require a higher degree of judgment than others in their application.

41

 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
   
   
   
 
   
      
      
      
  
   
   
   
   
   
   
   
   
   
   
   
   
 
 
 
 
 
 
When reviewing our financial statements, the following should also be considered: (1) our selection of critical accounting policies, (2) the judgment and
other  uncertainties  affecting  the  application  of  those  policies,  and  (3)  the  sensitivity  of  reported  results  to  changes  in  conditions  and  assumptions.  We
believe the following accounting policies involve the most significant judgment and estimates used in the preparation of our financial statements.

We consider the following to be the most critical accounting policies:

Revenue Recognition

We recognize revenues when our customer obtains control of promised goods or services, in an amount that reflects the consideration which it expects to
receive in exchange for those goods. We recognize revenues following the five step model prescribed under ASU No. 2014-09: (i) identify contract(s) with
a  customer;  (ii)  identify  the  performance  obligations  in  the  contract;  (iii)  determine  the  transaction  price;  (iv)  allocate  the  transaction  price  to  the
performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation.

Revenues from product sales are recognized when the customer obtains control of our product, which occurs at a point in time, typically upon delivery to
the customer. We expense incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that it would have
recognized is one year or less or the amount is immaterial.

Revenues from product sales are recorded net of reserves established for applicable discounts and allowances that are offered within contracts with our
customers.

Product revenue reserves, which are classified as a reduction in product revenues, are generally characterized in the categories: discounts and returns. These
reserves are based on estimates of the amounts earned or to be claimed on the related sales and are classified as reductions of accounts receivable as the
amount is payable to our customer.

Impairment of Long-lived Assets

Long-lived assets, which include property, plant and equipment, prepaid land use rights and intangible assets, are reviewed for impairment whenever events
or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future
cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment
charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.

Trade Accounts and Bills Receivable

Trade  accounts  and  bills  receivable  are  recorded  at  the  invoiced  amount,  net  of  allowances  for  doubtful  accounts  and  sales  returns.  The  allowance  for
doubtful accounts is our best estimate of the amount of probable credit losses in our existing trade accounts receivable. We determine the allowance based
on historical write-off experience, customer specific facts and economic conditions.

Outstanding  accounts  receivable  balances  are  reviewed  individually  for  collectability.  Account  balances  are  charged  off  against  the  allowance  after  all
means of collection have been exhausted and the potential for recovery is considered remote.

Inventories

Inventories  are  stated  at  the  lower  of  cost  or  net  realizable  value.  The  cost  of  inventories  is  determined  using  the  weighted  average  cost  method,  and
includes expenditure incurred in acquiring the inventories and bringing them to their existing location and condition. In case of finished goods and work in
progress, cost includes an appropriate share of production overhead based on normal operating capacity. Net realizable value is the estimated selling prices
in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.

We  record  adjustments  to  its  inventory  for  estimated  obsolescence  or  diminution  in  net  realizable  value  equal  to  the  difference  between  the  cost  of  the
inventory and the estimated net realizable value. At the point of loss recognition, a new cost basis for that inventory is established, and subsequent changes
in facts and circumstances do not result in the restoration or increase in that newly established cost basis.

Warranties

We provide a manufacturer’s warranty on all our products. We accrue a warranty reserve for the products sold, which includes our best estimate of the
projected  costs  to  repair  or  replace  items  under  warranty.  These  estimates  are  based  on  actual  claims  incurred  to  date  and  an  estimate  of  the  nature,
frequency  and  costs  of  future  claims.  These  estimates  are  inherently  uncertain  given  our  relatively  short  history  of  sales  of  our  current  products,  and
changes to our historical or projected warranty experience may cause material changes to the warranty reserve in the future. The portion of the warranty
reserve expected to be incurred within the next 12 months is included within accrued liabilities and other while the remaining balance is included within
other long-term liabilities on the consolidated balance sheets.

42

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Government Grants

Our subsidiaries in China receive government subsidies from local Chinese government agencies in accordance with relevant Chinese government policies.
In general, we present the government subsidies received as income unless the subsidies received are earmarked to compensate a specific expense, which
have  been  accounted  for  by  offsetting  the  specific  expense,  such  as  research  and  development  expense,  interest  expenses  and  removal  costs.  Unearned
government subsidies received are deferred for recognition until the criteria for such recognition could be met.

Grants applicable to land are amortized over the life of the depreciable facilities constructed on it. For research and development expenses, we match and
offset the government grants with the expenses of the research and development activities as specified in the grant approval document in the corresponding
period when such expenses are incurred.

Share-based Compensation

We adopted the provisions of ASC Topic 718 which requires us to measure and recognize compensation expenses for an award of an equity instrument
based  on  the  grant-date  fair  value.  The  cost  is  recognized  over  the  vesting  period  (or  the  requisite  service  period).  ASC  Topic  718  also  requires  us  to
measure the cost of a liability classified award based on its current fair value. The fair value of the award will be remeasured subsequently at each reporting
date through the settlement date. Changes in fair value during the requisite service period are recognized as compensation cost over that period. Further,
ASC Topic 718 requires us to estimate forfeitures in calculating the expense related to stock-based compensation.

The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Valuation Model. The expected volatility was based
on the historical volatilities of our listed common stocks in the United States and other relevant market information. We use historical data to estimate share
option exercises and employee departure behavior used in the valuation model. The expected terms of share options granted is derived from the output of
the option pricing model and represents the period of time that share options granted are expected to be outstanding. Since the share options once exercised
will primarily trade in the U.S. capital market, the risk-free rate for periods within the contractual term of the share option is based on the U.S. Treasury
yield curve in effect at the time of grant.

Warrant Liability

For warrants that are not indexed to the Company’s stock, the Company records the fair value of the issued warrants as a liability at each balance sheet date
and  records  changes  in  the  estimated  fair  value  as  a  non-cash  gain  or  loss  in  the  consolidated  statement  of  operations  and  comprehensive  income.  The
warrant  liability  is  recognized  in  the  balance  sheet  at  the  fair  value  (level  3).  The  fair  value  of  these  warrants  has  been  determined  using  the  Binomial
model.

Changes in Accounting Standards

Please refer to note 2 to our consolidated financial statements, “Summary of Significant Accounting Policies and Practices –Recently Issued Accounting
Standards,” for a discussion of relevant pronouncements.

Exchange Rates

The financial records of our PRC subsidiaries are maintained in RMB. In order to prepare our financial statements, we have translated amounts in RMB
into amounts in U.S. dollars. The amounts of our assets and liabilities on our balance sheets are translated using the closing exchange rate as of the date of
the  balance  sheet.  Revenues,  expenses,  gains  and  losses  are  translated  using  the  average  exchange  rate  prevailing  during  the  period  covered  by  such
financial statements. Adjustments resulting from the translation, if any, are included in our cumulative other comprehensive income in our stockholders’
equity section of our balance sheet. All other amounts that were originally booked in RMB and translated into U.S. dollars were translated using the closing
exchange rate on the date of recognition. Consequently, the exchange rates at which the amounts in those comparisons were computed varied from year to
year.

The exchange rates used to translate amounts in RMB into U.S. dollars in connection with the preparation of our financial statements were as follows:

Balance sheet items, except for equity accounts
Amounts included in the statement of income and comprehensive loss and statement of cash flows

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not applicable.

43

RMB per U.S. Dollar
Fiscal Year Ended
  December 31,     December 31,  

2019

2020

6.9630     
6.9073     

6.5286 
6.9032 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
   
   
 
 
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

FINANCIAL STATEMENTS
CBAK ENERGY TECHNOLOGY, INC. AND SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED
DECEMBER 31, 2019 AND 2020

CBAK ENERGY TECHNOLOGY, INC.
AND SUBSIDIARIES

TABLE OF CONTENTS

Contents
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets as of December 31, 2019 and 2020
Consolidated Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, 2019 and 2020
Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2019 and 2020
Consolidated Statements of Cash Flows for the years ended December 31, 2019 and 2020
Notes to the Consolidated Financial Statements

Page(s)
F-2 – F4
F-5
F-6
F-7
F-8
F-9 - F-52

F-1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors of
CBAK Energy Technology, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of CBAK Energy Technology, Inc. and subsidiaries (the “Company”) as of December 31,
2020 and 2019, and the related consolidated statements of operations and comprehensive income (loss), changes in shareholders’ equity and cash flows for
each of the two years in the period ended December 31, 2020, and the related notes (collectively referred to as the “consolidated financial statements”). In
our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December
31, 2020 and 2019, and the consolidated results of its operations and its cash flows for each of the two years in the period ended December 31, 2020, in
conformity with U.S. generally accepted accounting principles.

Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in
Note  1  to  the  consolidated  financial  statements,  the  Company  has  a  working  capital  deficiency,  accumulated  deficit  from  recurring  net  losses  and
significant short-term debt obligations maturing in less than one year as of December 31, 2020. All these factors raise substantial doubt about its ability to
continue as a going concern. Management’s plans in regard to these matters are also discussed in Note 1 to the consolidated financial statements. These
consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s
consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the
applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable
assurance  about  whether  the  consolidated  financial  statements  are  free  of  material  misstatement,  whether  due  to  error  or  fraud.  The  Company  is  not
required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain
an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal
control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and
disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by
management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis
for our opinion.

F-2

 
 
 
 
 
 
 
 
 
 
 
 
Critical Audit Matters

The  critical  audit  matters  communicated  below  are  matters  arising  from  the  current  period  audit  of  the  consolidated  financial  statements  that  were
communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated
financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not
alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below,
providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Going concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in
Note  1  to  the  consolidated  financial  statements,  the  Company  has  a  working  capital  deficiency,  accumulated  deficit  from  recurring  net  losses  and
significant  short-term  debt  obligations  maturing  in  less  than  one  year  as  of  December  31,  2020.  The  Company  has  contractual  obligations  such  as
commitments  for  purchases  of  equipment,  building  constructions  cost,  payable,  capital  injection  to  subsidiaries  and  short-term  loan  (collectively
“obligations”).  Currently  management’s  forecasts  and  related  assumptions  illustrate  their  ability  to  meet  the  obligations  through  management  of
expenditures and, if necessary, obtaining additional debt financing, loans from existing directors and shareholders and private placements of capital stock
for  additional  funding  to  meet  its  operating  needs.  Should  there  be  constraints  on  the  ability  to  access  such  financing,  the  Company  can  manage  cash
outflows to meet the obligations through reductions in capital expenditures and other operating expenditures.

We identified management’s assessment of the Company’s ability to continue as a going concern as a critical audit matter. Management made judgments to
conclude that it is probable that the Company’s plans will be effectively implemented and will provide the necessary cash flows to fund the Company’s
obligations  as  they  become  due.  Specifically,  the  judgments  with  the  highest  degree  of  impact  and  subjectivity  in  determining  it  is  probable  that  the
Company’s plans will be effectively implemented included the revenue growth and gross margin assumptions underlying its forecast operating cash flows,
its ability to reduce capital expenditures and other operating expenditures, its ability to access funding from the capital market and its ability to obtaining
loans from existing directors and shareholders. Auditing the judgments made by management required a high degree of auditor judgment and an increased
extent of audit effort.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated
financial statements. These procedures included the following, among others: (i) testing key assumptions underlying management’s forecast operating cash
flows, including revenue growth and gross margin assumptions; (ii) evaluating the probability that the Company will be able to access funding from the
capital market; (iii) evaluating the probability that the Company will be able to reduce capital expenditures and other operating expenditures if required and
(iv) evaluating the probability that the Company will be able to obtain the loan from existing directors and shareholders.

Inventory write-down

As described in Note 2 of the consolidated financial statements, inventories are stated at the lower of cost or net realizable value, with cost determined on a
weighted average cost method. Write-down of potential obsolete or slow moving inventories is recorded based on management’s assumptions about future
demands and market conditions. For the year ended December 31, 2020, the Company recorded inventory impairment charges of $1.5 million. Inventories
include items that have been written down to the Company’s best estimate of their realizable value, which includes consideration of various factors.

We identified the inventory write-down as a critical audit matter. The Company’s determination of future markdowns is subjective. Specifically, there was a
high degree of subjective auditor judgment in evaluating how the Company’s merchandising strategy and related inventory markdown assumptions affected
the realizable value of inventory.

F-3

 
 
 
 
 
 
 
 
 
 
 
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated
financial statements. These procedures included the following, among others: (i) observing the physical condition of inventories during inventory counts;
(ii)  evaluating  the  appropriateness  of  management’s  process  for  developing  the  estimates  of  net  realizable  value;  (iii)  testing  the  reasonableness  of  the
assumptions  about  quality,  damages,  future  demand,  selling  prices  and  market  conditions  by  considering  with  historical  trends  and  consistency  with
evidence  obtained  in  other  areas  of  the  audit;  and  corroborating  the  assumptions  with  individuals  within  the  product  team;  and  (iv)  assessing  the
Company’s adjustments of inventory costs to net realizable value for slow-moving and obsolete inventories by (1) comparing the historical estimate for net
realizable value adjustments to actual adjustments of inventory costs, and (2) analyzing sales subsequent to the measurement date.

Assessment of impairment of long-lived assets

As  discussed  in  Note  2  to  the  consolidated  financial  statements,  the  Company  reviews  long-lived  assets  for  impairment  whenever  events  or  changes  in
circumstances indicate the carrying value of these assets may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a
comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount
of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the
asset  exceeds  the  fair  value  of  the  asset.  Fair  value  is  generally  measured  based  on  either  quoted  market  prices,  if  available,  or  discounted  cash  flow
analyses. Based upon the analysis performed, the Company recognized impairment losses for long-lived assets of $4.3 million for the year ended December
31, 2020.

We identified the assessment of impairment of long-lived assets as a critical audit matter because of the significant estimates and assumptions management
used in the projections of future cash flows, including the expected production and sales volumes, production costs, operating expenses and discount rates
applied to these forecasted future cash flows. Performing audit procedures to evaluate the reasonableness of these estimates and assumptions required a
high degree of auditor judgment and an increased extent of effort.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated
financial statements. These procedures included the following, among others: (i) comparing the methodology used by the Company, that is, recoverable
amount calculations based on future discounted cash flows, to industry practice and testing the completeness and accuracy of the underlying data used in
the  projections;  (ii)  assessing  the  reasonableness  of  the  significant  assumptions  used  in  the  calculations,  which  comprised  of,  amongst  others,  expected
production  and  sales  volumes,  production  costs,  operating  expenses  and  discount  rates,  by  comparing  them  to  external  industry  outlook  reports  from  a
number  of  sources  and  by  analyzing  the  historical  accuracy  of  management’s  estimates;  and  (iii)  involving  our  valuation  specialists  to  assist  us  with
assessing the appropriateness of the valuation methodologies and the reasonableness of assumptions used, including the discount rates.

Assessment of allowances for doubtful accounts

As  discussed  in  Note  2  to  the  consolidated  financial  statements,  the  allowance  for  doubtful  accounts  is  the  Company’s  best  estimate  of  the  amount  of
probable  credit  losses  in  the  Company’s  existing  trade  accounts  receivable.  The  Company  determines  the  allowance  based  on  historical  write-off
experience,  customer  specific  facts  and  economic  conditions.  Outstanding  accounts  receivable  balances  are  reviewed  individually  for  collectability.
Account  balances  are  charged  off  against  the  allowance  after  all  means  of  collection  have  been  exhausted  and  the  potential  for  recovery  is  considered
remote. Based upon the analysis performed, the Company recognized a provision for doubtful accounts of $0.7 million for the year ended December 31,
2020.

We identified the assessment of allowances for doubtful accounts as a critical audit matter. Specifically, the specific allowance is an estimate that involved
assessing the likelihood of collection of a customer’s accounts receivable by considering various factors such as the nature of any dispute, communications
from the customer, historical collections, and number of days accounts receivables have been outstanding. Subjective auditor judgment was involved in
evaluating the relevance and reliability of the evidence obtained in evaluating these factors.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated
financial  statements.  These  procedures  included  the  following,  among  others:  (i)  investigating  significant  fluctuations  in  the  specific  allowance  as
compared to net accounts receivable and the prior year specific allowance; (ii) inquiring of Company personnel to evaluate the rationale for establishing a
specific  allowance  for  certain  customers;  (iii)  assessing  the  Company’s  estimate  of  the  specific  customer  allowance  by  evaluating  the  underlying
contractual documents, historical collection trends, communications with customers and other additional factors; and (iv) evaluating subsequent collections
occurring after the balance sheet date and considered the impact of potential subsequent events on the estimate of the specific allowance.

/s/ Centurion ZD CPA & Co.

Centurion ZD CPA & Co.

We have served as the Company’s auditor since 2016.
Hong Kong, China
April 13, 2021

F-4

 
 
 
 
 
 
 
 
 
 
 
 
 
 
CBAK Energy Technology, Inc. and Subsidiaries
Consolidated Balance Sheets
As of December 31, 2019 and 2020
(In US$ except for number of shares)

Assets
Current assets
Cash and cash equivalents
Pledged deposits
Trade accounts and bills receivable, net
Inventories
Prepayments and other receivables
Investment in sales-type lease, net

Total current assets

Property, plant and equipment, net
Construction in progress
Right-of-use assets
Intangible assets, net
Investment in sales-type lease, net

Total assets

Liabilities
Current liabilities
Trade accounts and bills payable
Current maturities of long-term bank loans
Other short-term loans
Notes payables
Accrued expenses and other payables
Payables to former subsidiaries, net
Deferred government grants, current
Product warranty provisions
Warrants liability

Total current liabilities

Long-term bank loans
Deferred government grants, non-current
Product warranty provisions
Long term tax payable

Total liabilities

Commitments and contingencies

Shareholders’ equity
Common stock $0.001 par value; 500,000,000 authorized; 53,220,902 issued and 53,076,696

outstanding as of December 31, 2019; and 79,310,249 issued and 79,166,043 outstanding as of
December 31, 2020

Donated shares
Additional paid-in capital
Statutory reserves
Accumulated deficit
Accumulated other comprehensive loss

Less: Treasury shares

Total shareholders’ equity
Non-controlling interests
Total equity

Total liabilities and shareholder’s equity

  December 31,     December 31,  

Note

2019

2020

  $

1,612,957    $
5,520,991     
7,952,420     
8,666,714     
4,735,913     
-     

11,681,750 
8,989,748 
29,571,274 
5,252,845 
7,439,544 
235,245 

28,488,995     

63,170,406 

38,177,565     
21,707,624     
7,194,195     
15,178     
-     

41,040,370 
30,193,309 
7,500,780 
11,807 
850,407 

  $

95,583,557    $ 142,767,079 

  $

15,072,108    $
16,574,752     
7,351,587     
2,846,736     
15,527,589     
1,483,352     
142,026     
-     
-     

28,352,292 
13,739,546 
1,253,869 
- 
11,645,459 
626,990 
151,476 
155,888 
17,783,000 

58,998,150     

73,708,520 

9,519,029     
4,118,807     
2,246,933     
7,042,582     

- 
7,304,832 
1,835,717 
7,511,182 

81,925,501     

90,360,251 

3
4
5
6
10

8
9
10
11
10

12
13
13
17
14
7
15
16
21

13
15
16

23

1,230,511     

53,222     
14,101,689     

79,310 
14,101,689 
    180,208,610      225,278,113 
1,230,511 
    (176,177,413)     (183,984,311)
(239,609)
56,465,703 
(4,066,610)

(1,744,730)    
17,671,889     
(4,066,610)    

13,605,279     
52,777     
13,658,056     

52,399,093 
7,735 
52,406,828 

  $

95,583,557    $ 142,767,079 

See accompanying notes to the consolidated financial statements.

F-5

 
 
 
 
 
 
 
 
 
   
 
 
 
   
   
  
 
 
   
   
  
 
 
 
   
 
   
 
   
 
   
 
   
 
 
 
 
 
  
 
 
  
 
 
   
 
 
 
 
 
  
 
 
  
 
   
 
   
 
   
 
   
 
   
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
  
 
 
  
 
 
   
      
  
 
 
   
      
  
 
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
 
 
 
 
  
 
 
  
 
 
   
 
 
 
 
 
  
 
 
  
 
   
 
   
 
   
 
 
   
 
 
 
 
 
  
 
 
  
 
 
   
 
 
 
 
 
  
 
 
  
 
   
      
  
 
 
 
 
 
  
 
 
  
 
 
   
      
  
 
 
   
 
 
   
 
 
 
 
   
 
 
 
 
   
 
 
 
   
 
 
   
 
 
 
 
 
  
 
 
  
 
 
   
 
 
   
 
 
   
 
 
 
 
 
  
 
 
  
 
 
 
CBAK Energy Technology, Inc. and Subsidiaries
Consolidated Statements of Operations and Comprehensive Income (Loss)
For the years ended December 31, 2019 and 2020
(In US$ except for number of shares)

Year ended    

Year ended  

Net revenues
Cost of revenues
Gross profit
Operating expenses:

Research and development expenses
Sales and marketing expenses
General and administrative expenses
Impairment charge on property, plant and equipment
Provision for doubtful accounts
Total operating expenses

Operating loss
Finance expenses, net
Other income (expenses), net
Changes in fair value of warrants liability
Loss before income tax
Income tax expense
Net loss
Less: Net loss attributable to non-controlling interests
Net loss attributable to shareholders of CBAK Energy Technology, Inc.

Net loss
Other comprehensive income (loss)

– Foreign currency translation adjustment

Comprehensive loss
Less: Comprehensive loss attributable to non-controlling interests
Comprehensive loss attributable to CBAK Energy Technology, Inc.

Loss per share

– Basic and diluted

Weighted average number of shares of common stock:

– Basic and diluted

Note
25

8
4

18

20

20

See accompanying notes to the consolidated financial statements.

F-6

  $

December 31,
2019
22,194,348    $
(21,571,822)    
622,526     

December 31,
2020
37,566,152 
(34,852,132)
2,714,020 

(1,905,504)    
(1,020,929)    
(4,411,878)    
(2,326,552)    
(1,046,360)    
(10,711,223)    
(10,088,697)    
(1,384,904)    
620,166     
-     
(10,853,435)    
-     
(10,853,435)    
85,912     
  $ (10,767,523)   $

(1,678,895)
(701,404)
(3,745,676)
(4,345,811)
(721,737)
(11,193,523)
(8,479,503)
(1,399,095)
(40,170)
2,072,000 
(7,846,768)
- 
(7,846,768)
39,870 
(7,806,898)

(10,853,435)    

(7,846,768)

(246,416)    
(11,099,851)    
86,538     
  $ (11,013,313)   $

1,499,949 
(6,346,819)
45,042 
(6,301,777)

  $

(0.28)   $

(0.10)

38,965,564     

61,992,386 

 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
   
 
 
   
 
 
   
      
  
 
 
   
 
 
   
 
 
   
 
   
 
   
 
 
   
 
 
   
 
 
   
   
   
 
 
   
 
 
   
 
   
 
 
   
 
 
   
 
 
 
 
 
   
      
  
 
 
   
 
 
   
      
  
 
 
   
 
 
   
 
 
   
 
 
 
 
 
   
      
  
 
   
      
  
 
 
 
 
 
   
      
  
 
   
      
  
 
 
   
 
 
CBAK Energy Technology, Inc. and Subsidiaries
Consolidated Statements of Changes in Shareholders’ Equity
For the years ended 2019 and 2020
(In US$ except for number of shares)

Common stock issued

    Additional

  Number
  of shares

    Amount

    Donated
shares

paid-in
capital

Statutory      
reserves
(Note 26)

Accumulated
other

Non-

Treasury shares

    Accumulated     comprehensive    controlling     Number
    of shares

interests

deficit

loss

Amount

Total
    shareholders’ 
equity

Balance as of

January 1, 2019     26,791,684    $

26,792    $ 14,101,689    $ 155,931,770    $ 1,230,511    $(165,409,890)  $

(1,498,940)  $

11,977     

(144,206)  $ (4,066,610)  $

327,299 

Capital contribution

from non-
controlling
interests of a
subsidiary

Net loss

Share-based

compensation for
employee and
director stock
awards

Common stock
issued to
employees and
directors for stock
award

Common stock

Foreign currency
translation
adjustment

Balance as of

December 31,
2019

Net loss

Share-based

compensation for
employee and
director stock
awards

Common stock
issued to
employees and
directors for stock
award

Common stock

Proceeds from

issuance of shares
and warrants for
capital
contribution
Foreign currency
translation
adjustment

Balance as of

December 31,
2020

-     

-     

-     

-     

-     

-     

-     

-     

-     

-     

-     

(10,767,523)   

-     

-     

127,338     

(85,912)   

-     

-     

-     

127,338 

-      (10,853,435)

-     

-     

-     

770,113     

-     

-     

-     

-     

-     

-     

770,113 

433,337     

434     

-     

(434)   

issued to investors     25,995,881     

25,996     

-      23,507,161     

-     

-     

-     

-     

-     

-     

-     

-     

-     

-     

-     

-     

(245,790)   

(626)   

-     

-     

-     

-     

- 

-      23,533,157 

-     

(246,416)

    53,220,902    $

53,222    $ 14,101,689    $ 180,208,610    $ 1,230,511    $(176,177,413)  $

(1,744,730)  $

52,777     

(144,206)  $ (4,066,610)  $ 13,658,056 

-     

-     

-     

-     

-     

(7,806,898)   

-     

(39,870)   

-     

-     

(7,846,768)

-     

-     

-     

803,931     

-     

-     

-     

-     

-     

-     

803,931 

588,663     

588     

-     

(588)   

issued to investors     16,010,884     

16,010     

-      18,782,068     

9,489,800     

9,490     

-      25,484,092     

-     

-     

-     

-     

-     

-     

-     

-     

-     

-     

-     

-     

-     

-     

-     

-     

1,505,121     

(5,172)   

-     

-     

-     

-     

-     

- 

-      18,798,078 

-      25,493,582 

-     

1,499,949 

    79,310,249    $

79,310    $ 14,101,689    $ 225,278,113    $ 1,230,511    $ (183,984,311)  $

(239,609)  $

7,735     

(144,206)  $ (4,066,610)  $ 52,406,828 

See accompanying notes to the consolidated financial statements.

F-7

 
 
 
 
 
     
   
   
   
   
   
 
 
     
   
   
     
 
   
   
   
   
   
   
   
   
 
 
   
     
     
     
     
     
     
   
      
     
     
 
 
   
      
      
      
      
      
      
      
      
      
      
  
   
 
   
      
      
      
      
      
      
      
      
      
      
  
   
 
   
      
      
      
      
      
      
      
      
      
      
  
   
 
   
      
      
      
      
      
      
      
      
      
      
  
   
      
 
   
      
      
      
      
      
      
      
      
      
      
  
      
 
   
      
      
      
      
      
      
      
      
      
      
  
   
 
   
      
      
      
      
      
      
      
      
      
      
  
 
   
      
      
      
      
      
      
      
      
      
      
  
   
 
   
      
      
      
      
      
      
      
      
      
      
  
   
 
   
      
      
      
      
      
      
      
      
      
      
  
   
      
 
   
      
      
      
      
      
      
      
      
      
      
  
      
 
   
      
      
      
      
      
      
      
      
      
      
  
   
   
 
   
      
      
      
      
      
      
      
      
      
      
  
 
 
CBAK Energy Technology, Inc. and subsidiaries
Consolidated statements of cash flows
For the years ended December 31, 2019 and 2020
(In US$)

Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization
Provision for doubtful accounts
Write-down of inventories
Share-based compensation
Changes in fair value of warrants liability
Loss on disposal of property, plant and equipment
Impairment charge
Changes in operating assets and liabilities:

Trade accounts and bills receivable
Inventories
Prepayments and other receivables
Investment in sales-type lease
Trade accounts and bills payable
Accrued expenses and other payables and product warranty provisions
Trade receivable from and payables to former subsidiaries
Government grants

Net cash used in operating activities

Cash flows from investing activities
Proceeds on disposal of property, plant and equipment
Purchases of property, plant and equipment and construction in progress
Net cash used in investing activities

Cash flows from financing activities
Capital injection from non-controlling interests
Proceeds from bank borrowings
Repayment of bank borrowings
Borrowings from unrelated parties
Repayment of borrowings from unrelated parties
Borrowings from related parties
Repayment of borrowings from related parties
Borrowings from shareholders
Repayment of borrowings from shareholders
Repayment of earnest money to shareholders
Proceeds from issuance of shares
Proceeds from issuance of promissory notes (Note 17)
Net cash provided by financing activities

Effect of exchange rate changes on cash and cash equivalents and restricted cash
Net increase (decrease) in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash at the beginning of year
Cash and cash equivalents and restricted cash at the end of year

Supplemental non-cash investing and financing activities:
Transfer of construction in progress to property, plant and equipment

Non-cash payment for purchases of property, plant and equipment and construction in progress by new vehicles

Issuance of common stock (Note 1):
– offset short term borrowings (First Debt, Second Debt and Third Debt)

– offset construction cost payable (Fourth Debt)

– offset accounts payable (Fifth Debt) and unpaid earnest money

– offset repayment of promissory note

– offset payable to Shenzhen Bak (Sixth Debt)

– offset construction cost payable (Seventh Debt)

Cash paid during the year for:
Income taxes

Interest, net of amounts capitalized

Year Ended    

Year Ended  

December 31,
2019

December 31,
2020

  $ (10,853,435)   $

(7,846,768)

2,753,200     
1,046,360     
834,362     
770,113     
-     
213,749     
2,326,552     

10,313,229     
11,044     
2,808,375     
-     
(30,530,773)    
1,087,216     
(2,002,358)    
-     
(21,222,366)    

2,700,888 
721,737 
1,450,182 
803,931 
(2,072,000)
21,317 
4,345,811 

(20,767,355)
2,305,697 
(2,171,694)
(1,026,739)
11,088,116 
(975,687)
3,428,010 
2,897,207 
(5,097,347)

32,719     
(2,452,907)    
(2,420,188)    

- 
(5,709,975)
(5,709,975)

127,338     
5,776,497     
(3,643,971)    
6,341,117     
(14,477)    
492,233     
(1,365,714)    
4,053,682     
-     
(966,579)    
-     
2,750,000     
13,550,126     

- 
- 
(13,325,849)
3,505,621 
(9,778,074)
- 
- 
358,358 
(281,676)
- 
45,348,582 
- 
25,826,962 

(463,117)    
(10,555,545)    
17,689,493     
7,133,948    $

(1,482,090)
13,537,550 
7,133,948 
20,671,498 

5,975,163    $
-    $

8,434,331 
644,917 

15,029,948    $
3,343,378    $
5,159,831    $
-    $
-    $
-    $

- 
- 
- 
3,339,528 
4,285,532 
11,173,018 

-    $

- 

  $

  $
  $

  $
  $
  $
  $
  $
  $

  $

 
 
 
 
 
 
 
   
 
   
     
 
   
      
  
   
   
   
   
   
   
   
   
      
  
   
   
   
   
   
   
   
   
   
 
   
      
  
   
      
  
   
   
   
 
   
      
  
   
      
  
   
   
   
   
   
   
   
   
   
   
   
   
   
 
   
      
  
   
   
   
   
      
  
 
   
      
  
   
      
  
 
   
      
  
   
      
  
 
   
 
See accompanying notes to the consolidated financial statements.

F-8

$

1,378,349

$

989,529

 
 
CBAK Energy Technology, Inc. and subsidiaries
Notes to the consolidated financial statements
For the years ended December 31, 2019 and 2020
(In US$ except for number of shares)

1. Principal Activities, Basis of Presentation and Organization

Principal Activities

CBAK Energy Technology, Inc. (formerly known as China BAK Battery, Inc.) (“CBAK” or the “Company”) is a corporation formed in the State of Nevada
on October 4, 1999 as Medina Copy, Inc. The Company changed its name to Medina Coffee, Inc. on October 6, 1999 and subsequently changed its name to
China BAK Battery, Inc. on February 14, 2005. CBAK and its subsidiaries (hereinafter, collectively referred to as the “Company”) are principally engaged
in the manufacture, commercialization and distribution of a wide variety of standard and customized lithium ion (known as “Li-ion” or “Li-ion cell”) high
power  rechargeable  batteries.  Prior  to  the  disposal  of  BAK  International  Limited  (“BAK  International”)  and  its  subsidiaries  (see  below),  the  batteries
produced  by  the  Company  were  for  use  in  cellular  telephones,  as  well  as  various  other  portable  electronic  applications,  including  high-power  handset
telephones,  laptop  computers,  power  tools,  digital  cameras,  video  camcorders,  MP3  players,  electric  bicycles,  hybrid/electric  vehicles,  and  general
industrial  applications.  After  the  disposal  of  BAK  International  and  its  subsidiaries  on  June  30,  2014,  the  Company  will  focus  on  the  manufacture,
commercialization and distribution of high power lithium ion rechargeable batteries for use in cordless power tools, light electric vehicles, hybrid electric
vehicles, electric cars, electric busses, uninterruptable power supplies and other high power applications.

The shares of the Company traded in the over-the-counter market through the Over-the-Counter Bulletin Board from 2005 until May 31, 2006, when the
Company obtained approval to list its common stock on The NASDAQ Global Market, and trading commenced that same date under the symbol “CBAK”.

On January 10, 2017, the Company filed Articles of Merger with the Secretary of State of Nevada to effectuate a merger between the Company and the
Company’s newly formed, wholly owned subsidiary, CBAK Merger Sub, Inc. (the “Merger Sub”). According to the Articles of Merger, effective January
16,  2017,  the  Merger  Sub  merged  with  and  into  the  Company  with  the  Company  being  the  surviving  entity  (the  “Merger”).  As  permitted  by  Chapter
92A.180 of Nevada Revised Statutes, the sole purpose of the Merger was to effect a change of the Company’s name.

Effective  November  30,  2018,  the  trading  symbol  for  common  stock  of  the  Company  was  changed  from  CBAK  to  CBAT.  Effective  at  the  opening  of
business on June 21, 2019, the Company’s common stock started trading on the Nasdaq Capital Market.

Basis of Presentation and Organization

On November 6, 2004, BAK International, a non-operating holding company that had substantially the same shareholders as Shenzhen BAK Battery Co.,
Ltd (“Shenzhen BAK”), entered into a share swap transaction with the shareholders of Shenzhen BAK for the purpose of the subsequent reverse acquisition
of the Company. The share swap transaction between BAK International and the shareholders of Shenzhen BAK was accounted for as a reverse acquisition
of Shenzhen BAK with no adjustment to the historical basis of the assets and liabilities of Shenzhen BAK.

On  January  20,  2005,  the  Company  completed  a  share  swap  transaction  with  the  shareholders  of  BAK  International.  The  share  swap  transaction,  also
referred to as the “reverse acquisition” of the Company, was consummated under Nevada law pursuant to the terms of a Securities Exchange Agreement
entered by and among CBAK, BAK International and the shareholders of BAK International on January 20, 2005. The share swap transaction has been
accounted for as a capital-raising transaction of the Company whereby the historical financial statements and operations of Shenzhen BAK are consolidated
using historical carrying amounts.

F-9

 
 
 
 
 
 
 
 
 
 
 
 
Also on January 20, 2005, immediately prior to consummating the share swap transaction, BAK International executed a private placement of its common
stock with unrelated investors whereby it issued an aggregate of 1,720,087 shares of common stock for gross proceeds of $17,000,000. In conjunction with
this financing, Mr. Xiangqian Li, the Chairman and Chief Executive Officer of the Company (“Mr. Li”), agreed to place 435,910 shares of the Company’s
common stock owned by him into an escrow account pursuant to an Escrow Agreement dated January 20, 2005 (the “Escrow Agreement”). Pursuant to the
Escrow Agreement, 50% of the escrowed shares were to be released to the investors in the private placement if audited net income of the Company for the
fiscal  year  ended  September  30,  2005  was  not  at  least  $12,000,000,  and  the  remaining  50%  was  to  be  released  to  investors  in  the  private  placement  if
audited net income of the Company for the fiscal year ended September 30, 2006 was not at least $27,000,000. If the audited net income of the Company
for the fiscal years ended September 30, 2005 and 2006 reached the above-mentioned targets, the 435,910 shares would be released to Mr. Li in the amount
of 50% upon reaching the 2005 target and the remaining 50% upon reaching the 2006 target.

Under accounting principles generally accepted in the United States of America (“US GAAP”), escrow agreements such as the one established by Mr. Li
generally constitute compensation if, following attainment of a performance threshold, shares are returned to a company officer. The Company determined
that without consideration of the compensation charge, the performance thresholds for the year ended September 30, 2005 would be achieved. However,
after  consideration  of  a  related  compensation  charge,  the  Company  determined  that  such  thresholds  would  not  have  been  achieved.  The  Company  also
determined that, even without consideration of a compensation charge, the performance thresholds for the year ended September 30, 2006 would not be
achieved.

While the 217,955 escrow shares relating to the 2005 performance threshold were previously released to Mr. Li, Mr. Li executed a further undertaking on
August 21, 2006 to return those shares to the escrow agent for the distribution to the relevant investors. However, such shares were not returned to the
escrow agent, but, pursuant to a Delivery of Make Good Shares, Settlement and Release Agreement between the Company, BAK International and Mr. Li
entered into on October 22, 2007 (the “Li Settlement Agreement”), such shares were ultimately delivered to the Company as described below. Because the
Company failed to satisfy the performance threshold for the fiscal year ended September 30, 2006, the remaining 217,955 escrow shares relating to the
fiscal year 2006 performance threshold were released to the relevant investors. As Mr. Li has not retained any of the shares placed into escrow, and as the
investors party to the Escrow Agreement are only shareholders of the Company and do not have and are not expected to have any other relationship to the
Company, the Company has not recorded a compensation charge for the years ended September 30, 2005 and 2006.

At the time the escrow shares relating to the 2006 performance threshold were transferred to the investors in fiscal year 2007, the Company should have
recognized a credit to donated shares and a debit to additional paid-in capital, both of which are elements of shareholders’ equity. This entry is not material
because  total  ordinary  shares  issued  and  outstanding,  total  shareholders’  equity  and  total  assets  do  not  change;  nor  is  there  any  impact  on  income  or
earnings per share. Therefore, previously filed consolidated financial statements for the fiscal year ended September 30, 2007 will not be restated. This
share transfer has been reflected in these financial statements by reclassifying the balances of certain items as of October 1, 2007. The balances of donated
shares and additional paid-in capital as of October 1, 2007 were credited and debited by $7,955,358 respectively, as set out in the consolidated statements
of changes in shareholders’ equity.

In  November  2007,  Mr.  Li  delivered  the  217,955  shares  related  to  the  2005  performance  threshold  to  BAK  International  pursuant  to  the  Li  Settlement
Agreement;  BAK  International  in  turn  delivered  the  shares  to  the  Company.  Such  shares  (other  than  those  issued  to  investors  pursuant  to  the  2008
Settlement Agreements, as described below) are now held by the Company. Upon receipt of these shares, the Company and BAK International released all
claims  and  causes  of  action  against  Mr.  Li  regarding  the  shares,  and  Mr.  Li  released  all  claims  and  causes  of  action  against  the  Company  and  BAK
International  regarding  the  shares.  Under  the  terms  of  the  Li  Settlement  Agreement,  the  Company  commenced  negotiations  with  the  investors  who
participated  in  the  Company’s  January  2005  private  placement  in  order  to  achieve  a  complete  settlement  of  BAK  International’s  obligations  (and  the
Company’s obligations to the extent it has any) under the applicable agreements with such investors.

Beginning on March 13, 2008, the Company entered into settlement agreements (the “2008 Settlement Agreements”) with certain investors in the January
2005 private placement. Since the other investors have never submitted any claims regarding this matter, the Company did not reach any settlement with
them.

F-10

 
 
 
 
 
 
 
 
Pursuant to the 2008 Settlement Agreements, the Company and the settling investors have agreed, without any admission of liability, to a settlement and
mutual  release  from  all  claims  relating  to  the  January  2005  private  placement,  including  all  claims  relating  to  the  escrow  shares  related  to  the  2005
performance threshold that had been placed into escrow by Mr. Li, as well as all claims, including claims for liquidated damages relating to registration
rights granted in connection with the January 2005 private placement. Under the 2008 Settlement Agreement, the Company has made settlement payments
to each of the settling investors of the number of shares of the Company’s common stock equivalent to 50% of the number of the escrow shares related to
the  2005  performance  threshold  these  investors  had  claimed;  aggregate  settlement  payments  as  of  June  30,  2015amounted  to  73,749  shares.  Share
payments  to  date  have  been  made  in  reliance  upon  the  exemptions  from  registration  provided  by  Section  4(2)  and/or  other  applicable  provisions  of  the
Securities Act of 1933, as amended. In accordance with the 2008 Settlement Agreements, the Company filed a registration statement covering the resale of
such shares which was declared effective by the SEC on June 26, 2008.

Pursuant to the Li Settlement Agreement, the 2008 Settlement Agreements and upon the release of the 217,955 escrow shares relating to the fiscal year
2006  performance  threshold  to  the  relevant  investors,  neither  Mr.  Li  or  the  Company  have  any  obligations  to  the  investors  who  participated  in  the
Company’s January 2005 private placement relating to the escrow shares.

As  of  December  31,  2020,  the  Company  had  not  received  any  claim  from  the  other  investors  who  have  not  been  covered  by  the  “2008  Settlement
Agreements” in the January 2005 private placement.

As the Company has transferred the 217,955 shares related to the 2006 performance threshold to the relevant investors in fiscal year 2007 and the Company
also have transferred 73,749 shares relating to the 2005 performance threshold to the investors who had entered the “2008 Settlement Agreements” with us
in  fiscal  year  2008,  pursuant  to  “Li  Settlement  Agreement”  and  “2008  Settlement  Agreements”,  neither  Mr.  Li  nor  the  Company  had  any  remaining
obligations to those related investors who participated in the Company’s January 2005 private placement relating to the escrow shares.

On August 14, 2013, Dalian BAK Trading Co., Ltd was established as a wholly owned subsidiary of China BAK Asia Holding Limited (“BAK Asia”) with
a registered capital of $500,000. Pursuant to CBAK Trading’s articles of association and relevant PRC regulations, BAK Asia was required to contribute
the capital to CBAK Trading on or before August 14, 2015. On March 7, 2017, the name of Dalian BAK Trading Co., Ltd was changed to Dalian CBAK
Trading Co., Ltd (“CBAK Trading”). On August 5, 2019, CBAK Trading’s registered capital was increased to $5,000,000. Pursuant to CBAK Trading’s
amendment articles of association and relevant PRC regulations, BAK Asia was required to contribute the capital to CBAK Trading on or before August 1,
2033. Up to the date of this report, the Company has contributed $2,435,000 to CBAK Trading in cash.

On  December  27,  2013,  Dalian  BAK  Power  Battery  Co.,  Ltd  was  established  as  a  wholly  owned  subsidiary  of  BAK  Asia  with  a  registered  capital  of
$30,000,000. Pursuant to CBAK Power’s articles of association and relevant PRC regulations, BAK Asia was required to contribute the capital to CBAK
Power on or before December 27, 2015. On March 7, 2017, the name of Dalian BAK Power Battery Co., Ltd was changed to Dalian CBAK Power Battery
Co.,  Ltd  (“CBAK  Power”).  On  July  10,  2018,  CBAK  Power’s  registered  capital  was  increased  to  $50,000,000.  On  October  29,  2019,  CBAK  Power’s
registered capital was further increased to $60,000,000. Pursuant to CBAK Power’s amendment articles of association and relevant PRC regulations, BAK
Asia was required to contribute the capital to CBAK Power on or before December 31, 2021. Up to the date of this report, the Company has contributed
$29,999,978 to CBAK Power through injection of a series of patents and cash.

On May 4, 2018, CBAK New Energy (Suzhou) Co., Ltd (“CBAK Suzhou”) was established as a 90% owned subsidiary of CBAK Power with a registered
capital of RMB10,000,000 (approximately $1.5 million). The remaining 10% equity interest was held by certain employees of CBAK Suzhou. Pursuant to
CBAK  Suzhou’s  articles  of  association,  each  shareholder  is  entitled  to  the  right  of  the  profit  distribution  or  responsible  for  the  loss  according  to  its
proportion  to  the  capital  contribution.  Pursuant  to  CBAK  Suzhou’s  articles  of  association  and  relevant  PRC  regulations,  CBAK  Power  was  required  to
contribute  the  capital  to  CBAK  Suzhou  on  or  before  December  31,  2019.  Up  to  the  date  of  this  report,  the  Company  has  contributed  RMB9.0  million
(approximately  $1.3  million),  and  the  other  shareholders  have  contributed  RMB1.0  million  (approximately  $0.1  million)  to  CBAK  Suzhou  through
injection of a series of cash. The Company plan to dissolve CBAK Suzhou in 2021.

F-11

 
 
 
 
 
 
 
 
 
On November 21, 2019, Dalian CBAK Energy Technology Co., Ltd (“CBAK Energy”) was established as a wholly owned subsidiary of BAK Asia with a
registered capital of $50,000,000. Pursuant to CBAK Energy’s articles of association and relevant PRC regulations, BAK Asia was required to contribute
the capital to CBAK Energy on or before November 20, 2022. Up to the date of this report, the Company has contributed $6,920,000 to CBAK Energy.

On July 14, 2020, the Company acquired BAK Asia Investments Limited (“BAK Investments”), a company incorporated under Hong Kong laws, from Mr.
Xiangqian Li, the Company’s former CEO, for a cash consideration of HK$1.00. BAK Asia Investments Limited is a holding company without any other
business operations.

On  July  31,  2020,  BAK  Investments  formed  a  wholly  owned  subsidiary  CBAK  New  Energy  (Nanjing)  Co.,  Ltd.  (“CBAK  Nanjing”)  in  China  with  a
registered capital of $100,000,000. Pursuant to CBAK Nanjing’s articles of association and relevant PRC regulations, BAK Investments was required to
contribute the capital to CBAK Nanjing on or before July 29, 2040. Up to the date of this report, the Company has contributed $46,989,915 to CBAK
Nanjing.

On  August  6,  2020,  Nanjing  CBAK  New  Energy  Technology  Co.,  Ltd.  (“Nanjing  CBAK”)  was  established  as  a  wholly  owned  subsidiary  of  CBAK
Nanjing with a registered capital of RMB700,000,000 (approximately $107 million). Pursuant to Nanjing CBAK’s articles of association and relevant PRC
regulations,  CBAK  Nanjing  was  required  to  contribute  the  capital  to  Nanjing  CBAK  on  or  before  August  5,  2040.  Up  to  the  date  of  this  report,  the
Company has contributed RMB270,933,736 (approximately $41.5 million) to Nanjing CBAK.

On  November  9,  2020,  Nanjing  Daxin  New  Energy Automobile  Industry  Co.,  Ltd  (“Nanjing  Daxin”)  was  established  as  a  wholly  owned  subsidiary  of
CBAK  Nanjing  with  a  register  capital  of  RMB50,000,000  (approximately  $7.7  million).  Up  to  the  date  of  this  report,  the  Company  has  contributed
RMB10,000,000 (approximately $1.55 million) to Nanjing Daxin.

The Company’s consolidated financial statements have been prepared under US GAAP.

The  preparation  of  financial  statements  in  conformity  with  US  GAAP  requires  management  to  make  estimates  and  assumptions  that  affect  the  reported
amounts  of  assets  and  liabilities  and  disclosures  of  contingent  assets  and  liabilities  at  the  date  of  the  financial  statements  and  the  reported  amounts  of
revenues and expenses during the reporting periods. Actual results could differ from those estimates. This basis of accounting differs in certain material
respects from that used for the preparation of the books of account of the Company’s principal subsidiaries, which are prepared in accordance with the
accounting  principles  and  the  relevant  financial  regulations  applicable  to  enterprises  with  limited  liability  established  in  the  PRC  or  Hong  Kong.  The
accompanying  consolidated  financial  statements  reflect  necessary  adjustments  not  recorded  in  the  books  of  account  of  the  Company’s  subsidiaries  to
present them in conformity with US GAAP.

After  the  disposal  of  BAK  International  Limited  and  its  subsidiaries,  namely  Shenzhen  BAK,  Shenzhen  BAK  Power  Battery  Co.,  Ltd  (formerly  BAK
Battery  (Shenzhen)  Co.,  Ltd.)  (“BAK  Shenzhen”),  BAK  International  (Tianjin)  Ltd.  (“BAK  Tianjin”),  Tianjin  Chenhao  Technological  Development
Limited (a subsidiary of BAK Tianjin established on May 8, 2014, “Tianjin Chenhao”), BAK Battery Canada Ltd. (“BAK Canada”), BAK Europe GmbH
(“BAK  Europe”)  and  BAK  Telecom  India  Private  Limited  (“BAK  India”),  effective  on  June  30,  2014,  and  as  of  December  31,  2019,  the  Company’s
subsidiaries consisted of: i) China BAK Asia Holdings Limited (“BAK Asia”), a wholly owned limited liability company incorporated in Hong Kong on
July 9, 2013; ii) Dalian CBAK Trading Co., Ltd. (“CBAK Trading”), a wholly owned limited company established on August 14, 2013 in the PRC; iii)
Dalian CBAK Power Battery Co., Ltd. (“CBAK Power”), a wholly owned limited liability company established on December 27, 2013 in the PRC; iv)
CBAK  New  Energy  (Suzhou)  Co.,  Ltd.  (“CBAK  Suzhou”),  a  90%  owned  limited  liability  company  established  on  May  4,  2018  in  the  PRC;  v)  Dalian
CBAK  Energy  Technology  Co.,  Ltd  (“CBAK  Energy”),  a  wholly  owned  limited  liability  company  established  on  November  21,  2019  in  the  PRC;  (vi)
BAK Asia Investments Limited (“BAK Investments”), a wholly owned limited liability company incorporated in Hong Kong acquired on July 14, 2020;
(vii) CBAK New Energy (Nanjing) Co., Ltd. (“CBAK Nanjing”), a wholly owned limited liability company established on July 31, 2020 in the PRC; (viii)
Nanjing CBAK New Energy Technology Co., Ltd, (“Nanjing CBAK”), a wholly owned limited liability company established on August 6, 2020 in the
PRC  and  (ix)  Nanjing  Daxin  New  Energy  Automobile  Industry  Co.,  Ltd  (“Nanjing  Daxin”),  a  wholly  owned  limited  liability  company  established  on
November 9, 2020.

The Company continued its business and continued to generate revenues from sale of batteries via subcontracting the production to BAK Tianjin and BAK
Shenzhen,  former  subsidiaries  before  the  completion  of  construction  and  operation  of  its  facility  in  Dalian.  BAK  Tianjin  and  BAK  Shenzhen  are  now
suppliers  of  the  Company  and  the  Company  does  not  have  any  significant  benefits  or  liability  from  the  operating  results  of  BAK  Tianjin  and  BAK
Shenzhen except the normal risk with any major supplier.

F-12

 
 
 
 
 
 
 
 
 
 
 
As of the date of this report, Mr. Xiangqian Li is no longer a director of BAK International and BAK Tianjin. He remained as a director of Shenzhen BAK
and BAK Shenzhen.

On and effective March 1, 2016, Mr. Xiangqian Li resigned as Chairman, director, Chief Executive Officer, President and Secretary of the Company. On
the  same  date,  the  Board  of  Directors  of  the  Company  appointed  Mr.  Yunfei  Li  as  Chairman,  Chief  Executive  Officer,  President  and  Secretary  of  the
Company. On March 4, 2016, Mr. Xiangqian Li transferred 3,000,000 shares to Mr. Yunfei Li for a price of $2.4 per share. After the share transfer, Mr.
Yunfei  Li  held  3,000,000  shares  or  17.3%  and  Mr.  Xiangqian  Li  held  760,557  shares  at  4.4%  of  the  Company’s  outstanding  stock,  respectively. As  of
December  31,  2020,  Mr.  Yunfei  Li  held  10,785,872  shares  or  13.62%  of  the  Company’s  outstanding  stock,  and  Mr.  Xiangqian  Li  held  none  of  the
Company’s outstanding stock.

The Company had a working capital deficiency, accumulated deficit from recurring net losses and short-term debt obligations as of December 31, 2020.
These factors raise substantial doubts about the Company’s ability to continue as a going concern.

In  June  and  July  2015,  the  Company  received  advances  of  approximately  $9.8  million  from  potential  investors.  On  September  29,  2015,  the  Company
entered into a Debt Conversion Agreement with these investors. Pursuant to the terms of the Debt Conversion Agreement, each of the creditors agreed to
convert existing loan principal of $9,847,644 into an aggregate 4,376,731 shares of common stock of the Company (“the Shares”) at a conversion price of
$2.25  per  share.  Upon  receipt  of  the  Shares  on  October  16,  2015,  the  creditors  released  the  Company  from  all  claims,  demands  and  other  obligations
relating to the Debts. As such, no interest was recognized by the Company on the advances from investors pursuant to the supplemental agreements with
investors and the Debt Conversion Agreement.

In  June  2016,  the  Company  received  further  advances  in  the  aggregate  of  $2.9  million  from  Mr.  Jiping  Zhou  and  Mr.  Dawei  Li.  These  advances  were
unsecured, non-interest bearing and repayable on demand. On July 8, 2018, the Company received further advances of $2.6 million from Mr. Jiping Zhou.
On  July  28,  2016,  the  Company  entered  into  securities  purchase  agreements  with  Mr.  Jiping  Zhou  and  Mr.  Dawei  Li  to  issue  and  sell  an  aggregate  of
2,206,640 shares of common stock of the Company, at $2.5 per share, for an aggregate consideration of approximately $5.52 million. On August 17, 2016,
the Company issued these shares to the investors.

On February 17, 2017, the Company signed investment agreements with eight investors (including Mr. Yunfei Li, the Company’s CEO, and seven of the
Company’s existing shareholders) whereby the investors agreed to subscribe new shares of the Company totaling $10 million. Pursuant to the investment
agreements, in January 2017 the 8 investors paid the Company a total of $2.06 million as down payments. Mr. Yunfei Li agrees to subscribe new shares of
the Company totaled $1,120,000 and paid the earnest money of $225,784 in January 2017. On April 1, April 21, April 26 and May 10, 2017, the Company
received $1,999,910, $3,499,888, $1,119,982 and $2,985,497 from these investors, respectively. On May 31, 2017, the Company entered into a securities
purchase agreement with the eight investors, pursuant to which the Company agreed to issue an aggregate of 6,403,518 shares of common stock to these
investors, at a purchase price of $1.50 per share, for an aggregate price of $9.6 million, among which 746,018 shares issued to Mr. Yunfei Li. On June 22,
2017, the Company issued the shares to the investors.

In  2019,  according  to  the  investment  agreements  and  agreed  by  the  investors,  the  Company  returned  partial  earnest  money  of  $966,579  (approximately
RMB6.7 million) to these investors.

On January 7, 2019, each of Mr. Dawei Li and Mr. Yunfei Li entered into an agreement with CBAK Power and Tianjin New Energy whereby Tianjin New
Energy  assigned  its  rights  to  loans  to  CBAK  Power  of  approximately  $3.4  million  (RMB23,980,950)  and  $1.7  million  (RMB11,647,890)  (totaled  $5.1
million, the “First Debt”) to Mr. Dawei Li and Mr. Yunfei Li, respectively.

On January 7, 2019, the Company entered into a cancellation agreement with Mr. Dawei Li and Mr. Yunfei Li. Pursuant to the terms of the cancellation
agreement,  Mr.  Dawei  Li  and  Mr. Yunfei  Li  agreed  to  cancel  the  First  Debt  in  exchange  for  3,431,373  and  1,666,667  shares  of  common  stock  of  the
Company, respectively, at an exchange price of $1.02 per share. Upon receipt of the shares, the creditors released the Company from any claims, demands
and other obligations relating to the First Debt.

F-13

 
 
 
 
  
 
 
 
 
 
 
On April 26, 2019, each of Mr. Jun Lang, Ms. Jing Shi and Asia EVK Energy Auto Limited (“Asia EVK”) entered into an agreement with CBAK Power
and Tianjin New Energy whereby Tianjin New Energy assigned its rights to loans to CBAK Power of approximately $0.3 million (RMB2,225,082), $0.1
million (RMB 912,204) and $5.0 million (RMB35,406,036) (collectively $5.4 million, the “Second Debt”) to Mr. Jun Lang, Ms. Jing Shi and Asia EVK,
respectively.

On April 26, 2019, the Company entered into a cancellation agreement with Mr. Jun Lang, Ms. Jing Shi and Asia EVK (the creditors). Pursuant to the
terms of the cancellation agreement, the creditors agreed to cancel the Second Debt in exchange for 300,534, 123,208 and 4,782,163 shares of common
stock of the Company, respectively, at an exchange price of $1.1 per share. Upon receipt of the shares, the creditors released the Company from any claims,
demands and other obligations relating to the Second Debt.

On  June  28,  2019,  each  of  Mr.  Dawei  Li  and  Mr.  Yunfei  Li  entered  into  an  agreement  with  CBAK  Power  to  loan  approximately  $1.4  million
(RMB10,000,000) and $2.5 million (RMB18,000,000) respectively to CBAK Power for a terms of six months (collectively $3.9 million, the “Third Debt”).
The loan was unsecured, non-interest bearing and repayable on demand.

On July 16, 2019, each of Asia EVK and Mr. Yunfei Li entered into an agreement with CBAK Power and Dalian Zhenghong Architectural Decoration and
Installation  Engineering  Co.  Ltd.  (the  Company’s  construction  contractor)  whereby  Dalian  Zhenghong  Architectural  Decoration  and  Installation
Engineering Co. Ltd. assigned its rights to the unpaid construction fees owed by CBAK Power of approximately $2.8 million (RMB20,000,000) and $0.4
million (RMB2,813,810) (collectively $3.2 million, the “Fourth Debt”) to Asia EVK and Mr. Yunfei Li, respectively.

On July 26, 2019, the Company entered into a cancellation agreement with Mr. Dawei Li, Mr. Yunfei Li and Asia EVK (the creditors). Pursuant to the
terms  of  the  cancellation  agreement,  Mr.  Dawei  Li,  Mr.  Yunfei  Li  and  Asia  EVK  agreed  to  cancel  the  Third  Debt  and  Fourth  Debt  in  exchange  for
1,384,717, 2,938,067 and 2,769,435 shares of common stock of the Company, respectively, at an exchange price of $1.05 per share. Upon receipt of the
shares, the creditors released the Company from any claims, demands and other obligations relating to the Third Debt and Fourth Debt. The cancellation
agreement contains customary representations and warranties of the creditors. The creditors do not have registration rights with respect to the shares.

On July 24, 2019, the Company entered into a securities purchase agreement with Atlas Sciences, LLC (the “Lender”), pursuant to which the Company
issued a promissory note (the “Note 1”) to the Lender. The Note has an original principal amount of $1,395,000, bears interest at a rate of 10% per annum
and will mature 12 months after the issuance, unless earlier paid or redeemed in accordance with its terms. The Company received proceeds of $1,250,000
after an original issue discount of $125,000 and payment of Lender’s expenses of $20,000.

On October 10, 2019, each of Mr. Shibin Mao, Ms. Lijuan Wang and Mr. Ping Shen entered into an agreement with CBAK Power and Zhengzhou BAK
New Energy Vehicle Co., Ltd. (the Company’s supplier of which Mr. Xiangqian Li, the former CEO, is a director of this company) whereby Zhengzhou
BAK  New  Energy  Vehicle  Co.,  Ltd.  assigned  its  rights  to  the  unpaid  inventories  cost  owed  by  CBAK  Power  of  approximately  $2.1  million
(RMB15,000,000), $1.0 million (RMB7,380,000) and $1.0 million (RMB7,380,000) (collectively $4.2 million, the “Fifth Debt”) to Mr. Shibin Mao, Ms.
Lijuan Wang and Mr. Ping Shen, respectively.

On October 14, 2019, the Company entered into a cancellation agreement with Mr. Shangdong Liu, Mr. Shibin Mao, Ms. Lijuan Wang and Mr. Ping Shen
(the creditors). Pursuant to the terms of the cancellation agreement, Mr. Shangdong Liu, Mr. Shibin Mao, Ms. Lijuan Wang and Mr. Ping Shen agreed to
cancel  and  convert  the  Fifth  Debt  and  the  Unpaid  Earnest  Money  of  approximately  $1  million  (RMB6,720,000)  in  exchange  for  528,053,  3,536,068,
2,267,798 and 2,267,798 shares of common stock of the Company, respectively, at an exchange price of $0.6 per share. Upon receipt of the shares, the
creditors released the Company from any claims, demands and other obligations relating to the Fifth Debt and the Unpaid Earnest Money. The cancellation
agreement contains customary representations and warranties of the creditors. The creditors do not have registration rights with respect to the shares.

F-14

 
 
 
 
 
 
 
 
 
 
On December 30, 2019, the Company entered into a second securities purchase agreement with Atlas Sciences, LLC (the “Lender”), pursuant to which the
Company issued a promissory note (the “Note II”) to the Lender. The Note II has an original principal amount of $1,670,000, bears interest at a rate of 10%
per annum and will mature 12 months after the issuance, unless earlier paid or redeemed in accordance with its terms. The Company received proceeds of
$1,500,000 after an original issue discount of $150,000 and payment of Lender’s expenses of $20,000.

On  January  27,  2020,  the  Company  entered  into  an  exchange  agreement  (the  “First  Exchange  Agreement”)  with  Atlas  Sciences,  LLC  (the  “Lender”),
pursuant  to  which  the  Company  and  the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to  $100,000  (the
“Partitioned Promissory Note) from the outstanding balance of certain promissory note that the Company issued to the Lender on July 24, 2019, which has
an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  160,256  shares  of  the  Company’s
common stock, par value $0.001 per share to the Lender.

On  February  20,  2020,  the  Company  entered  into  a  second  exchange  agreement  (the  “Second  Exchange  Agreement”)  with  Atlas  Sciences,  LLC  (the
“Lender”), pursuant to which the Company and the Lender agreed to (i) partition a new promissory note in the original principal amount equal to $100,000
(the  “Partitioned  Promissory  Note”)  from  the  outstanding  balance  of  certain  promissory  note  that  the  Company  issued  to  the  Lender  on  July  24,  2019,
which  has  an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  207,641  shares  of  the
Company’s common stock, par value $0.001 per share to the Lender.

On April  10,  2020,  each  of  Mr.  Yunfei  Li,  Mr.  Ping  Shen  and  Asia  EVK  entered  into  an  agreement  with  CBAK  Power  and  Shenzhen  BAK,  whereby
Shenzhen  BAK  assigned  its  rights  to  the  unpaid  inventories  cost  (note  7)  owed  by  CBAK  Power  of  approximately  $1.0  million  (RMB7,000,000),  $2.3
million (RMB16,000,000) and $1.0 million (RMB7,300,000) (collectively $4.3 million, the “Sixth Debt”) to Mr. Yunfei Li, Mr. Ping Shen and Asia EVK,
respectively.

On April 27, 2020, the Company entered into a cancellation agreement with Mr. Yunfei Li, Mr. Ping Shen and Asia EVK (the “creditors”). Pursuant to the
terms of the cancellation agreement, Mr. Yunfei Li, Mr. Ping Shen and Asia EVK agreed to cancel the Sixth Debt in exchange for 2,062,619, 4,714,557 and
2,151,017 shares of common stock of the Company, respectively, at an exchange price of $0.48 per share. Upon receipt of the shares, the creditors released
the Company from any claims, demands and other obligations relating to the Sixth Debt. The cancellation agreement contains customary representations
and warranties of the creditors. The creditors do not have registration rights with respect to the shares.

On April 28, 2020, the Company entered into a third exchange agreement (the “Third Exchange Agreement”) with Atlas Sciences, LLC (the “Lender”),
pursuant  to  which  the  Company  and  the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to  $100,000  (the
“Partitioned Promissory Note”) from the outstanding balance of certain promissory note that the Company issued to the Lender on July 24, 2019, which has
an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  312,500  shares  of  the  Company’s
common stock, par value $0.001 per share to the Lender.

On June 8, 2020, the Company entered into a fourth exchange agreement (the “Fourth Exchange Agreement”) with Atlas Sciences, LLC (the “Lender”),
pursuant  to  which  the  Company  and  the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to  $100,000  (the
“Partitioned Promissory Note”) from the outstanding balance of certain promissory note that the Company issued to the Lender on July 24, 2019, which has
an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  271,739  shares  of  the  Company’s
common stock, par value $0.001 per share to the Lender.

On  June  10,  2020,  the  Company  entered  into  a  Fifth  exchange  agreement  (the  “Fifth  Exchange  Agreement”)  with  Atlas  Sciences,  LLC  (the  “Lender”),
pursuant  to  which  the  Company  and  the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to  $150,000  (the
“Partitioned Promissory Note”) from the outstanding balance of certain promissory note that the Company issued to the Lender on July 24, 2019, which has
an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  407,609  shares  of  the  Company’s
common stock, par value $0.001 per share to the Lender.

On  July  6,  2020,  the  Company  entered  into  a  Sixth  exchange  agreement  (the  “Sixth  Exchange  Agreement”)  with  Atlas  Sciences,  LLC  (the  “Lender”),
pursuant  to  which  the  Company  and  the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to  $250,000  (the
“Partitioned Promissory Note”) from the outstanding balance of certain promissory note that the Company issued to the Lender on July 24, 2019, which has
an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  461,595  shares  of  the  Company’s
common stock, par value $0.001 per share to the Lender.

On July 8, 2020, the Company entered into a First exchange agreement for Note II (the “First Exchange Agreement- Note II”) with Atlas Sciences, LLC
(the  “Lender”),  pursuant  to  which  the  Company  and  the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to
$250,000 (the “Partitioned Promissory Note”) from the outstanding balance of certain promissory note that the Company issued to the Lender on December
30, 2019, which has an original principal amount of $1,670,000, and (ii) exchange the Partitioned Promissory Note for the issuance of 453,161 shares of
the Company’s common stock, par value $0.001 per share to the Lender.

F-15

 
 
 
 
 
 
 
 
 
 
 
 
On  July  29,  2020,  the  Company  entered  into  a  Seventh  exchange  agreement  (the  “Seventh  Exchange  Agreement”)  with  Atlas  Sciences,  LLC  (the
“Lender”), pursuant to which the Company and the Lender agreed to (i) partition a new promissory note in the original principal amount equal to $365,000
(the  “Partitioned  Promissory  Note”)  from  the  outstanding  balance  of  certain  promissory  note  that  the  Company  issued  to  the  Lender  on  July  24,  2019,
which  has  an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  576,802  shares  of  the
Company’s common stock, par value $0.001 per share to the Lender.

On October 12, 2020, the Company entered into an Amendment to Promissory Notes (the “Amendment”) with Atlas Sciences, LLC (the Lender), pursuant
to which the Lender has the right at any time until the outstanding balance of the Notes has been paid in full, at its election, to convert all or any portion of
the outstanding balance of the Notes into shares of common stock of the Company. The conversion price for each conversion will be calculated pursuant to
the following formula: 80% multiplied by the lowest closing price of the Company common stock during the ten (10) trading days immediately preceding
the applicable conversion (the “Conversion Price”). Notwithstanding the foregoing, in no event will the Conversion Price be less than $1.00.

According  to  the  Amendment,  on  October  13,  2020,  the  Company  exchange  $230,000  in  principal  and  $141,275  coupon  interest  under  the  Note  I  and
$775,000 principal under the Note II for the issuance of 229,750 and 479,579 shares of the Company’s common stock, par value $0.001 per share to the
Lender, respectively.

On October 20, 2020, the Company further exchange $645,000 in principal and $133,252 coupon interests under Note II for the issuance of 329,768 shares
of the Company’s common stock, par value $0.001 per share to the Lender. Up to the date of this report, the Company has fully repaid the principal and
coupon interests of Note I and Note II.

On November 5, 2020, each of Tillicum Investment Company Limited , an unrelated party, entered into an agreement with CBAK Nanjing and Shenzhen
ESTAR Industrial Company Limited, whereby Shenzhen ESTAR Industrial Company Limited assigned its rights to the unpaid equipment cost owed by
CBAK Nanjing of approximately $11.17 million (RMB75,000,000) (the “Seventh Debt”) to Tillicum Investment Company Limited.

On November 11, 2020, the Company entered into a cancellation agreement with Tillicum Investment Company Limited (the “creditor”). Pursuant to the
terms  of  the  cancellation  agreement,  Tillicum  Investment  Company  Limited  agreed  to  cancel  the  Seventh  Debt  in  exchange  for  3,192,291  shares  of
common stock of the Company, at an exchange price of $3.5 per share. Upon receipt of the shares, the creditor released the Company from any claims,
demands and other obligations relating to the Seventh Debt. The cancellation agreement contains customary representations and warranties of the creditor.
The creditor does not have registration rights with respect to the shares.

On  December  8,  2020,  the  Company  entered  into  a  securities  purchase  agreement  with  certain  institutional  investors,  pursuant  to  which  the  Company
issued  in  a  registered  direct  offering,  an  aggregate  of  9,489,800  shares  of  common  stock  of  the  Company  at  a  per  share  purchase  price  of  $5.18,  and
warrants to purchase an aggregate of 3,795,920 shares of common stock of the Company at an exercise price of $6.46 per share exercisable for 36 months
from the date of issuance, for gross proceeds of approximately $49.16 million, before deducting fees to the placement agent and other estimated offering
expenses  of  $3.81  million  payable  by  the  Company.  In  addition,  the  placement  agent  for  this  transaction  also  received  warrants  (“Placement  Agent
Warrants”) for the purchase of up to 379,592 shares of the Company’s common stock at an exercise price of $6.475 per share exercisable for 36 months
after 6 months from the issuance.

On February 8, 2021, the Company entered into another securities purchase agreement with the same investors, pursuant to which the Company issued in a
registered  direct  offering,  an  aggregate  of  8,939,976  shares  of  common  stock  of  the  Company  at  a  per  share  purchase  price  of  $7.83.  In  addition,  the
Company issued to the investors (i) in a concurrent private placement, the Series A-1 warrants to purchase a total of 4,469,988 shares of common stock, at
a per share exercise price of $7.67 and exercisable for 42 months from the date of issuance; (ii) in the registered direct offering, the Series B warrants to
purchase a total of 4,469,988 shares of common stock, at a per share exercise price of $7.83 and exercisable for 90 days from the date of issuance; and (iii)
in the registered direct offering, the Series A-2 warrants to purchase up to 2,234,992 shares of common stock, at a per share exercise price of $7.67 and
exercisable  for  45  months  from  the  date  of  issuance.  The  Company  received  gross  proceeds  of  approximately  $70  million  from  the  registered  direct
offering and the concurrent private placement, before deducting fees to the placement agent and other estimated offering expenses of $5.0 million payable
by  the  Company.  In  addition,  the  placement  agent  for  this  transaction  also  received  warrants  (“Placement  Agent  Warrants”)  for  the  purchase  of  up  to
446,999 shares of the Company’s common stock at an exercise price of $9.204 per share exercisable for 36 months after 6 months from the issuance.

As  of  December  31,  2020,  the  Company  had  aggregate  interest-bearing  bank  loans  of  approximately  $13.7  million,  due  in  2021,  in  addition  to
approximately $42.2 million of other current liabilities (excluding warrants derivative liability).

As of December 31, 2020, the Company had unutilized committed banking facilities from banks and Jilin Province Trust Co., Ltd (see “Other Short-term
Loans” below) of $7.4 million.

The Company is currently expanding its product lines and manufacturing capacity in its Dalian plant and Nanjing plant which requires more funding to
finance the expansion. The Company plans to raise additional funds through banks borrowings and equity financing in the future to meet its daily cash
demands, if required.

F-16

 
 
 
 
 
 
 
 
 
 
 
 
 
2. Summary of Significant Accounting Policies and Practices

(a) Principles of Consolidation

The  consolidated  financial  statements  include  the  financial  statements  of  the  Company  and  its  subsidiaries  up  to  the  date  of  disposal.  All  significant
intercompany balances and transactions have been eliminated prior to consolidation.

(b) Cash and Cash Equivalents

Cash consists of cash on hand and in banks excluding pledged deposits. The Company considers all highly liquid debt instruments, with initial terms of less
than three months to be cash equivalents.

(c) Trade Accounts and Bills Receivable

Trade  accounts  and  bills  receivable  are  recorded  at  the  invoiced  amount,  net  of  allowances  for  doubtful  accounts  and  sales  returns.  The  allowance  for
doubtful  accounts  is  the  Company’s  best  estimate  of  the  amount  of  probable  credit  losses  in  the  Company’s  existing  trade  accounts  receivable.  The
Company determines the allowance based on historical write-off experience, customer specific facts and economic conditions.

Outstanding  accounts  receivable  balances  are  reviewed  individually  for  collectability.  Account  balances  are  charged  off  against  the  allowance  after  all
means of collection have been exhausted and the potential for recovery is considered remote.

(d) Inventories

Inventories  are  stated  at  the  lower  of  cost  or  net  realizable  value.  The  cost  of  inventories  is  determined  using  the  weighted  average  cost  method,  and
includes expenditures incurred in acquiring the inventories and bringing them to their existing location and condition. In case of finished goods and work in
progress, the cost includes an appropriate share of production overhead based on normal operating capacity. Net realizable value is the estimated selling
prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.

The Company records adjustments to its inventory for estimated obsolescence or diminution in net realizable value equal to the difference between the cost
of the inventory and the estimated net realizable value. At the point of loss recognition, a new cost basis for that inventory is established, and subsequent
changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.

(e) Property, Plant and Equipment

Property, plant and equipment (except construction in progress) are stated at cost less accumulated depreciation and impairment charges. Depreciation is
calculated  based  on  the  straight-line  method  (after  taking  into  account  their  respective  estimated  residual  values)  over  the  estimated  useful  lives  of  the
assets as follows:

Buildings
Machinery and equipment
Office equipment
Motor vehicles

  5 – 35 years
  1 – 15 years
  1 – 5 years
  5 – 10 years

The  cost  and  accumulated  depreciation  of  property,  plant  and  equipment  sold  are  removed  from  the  consolidated  balance  sheets  and  resulting  gains  or
losses are recognized in the consolidated statements of operations and comprehensive loss.

Construction in progress mainly represents expenditures in respect of the Company’s corporate campus, including offices, factories and staff dormitories,
under construction. All direct costs relating to the acquisition or construction of the Company’s corporate campus and equipment, including interest charges
on borrowings, are capitalized as construction in progress. No depreciation is provided in respect of construction in progress.

A long-lived asset to be disposed of by abandonment continues to be classified as held and used until it is disposed of.

F-17

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(f) Lease

(i) Right of use assets

Prior  to  the  adoption  of  Accounting  Standards  Update  (“ASU”)  No.  2016-02,  Leases  (Topic  842)  (“ASC  842”),  land  use  rights  are  carried  at  cost  and
amortized on a straight-line basis over the period of rights of 50 years. Upon the adoption of ASC 842 on January 1, 2019, land use rights acquired are
assessed in accordance with ASC 842 and recognized in right-of-use assets if they meet the definition of lease.

(ii) Net Investment in Sales Type Leases

The Company derives a portion of its revenue from vehicles leasing arrangements. Such arrangements provide for monthly payments covering the vehicles
sales and interest. These arrangements meet the criteria to be accounted for as sales-type leases. A lease is classified as a sales-type lease if at least one of
the following criteria is met: (1) the lease transfers ownership of the underlying asset to the lessee, (2) the lease grants the lessee an option to purchase the
underlying asset that the lessee is reasonably certain to exercise, (3) the lease term is for a major part of the remaining economic life of the underlying
asset,  (4)  the  present  value  of  the  sum  of  the  lease  payments  equals  or  exceeds  substantially  all  of  the  fair  value  of  the  underlying  assets,  or  (5)  the
underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. Accordingly, vehicle
sale net of cost is recorded as other income and recognized upon delivery of the vehicle and its acceptance by the customer. Upon the recognition of such
revenue, an asset is established for the investment in sales-type leases. Interests are recognized monthly over the lease term.

(g) Foreign Currency Transactions and Translation

The reporting currency of the Company is the United States dollar (“US dollar”). The financial records of the Company’s PRC operating subsidiaries are
maintained  in  their  local  currency,  the  Renminbi  (“RMB”),  which  is  the  functional  currency.  The  financial  records  of  the  Company’s  subsidiaries
established in other countries are maintained in their local currencies. Assets and liabilities of the subsidiaries are translated into the reporting currency at
the exchange rates at the balance sheet date, equity accounts are translated at historical exchange rates, and income and expense items are translated using
the average rate for the period. The translation adjustments are recorded in accumulated other comprehensive loss under shareholders’ equity.

Monetary assets and liabilities denominated in currencies other than the applicable functional currencies are translated into the functional currencies at the
prevailing  rates  of  exchange  at  the  balance  sheet  date.  Nonmonetary  assets  and  liabilities  are  remeasured  into  the  applicable  functional  currencies  at
historical  exchange  rates.  Transactions  in  currencies  other  than  the  applicable  functional  currencies  during  the  period  are  converted  into  the  functional
currencies at the applicable rates of exchange prevailing at the transaction dates. Transaction gains and losses are recognized in the consolidated statements
of operations.

RMB is not a fully convertible currency. All foreign exchange transactions involving RMB must take place either through the People’s Bank of China (the
“PBOC”) or other institutions authorized to buy and sell foreign exchange. The exchange rates adopted for the foreign exchange transactions are the rates
of exchange quoted by the PBOC, which are determined largely by supply and demand. Translation of amounts from RMB into US dollars has been made
at the following exchange rates for the respective periods:

Year ended December 31, 2019
Balance sheet, except for equity accounts
Income statement and cash flows

Year ended December 31, 2020
Balance sheet, except for equity accounts
Income statement and cash flows

(h) Intangible Assets

  RMB 6.9630 to US$1.00  
  RMB 6.9073 to US$1.00  

  RMB 6.5286 to US$1.00  
  RMB 6.9032 to US$1.00  

Intangible  assets  are  stated  in  the  balance  sheet  at  cost  less  accumulated  amortization  and  impairment,  if  any.  The  costs  of  the  intangible  assets  are
amortized on a straight-line basis over their estimated useful lives. The respective amortization periods for the intangible assets are as follows:

Computer software

(i) Impairment of Long-lived Assets

10 years

Long-lived assets, which include property, plant and equipment, prepaid land use rights and intangible assets, are reviewed for impairment whenever events
or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future
cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment
charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is generally measured based on
either quoted market prices, if available, or discounted cash flow analyses.

F-18

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(j) Revenue Recognition

The Company recognizes revenues when its customer obtains control of promised goods or services, in an amount that reflects the consideration which it
expects to receive in exchange for those goods. The Company recognizes revenues following the five step model prescribed under ASU No. 2014-09: (i)
identify  contract(s)  with  a  customer;  (ii)  identify  the  performance  obligations  in  the  contract;  (iii)  determine  the  transaction  price;  (iv)  allocate  the
transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation.

Revenues from product sales are recognized when the customer obtains control of the Company’s product, which occurs at a point in time, typically upon
delivery to the customer. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the
asset that it would have recognized is one year or less or the amount is immaterial.

Revenues from product sales are recorded net of reserves established for applicable discounts and allowances that are offered within contracts with the
Company’s customers.

Product revenue reserves, which are classified as a reduction in product revenues, are generally characterized in the categories: discounts and returns. These
reserves are based on estimates of the amounts earned or to be claimed on the related sales and are classified as reductions of accounts receivable as the
amount is payable to the Company’s customer.

(k) Cost of Revenues

Cost  of  revenues  consists  primarily  of  material  costs,  employee  compensation,  depreciation  and  related  expenses,  which  are  directly  attributable  to  the
production of products. Write-down of inventories to lower of cost or market is also recorded in cost of revenues.

(l) Income Taxes

Income  taxes  are  accounted  for  under  the  asset  and  liability  method.  Deferred  tax  assets  and  liabilities  are  recognized  for  the  future  tax  consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating
loss and tax credit carry forwards. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not
that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates applied to taxable income in the years in which
those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in
the statement of operations and comprehensive loss in the period that includes the enactment date.

The  impact  of  an  uncertain  income  tax  positions  on  the  income  tax  return  must  be  recognized  at  the  largest  amount  that  is  more  likely  than  not  to  be
sustained upon audit by the relevant tax authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being
sustained. Interest and penalties on income taxes will be classified as a component of the provisions for income taxes.

The significant uncertain tax position arose from the subsidies granted by the local government for the Company’s PRC subsidiary, which may be modified
or challenged by the central government or the tax authority. A reconciliation of January 1, 2019, through December 31, 2020 amount of unrecognized tax
benefits excluding interest and penalties (“Gross UTB”) is as follows:

Balance as of January 1, 2019
Decrease in unrecognized tax benefits taken in current period
Balance as of December 31, 2019
Increase in unrecognized tax benefits taken in current year
Balance as of December 31, 2020

  Gross UTB    
7,129,285     
  $
(86,703)    
7,042,582     
468,600     
7,511,182    $

  $

Surcharge

Net UTB

         -     
-     
-     
-     
-    $

7,129,285 
(86,703)
7,042,582 
468,600 
7,511,182 

As of December 31, 2019 and 2020, the Company had not accrued any interest and penalties related to unrecognized tax benefits.

F-19

 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
   
   
   
 
 
(m) Research and Development and Advertising Expenses

Research and development and advertising expenses are expensed as incurred. Research and development expenses consist primarily of remuneration for
research and development staff, depreciation and material costs for research and development.

(n) Bills Payable

Bills  payable  represent  bills  issued  by  financial  institutions  to  the  Company’s  vendors.  The  Company’s  vendors  receive  payments  from  the  financial
institutions directly upon maturity of the bills and the Company is obliged to repay the face value of the bills to the financial institutions.

(o) Warranties

The Company provides a manufacturer’s warranty on all its products. It accrues a warranty reserve for the products sold, which includes management’s
best estimate of the projected costs to repair or replace items under warranty. These estimates are based on actual claims incurred to date and an estimate of
the nature, frequency and costs of future claims. These estimates are inherently uncertain given the Company’s relatively short history of sales of its current
products, and changes to its historical or projected warranty experience may cause material changes to the warranty reserve in the future.

(p) Government Grants

The  Company’s  subsidiaries  in  China  receive  government  subsidies  from  local  Chinese  government  agencies  in  accordance  with  relevant  Chinese
government  policies.  In  general,  the  Company  presents  the  government  subsidies  received  as  part  of  other  income  unless  the  subsidies  received  are
earmarked to compensate a specific expense, which have been accounted for by offsetting the specific expense, such as research and development expense,
interest expenses and removal costs. Unearned government subsidies received are deferred for recognition until the criteria for such recognition could be
met.

Grants applicable to land are amortized over the life of the depreciable facilities constructed on it. For research and development expenses, the Company
matches and offsets the government grants with the expenses of the research and development activities as specified in the grant approval document in the
corresponding period when such expenses are incurred.

(q) Share-based Compensation

The Company adopted the provisions of ASC Topic 718 which requires the Company to measure and recognize compensation expenses for an award of an
equity instrument based on the grant-date fair value. The cost is recognized over the vesting period (or the requisite service period). ASC Topic 718 also
requires the Company to measure the cost of a liability classified award based on its current fair value. The fair value of the award will be remeasured
subsequently at each reporting date through the settlement date. Changes in fair value during the requisite service period are recognized as compensation
cost over that period. Further, ASC Topic 718 requires the Company to estimate forfeitures in calculating the expense related to stock-based compensation.

The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Valuation Model. The expected volatility was based
on  the  historical  volatilities  of  the  Company’s  listed  common  stocks  in  the  United  States  and  other  relevant  market  information.  The  Company  uses
historical  data  to  estimate  share  option  exercises  and  employee  departure  behavior  used  in  the  valuation  model.  The  expected  terms  of  share  options
granted is derived from the output of the option pricing model and represents the period of time that share options granted are expected to be outstanding.
Since the share options once exercised will primarily trade in the U.S. capital market, the risk-free rate for periods within the contractual term of the share
option is based on the U.S. Treasury yield curve in effect at the time of grant.

F-20

 
 
 
 
 
 
 
 
 
 
 
 
 
 
(r) Retirement and Other Postretirement Benefits

Contributions to retirement schemes (which are defined contribution plans) are charged to cost of revenues, research and development expenses, sales and
marketing  expenses  and  general  and  administrative  expenses  in  the  statement  of  operations  and  comprehensive  loss  as  and  when  the  related  employee
service is provided.

(s) Loss per Share

Basic and diluted loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the year.

(t) Use of Estimates

The  preparation  of  the  consolidated  financial  statements  in  accordance  with  US  GAAP  requires  management  of  the  Company  to  make  a  number  of
estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the
consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.
Significant  items  subject  to  such  estimates  and  assumptions  include  revenue  recognition,  the  recoverability  of  the  carrying  amount  of  long-lived  assets,
unrecognized tax benefits, impairment on inventories, valuation allowance for receivables and deferred tax assets, provision for warranty and sales returns,
valuation of share-based compensation expense and warrants liability. Actual results could differ from those estimates.

(u) Segment Reporting

The  Company  uses  the  “management  approach”  in  determining  reportable  operating  segments.  The  management  approach  considers  the  internal
organization and reporting used by the Company’s chief operating decision maker for making operating decisions and assessing performance as the source
for  determining  the  Company’s  reportable  segments.  Management,  including  the  chief  operating  decision  maker,  reviews  operating  results  solely  by
monthly revenue of li-ion rechargeable batteries (but not by sub product type or geographic area) and operating results of the Company and, as such, the
Company has determined that the Company has one operating segment as defined by ASC Topic 280 “Segment Reporting”.

(v) Commitments and Contingencies

Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a
liability has been incurred and the amount of the assessment can be reasonably estimated.

(w) Warrant Liability

For warrants that are not indexed to the Company’s stock, the Company records the fair value of the issued warrants as a liability at each balance sheet date
and  records  changes  in  the  estimated  fair  value  as  a  non-cash  gain  or  loss  in  the  consolidated  statement  of  operations  and  comprehensive  income.  The
warrant  liability  is  recognized  in  the  balance  sheet  at  the  fair  value  (level  3).  The  fair  value  of  these  warrants  has  been  determined  using  the  Binomial
model.

Recently Adopted Accounting Standards

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for
Fair Value Measurement, which modifies the disclosure requirements for Level 1, Level 2 and Level 3 instruments in the fair value hierarchy. The guidance
is  effective  for  fiscal  years  beginning  after  December  15,  2019,  and  interim  periods  within  those  fiscal  years,  with  early  adoption  permitted  for  any
eliminated or modified disclosures. The Company applied the new standard beginning January 1, 2020.

F-21

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recently Issued Accounting Standards

In  May  2019,  the  Financial  Accounting  Standards  Board  (“FASB”)  issued  ASU  2019-05,  which  is  an  update  to  ASU  Update  No.  2016-13,  Financial
Instruments—Credit  Losses  (Topic  326):  Measurement  of  Credit  Losses  on  Financial  Instruments,  which  introduced  the  expected  credit  losses
methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology.
The  amendments  in  Update  2016-13  added  Topic  326,  Financial  Instruments—Credit  Losses,  and  made  several  consequential  amendments  to  the
Codification.  Update  2016-13  also  modified  the  accounting  for  available-for-sale  debt  securities,  which  must  be  individually  assessed  for  credit  losses
when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt
Securities. The amendments in this ASU address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain
financial  assets  previously  measured  at  amortized  cost  basis.  For  those  entities,  the  targeted  transition  relief  will  increase  comparability  of  financial
statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief
also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-
useful information. ASU 2019-05 is effective for the Company for fiscal year beginning after December 15, 2022. The Company is currently evaluating the
impact of this new standard on its condensed consolidated financial statements and related disclosures.

In  December  2019,  the  FASB  issued  ASU  2019-12,  Simplifying  the  Accounting  for  Income  Taxes,  which  simplifies  the  accounting  for  income  taxes,
eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistent application among
reporting entities. The guidance is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early
adoption permitted. Upon adoption, the Company must apply certain aspects of this standard retrospectively for all periods presented while other aspects
are applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption.
The Company is evaluating the impact this update will have on its financial statements.

In  March  2020,  the  FASB  issued  ASU  2020-04,  Reference  Rate  Reform  (Topic  848)  (Topic  718):  Improvemen20-04  contains  practical  expedients  for
reference  rate  reform  related  activities  that  impact  debt,  leases,  derivatives  and  other  contracts.  The  guidance  in  ASU  2020-04  is  optional  and  may  be
elected over time as reference rate reform activities occur. The Company continues to evaluate the impact of the guidance and may apply the elections as
applicable as changes in the market occur.

In  August  2020,  the  FASB  issued  ASU  2020-06,  Debt  -  Debt  with  Conversion  and  Other  Options  (Subtopic  470-  20)  and  Derivatives  and  Hedging  -
Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”),
which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This ASU (1) simplifies the accounting for
convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other
Options, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt
or preferred stock; (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features
that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification; and (3)
revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using
the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in
cash or shares.

For  SEC  filers,  excluding  smaller  reporting  companies,  ASU  2020-06  is  effective  for  fiscal  years  beginning  after  December  15,  2021  including  interim
periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. For all other entities, ASU
2020-06  is  effective  for  fiscal  years  beginning  after  December  15,  2023,  including  interim  periods  within  those  fiscal  years.  Entities  should  adopt  the
guidance  as  of  the  beginning  of  the  fiscal  year  of  adoption  and  cannot  adopt  the  guidance  in  an  interim  reporting  period.  The  Company  is  currently
evaluating the impact that ASU 2020-06 may have on its condensed consolidated financial statements and related disclosures.

Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date
are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

F-22

 
 
 
 
 
 
 
 
 
3. Pledged deposits

Pledged deposits as of December 31, 2019 and 2020 consisted of the following:

Pledged deposits with banks for:
Bills payable
Others*

  December 31,     December 31,  

2019

2020

  $

  $

4,021,255    $
1,499,736     
5,520,991    $

8,791,499 
198,249 
8,989,748 

* On July 7, 2016, Shenzhen Huijie Purification System Engineering Co., Ltd (“Shenzhen Huijie”), one of the Company’s contractors, filed a lawsuit
against CBAK Power in the Peoples’ Court of Zhuanghe City, Dalian for the failure to pay pursuant to the terms of the contract and for entrusting part
of the project to a third party without their prior consent. The plaintiff sought a total amount of $1,210,799 (RMB8,430,792), including construction
costs  of  $0.9  million  (RMB6.1  million),  interest  of  $29,812  (RMB0.2  million)  and  compensation  of  $0.3  million  (RMB1.9  million),  which  were
already  accrued  for  as  of  September  30,  2016.  On  September  7,  2016,  upon  the  request  of  Shenzhen  Huijie,  the  Court  froze  CBAK  Power’s  bank
deposits totaling $1,210,799 (RMB8,430,792) for a period of one year. On September 1, 2017, upon the request of Shenzhen Huijie, the Court froze
the bank deposits for another one year until August 31, 2018. The Court further froze the bank deposits for another one year until August 27, 2019
upon  the  request  of  Shenzhen  Huijie  on  August  27,  2018.  On  August  27,  2019,  the  Court  again  froze  the  bank  deposits  for  another  one  year  until
August 27, 2020, upon the request of Shenzhen Huijie. On June 28, 2020, the Court of Dalian entered the final judgement and the frozen bank deposit
was released in July 2020.

On July 25, 2019, CBAK Power received notice from Shenzhen Court of International Arbitration that Shenzhen Xinjiatuo Automobile Technology
Co., Ltd filed arbitration against the Company for the failure to pay pursuant to the terms of the contract. The plaintiff sought a total amount of $0.16
million (RMB1,112,269), including equipment cost of $0.14 million (RMB976,000) and interest of $0.02 million (RMB136,269). On August 9, 2019,
upon  the  request  of  Shenzhen  Xinjiatuo Automobile  Technology  Co.,  Ltd,  Shenzhen  Court  of  International  Arbitration  froze  CBAK  Power’s  bank
deposits  totaling  $0.16  million  (RMB1,117,269)  for  a  period  of  one  year  to  August  2020.  In  early  July  2020,  Shenzhen  Court  of  International
Arbitration made arbitration award dismissing the plaintiff’s claim and CBAK Power’s counterclaim and the bank deposit was released in early August
2020. 

In early September of 2019, several employees of CBAK Suzhou filed arbitration with Suzhou Industrial Park Labor Disputes Arbitration Commission
against CBAK Suzhou for failure to pay their salaries in time. The employees seek for a payment including salaries of $97,779 (RMB638,359) and
compensation  of  $83,173  (RMB543,000),  totaling  $0.17  million  (RMB1,181,359).  In  addition,  upon  the  request  of  the  employees  for  property
preservation,  bank  deposit  of  $0.17  million  (RMB1,181,359)  was  frozen  by  the  court  of  Suzhou  for  a  period  of  one  year.  On  September  5,  2019,
CBAK Suzhou and the employees reached an agreement that CBAK Suzhou will pay these salaries and compensation. In February 2020, the Company
had made full payment. As of December 31, 2019, $6 (RMB43) was frozen by bank and bank deposit was released in October 2020.

In  November  2019,  CBAK  Suzhou  received  notice  from  Court  of  Suzhou  city  that  Suzhou  Industrial  Park  Security  Service  Co.,  Ltd  (“Suzhou
Security”)  filed  a  lawsuit  against  CBAK  Suzhou  for  the  failure  to  pay  pursuant  to  the  terms  of  the  sales  contract.  Suzhou  Security  sought  a  total
amount of $21,400 (RMB139,713), including services expenses amount of $21,277 (RMB138,908) and interest of $123 (RMB805). Upon the request
of Suzhou Security for property preservation, the Court of Suzhou froze CBAK Suzhou’s bank deposits totaling $0.02 million (RMB150,000) for a
period of one year. As of December 31, 2020, $5,062 (RMB33,048) was frozen by bank and the Company had accrued the service cost of $21,277
(RMB138,908). 

F-23

 
 
 
 
 
 
 
   
 
   
   
  
   
 
 
 
 
 
  
 
In  December  2019,  CBAK  Power  received  notice  from  Court  of  Zhuanghe  that  Dalian  Construction  Electrical  Installation  Engineering  Co.,  Ltd.
(“Dalian  Construction”)  filed  a  lawsuit  against  CBAK  Power  for  the  failure  to  pay  pursuant  to  the  terms  of  the  construction  contract.  Dalian
Construction  sought  a  total  amount  of  $101,780  (RMB691,086)  and  interest  $1,905  (RMB12,934).  As  of  December  31,  2019,  the  Company  has
accrued the construction cost of $101,780 (RMB691,086). Upon the request of Dalian Construction for property preservation, the Court of Zhuanghe
ordered to freeze CBAK Power’s bank deposits totaling $103,685 (RMB704,020) for a period of one year to December 2020. As of December 31,
2019, $97,384 (RMB661,240) was frozen by bank. In January 2020, CBAK Power and Dalian Construction have come to a settlement, and the bank
deposit was then released. CBAK Power has settled the construction cost and related interests as of December 31, 2020.

On March 20, 2020, CBAK Power received notice from Court of Nanpi County, Hebei Province that Cangzhou Huibang Engineering Manufacturing
Co., Ltd (“Cangzhou Huibang”) filed a lawsuit against CBAK Power for the failure to pay pursuant to the terms of the purchase contract. Cangzhou
Huibang sought a total amount of $0.31 million (RMB2,029,594), including materials purchase cost of $0.3 million (RMB1,932,947), and interest of
$14,804  (RMB96,647).  As  of  December  31,  2020,  the  Company  has  accrued  materials  purchase  cost  of  $0.3  million  (RMB1,932,947).  Upon  the
request  of  Cangzhou  Huibang  for  property  preservation,  the  Court  of  Nanpi  ordered  to  freeze  CBAK  Power’s  bank  deposits  totaling  $0.4  million
(RMB2,650,000) for a period of two year to March 2, 2022. As of December 31, 2020, $18,518 (RMB120,898) was frozen by bank. 

In February 2020, CBAK Power received notice from Court of Zhuanghe that Dongguan Shanshan Battery Material Co., Ltd (“Dongguan Shanshan”)
filed lawsuit against CBAK Power for the failure to pay pursuant to the terms of the purchase contract. Dongguan Shanshan sought a total amount of
$0.7 million (RMB4,434,209). Upon the request of Dongguan Shanshan for property preservation, the Court of Zhuanghe ordered to freeze CBAK
Power’s  bank  deposits  totaling  $0.7  million  (RMB4,434,209)  for  a  period  of  one  year  to  December  17,  2020.  In  July  2020,  CBAK  Power  and
Dongguan Shanshan have come to a settlement amount of $0.6 million (RMB3,635,192) and the bank deposit was then released. In October 2020,
CBAK Power fail to pay according to the settlement, Dongguan Shanshan sought a total amount of $0.6 million (RMB3,635,192). Upon the request of
Dongguan  Shanshan  for  property  preservation,  the  Court  of  Zhuanghe  ordered  to  freeze  CBAK  Power’s  bank  deposits  totaling  $0.6  million
(RMB3,365,192)  for  a  period  of  one  year  to  October  21,  2021.  As  of  December  31,  2020,  $55,230  (RMB360,576)  was  frozen  by  bank  and  the
Company  has  accrued  the  material  purchase  cost  of  $516,865  (RMB3,374,403).  Upto  the  date  of  this  report,  CBAK  Power  paid  $336,979
(RMB2,20,00) to Dongguan Shanshan and the frozen bank deposits were released in March 2021.

In June 2020, CBAK Power received notice from Court of Dalian Economic and Technology Development Zone that Nanjing Jinlong Chemical Co.,
Ltd. (“Nanjing Jinlong”) filed a lawsuit against CBAK Power for the failure to pay pursuant to the terms of the purchase contract. Nanjing Jinlong
sought a total amount of $125,908 (RMB822,000). Upon the request of Nanjing Jinlong for property preservation, the Court of Dalian Economic and
Technology  Development  Zone  ordered  to  freeze  CBAK  Power’s  bank  deposits  totaling  $125,908  (RMB822,000)  for  a  period  of  one  year.  As  of
December 31, 2020, $16 (RMB107) was frozen by bank and the Company had accrued the material purchase cost of $125,908 (RMB822,000).

In  June  2020,  CBAK  Power  received  notice  from  Court  of  Dalian  Economic  and  Technology  Development  Zone  that  Xi’an  Anpu  New  Energy
Technology  Co.  LTD  (“Xi’an  Anpu”)  filed  a  lawsuit  against  CBAK  Power  for  the  failure  to  pay  pursuant  to  the  terms  of  the  equipment  purchase
contract.  Xi’an  Anpu  sought  a  total  amount  of  $129,270  (RMB843,954),  including  $117,636  (RMB768,000)  for  equipment  cost  and  $11,634
(RMB75,954)  for  liquidated  damages.  Upon  the  request  of  Xi’an  Anpu  for  property  preservation,  the  Court  of  Dalian  Economic  and  Technology
Development Zone ordered to freeze CBAK Power’s bank deposits $0.1 million (RMB843,954) for a period to May 11, 2021. As of December 31,
2020,  $98,284  (RMB641,656)  was  frozen  by  bank  and  CBAK  Power  had  accrued  the  equipment  purchase  cost  of  $117,636  (RMB768,000).  The
property preservation was released on February 25, 2021 upon CBAK Power settlement.

F-24

 
 
 
 
 
 
 
 
In  May  2020,  CBAK  Power  received  notice  from  Court  of  Wuqing  District,  Tianjin  that  Tianjin  Changyuan  Electric  Material  Co.,  Ltd  (“Tianjin
Changyuan”) filed lawsuit against CBAK Power for failure to pay pursuant to the terms of the purchase contract. The plaintiff sought a total amount of
$13,040  (RMB85,136),  including  material  cost  of  $12,166  (RMB79,429)  and  interest  of  $874  (RMB5,707).  In  July,  2020,  upon  the  request  of  the
plaintiff  for  property  preservation,  the  Court  of  Wuqing  District,  Tianjin  ordered  to  freeze  CBAK  Power’s  bank  deposits  totaling  $13,041
(RMB85,136)  for  a  period  of  one  year.  As  of  December  31,  2020,  $13,041  (RMB85,136)  was  frozen  by  bank  and  the  Company  had  accrued  the
material purchase cost and interest of $13,041 (RMB85,136).

In  October  2020,  CBAK  Power  received  a  notice  from  Court  of  Dalian  Economic  and  Technology  Development  Zone  that  Jiuzhao  New  Energy
Technology Co., Ltd. (“Jiuzhao”) filed a lawsuit against CBAK Power for failure to pay pursuant to the terms of certain purchase contract. Jiuzhao
sought  a  total  amount  of  $0.9  million  (RMB6.0  million),  including  material  cost  of  $0.9  million  (RMB5,870,267)  and  interest  of  $19,871
(RMB129,732). Upon the request of the plaintiff for property preservation, the Court of Dalian Economic and Technology Development Zone, Jiuzhao
ordered to freeze CBAK Power’s bank deposits totaling $0.9 million (RMB6.0 million) for a period to September 17, 2021. As of December 31, 2020,
$5,874 (RMB38,346) was frozen by bank and the Company had accrued the material purchase cost of $0.9 million (RMB5,870,267).

In  October  2019,  CBAK  Power  received  notice  from  Court  of  Changshou  District,  Chongqing  that  Chongqing  Zhongrun  Chemistry  Co.,  Ltd
(“Chongqing Zhongrun”) filed arbitration claims against the Company for failure to pay pursuant to the terms of the contract. The plaintiff sought a
total  amount  of  $0.4  million  (RMB2,484,948),  including  material  cost  of  $0.4  million  (RMB2,397,660)  and  interest  of  $13,370  (RMB87,288).  On
October  31,  2019,  CBAK  Power  and  Chongqing  Zhongrun  reached  an  agreement  that  CBAK  Power  would  pay  the  material  cost  by  the  end  of
December  31,  2019.  In  2020,  CBAK  Power  had  paid  $198,144  (RMB1,293,600).  In  August  2020,  upon  the  request  of  Chongqing  Zhongrun  for
property preservation, the Court of Changshou District ordered to freeze CBAK Power’s bank deposits totaling $0.2 million (RMB1,249,836) for a
period  of  one  year  to  August  2021.  As  of  December  31,  2020,  the  Company  has  accrued  the  remaining  material  purchase  cost  of  $0.2  million
(RMB1,104,007)  and  $2,224  (RMB14,521)  was  frozen  by  bank.  The  property  preservation  was  released  in  March,  2021  upon  CBAK  Power
settlement.

4. Trade Accounts and Bills Receivable, net

Trade accounts and bills receivable as of December 31, 2019 and 2020:

Trade accounts receivable
Less: Allowance for doubtful accounts

Bills receivable

  December 31,     December 31,  

2019
12,517,626    $
(4,650,686)    
7,866,940     
85,480     
7,952,420    $

2020
33,305,997 
(5,266,828)
28,039,169 
1,532,105 
29,571,274 

  $

  $

Included  in  trade  accounts  and  bills  receivables  are  retention  receivables  of  $2,159,356  and  $1,896,068  as  of  December  31,  2019  and  2020.  Retention
receivables are interest-free and recoverable either at the end of the retention period of three to five years since the sales of the EV batteries or 200,000 km
since the sales of the motor vehicles (whichever comes first).

An analysis of the allowance for doubtful accounts is as follows:

Balance at beginning of year
Provision for the year
Reversal - recoveries by cash
Charged to consolidated statements of operations and comprehensive (loss) income
Write off
Foreign exchange adjustment
Balance at end of year

F-25

  December 31,     December 31,  

2019
3,657,173    $
1,613,402     
(567,042)    
1,046,360    $
-     
(52,847)    
4,650,686    $

2020
4,650,686 
1,656,128 
(934,391)
721,737 
(431,684)
326,089 
5,266,828 

  $

  $

  $

 
 
 
 
 
 
 
 
 
 
   
 
   
 
   
   
 
 
 
 
 
 
 
   
 
   
   
   
   
 
5.

Inventories

Inventories as of December 31, 2019 and 2020 consisted of the following:

Raw materials
Work in progress
Finished goods

  December 31,     December 31,  

2019

482,836    $
1,254,490     
6,929,388     
8,666,714    $

2020

757,857 
2,338,342 
2,156,646 
5,252,845 

  $

  $

During  the  years  ended  December  31,  2019  and  2020,  write-downs  of  obsolete  inventories  to  lower  of  cost  or  net  realizable  value  of  $834,362  and
$1,450,182, respectively, were charged to cost of revenues.

6. Prepayments and Other Receivables

Prepayments and other receivables as of December 31, 2019 and 2020 consisted of the following:

Value added tax recoverable
Loan receivables
Prepayments to suppliers
Deposits
Staff advances
Prepaid operating expenses
Others

Less: Allowance for doubtful accounts

  December 31,     December 31,  

2019
4,124,624    $
-     
60,090     
63,184     
53,731     
317,151     
124,133     
4,742,913     
(7,000)    
4,735,913    $

2020
4,524,475 
1,358,637 
424,311 
17,385 
67,867 
529,401 
524,468 
7,446,544 
(7,000)
7,439,544 

  $

  $

Nanjing CBAK entered into a loan agreement with Shen Zhen Asian Plastics Technology Co., Ltd (SZ Asian Plastics), to loan SZ Asian Plastics a total
amount of $1.4 million (RMB8,870,000) for a period of 6 months from December 1, 2020 to May 31, 2021. The loan is unsecured and bears fixed interest
at  6%  per  annum.  The  Company’s  shareholder  Mr.  Jiping  Zhao,  holding  2.39%  equity  interest  in  the  Company,  at  the  same  time  held  79.13%  equity
interests in SZ Asian Plastics. In March 2021, SZ Asian Plastics has fully repaid the loan principal.

7. Payables to former subsidiaries, net

Payables to former subsidiaries as of December 31, 2019 and 2020 consisted of the following:

BAK Tianjin
BAK Shenzhen

  December 31,     December 31,  

2019

2020

  $

  $

-    $
1,483,352     
1,483,352    $

29,852 
597,138 
626,990 

Balance as of December 31, 2019 and December 31, 2020 consisted of payables for purchase of inventories from BAK Tianjin and BAK Shenzhen. From
time to time, to meet the needs of its customers, the Company purchased products from these former subsidiaries that it did not produce to meet the needs
of its customers.

On  April  10,  2020,  each  of  Mr.  Yunfei  Li,  Mr.  Ping  Shen  and  Asia  EVK  entered  into  an  agreement  with  CBAK  Power  and  Shenzhen  BAK,  whereby
Shenzhen  BAK  assigned  its  rights  to  the  unpaid  inventories  cost  owed  by  CBAK  Power  of  approximately  $1.0  million  (RMB7,000,000),  $2.3  million
(RMB16,000,000)  and  $1.0  million  (RMB7,300,000)  (collectively  $4.3  million,  the  “Sixth  Debt”)  to  Mr.  Yunfei  Li,  Mr.  Ping  Shen  and  Asia  EVK,
respectively (see Note 1). 

The above balance is unsecured and non-interest bearing and repayable on demand.

F-26

 
 
 
 
 
 
 
   
 
   
   
 
 
 
 
 
 
 
 
   
 
   
   
   
   
   
   
 
   
   
 
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
8. Property, Plant and Equipment, net

Property, plant and equipment as of December 31, 2019 and 2020 consisted of the following:

Buildings
Machinery and equipment
Office equipment
Motor vehicles

Impairment
Accumulated depreciation
Carrying amount

  $

  December 31,
2019
27,262,301    $
22,719,932     
204,196     
161,980     
50,348,409     
(4,126,152)    
(8,044,692)    
38,177,565    $

    December 31,  
2020
28,150,137 
32,753,952 
258,458 
197,790 
61,360,337 
(8,980,020)
(11,339,947)
41,040,370 

  $

During the years ended December 31, 2019 and 2020, the Company incurred depreciation expense of $2,728,224 and $2,677,238, respectively.

The Company has not yet obtained the property ownership certificates of the buildings in its Dalian manufacturing facilities with a carrying amount of
$24,671,045  and  $24,611,468  as  of  December  31,  2019  and  2020,  respectively.  The  Company  built  its  facilities  on  the  land  for  which  it  had  already
obtained the related land use right. The Company has submitted applications to the Chinese government for the ownership certificates on the completed
buildings located on these lands. However, the application process takes longer than the Company expected and it has not obtained the certificates as of the
date of this report. However, since the Company has obtained the land use right in relation to the land, the management believe the Company has legal title
to the buildings thereon albeit the lack of ownership certificates.

During  the  course  of  the  Company’s  strategic  review  of  its  operations  in  the  years  ended  December  31,  2019  and  2020,  the  Company  assessed  the
recoverability of the carrying value of certain property, plant and equipment which resulted in impairment losses of approximately $2.3 million and $4.3
million,  respectively.  The  impairment  charge  represented  the  excess  of  carrying  amounts  of  the  Company’s  property,  plant  and  equipment  over  the
estimated fair value of the Company’s production facilities in Dalian primarily for the production of high-power lithium batteries.

9. Construction in Progress

Construction in progress as of December 31, 2019 and 2020 consisted of the following:

Construction in progress
Prepayment for acquisition of property, plant and equipment
Carrying amount

  December 31,     December 31,  

2019
21,613,577    $
94,047     
21,707,624    $

2020
27,070,916 
3,122,393 
30,193,309 

  $

  $

Construction in progress as of December 31, 2019 and 2020 mainly comprised capital expenditures for the construction of the facilities and production
lines of CBAK Power and Nanjing CBAK.

For the years ended December 31, 2019 and 2020, the Company capitalized interest of $1,516,244 and $1,308,274, respectively, to the cost of construction
in progress. 

10. Lease

(a) Right-of-use assets

Balance as of January 1, 2020
Amortization charge for the year
Foreign exchange adjustment
Balance as of December 31, 2020

Prepaid
land lease 
payments

  $

  $

7,194,195 
(162,763)
469,348 
7,500,780 

Lump sum payments were made upfront to acquire the leased land from the owners with lease period for 50 years up to August 9, 2064, and no ongoing
payments will be made under the terms of these land leases.

F-27

 
 
 
 
 
 
 
   
 
   
   
   
 
   
   
   
 
 
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
 
 
 
   
   
 
 
(b) Company as Lessor

The Company derives a portion of its revenue from leasing arrangements of these vehicles to end users. Such arrangements provide for monthly payments
covering the vehicles sales and interest. These arrangements meet the criteria to be accounted for as sales-type leases. Accordingly, vehicle sale net of cost
is recorded as other income and recognized upon delivery of the vehicle and its acceptance by the end user. Upon the recognition of such revenue, an asset
is established for the investment in sales-type leases. Interests are recognized monthly over the lease term. The components of the net investment in sales-
type leases as of December 31, 2019 and 2020 are as follows:

Total future minimum lease payments receivable
Less: unearned income, representing interest
Present value of minimum lease payments receivables
Less: Current portion
Non-current portion

  December 31,     December 31,  

2019

       -     
-     
-     
-     
-     

2020
1,210,305 
(124,653)
1,085,652 
(235,245)
850,407 

  $

  $

Vehicle sale net of cost recognized in other income (expense) and interest income from vehicle leasing was $(410,774) and $13,106 for the year ended
December 31, 2020, respectively.

The future minimum lease payments receivable for sales type leases are as follows:

Fiscal years ending December
2021
2022
2023
2024
2025
Thereafter

11. Intangible Assets, net

Total Minimum
Lease
Payments to be
Received

Amortization
of Unearned
Income

Net Investment
in Sales Type
Leases

  $

299,850    $
422,755     
422,755     
64,945     
-     
-     
1,210,305     

64,605    $
41,852     
17,654     
542     
-     
-     
124,653     

235,245 
380,903 
405,101 
64,403 
- 
- 
1,085,652 

Intangible assets as of December 31, 2019 and 2020 consisted of the followings:

Computer software at cost
Accumulated amortization

Amortization expenses were $5,482 and $4,143 for the years ended December 31, 2019 and 2020, respectively.

12. Trade Accounts and Bills Payable

Trade accounts and bills payable as of December 31, 2019 and 2020 consisted of the followings:

Trade accounts payable
Bills payable
– Bank acceptance bills

All the bills payable are of trading nature and will mature within one year from the issue date.

The bank acceptance bills were pledged by the Company’s bank deposits (Note 3).

F-28

  December 31,     December 31,  

2019

2020

  $

  $

30,648     
(15,470)    
15,178     

32,686 
(20,879)
11,807 

  December 31,     December 31,  

2019
11,157,014    $

2020
19,560,793 

  $

3,915,094     

8,791,499 

  $

15,072,108    $

28,352,292 

 
 
 
 
 
 
 
 
   
 
   
   
   
 
 
 
 
   
   
 
   
   
   
   
   
 
   
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
 
 
   
 
   
      
  
   
 
   
      
  
 
 
 
 
13. Loans

Bank loans:

Bank borrowings as of December 31, 2019 and 2020 consisted of the followings:

Current maturities of long-term bank loans
Long-term bank borrowings

  December 31,     December 31,  

2019
16,574,752    $
9,519,029     
26,093,781    $

2020
13,739,546 
- 
13,739,546 

  $

  $

On  June  4,  2018,  the  Company  obtained  banking  facilities  from  China  Everbright  Bank  Dalian  Branch  with  a  maximum  amount  of  RMB200  million
(approximately $30.63 million) with the term from June 12, 2018 to June 10, 2021, bearing interest at 130% of benchmark rate of the People’s Bank of
China (“PBOC”) for three-year long-term loans, at current rate 6.175% per annum. The facilities were secured by the Company’s land use rights, buildings,
machinery and equipment. According to the original repayment schedule, the loans are repayable in six installments of RMB0.8 million ($0.12 million) on
December  10,  2018,  RMB24.3  million  ($3.72  million)  on  June  10,  2019,  RMB0.8  million  ($0.12  million)  on  December  10,  2019,  RMB74.7  million
($11.44 million) on June 10, 2020, RMB0.8 million ($0.12 million) on December 10, 2020 and RMB66.3 million ($10.16 million) on June 10, 2021. The
Company repaid the bank loan of RMB0.8 million ($0.12 million), RMB24.3 million ($3.72 million) and RMB0.8 million ($0.12 million) in December
2018, June 2019 and December 2019, respectively.

On June 28, 2020, the Company entered into a supplemental agreement with China Everbright Bank Dalian Branch to change the repayment schedule.
According  to  the  modification  agreement,  the  remaining  RMB141.8  million  (approximately  $21.72  million)  loans  are  repayable  in  eight  instalments
consisting of RMB1.09 million ($0.17 million) on June 10, 2020, RMB1 million ($0.15 million) on December 10, 2020, RMB2 million ($0.31 million) on
January 10, 2021, RMB2 million ($0.31 million) on February 10, 2021, RMB2 million ($0.31 million) on March 10, 2021, RMB2 million ($0.31 million)
on April 10, 2021, RMB2 million ($0.31 million) on May 10, 2021, and RMB129.7 million ($19.9 million) on June 10, 2021, respectively. The Company
repaid the bank loan of RMB1.09 million ($0.17 million) and RMB51 million ($7.8 million) in June and December 2020, respectively.

Under  the  facilities,  as  of  December  31,  2020,  outstanding  loan  balance  owing  to  China  Everbright  Bank  Dalian  Branch  was  RMB89.7  million
(approximately $13.7 million).

In August 2018, the Company borrowed a total of RMB60 million (approximately $8.8 million) in the form of bills payable from China Everbright Bank
Dalian Branch for a term until August 14, 2019, which was secured by the Company’s cash totaled $8.8 million. The Company discounted these two bills
payable of even date to China Everbright Bank at a rate of 4.0%. The Company repaid these bills payable in August 2019.

On August  22,  2018,  the  Company  obtained  one-year  term  facilities  from  China  Everbright  Bank  Dalian  Branch  with  a  maximum  amount  of  RMB100
million (approximately $14.7 million) including revolving loans, trade finance, notes discount, and acceptance of commercial bills etc. Any amount drawn
under the facilities requires security in the form of cash or banking acceptance bills receivables of at least the same amount. The Company borrowed a
series  of  bank  acceptance  bills  totaled  RMB28.8  million  (approximately  $4.24  million)  for  a  term  until  March  7,  2019.  The  Company  repaid  the  bank
acceptance bills on March 7, 2019.

In November 2018, the Company borrowed a total of RMB100 million (approximately $14.7 million) in the form of bills payable from China Everbright
Bank Dalian Branch for a term until November 12, 2019, which was secured by the Company’s cash totaled RMB50 million (approximately $7.4 million)
and the 100% equity in CBAK Power held by BAK Asia. The Company discounted the bills payable of even date to China Everbright Bank at a rate of
4.0%. The Company repaid the bills payable in November 2019.

The  Company  also  borrowed  a  series  of  acceptance  bills  from  Industrial  Bank  Co.,  Ltd.  Dalian  Branch  totaled  RMB1.5  million  (approximately  $0.2
million) for various terms through May 21, 2019, which was secured by bills receivable of RMB1.5 million (approximately $0.2 million). The Company
repaid the bank acceptance bills on May 21, 2019.

F-29

 
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
 
 
 
On October 15, 2019, the Company borrowed a total of RMB28 million (approximately $4.12 million) in the form of bills payable from China Everbright
Bank Dalian Branch for a term until October 15, 2020, which was secured by the Company’s cash totaled RMB28 million (approximately $4.12 million).
The Company discounted the bills payable of even date to China Everbright Bank at a rate of 3.3%. The Company repaid the bills on October 15, 2020.

In  December  2019,  the  Company  obtained  banking  facilities  from  China  Everbright  Bank  Dalian  Friendship  Branch  totaled  RMB39.9  million
(approximately $6.1 million) for a term until November 6, 2020, bearing interest at 5.655% per annum. The facility was secured by 100% equity in CBAK
Power held by BAK Asia and buildings of Hubei BAK Real Estate Co., Ltd., which Mr. Yunfei Li (“Mr. Li”), the Company’s CEO holding 15% equity
interest. The Company repaid the bank loan of RMB39.9 million (approximately $6.1 million) in December 2020.

In July to December 2020, the Company borrowed a series of acceptance bills from China Merchants Bank totaled RMB24.9 million (approximately $3.82
million)  for  various  terms  through  January  to  June  2021,  which  was  secured  by  the  Company’s  cash  totaled  RMB24.9  million  (approximately  $3.82
million) (Note 3).

In December 2020, the Company borrowed a series of acceptance bills from Agricultural Bank of China totaled RMB32.5 million (approximately $4.97
million) for various terms to June 2021, which was secured by the Company’s cash totaled RMB32.5 million (approximately $4.97 million) (Note 3).

The facilities were secured by the Company’s assets with the following carrying amounts:

Pledged deposits (note 3)
Right-of-use assets (note 10)
Buildings
Machinery and equipment

  December 31,     December 31,  

2019
4,021,255    $
7,194,195     
17,683,961     
7,196,810     
36,096,221    $

2020
8,791,499 
7,500,780 
16,721,178 
4,926,886 
37,940,343 

  $

  $

As of December 31, 2020, the Company had unutilized committed banks and Jilin Province Trust Co., Ltd (see “Other Short-term Loans” below) totaled
$7.4 million.

During  the  years  ended  December  31,  2019  and  2020,  interest  of  $2,293,440  and  $1,710,183  were  incurred  on  the  Company’s  bank  borrowings,
respectively.

Other short-term loans:

Other short-term loans as of December 31, 2019 and 2020 consisted of the following:

Advance from related parties
– Mr. Xiangqian Li, the Company’s Former CEO
– Mr. Yunfei Li
– Shareholders

Advances from unrelated third party
– Mr. Wenwu Yu
– Ms. Longqian Peng
– Mr. Shulin Yu
– Jilin Province Trust Co. Ltd
– Suzhou Zhengyuanwei Needle Ce Co., Ltd

  December 31,     December 31,  

Note

2019

2020

(a)
(b)
(c)

(d)
(d)
(e)
(f)
(g)

  $

  $

100,000    $
212,470     
86,679     
399,149     

30,135     
646,273     
517,018     
5,687,204     
71,808     
6,952,438     
7,351,587    $

100,000 
278,739 
92,446 
471,185 

16,823 
689,275 
- 
- 
76,586 
782,684 
1,253,869 

(a) Advances from Mr. Xiangqian Li, the Company’s former CEO, was unsecured, non-interest bearing and repayable on demand.

(b) Advances from Mr. Yunfei Li, the Company’s CEO, was unsecured, non-interest bearing and repayable on demand.

F-30

 
 
 
 
 
 
 
 
 
 
   
 
   
   
   
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
   
      
  
 
 
   
 
   
 
 
 
   
 
 
   
      
  
 
   
 
   
 
   
 
   
 
   
 
 
 
   
 
 
 
 
 
 
 
(c) The earnest money paid by certain shareholders in relation to share purchase (note 1) were unsecured, non-interest bearing and repayable on demand.

In 2019, according to the investment agreements and agreed by the investors, the Company returned partial earnest money of $966,579 (approximately
RMB6.7 million) to these investors.

On October 14, 2019, the Company entered into a cancellation agreement with Mr. Shangdong Liu, Mr. Shibin Mao, Ms. Lijuan Wang and Mr. Ping
Shen (the creditors). Pursuant to the terms of the cancellation agreement, Mr. Shangdong Liu, Mr. Shibin Mao, Ms. Lijuan Wang and Mr. Ping Shen
agreed  to  cancel  and  convert  the  Fifth  Debt  (note  1)  and  the  Unpaid  Earnest  Money  in  exchange  for  528,053,  3,536,068,  2,267,798  and  2,267,798
shares of common stock of the Company, respectively, at an exchange price of $0.6 per share. Upon receipt of the shares, the creditors will release the
Company from any claims, demands and other obligations relating to the Fifth Debt and the Unpaid Earnest Money.

As of December 31, 2020, earnest money of $92,446 remained outstanding.

(d) Advances from unrelated third parties were unsecured, non-interest bearing and repayable on demand.

(e) On June 25, 2019, the Company entered into a loan agreement with Mr. Shulin Yu, an unrelated party, to loan RMB3.6 million (approximately $0.5
million) for a term of one year, bearing annual interest of 10% and the repayment was guaranteed by Mr. Yunfei Li (the Company’s CEO) and Mr.
Wenwu Wang (the Company’s former CFO). On June 22, 2020, the Company and Mr. Shulin Yu entered into a supplemental agreement to extend the
loan for one year to June 24, 2021. The Company fully repaid the loan principal and accrued interests in October 2020.

(f)

In January  2019,  the  Company  obtained  one-year  term  facilities  from  Jilin  Province  Trust  Co.  Ltd.  with  a  maximum  amount  of  RMB40.0  million
(approximately $5.8 million), which was secured by land use rights and buildings of Eodos Liga Energy Co., Ltd. Under the facilities, the Company
borrowed  a  total  of  RMB39.6  million  ($5.7  million)  in  2019,  bearing  annual  interest  from  11.3%  to  11.6%.  The  Company  fully  repaid  the  loan
principal and accrued interests in March 2020.

In March 2020, the Company obtained additional one-year term facilities from Jilin Province Trust Co., Ltd with a maximum amount of RMB40.0
million  (approximately  $5.9  million),  which  was  secured  by  land  use  rights  and  buildings  of  Eodos  Liga  Energy  Co.,  Ltd.  Under  the  facilities,  the
Company  borrowed  RMB24.2  million  ($3.6  million)  on  March  13,  2020,  bearing  annual  interest  of  13.5%.  The  Company  fully  repaid  the  loan
principal and accrued interests in December 2020.

(g) In 2019, the Company entered into a short term loan agreement with Suzhou Zhengyuanwei Needle Ce Co., Ltd, an unrelated party to loan RMB0.6
million  (approximately  $0.1  million),  bearing  annual  interest  rate  of  12%.  As  of  December  31,  2020,  loan  amount  of  RMB0.5  million  ($76,586)
remained outstanding.

During  the  years  ended  December  31,  2019  and  2020,  interest  of  $601,153  and  $587,620  were  incurred  on  the  Company’s  borrowings  from  unrelated
parties, respectively.

F-31

 
 
 
 
 
 
 
 
 
 
 
 
14. Accrued Expenses and Other Payables

Accrued expenses and other payables as of December 31, 2019 and 2020 consisted of the following:

Construction costs payable
Equipment purchase payable
Liquidated damages (note a)
Accrued staff costs
Compensation costs
Customer deposits
Other payables and accruals

  December 31,     December 31,  

2019
1,335,483    $
7,440,131     
1,210,119     
2,485,384     
109,311     
600,758     
2,346,403     
15,527,589    $

2020

273,279 
5,431,132 
1,210,119 
2,083,660 
- 
394,536 
2,252,733 
11,645,459 

  $

  $

(a) On  August  15,  2006,  the  SEC  declared  effective  a  post-effective  amendment  that  the  Company  had  filed  on  August  4,  2006,  terminating  the
effectiveness of a resale registration statement on Form SB-2 that had been filed pursuant to a registration rights agreement with certain shareholders to
register the resale of shares held by those shareholders. The Company subsequently filed Form S-1 for these shareholders. On December 8, 2006, the
Company filed its Annual Report on Form 10-K for the year ended September 30, 2006 (the “2006 Form 10-K”). After the filing of the 2006 Form 10-
K, the Company’s previously filed registration statement on Form S-1 was no longer available for resale by the selling shareholders whose shares were
included  in  such  Form  S-1.  Under  the  registration  rights  agreement,  those  selling  shareholders  became  eligible  for  liquidated  damages  from  the
Company relating to the above two events totaling approximately $1,051,000. As of December 31, 2019 and 2020, no liquidated damages relating to
both events have been paid.

On November 9, 2007, the Company completed a private placement for the gross proceeds to the Company of $13,650,000 by selling 3,500,000 shares
of common stock at the price of $3.90 per share. Roth Capital Partners, LLC acted as the Company’s exclusive financial advisor and placement agent
in connection with the private placement and received a cash fee of $819,000. The Company may have become liable for liquidated damages to certain
shareholders  whose  shares  were  included  in  a  resale  registration  statement  on  Form  S-3  that  the  Company  filed  pursuant  to  a  registration  rights
agreement that the Company entered into with such shareholders in November 2007. Under the registration rights agreement, among other things, if a
registration statement filed pursuant thereto was not declared effective by the SEC by the 100th calendar day after the closing of the Company’s private
placement on November 9, 2007, or the “Effectiveness Deadline”, then the Company would be liable to pay partial liquidated damages to each such
investor of (a) 1.5% of the aggregate purchase price paid by such investor for the shares it purchased on the one month anniversary of the Effectiveness
Deadline; (b) an additional 1.5% of the aggregate purchase price paid by such investor every thirtieth day thereafter (pro rated for periods totaling less
than thirty days) until the earliest of the effectiveness of the registration statement, the ten-month anniversary of the Effectiveness Deadline and the
time that the Company is no longer required to keep such resale registration statement effective because either such shareholders have sold all of their
shares or such shareholders may sell their shares pursuant to Rule 144 without volume limitations; and (c) 0.5% of the aggregate purchase price paid
by  such  investor  for  the  shares  it  purchased  in  the  Company’s  November  2007  private  placement  on  each  of  the  following  dates:  the  ten-month
anniversary of the Effectiveness Deadline and every thirtieth day thereafter (prorated for periods totaling less than thirty days), until the earlier of the
effectiveness  of  the  registration  statement  and  the  time  that  the  Company  no  longer  is  required  to  keep  such  resale  registration  statement  effective
because  either  such  shareholders  have  sold  all  of  their  shares  or  such  shareholders  may  sell  their  shares  pursuant  to  Rule  144  without  volume
limitations. Such liquidated damages would bear interest at the rate of 1% per month (prorated for partial months) until paid in full.

On December 21, 2007, pursuant to the registration rights agreement, the Company filed a registration statement on Form S-3, which was declared
effective  by  the  SEC  on  May  7,  2008.  As  a  result,  the  Company  estimated  liquidated  damages  amounting  to  $561,174  for  the  November  2007
registration  rights  agreement.  As  of  December  31,  2019  and  2020,  the  Company  had  settled  the  liquidated  damages  with  all  the  investors  and  the
remaining provision of approximately $159,000 was included in other payables and accruals.

F-32

 
 
 
 
 
 
 
   
 
   
   
   
   
   
   
 
 
 
 
 
 
15. Deferred Government Grants

Deferred government grants as of December 31, 2019 and 2020 consist of the following:

Total government grants
Less: Current portion
Non-current portion

  $

  December 31,
2019
4,260,833    $
(142,026)    
4,118,807    $

    December 31,  
2020
7,456,308 
(151,476)
7,304,832 

  $

In September 2013, the Management Committee of Dalian Economic Zone Management Committee (the “Management Committee”) provided a subsidy of
RMB150 million to finance the costs incurred in moving our facilities to Dalian, including the loss of sales while the new facilities were being constructed.
For the year ended September 30, 2015, the Company recognized $23,103,427 as income after offset of the related removal expenditures of $1,004,027. No
such income or offset was recognized in years ended December 31, 2019 and 2020.

On October 17, 2014, the Company received a subsidy of RMB46.2 million (approximately $6.7 million) pursuant to an agreement with the Management
Committee dated July 2, 2013 for costs of land use rights and to be used to construct the new manufacturing site in Dalian. Part of the facilities had been
completed  and  was  operated  in  July  2015  and  the  Company  has  initiated  amortization  on  a  straight-line  basis  over  the  estimated  useful  lives  of  the
depreciable facilities constructed thereon.

On June 23, 2020, BAK Asia, the Company wholly-owned Hong Kong subsidiary, entered into a framework investment agreement with Jiangsu Gaochun
Economic  Development  Zone  Development  Group  Company  (“Gaochun  EDZ”),  pursuant  to  which  the  Company  intended  to  develop  certain  lithium
battery  projects  that  aim  to  have  a  production  capacity  of  8Gwh.  Gaochun  EDZ  agreed  to  provide  various  support  to  facilitate  the  development  and
operation of the projects. As of the date of this report, the Company received RMB20 million (approximately $3.06 million) subsidy from Gaochun EDZ.
The  Company  will  recognize  the  government  subsidies  as  income  or  offsets  them  against  the  related  expenditures  when  there  are  no  present  or  future
obligations for the subsidized projects.

The Company offset government grants of $143,172 and $143,256 for the years ended December 31, 2019 and 2020, respectively, against depreciation
expenses of the Dalian facilities.

16. Product Warranty Provisions

The Company maintains a policy of providing after sales support for certain of its new EV and LEV battery products introduced since October 1, 2015 by
way of a warranty program. The limited cover covers a period of six to twenty four months for battery cells, a period of twelve to twenty seven months for
battery modules for light electric vehicles (LEV) such as electric bicycles, and a period of three years to eight years (or 120,000 or 200,000 km if reached
sooner)  for  battery  modules  for  electric  vehicles  (EV).  The  Company  accrues  an  estimate  of  its  exposure  to  warranty  claims  based  on  both  current  and
historical product sales data and warranty costs incurred. The Company assesses the adequacy of its recorded warranty liability at least annually and adjusts
the amounts as necessary.

Warranty expense is recorded as a component of sales and marketing expenses. Accrued warranty activity consisted of the following:

Balance at beginning of year
Warranty costs incurred
Provision for the year
Foreign exchange adjustment
Balance at end of year
Less: Current portion
Non-current portion

F-33

December 31,
2019
2,250,615    $
(85,397)    
109,248     
(27,533)    
2,246,933     
-     
2,246,933    $

December 31,
2020
2,246,933 
(395,864)
12,998 
127,538 
1,991,605 
(155,888)
1,835,717 

  $

  $

 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
 
 
 
 
   
 
   
   
   
   
   
 
17. Notes payable

Notes payable as of December 31, 2019 and December 31, 2020 consist of the following:

Notes payable, net of debt discount

Note I

  December 31,
2019
2,846,736    $

  $

    December 31,  
2020

        - 

On July 24, 2019, the Company entered into a securities purchase agreement with Atlas Sciences, LLC (the “Lender”), pursuant to which the Company
issued a promissory note (the “Note I”) to the Lender. The Note has an original principal amount of $1,395,000, bears interest at a rate of 10% per annum
and will mature 12 months after the issuance, unless earlier paid or redeemed in accordance with its terms. The Company received proceeds of $1,250,000
after an original issue discount of $125,000 and payment of Lender’s expenses of $20,000. Beginning on the date that is six months after July 24, 2019,
Lender shall have the right, exercisable at any time in its sole and absolute discretion, to redeem any amount of this Note up to $250,000.00 per calendar
month by providing written notice to Borrower.

The Company recorded the $125,000 as debt discount and is amortized as interest expense over 12 months period. The Company did not assign any value
to the redemption feature of the Note because the redemption of the Note has no value on the redemption portion as of December 31, 2020.

On  January  27,  2020,  the  Company  entered  into  an  exchange  agreement  (the  “First  Exchange  Agreement”)  with  Atlas  Sciences,  LLC  (the  “Lender”),
pursuant  to  which  the  Company  and  the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to  $100,000  (the
“Partitioned Promissory Note) from the outstanding balance of certain promissory note that the Company issued to the Lender on July 24, 2019, which has
an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  160,256  shares  of  the  Company’s
common stock, par value $0.001 per share to the Lender.

On  February  20,  2020,  the  Company  entered  into  a  second  exchange  agreement  (the  “Second  Exchange  Agreement”)  with  Atlas  Sciences,  LLC  (the
“Lender”), pursuant to which the Company and the Lender agreed to (i) partition a new promissory note in the original principal amount equal to $100,000
(the  “Partitioned  Promissory  Note”)  from  the  outstanding  balance  of  certain  promissory  note  that  the  Company  issued  to  the  Lender  on  July  24,  2019,
which  has  an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  207,641  shares  of  the
Company’s common stock, par value $0.001 per share to the Lender.

On April 28, 2020, the Company entered into a third exchange agreement (the “Third Exchange Agreement”) with Atlas Sciences, LLC (the “Lender”),
pursuant  to  which  the  Company  and  the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to  $100,000  (the
“Partitioned Promissory Note”) from the outstanding balance of certain promissory note that the Company issued to the Lender on July 24, 2019, which has
an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  312,500  shares  of  the  Company’s
common stock, par value $0.001 per share to the Lender.

On June 8, 2020, the Company entered into a fourth exchange agreement (the “Fourth Exchange Agreement”) with Atlas Sciences, LLC (the “Lender”),
pursuant  to  which  the  Company  and  the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to  $100,000  (the
“Partitioned Promissory Note”) from the outstanding balance of certain promissory note that the Company issued to the Lender on July 24, 2019, which has
an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  271,739  shares  of  the  Company’s
common stock, par value $0.001 per share to the Lender.

On  June  10,  2020,  the  Company  entered  into  a  fifth  exchange  agreement  (the  “Fifth  Exchange  Agreement”)  with  Atlas  Sciences,  LLC  (the  “Lender”),
pursuant  to  which  the  Company  and  the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to  $150,000  (the
“Partitioned Promissory Note”) from the outstanding balance of certain promissory note that the Company issued to the Lender on July 24, 2019, which has
an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  407,609  shares  of  the  Company’s
common stock, par value $0.001 per share to the Lender.

F-34

 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
On  July  6,  2020,  the  Company  entered  into  a  Sixth  exchange  agreement  (the  “Sixth  Exchange  Agreement”)  with  Atlas  Sciences,  LLC  (the  “Lender”),
pursuant  to  which  the  Company  and  the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to  $250,000  (the
“Partitioned Promissory Note”) from the outstanding balance of certain promissory note that the Company issued to the Lender on July 24, 2019, which has
an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  461,595  shares  of  the  Company’s
common stock, par value $0.001 per share to the Lender.

On  July  29,  2020,  the  Company  entered  into  a  Seventh  exchange  agreement  (the  “Seventh  Exchange  Agreement”)  with  Atlas  Sciences,  LLC  (the
“Lender”), pursuant to which the Company and the Lender agreed to (i) partition a new promissory note in the original principal amount equal to $365,000
(the  “Partitioned  Promissory  Note”)  from  the  outstanding  balance  of  certain  promissory  note  that  the  Company  issued  to  the  Lender  on  July  24,  2019,
which  has  an  original  principal  amount  of  $1,395,000,  and  (ii)  exchange  the  Partitioned  Promissory  Note  for  the  issuance  of  576,802  shares  of  the
Company’s common stock, par value $0.001 per share to the Lender.

On October 12, 2020, the Company entered into an amendment to Promissory Notes (the “Amendment”) with Atlas Sciences, LLC (the Lender), pursuant
to which the Lender has the right at any time until the outstanding balance of the Notes has been paid in full, at its election, to convert all or any portion of
the outstanding balance of the Notes into shares of common stock of the Company. The conversion price for each conversion will be calculated pursuant to
the following formula: 80% multiplied by the lowest closing price of the Company common stock during the ten (10) trading days immediately preceding
the applicable conversion (the “Conversion Price”). Notwithstanding the foregoing, in no event will the Conversion Price be less than $1.00.

According to the amendment, on October 13, 2020, the Company exchanged $230,000 in principal and $141,275 coupon interests under the Note I for the
issuance of 229,750 shares of the Company’s common stock, par value $0.001 per share to the Lender. As of the date of this report, the Company has fully
repaid the principal and coupon interests of Note I.

The  Company  recorded  $66,097  and  $78,888  to  interest  expense  from  the  amortization  of  debt  discount  and  coupon  interest,  respectively,  for  the  year
ended December 31, 2020.

The Company recorded $55,903 and $62,387 to interest expense from the amortization of debt discount and coupon interest for Note I, respectively, for the
year ended December 31, 2019.

As  of  December  31,  2019  and  2020,  accrued  coupon  interest  of  $55,903  and  nil  on  the  Note  I  was  included  in  other  payables  and  accruals  (note  14),
respectively.

Note II

On  December  30,  2019,  the  Company  entered  into  a  securities  purchase  agreement  with  Atlas  Sciences,  LLC  (the  “Lender”),  pursuant  to  which  the
Company issued a promissory note (the “Note II”) to the Lender. The Note has an original principal amount of $1,670,000, bears interest at a rate of 10%
per annum and will mature 12 months after the issuance, unless earlier paid or redeemed in accordance with its terms. The Company received proceeds of
$1,500,000 after an original issue discount of $150,000 and payment of Lender’s expenses of $20,000. Beginning on the date that is six months after June
30, 2020, Lender shall have the right, exercisable at any time in its sole and absolute discretion, to redeem any amount of this Note up to $250,000.00 per
calendar month by providing written notice to Borrower. The Company recorded the $150,000 as debt discount and is being amortized as interest expense
over 12 months period. The Company did not assign any value to the redemption feature of the Note because the redemption of the Note has no value on
the redemption portion as of December 31, 2019 and September 30, 2020.

On July 8, 2020, the Company entered into a First exchange agreement for Note II (the “First Exchange Agreement- Note II”) with Atlas Sciences, LLC
(the  “Lender”),  pursuant  to  which  the  Company  and  the  Lender  agreed  to  (i)  partition  a  new  promissory  note  in  the  original  principal  amount  equal  to
$250,000 (the “Partitioned Promissory Note”) from the outstanding balance of certain promissory note that the Company issued to the Lender on December
30, 2019, which has an original principal amount of $1,670,000, and (ii) exchange the Partitioned Promissory Note for the issuance of 453,161 shares of
the Company’s common stock, par value $0.001 per share to the Lender.

F-35

 
 
 
 
 
 
 
 
 
 
 
 
On October 12, 2020, the Company entered into an amendment to Promissory Notes (the “Amendment”) with Atlas Sciences, LLC (the Lender), pursuant
to which the Lender has the right at any time until the outstanding balance of the Notes has been paid in full, at its election, to convert all or any portion of
the outstanding balance of the Notes into shares of common stock of the Company. The conversion price for each conversion will be calculated pursuant to
the following formula: 80% multiplied by the lowest closing price of the Company common stock during the ten (10) trading days immediately preceding
the applicable conversion (the “Conversion Price”). Notwithstanding the foregoing, in no event will the Conversion Price be less than $1.00.

According to the amendment, on October 13, 2020, the Company exchanged $775,000 in principal under the Note II for the issuance of 479,579 shares of
the Company’s common stock, par value $0.001 per share to the Lender, On October 20, 2020, the Company exchanged additional $645,000 in principal
and $133,252 coupon interests under Note II for the issuance of 329,768 shares of the Company’s common stock, par value $0.001 per share to the Lender,
As of the date of this report, the Company has fully repaid the principal and coupon interests of Note II.

The Company recorded $149,167 and $132,324 to interest expense from the amortization of debt discount and coupon interest for Note II, respectively, for
the year ended December 31, 2020.

The Company recorded $833 and $597 to interest expense from the amortization of debt discount and coupon interest for Note II, respectively, for the year
ended December 31, 2019.

As  of  December  31,  2019  and  2020,  accrued  coupon  interest  of  $597  and  nil  on  the  Note  II  was  included  in  other  payables  and  accruals  (note  14),
respectively.

18. Income Taxes, Deferred Tax Assets and Deferred Tax Liabilities

(a) Income taxes in the consolidated statements of comprehensive loss(income)

The Company’s provision for income taxes expenses (credit) consisted of:

PRC income tax
Current
Deferred

United States Tax

  December 31,
2019

    December 31,  
2020

  $

  $

        -    $
-     
-    $

        - 
- 
- 

CBAK is a Nevada corporation that is subject to U.S. corporate income tax on its taxable income at a rate of up to 21% for taxable years beginning after
December  31,  2017  and  U.S.  corporate  income  tax  on  its  taxable  income  of  up  to  35%  for  prior  tax  years.  The  U.S.  Tax  Reform  signed  into  law  on
December 22, 2017 significantly modified the U.S. Internal Revenue Code by, among other things, reducing the statutory U.S. federal corporate income tax
rate from 35% to 21% for taxable years beginning after December 31, 2017; limiting and/or eliminating many business deductions; migrating the U.S. to a
territorial  tax  system  with  a  one-time  transition  tax  on  a  mandatory  deemed  repatriation  of  previously  deferred  foreign  earnings  of  certain  foreign
subsidiaries; subject to certain limitations, generally eliminating U.S. corporate income tax on dividends from foreign subsidiaries; and providing for new
taxes on certain foreign earnings. Taxpayers may elect to pay the one-time transition tax over eight years, or in a single lump sum.

The U.S. Tax Reform also includes provisions for a new tax on GILTI effective for tax years of foreign corporations beginning after December 31, 2017.
The GILTI provisions impose a tax on foreign income in excess of a deemed return on tangible assets of controlled foreign corporations (“CFCs”), subject
to the possible use of foreign tax credits and a deduction equal to 50 percent to offset the income tax liability, subject to some limitations.

To the extent that portions of CBAK’s U.S. taxable income, such as Subpart F income or GILTI, are determined to be from sources outside of the U.S.,
subject to certain limitations, the Company may be able to claim foreign tax credits to offset its U.S. income tax liabilities. If dividends that CBAK receives
from its subsidiaries are determined to be from sources outside of the U.S., subject to certain limitations, CBAK will generally not be required to pay U.S.
corporate  income  tax  on  those  dividends.  Any  liabilities  for  U.S.  corporate  income  tax  will  be  accrued  in  the  Company’s  consolidated  statements  of
comprehensive loss and estimated tax payments will be made when required by U.S. law.

No provision for income taxes in the United States has been made as CBAK had no taxable income for the years ended December 31, 2019 and 2020.

F-36

 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
Hong Kong Tax

BAK Asia is subject to Hong Kong profits tax rate of 16.5% and did not have any assessable profits arising in or derived from Hong Kong for the years
ended December 31, 2019 and 2020 and accordingly no provision for Hong Kong profits tax was made in these periods.

PRC Tax

The  CIT  Law  in  China  applies  an  income  tax  rate  of  25%  to  all  enterprises  but  grants  preferential  tax  treatment  to  High-New  Technology  Enterprises.
CBAK Power was regarded as a “High-new technology enterprise” pursuant to a certificate jointly issued by the relevant Dalian Government authorities.
The certificate was valid for three years commencing from year 2019. Under the preferential tax treatment, CBAK Power was entitled to enjoy a tax rate of
15% for the years from 2019 to 2021 provided that the qualifying conditions as a High-new technology enterprise were met.

A reconciliation of the provision for income taxes determined at the statutory income tax rate to the Company’s income taxes is as follows:

Loss before income taxes
United States federal corporate income tax rate
Income tax credit computed at United States statutory corporate income tax rate
Reconciling items:
Over provision of deferred taxation in prior year
Rate differential for PRC earnings
Non-taxable income
Non-deductible expenses
Share based payments
(Under) Over provision of tax losses
Valuation allowance on deferred tax assets
Income tax expenses

(b) Deferred tax assets and deferred tax liabilities

Year ended
December 31,
2019

  $ (10,853,435)   $
21%   
(2,279,221)    

Year ended
December 31,
2020
(7,846,768)
21%
(1,647,821)

(372,518)    

- 
161,576 
161,724 
(92,668)    

2,421,107 
- 

  $

(318,383)
(435,120)
241,843 
168,826 
174,558 
1,816,097 
- 

  $

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities as of December 31, 2019 and 2020 are
presented below:

Deferred tax assets
Trade accounts receivable
Inventories
Property, plant and equipment
Provision for product warranty
Net operating loss carried forward
Valuation allowance
Deferred tax assets, non-current

Deferred tax liabilities, non-current

F-37

December 31,
2019

December 31, 
2020

  $

  $

  $

1,225,916    $
1,026,483     
768,975     
561,733     
29,361,274     
(32,944,381)    
-    $

1,354,762 
575,575 
1,271,986 
497,901 
31,060,254 
(34,760,478)
- 

-    $

- 

 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
  
   
  
   
  
   
  
   
   
   
   
   
   
   
   
   
   
 
 
 
 
 
 
   
 
 
    
  
   
   
   
   
   
 
   
      
  
 
As of December 31, 2020, the Company’s U.S. entity had net operating loss carry forwards of $103,580,741, of which $102,293 available to reduce future
taxable income which will expire in various years through 2035 and $103,478,448 available to offset capital gains recognized in the succeeding 5 tax years.
As  of  December  31,  2020,  the  Company’s  PRC  subsidiaries  had  net  operating  loss  carry  forwards  of  $37,536,687,  which  will  expire  in  various  years
through 2021 to 2030. Management believes it is more likely than not that the Company will not realize these potential tax benefits as these operations will
not generate any operating profits in the foreseeable future. As a result, a valuation allowance was provided against the full amount of the potential tax
benefits.

According to the PRC Tax Administration and Collection Law, the statute of limitations is three years if the underpayment of taxes is due to computational
errors made by the taxpayer or its withholding agent. The statute of limitations extends to five years under special circumstances, which are not clearly
defined. In the case of a related party transaction, the statute of limitations is ten years. There is no statute of limitations in the case of tax evasion.

19. Share-based Compensation

Restricted Shares and Restricted Share Units

Restricted shares granted on June 30, 2015

On  June  12,  2015,  the  Board  of  Director  approved  the  CBAK  Energy  Technology,  Inc.  2015  Equity  Incentive  Plan  (the  “2015  Plan”)  for  Employees,
Directors and Consultants of the Company and its Affiliates. The maximum aggregate number of Shares that may be issued under the Plan is ten million
(10,000,000) Shares.

On  June  30,  2015,  pursuant  to  the  2015  Plan,  the  Compensation  Committee  of  the  Company’s  Board  of  Directors  granted  an  aggregate  of  690,000
restricted shares of the Company’s common stock, par value $0.001, to certain employees, officers and directors of the Company with a fair value of $3.24
per share on June 30, 2015. In accordance with the vesting schedule of the grant, the restricted shares will vest in twelve equal quarterly installments on the
last day of each fiscal quarter beginning on June 30, 2015 (i.e. last vesting period: quarter ended March 31, 2018). The Company recognizes the share-
based compensation expenses on a graded-vesting method.

All the restricted shares granted in respect of the restricted shares granted on June 30, 2015 have been vested on March 31, 2018.

As of December 31, 2020, there was no unrecognized stock-based compensation associated with the above restricted shares. As of December 31, 2020,
1,667 vested shares were to be issued.

Restricted shares granted on April 19, 2016

On April 19, 2016, pursuant to the Company’s 2015 Plan, the Compensation Committee of the Board of Directors of the Company granted an aggregate of
500,000  restricted  shares  of  the  Company’s  common  stock,  par  value  $0.001  ,  to  certain  employees,  officers  and  directors  of  the  Company,  of  which
220,000 restricted shares were granted to the Company’s executive officers and directors. There are three types of vesting schedules. First, if the number of
restricted shares granted is below 3,000, the shares will vest annually in 2 equal installments over a two year period with the first vesting on June 30, 2017.
Second, if the number of restricted shares granted is larger than or equal to 3,000 and is below 10,000, the shares will vest annually in 3 equal installments
over a three year period with the first vesting on June 30, 2017. Third, if the number of restricted shares granted is above or equal to 10,000, the shares will
vest semi-annually in 6 equal installments over a three year period with the first vesting on December 31, 2016. The fair value of these restricted shares was
$2.68  per  share  on  April  19,  2016.  The  Company  recognizes  the  share-based  compensation  expenses  over  the  vesting  period  (or  the  requisite  service
period) on a graded-vesting method.

The Company recorded non-cash share-based compensation expense of $36,641 for the year ended December 31,2019, in respect of the restricted shares
granted on April 19, 2016 of which $27,774, $4,763, $2,272 and $1,832 were allocated to general and administrative expenses, research and development
expenses, sales and marketing expenses and cost of revenues, respectively.

No such non-cash share-based compensation expense was recognized for the year ended December 31, 2020, in respect of the restricted shares granted on
April 19, 2016.

As of December 31, 2020, there was no unrecognized stock-based compensation associated with the above restricted shares and 4,167 vested shares were
to be issued.

F-38

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restricted share units granted on August 23, 2019

On August 23, 2019, pursuant to the Company’s 2015 Plan, the Compensation Committee granted an aggregate of 1,887,000 restricted share units of the
Company’s  common  stock  to  certain  employees,  officers  and  directors  of  the  Company,  of  which  710,000  restricted  share  units  were  granted  to  the
Company’s executive officers and directors. There are two types of vesting schedules, (i) the share units will vest semi-annually in 6 equal installments
over a three year period with the first vesting on September 30, 2019; (ii) the share units will vest annual in 3 equal installments over a three year period
with the first vesting on March 31, 2021. The fair value of these restricted shares was $0.9 per share on August 23, 2019. The Company recognizes the
share-based compensation expenses over the vesting period (or the requisite service period) on a graded-vesting method.

The Company recorded non-cash share-based compensation expense of $711,740 for the year ended December 31, 2020, in respect of the restricted shares
granted on August 23, 2019 of which $575,200, $22,631 and $113,909 were allocated to general and administrative expenses, sales and marketing expenses
and research and development expenses.

The Company recorded non-cash share-based compensation expense of $733,472 for the year ended December 31, 2019, in respect of the restricted shares
granted  on  August  23,  2019  of  which  $567,081,  $21,822  and  $144,569  were  allocated  to  general  and  administrative  expenses,  sales  and  marketing
expenses and research and development expenses.

As of December 31, 2020, non-vested restricted share units granted on August 23, 2019 are as follows:

Non-vested share units as of August 23, 2019
Granted
Vested
Forfeited
Non-vested share units as of January 1, 2020
Granted
Vested
Forfeited
Non-vested share units as of December 31, 2020

1,887,000 
(307,000)
(74,167)
1,505,833 
- 
(571,996)
(78,333)
855,504 

As  of  December  31,  2020,  there  was  unrecognized  stock-based  compensation  $253,088  associated  with  the  above  restricted  share  units  and  no  vested
shares were to be issued.

Restricted share units granted on October 23, 2020

On October 23, 2020, pursuant to the Company’s 2015 Plan, the Compensation Committee granted an aggregate of 100,000 restricted share units of the
Company’s  common  stock  to  an  employee  of  the  Company.  In  accordance  with  the  vesting  schedule  of  the  grant,  the  restricted  shares  will  vest  semi-
annually in 6 equal installments over a three year period with the first vesting on October 30, 2020. The fair value of these restricted shares was $3 per
share on October 23, 2020. The Company recognizes the share-based compensation expenses over the vesting period (or the requisite service period) on a
graded-vesting method.

The Company recorded non-cash share-based compensation expense of $92,191 for the year ended December 31, 2020, in respect of the restricted shares
granted on October 23, 2020 of which allocated to research and development expenses.

As of December 31, 2020, non-vested restricted share units granted on October 23, 2020 are as follows:

Non-vested share units as of October 23, 2020
Granted
Vested
Non-vested share units as of December 31, 2020

100,000 
(16,667)
83,333 

As  of  December  31,  2020,  there  was  unrecognized  stock-based  compensation  $207,809  associated  with  the  above  restricted  share  units  and  no  vested
shares were to be issued.

As the Company itself is an investment holding company which is not expected to generate operating profits to realize the tax benefits arising from its net
operating loss carried forward, no income tax benefits were recognized for such stock-based compensation cost under the stock option plan for the years
ended December 31, 2019 and 2020.

F-39

 
 
 
 
 
 
 
 
  
   
   
   
   
   
   
   
   
 
 
 
 
 
 
 
 
 
   
   
   
 
 
 
20. Loss Per Share

The following is the calculation of loss per share:

Net loss
Less: Net loss attributable to non-controlling interests
Net loss attributable to shareholders of CBAK Energy Technology, Inc.

Weighted average shares used in basic and diluted computation

Loss per share - basic and diluted

Year ended
December 31, 
2019

  $ (10,853,435)   $
85,912     
(10,767,523)    

Year ended
December 31, 
2020
(7,846,768)
39,870 
(7,806,898)

38,965,564     

61,992,386 

  $

(0.28)   $

(0.10)

Note:

Including 5,834 and nil vested restricted shares granted pursuant to the 2015 Plan that were not yet issued as of December 31, 2019 and 2020,
respectively.

For the years ended December 31, 2019 and 2020, 1,505,833 and 938,837 unvested restricted shares, respectively, and all the outstanding warrants were
anti-dilutive and excluded from shares used in the diluted computation.

21. Warrants

On December 8, 2020, the Company entered in a securities purchase agreement with certain institutional investors, pursuant to which the Company issued
in  a  registered  direct  offering,  an  aggregate  of  9,489,800  shares  of  its  common  stock  at  a  price  of  $5.18  per  share,  for  aggregate  gross  proceeds  to  the
Company of approximately $49 million, before deducting fees to the placement agent and other estimated offering expenses payable by the Company. As
part of the transaction, the institutional investors also received warrants (“Investor Warrants”) for the purchase of up to 3,795,920 shares of the Company’s
common  stock  at  an  exercise  price  of  $6.46  per  share  exercisable  for  36  months  from  the  date  of  issuance.  In  addition,  the  placement  agent  for  this
transaction also received warrants (“Placement Agent Warrants”) for the purchase of up to 379,592 shares of the Company’s common stock at an exercise
price of $6.475 per share exercisable for 36 months after 6 months from the issuance. The Company has performed a thorough reassessment of the terms of
its warrants with reference to the provisions of ASC Topic 815-40-15-7I, regarding its exposure to changes in currency exchange rates. This reassessment
has led to the management’s conclusion that the Company’s warrants issued to the investors should not be considered indexed to the Company’s own stock
because the warrants are denominated in U.S. dollar, which is different from the Company’s functional currency, Renminbi. Warrants are remeasured at fair
value with changes in fair value recorded in earnings in each reporting period.

There was a total of 4,175,512 warrants issued and outstanding as of December 31, 2020.

The fair value of the outstanding warrants was calculated using Binomial Model based on backward induction with the following assumptions:

Warrants holder

Appraisal Date (Inception Date)
Market price per share (USD/share)
Exercise price (USD/price)
Risk free rate
Dividend yield
Expected term/ Contractual life (years)
Expected volatility

Appraisal Date
Market price per share (USD/share)
Exercise price (USD/price)
Risk free rate
Dividend yield
Expected term/ Contractual life (years)
Expected volatility

F-40

Investor
Warrants
December 10, 
2020

Placement
Agent
Warrants
December 10, 
2020

  $

  $

5.36 
6.46 
0.2%   
0.0%   

5.36 
6.475 

0.2%
0.0%

3.0 years 

211.5%   

3.0 years 

211.5%

December 31, 
2020

December 31, 
2020

  $

  $

5.06 
6.46 
0.2%   
0.0%   

5.06 
6.475 

0.2%
0.0%

2.9 years 

187.6%   

2.9 years 

187.6%

 
 
 
 
 
 
   
 
   
   
 
   
      
  
   
 
   
      
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
   
   
   
   
 
 
 
 
 
   
   
   
   
   
   
   
 
The following is a reconciliation of the beginning and ending balances of warrants liability measured at fair value on a recurring basis using Level 3 inputs:

Balance at the beginning of the year
Warrants issued to institution investors
Warrants issued to placement agent
Warrants redeemed
Fair value change of the issued warrants included in earnings
Balance at end of year

The following is a summary of the warrant activity: 

Outstanding at January 1, 2020
Exercisable at January 1, 2020
Granted
Exercised / surrendered
Expired
Outstanding at December 31, 2020
Exercisable at December 31, 2020

22. Fair Value of Financial Instruments

Year ended
December 31, 
2019

Year ended
December 31, 
2020

  $

       -    $
-     
-     
-     
-     
-     

- 
17,980,000 
1,875,000 
- 
(2,072,000)
17,783,000 

Number of
Warrants

Average
Exercise Price   

Weighted
Average
Remaining
Contractual
Term in Years 

-    $
-    $
4,175,512     
-     
-     
4,175,512    $
3,795,920    $

-     
-     
6.46     
-     
-     
6.46     
6.46     

3 

2.9 
2.9 

ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a
liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the
measurement  date.  This  topic  also  establishes  a  fair  value  hierarchy,  which  requires  classification  based  on  observable  and  unobservable  inputs  when
measuring fair value. Certain current assets and current liabilities are financial instruments. Management believes their carrying amounts are a reasonable
estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and, if applicable, their
current interest rates are equivalent to interest rates currently available. The three levels of valuation hierarchy are defined as follows:

● Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable

for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

● Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, trade accounts and bills receivable, other receivables, balances
with  former  subsidiaries,  notes  payable,  other  short-term  loans,  short-term  and  long-term  bank  loans  and  other  payables  approximate  their  fair  values
because of the short maturity of these instruments or the rate of interest of these instruments approximate the market rate of interest.

The fair value of warrants was determined using the Binomial Model, with level 3 inputs (Note 21).

F-41

 
 
 
 
 
   
 
   
   
   
   
   
 
 
 
 
   
 
   
     
     
 
   
  
   
  
   
   
  
   
  
   
   
 
 
 
 
 
 
 
 
 
 
 
23. Commitments and Contingencies

(i) Capital Commitments

As of December 31, 2019 and 2020, the Company had the following contracted capital commitments:

For construction of buildings
For purchases of equipment
Capital injection

(ii) Litigation

December 31,
2019
3,397,961    $
-     

December 31,
2020
2,465,092 
10,308,416 
83,900,000      228,115,914 
87,297,961    $ 240,889,422 

  $

  $

During  its  normal  course  of  business,  the  Company  may  become  involved  in  various  lawsuits  and  legal  proceedings.  However,  litigation  is  subject  to
inherent  uncertainties,  and  an  adverse  result  may  arise  from  time  to  time  will  affect  its  operation.  Other  than  the  legal  proceedings  set  forth  below,  the
Company is currently not aware of any such legal proceedings or claims that the Company believe will have an adverse effect on the Company’s operation,
financial condition or operating results.

On July 7, 2016, Shenzhen Huijie Purification System Engineering Co., Ltd (“Shenzhen Huijie”), one of the Company’s contractors, filed a lawsuit against
CBAK  Power  in  the  Peoples’  Court  of  Zhuanghe  City,  Dalian,  (the  “Court  of  Zhuanghe”)  for  failure  to  pay  pursuant  to  the  terms  of  the  contract  and
entrusting part of the project of the contract to a third party without their prior consent. The plaintiff sought a total amount of $1,241,648 (RMB8,430,792),
including construction costs of $0.9 million (RMB6.1 million, which the Company already accrued for at June 30, 2016), interest of $29,812 (RMB0.2
million) and compensation of $0.3 million (RMB1.9 million). On September 7, 2016, upon the request of Shenzhen Huijie for property preservation, the
Court of Zhuanghe froze CBAK Power’s bank deposits totaling $1,210,799 (RMB8,430,792) for a period of one year. On September 1, 2017, upon the
request of Shenzhen Huijie, the Court of Zhuanghe froze the bank deposits for another one year until August 31, 2018. The Court further froze the bank
deposits for another one year until August 27, 2019 upon the request of Shenzhen Huijie on August 27, 2018. On August 27, 2019, the Court froze the bank
deposits for another year until August 27, 2020, upon the request of Shenzhen Huijie. On June 28, 2020, the Court of Dalian entered the final judgement as
described below and the frozen bank deposit was released in July 2020.

On June 30, 2017, according to the trial of first instance, the Court of Zhuanghe ruled that CBAK Power should pay the remaining contract amount of
RMB6,135,860 (approximately $0.9 million) claimed by Shenzhen Huijie as well as other expenses incurred including deferred interest, discounted charge
on bills payable, litigation fee and property preservation fee totaled $0.1 million. The Company has accrued for these amounts as of December 31, 2017.
On  July  24,  2017,  CBAK  Power  filed  an  appellate  petition  to  the  Intermediate  Peoples’  Court  of  Dalian  (“Court  of  Dalian)”  to  appeal  the  adjudication
dated on June 30, 2017. On November 17, 2017, the Court of Dalian rescinded the original judgement and remanded the case to the Court of Zhuanghe for
retrial. The Court of Zhuanghe conducted a retrial and requested an appraisal to be performed by a third-party appraisal institution on the construction cost
incurred  and  completed  by  Shenzhen  Huijie  on  the  subject  project.  On  November  8,  2018,  the  Company  received  from  the  Court  of  Zhuanghe  the
construction-cost-appraisal  report  which  determined  that  the  construction  cost  incurred  and  completed  by  Shenzhen  Huijie  for  the  subject  project  to  be
$1,344,605  (RMB9,129,868).  On  May  20,  2019,  the  Court  of  Zhuanghe  entered  a  judgment  that  Shenzhen  Huijie  should  pay  back  to  CBAK  Power
$261,316  (RMB1,774,337)  (the  amount  CBAK  Power  paid  in  excess  of  the  construction  cost  appraised  by  the  appraisal  institution)  and  the  interest
incurred since April 2, 2019. Shenzhen Huijie filed an appellate petition to the Court of Dalian. On June 28, 2020, the Court of Dalian entered the final
judgment that Shenzhen Huijie should pay back to CBAK Power $245,530 (RMB1,667,146) (the amount CBAK Power paid in excess of the construction
cost appraised by the appraisal institution) and the interest incurred since April 2, 2019, and reimburse the litigation fees totaling $30,826 (RMB209,312)
that CBAK Power has paid. As of December 31, 2020, CBAK Power have not received the final judgement amount totaled $276,356 (RMB 1,876,458)
from Shenzhen Huijie.

F-42

 
 
 
 
 
 
 
 
   
 
   
   
 
 
 
 
 
 
 
In May 2017, CBAK Power filed a lawsuit in the Court of Zhuanghe against Pingxiang Anyuan Tourism Bus Manufacturing Co., Ltd., (“Anyuan Bus”) one
of  CBAK  Power’s  customers,  for  failure  to  pay  pursuant  to  the  terms  of  the  sales  contract.  CBAK  Power  sought  a  total  amount  of  RMB18,279,858
($2,692,174),  including  goods  amount  of  RMB17,428,000  ($2,566,716)  and  interest  of  RMB851,858  ($125,458).  On  December  19,  2017,  the  Court  of
Zhuanghe determined that Anyuan Bus should pay the goods amount of RMB17,428,000 ($2,566,716) and the interest until the goods amount was paid off,
and a litigation fee of RMB131,480 ($19,364). Anyuan Bus did not appeal and as a result, the judgment is currently in the enforcement phase. On June 29,
2018,  the  Company  filed  application  petition  with  the  Court  of  Zhuanghe  for  enforcement  of  the  judgement  against  all  of  Anyuan  Bus’s  shareholders,
including Jiangxi Zhixin Automobile Co., Ltd, Anyuan Bus Manufacturing Co., Ltd, Anyuan Coal Group Co., Ltd, Qian Ronghua, Qian Bo and Li Junfu.
On October 22, 2018, the Court of Zhuanghe issued a judgment supporting the Company’s petition that all the Anyuan Bus’s shareholders should be liable
to pay the Company the debt as confirmed under the trial. On November 9, 2018, all the shareholders of Anyuan Bus appealed against the judgment after
receiving the notice from the Court. On March 29, 2019, the Company received judgment from the Court of Zhuanghe that all these six shareholders cannot
be  added  as  judgment  debtors.  On  April  11,  2019,  the  Company  filed  appellate  petition  to  the  Intermediate  Peoples’  Court  of  Dalian  challenging  the
judgment from the Court of Zhuanghe. On October 9, 2019, the Intermediate Peoples’ Court of Dalian dismissed the appeal by the Company and affirmed
the original judgment. As of December 31, 2019 and December 31, 2020, CBAK Power made a full provision against the receivable from Anyuan Bus of
RMB 17,428,000 ($2,566,716).

On July 25, 2019, CBAK Power received notice from Shenzhen Court of International Arbitration that Shenzhen Xinjiatuo Automobile Technology Co.,
Ltd  filed  arbitration  against  the  Company  for  failure  to  pay  pursuant  to  the  terms  of  the  contract.  The  plaintiff  sought  a  total  amount  of  $0.16  million
(RMB1,112,269), including equipment cost of $0.14 million (RMB976,000) and interest of $0.02 million (RMB136,269). On August 9, 2019, upon the
request of Shenzhen Xinjiatuo Automobile Technology Co., Ltd, Shenzhen Court of International Arbitration froze CBAK Power’s bank deposits totaling
$0.16 million (RMB1,117,269), including equipment cost $0.14 million (RMB976,000) , interest $0.02 million (RMB136,269) and litigation fees of $736
(RMB5,000)  for  a  period  of  one  year  to  August  2020.  On  August  7,  2019,  CBAK  Power  filed  counter  claim  arbitration  against  Shenzhen  Xinjiatuo
Automobile  Technology  Co.,  Ltd  for  return  of  the  prepayment  due  to  the  unqualified  equipment,  and  sought  a  total  amount  of  $0.29  million
(RMB1,986,440), including return of prepayment of $0.2 million (RMB1,440,000), liquidated damages of $70,692 (RMB480,000) and litigation fees of
$9,785 (RMB66,440). In early July 2020, Shenzhen Court of International Arbitration made arbitration award dismissing the plaintiff’s claim and CBAK
Power’s counterclaim and the frozen bank deposits were released in early August 2020.

In  early  September  2019,  CBAK  Power  received  notice  from  Court  of  Nanshan  District,  Shenzhen  that  Shenzhen  HSL  Business  Technology  Co.,  Ltd
(“HSL”)  filed  lawsuit  against  CBAK  Power  for  failure  to  pay  pursuant  to  the  terms  of  purchase  contract.  The  plaintiff  sought  an  amount  of  $44,751
(RMB292,164) for material cost and interest as accrued until settlement. In late September 2019, CBAK Power and HSL reached agreement that CBAK
Power  would  pay  $15,317  (RMB100,000),  $7,659  (RMB50,000)  and  $21,775  (RMB142,164)  by  October  15,  October  30  and  November  30,  2019,
respectively, and CBAK Power would pay litigation fees of $550 (RMB 3,589) to HSL by the end of November 2019. The Company has settled $22,976
(RMB150,000) in 2019, $11,794 (RMB77,005) in 2020. As of December 31, 2020, CBAK Power had not settled the remaining material purchase cost of
$9,981 (RMB 65,159) and accrued the material purchase cost.

In November 2019, CBAK Suzhou received notice from Court of Suzhou city that Suzhou Industrial Park Security Service Co., Ltd (“Suzhou Security”)
filed  a  lawsuit  against  CBAK  Suzhou  for  failure  to  pay  pursuant  to  the  terms  of  the  sales  contract.  Suzhou  Security  sought  a  total  amount  of  $21,400
(RMB139,713), including services expenses amount of $21,277 (RMB138,908) and interest of $123 (RMB805). Upon the request of Suzhou Security for
property  preservation,  the  Court  of  Suzhou  froze  CBAK  Suzhou’s  bank  deposits  totaling  $0.02  million  (RMB150,000)  for  a  period  of  one  year.  As  of
December 31, 2020, $5,062 (RMB33,048) was frozen by bank and CBAK Suzhou accrued the service cost of $21,277 (RMB138,908).

In early September of 2019, several employees of CBAK Suzhou filed arbitration with Suzhou Industrial Park Labor Disputes Arbitration Commission
against  CBAK  Suzhou  for  failure  to  pay  their  salaries  in  time.  The  employees  seek  for  a  payment  including  salaries  of  $97,779  (RMB638,359)  and
compensation of $83,173 (RMB543,000), totaling $0.18 million (RMB1,181,359). In addition, upon the request of the employees for property preservation,
bank deposit of $0.18 million (RMB1,181,359) was frozen by the court of Suzhou for a period of one year. On September 5, 2019, CBAK Suzhou and the
employees reached an agreement that CBAK Suzhou will pay these salaries and compensation. In February 2020, CBAK Suzhou had made full payment
and the frozen bank deposit was released in October 2020.

In October 2019, CBAK Power received notice from Court of Changshou District, Chongqing that Chongqing Zhongrun Chemistry Co., Ltd (“Chongqing
Zhongrun”) filed arbitration claims against the Company for failure to pay pursuant to the terms of the contract. The plaintiff sought a total amount of $0.4
million (RMB2,484,948), including material cost of $0.4 million (RMB2,397,660) and interest of $13,370 (RMB87,288). On October 31, 2019, CBAK
Power and Chongqing Zhongrun reached an agreement that CBAK Power would pay the material cost by the end of December 31, 2019. In 2020, CBAK
Power had paid $198,152 (RMB1,293,653). In August 2020, upon the request of Chongqing Zhongrun for property preservation, the Court of Changshou
District ordered to freeze CBAK Power’s bank deposits totaling $0.2 million (RMB1,249,836) for a period of one year to August 2021. As of December
31, 2020, the Company has accrued the material purchase cost of $0.2 million (RMB1,104,007) and $2,224 (RMB14,521) was frozen by bank. In February
2021, CBAK Power and Chongqing Zhongrun entered into a settlement agreement that if CBAK Power would pay $172,813 (RMB1,128,227, including
RMB24,220  litigation  expenses  incurred)  to  Chongqing  Zhongrun  before  March  5,  2021,  Chongqing  Zhongrun  would  waive  the  claims  on  interests.
Thereafter, CBAK Power fully repaid to Chongqing Zhongrun and the frozen bank deposits were released in March 2021.

F-43

 
 
 
 
 
 
 
 
In October 2019, CBAK Power received notice from Court of Zhuanghe City that Hunan Zhongke Xingcheng Co., Ltd (“Hunan Zhongke”) filed a lawsuit
against  CBAK  Power  for  failure  to  pay  pursuant  to  the  terms  of  the  purchase  contract.  Hunan  Zhongke  sought  a  total  amount  of  $154,003
(RMB1,005,425). In 2020, the Company have paid $38,293 (RMB250,000). Upon the request of Hunan Zhongke for property preservation, the Court of
Zhuanghe City ordered to freeze CBAK Power’s bank deposits totaling $0.1 million (RMB768,876) for a period of one year to July 2021. As of December
31, 2020, the Company accrued the remaining material purchase cost of $115,710 (RMB755,425) and nil was frozen by bank. In December 2020, CBAK
Power and Hunan Zhongke entered into a debt reduction agreement that if CBAK Power would pay $81,368 (RMB531,220) to Hunan Zhongke before
January  10,  2021,  Hunan  Zhongke  would  cancel  the  remaining  debts  of  $34,342  (RMB224,205).  Thereafter,  CBAK  Power  fully  paid  $81,368
(RMB531,220) to Hunan Zhongke and the frozen bank deposits were released in January 2021.

In December 2019, CBAK Power received notice from Court of Zhuanghe that Dalian Construction Electrical Installation Engineering Co., Ltd. (“Dalian
Construction”) filed a lawsuit against CBAK Power for the failure to pay pursuant to the terms of the construction contract. Dalian Construction sought a
total amount of $101,780 (RMB691,086) and interest $1,905 (RMB12,934). As of December 31, 2019, the Company has accrued the construction cost of
$101,780  (RMB691,086).  Upon  the  request  of  Dalian  Construction  for  property  preservation,  the  Court  of  Zhuanghe  ordered  to  freeze  CBAK  Power’s
bank deposits totaling $103,685 (RMB704,020) for a period of one year to December 2020. As of December 31, 2019, $97,384 (RMB661,240) was frozen
by bank. In January 2020, CBAK Power and Dalian Construction reached a settlement agreement, and the bank deposit was then released. The Company
has repaid all the construction cost as of December 31, 2020.

In February 2020, CBAK Power received notice from Court of Zhuanghe that Dongguan Shanshan Battery Material Co., Ltd (“Dongguan Shanshan”) filed
lawsuit against CBAK Power for failure to pay pursuant to the terms of the purchase contract. Dongguan Shanshan sought a total amount of $0.7 million
(RMB4,434,209).  Upon  the  request  of  Dongguan  Shanshan  for  property  preservation,  the  Court  of  Zhuanghe  ordered  to  freeze  CBAK  Power’s  bank
deposits totaling $0.7 million (RMB4,434,209) for a period of one year to December 17, 2020. In July 2020, CBAK Power and Dongguan Shanshan have
agreed to a settlement amount of $0.5 million (RMB3,635,192) and the bank deposit was then released. In October 2020, because the Company failed to
pay according to the settlement, Dongguan Shanshan sought a total amount of $0.6 million (RMB3,635,192). Upon the request of Dongguan Shanshan for
property preservation, the Court of Zhuanghe ordered to freeze CBAK Power’s bank deposits totaling $0.6 million (RMB3,365,192) for a period of one
year to October 21, 2021. As of December 31, 2020, CBAK Power has accrued the materials purchase cost of $0.5 million (RMB3.4 million) and $55,230
(RMB360,576) was frozen by bank. In late February 2021, CBAK Power and Dongguan Shanshan entered into a settlement agreement that CBAK would
pay $260,393, $76,586, $76,586, $76,586, and $32,088 (RMB 1,700,000, RMB 500,000, RMB 500,000, RMB 500,000 and RMB 209,487) by March 5,
March 31, April 30, May 31 and June 30, 2021, respectively, and after the first payment of RMB 1,700,000 by March 5, 2021, Dongguan Shanshan would
release  all  the  enforcement  measures  against  CBAK  Power.  As  of  the  date  of  this  report,  CBAK  Power  paid  $336,979  (RMB2,200,000)  to  Dongguan
Shanshan and the frozen bank deposits were released in March 2021.

In  March  2020,  CBAK  Power  received  notice  from  Court  of  Baodi  District,  Tianjin  that  BTR  Tianjin  Nanomaterial  Manufacturing  Co.,  Ltd  (“Tianjin
BTR”)  filed  lawsuit  against  CBAK  Power  for  failure  to  pay  pursuant  to  the  terms  of  purchase  contract.  The  plaintiff  sought  an  amount  of  $49,398
(RMB322,500)  for  material  cost  that  CBAK  Power  owed  to  Tianjin  BTR  and  its  related  party  Shenzhen  BTR  Nanomaterial  Technology  Co.,  Ltd
(“Shenzhen BTR”) (together “BTRs”) and interest as accrued until settlement. In April 2020, CBAK Power and BTRs reached an agreement that CBAK
Power would pay BTR $7,659, $19,912 and $21,827 (RMB 50,000, RMB130,000 and RMB142,500) by the end of April, May and June 2020, respectively,
and  CBAK  Power  would  pay  litigation  fees  of  $456  (RMB  2,975)  to  Tianjing  BTR  by  the  end  of  November,  2020.  As  of  December  31,  2020,  CBAK
Power  has  paid  $15,317  (RMB100,000)  to  Tianjin  BTR  and  accrued  remaining  materials  cost  $27,234  (RMB177,800)  and  $6,847  (RMB44,700)  for
Tianjin BTR and Shenzhen BTR respectively. In late January 2021, CBAK Power and Tianjing BTR reached another settlement agreement to settle all the
outstanding  debts  (including  $773  (RMB5,045)  litigation  expenses)  by  paying  $13,253  (RMB86,525)  in  cash  and  return  of  LFP  materials  at  a  value  of
$14,754  (RMB96,320)  and  CBAK  Power  and  Shenzhen  BTR  reached  a  settlement  agreement  by  returning  LFP  materials  at  a  value  of  $6,847
(RMB44,700). Thereafter, CBAK Power fully paid $13,253 (RMB 86,525) and delivered the LFP materials to BTRs, and the lawsuit was settled in March
2021.

In  May  2020,  CBAK  Power  received  notice  from  Court  of  Dalian  Economic  and  Technology  Development  Zone  that  United  Winners  Laser  Co.,  Ltd
(“United  Winners”)  filed  3  lawsuits  against  CBAK  Power  for  failure  to  pay  pursuant  to  the  terms  of  3  purchase  contracts.  The  plaintiff  sought  a  total
amount  of  $0.4  million  (RMB2,845,844),  including  equipment  cost  of  $0.4  (RMB2,692,000)  and  interest  of  $23,565  (RMB153,844).  In  late  December
2020, CBAK Power and United Winners reached a settlement agreement to settle all the debts by paying $0.29 million (RMB1,884,400) by December 30,
2020  in  cash  and  delivery  of  3  electric  vehicles  to  offset  debt  of  $41,234  (RMB269,200),  and  the  remaining  debt  of  $82,468  (RMB538,400)  would  be
relieved. CBAK Power paid $0.29 million (RMB1,884,400) and delivered the 3 electric vehicles to United Winners in December 31, 2020, and the lawsuit
was settled in February 2021.

In June 2020, CBAK Power received notice from Court of Tongzhou District, Beijing that Beijing Hongfa Electric Technology Co., Ltd (“Hongfa”) filed
lawsuit against CBAK Power for failure to pay pursuant to the terms of purchase contract. The plaintiff sought a total amount of $29,993 (RMB195,810)
for  material  cost  and  interest  as  accrued  until  settlement.  In  December  2020,  CBAK  Power  and  Hongfa  reached  debt  reduction  agreement  that  CBAK
Power  would  pay  Hongfa  $23,646  (RMB  154,375)  by  the  January  10,  2021,  and  the  remaining  debt  of  $6,347  (RMB41,435)  would  be  relieved. As  of
December 31, 2020, CBAK Power repaid $22,976 (RMB150,000) and accrued materials cost of $7, 017 (RMB45,810). Thereafter, CBAK Power fully
paid to Hongfa, and the lawsuit was settled in January 2021.

F-44

 
 
 
 
 
 
 
 
On March 20, 2020, CBAK Power received notice from Court of Nanpi County, Hebei Province that Cangzhou Huibang Engineering Manufacturing Co.,
Ltd (“Cangzhou Huibang”) filed lawsuit against CBAK Power for failure to pay pursuant to the terms of the purchase contract. Cangzhou Huibang sought
a  total  amount  of  $0.31  million  (RMB2,029,594),  including  materials  purchase  cost  of  $0.30  million  (RMB1,932,947),  and  interest  of  $14,804
(RMB96,647).  Upon  the  request  of  Cangzhou  Huibang  for  property  preservation,  the  Court  of  Nanpi  ordered  to  freeze  CBAK  Power’s  bank  deposits
totaling $0.4 million (RMB2,650,000) for a period of one year to March 3, 2021. As of December 31, 2020, the Company has accrued materials purchase
cost  of  $0.3  million  (RMB1,932,947)  and  $18,518  (RMB120,898)  was  frozen  by  bank.  In  late  February  2021,  CBAK  Power  and  Cangzhou  Huibang
entered into a settlement agreement that if CBAK Power would pay $0.3 million (RMB1,965,447) within 10 days from the signature date of the agreement,
Cangzhou Huibang would waive the remaining claims. Thereafter, CBAK Power paid $0.3 million (RMB1,965,447) to Cangzhou Huibang and the frozen
bank deposits were released in March 2021.

In early January 2020, CBAK Power received notice from Court of Nanshan District of Shenzhen that Shenzhen Klclear Technology Co., Ltd. (“Shenzhen
Klclear”) filed lawsuit against CBAK Power for failure to pay pursuant to the terms of the materials purchase contract. Shenzhen Klclear sought a total
amount of $1 million (RMB6,250,764), which the Company have already accrued for as of December 31, 2020. In February 2020, the Court of Nanshan
District ruled that the Company should pay $0.8 million (RMB5,238,495) and the interest fees incurred from September 28, 2018. In April 2020, CBAK
Power filed an appellate petition to the Intermediate Peoples’ Court of Shenzhen to appeal the adjudication in February 2020. As of the date of this report,
the Intermediate Peoples’ Court of Shenzhen has not yet rendered the judgment.

In May 2020, CBAK Power received notice from Court of Dalian Economic and Technology Development Zone that Tianjin Changxing Metal Co., Ltd
(“Tianjin Changxing”) filed a lawsuit against CBAK Power for failure to pay pursuant to the terms of the purchase contract. Tianjin Changxing sought a
total  amount  of  $29,652  (RMB193,588).  On  August  24,  2020,  upon  the  request  of  Tianjin  Changxing  for  property  preservation,  the  Court  of  Dalian
Economic and Technology Development Zone ordered to freeze CBAK Power’s bank deposits totaling $32,915 (RMB214,892) for a period of one year. As
of December 31, 2020, nil was frozen by bank and CBAK Power accrued the material purchase cost of $29,652 (RMB193,588). In late December 2020,
CBAK  Power  and  Tianjin  Changxing  entered  into  a  debt  reduction  agreement  that  if  CBAK  Power  would  pay  $26,755  (RMB174,671)  to  Tianjin
Changxing, Tianjin Changxing would cancel the remaining debts. Thereafter, CBAK Power fully paid to Tianjin Changxing and the frozen bank deposits
were released in January 2021.

In  May  2020,  CBAK  Power  received  notice  from  Court  of  Wuqing  District,  Tianjin  that  Tianjin  Changyuan  Electric  Material  Co.,  Ltd  (“Tianjin
Changyuan”) filed lawsuit against CBAK Power for failure to pay pursuant to the terms of the purchase contract. The plaintiff sought a total amount of
$13,040 (RMB85,136), including material cost of $12,166 (RMB79,429) and interest of $874 (RMB5,707). In July, 2020, upon the request of the plaintiff
for property preservation, the Court of Wuqing District, Tianjin ordered to freeze CBAK Power’s bank deposits totaling $13,041 (RMB85,136) for a period
of one year. As of December 31, 2020, $13,041 (RMB85,136) was frozen by bank and the Company had accrued the material purchase cost and litigation
expenses of $12,314 (RMB80,393). In March 2021, CBAK Power and Tianjin Changyuan entered into a debt reduction agreement that if CBAK Power
would  pay  $9,851  (RMB  64,314)  to  Tianjin  Changyuan  before  April  30,  2021,  Tianjin  Changyuan  would  cancel  the  remaining  debts  of  $2,463
(RMB16,079). CBAK Power has paid $9,851 (RMB 64,314) in March 2021.

In June 2020, CBAK Suzhou received notice from Court of Suzhou Industrial Park that Ligao (Shandong) New Energy Technology Co., Ltd (“Ligao”)
filed  a  lawsuit  against  CBAK  Suzhou  for  failure  to  pay  pursuant  to  the  terms  of  the  purchase  contract.  Ligao  sought  a  total  amount  of  $11,886
(RMB77,599),  including  contract  amount  of  $11,240  (RMB73,380)  and  interest  of  $646  (RMB4,219).  As  of  December  31,  2020,  CBAK  Suzhou  had
accrued  the  material  purchase  cost  of  $11,240  (RMB73,380).  On  December  31,  2020,  CBAK  Power,  CBAK  Suzhou  and  Ligao  entered  into  a  debt
reduction agreement that if CBAK Power would pay $7,961 (RMB51,975) to Ligao, Ligao would cancel all the remaining debts. Thereafter, CBAK Power
fully paid $7,961 (RMB51,975) to Ligao, and the lawsuit was settled in January 2021.

In  June  2020,  CBAK  Suzhou  received  notice  from  Court  of  Yushui  District,  Xinyu  City  that  Jiangxi  Ganfeng  Battery  Technology  Co.,  Ltd  (“Ganfeng
Battery”) filed a lawsuit against CBAK Suzhou for failure to pay pursuant to the terms of the purchase contract. Ganfeng Battery sought a total amount of
$115,764  (RMB755,780),  including  contract  amount  of  $112,277  (RMB733,009)  and  interest  of  $3,487  (RMB22,771).  Upon  the  request  of  Ganfeng
Battery for property preservation, the Court of Yushui ordered to freeze CBAK Suzhou’s bank deposits totaling $115,764 (RMB755,780) for a period of
one year to May 2021. In October 2020, CBAK Power, Ganfeng Battery, CBAK Suzhou and Zhengzhou Jingfan New Energy Automobile Co., Ltd entered
into  a  settlement  agreement  that  CBAK  Power  would  deliver  7  eletric  vehicles  to  Ganfeng  Battery  to  offset  all  the  CBAK  Suzhou’  debts  to  Ganfeng
Battery and all vehicles were delivered to before December 31, 2020. As of December 31, 2020, nil was frozen by bank.

In June 2020, CBAK Suzhou received notice from Court of Suzhou Industrial Park that Suzhou Jihongkai Machine Equipment Co., Ltd (“Jihongkai”) filed
a  lawsuit  against  CBAK  Suzhou  for  failure  to  pay  pursuant  to  the  terms  of  the  purchase  contract.  Jihongkai  sought  contract  amount  of  $26,916
(RMB175,722)  and  interest  as  accrued  until  settlement.  As  of  December  31,  2020,  the  Company  had  accrued  the  material  purchase  cost  of  $26,916
(RMB175,722).  In  January  2021,  CBAK  Power,  CBAK  Suzhou  and  Jihongkai  entered  into  a  settlement  agreement  to  settle  all  the  debts  and  related
litigation expenses by paying $12,213 (RMB79,736) in cash and delivery of an electric vehicle at a value of $15,287 (RMB99,800) from CBAK Power to
Jihongkai. Thereafter, CBAK Power fully paid $12,213 (RMB79,736) and delivered the electric vehicle to Jihongkai, and the lawsuit was settled in January
2021.

F-45

 
 
  
 
 
 
 
 
 
In June 2020, CBAK Power received notice from Court of Dalian Economic and Technology Development Zone that Nanjing Jinlong Chemical Co., Ltd.
(“Nanjing Jinlong”) filed a lawsuit against CBAK Power for failure to pay pursuant to the terms of the purchase contract. Nanjing Jinlong sought a total
amount  of  $125,908  (RMB822,000).  Upon  the  request  of  Nanjing  Jinlong  for  property  preservation,  the  Court  of  Dalian  Economic  and  Technology
Development  Zone  ordered  to  freeze  CBAK  Power’s  bank  deposits  totaling  $125,908  (RMB822,000)  for  a  period  of  one  year  to  May  2021.  As  of
December 31, 2020, $16 (RMB107) was frozen by bank and CBAK Power accrued the material purchase cost of $125,908 (RMB822,000).

In June 2020, CBAK Power received notice from Court of Dalian Economic and Technology Development Zone that Xi’an Anpu New Energy Technology
Co. LTD (“Xi’an Anpu”) filed a lawsuit against CBAK Power for failure to pay pursuant to the terms of the equipment purchase contract. Xi’an Anpu
sought  a  total  amount  of  $129,270  (RMB843,954),  including  $117,636  (RMB768,000)  for  equipment  cost  and  $11,634  (RMB75,954)  for  liquidated
damages. Upon the request of Xi’an Anpu for property preservation, the Court of Dalian Economic and Technology Development Zone ordered to freeze
CBAK Power’s bank deposits $129,270 (RMB843,954) for a period to May 11, 2021. As of December 31, 2020, $98,284 (RMB641,656) was frozen by
bank and CBAK Power accrued the equipment purchase cost of $117,636 (RMB768,000). In January 2021, CBAK Power and Xi’an Anpu entered into a
settlement  agreement  to  settle  all  the  debts  by  paying  $64,406  (RMB420,478)  in  cash  and  delivery  of  3  electric  vehicles  at  a  value  of  $45,952
(RMB300,000).  Thereafter,  CBAK  Power  fully  paid  $64,406  (RMB420,479)  and  delivered  the  3  electric  vehicles  to  Xi’an Anpu,  and  the  lawsuit  was
settled in February 2021.

In June 2020, CBAK Power received notice from Court of Dalian Economic and Technology Development Zone that Shenzhen Gd Laser Technology Co.,
Ltd.  (“Shenzhen  Gd”)  filed  lawsuit  against  CBAK  Power  for  failure  to  pay  pursuant  to  the  terms  of  the  purchase  contract.  Shenzhen  Gd  sought  a  total
amount of $24,713 (RMB161,346), including equipment cost of $22,975 (RMB150,000) and interest amount of $1,738 (RMB11,346). As of December 31,
2020,  the  equipment  was  not  received  by  CBAK  Power.  CBAK  Power  has  included  the  equipment  cost  of  $22,975  (RMB150,000)  under  capital
commitments.

In  July  2020,  CBAK  Power  received  notice  from  Court  of  Shandong  Linyi  Economic  and  Technology  Development  Zone  (“Court  of  Shandong”)  that
Shandong  Tianjiao  New  Energy  Co.  LTD  (“Tianjiao”)  filed  a  lawsuit  against  CBAK  Power  for  failure  to  pay  pursuant  to  the  terms  of  the  equipment
purchase contract. Tianjiao sought an amount of $391,777 (RMB2,557,756) for equipment cost and interest as accrued until settlement. Upon the request of
Tianjiao for property preservation, the Court of Shandong ordered to freeze CBAK Power’s bank deposits $0.5 million (RMB3,000,000) for a period of one
year. In December 2020, CBAK and Tianjiao reached an agreement that CBAK would pay Tianjiao $45,952 (RMB300,000) by the end of each month from
December 2020 to July 2021, and RMB 157,756 by the end of August 2021. As of December 31, 2020, CBAK Power accrued materials cost $315,191
(RMB2,057,756) and nil was frozen by bank. As of the date of this report, CBAK Power has repaid $183,807 (RMB1,200,000) to Tianjiao.

In October 2020, CBAK Power received notice from Court of Dalian Economic and Technology Development Zone that Shanghai Shengmeng Industrial
Technology Co., Ltd. (“Shengmeng”) filed a lawsuit against CBAK Power for failure to pay pursuant to the terms of the purchase contract. Shengmeng
sought  a  total  amount  of  $13,429  (RMB87,672)  for  material  cost  and  interest  as  accrued  until  settlement.  In  November  2020,  CBAK  and  Shengmeng
reached an agreement that CBAK would pay $4,595 (RMB30,000) by November 30, 2020 and $5,004 (RMB 32,672) by December 20, 2020, and CBAK
would pay litigation fees of $156 (RMB1,021) to Shengmeng. Thereafter, CBAK Power fully paid off the debts to Shengmeng, and the lawsuit was settled
in March 2021.

In October 2020, CBAK Power received notice from Court of Dalian Economic and Technology Development Zone that Jiuzhao New Energy Technology
Co., Ltd. (“Jiuzhao”) filed a lawsuit against CBAK Power for failure to pay pursuant to the terms of the purchase contract. Jiuzhao sought a total amount of
$0.9 million (RMB6,000,000), including material cost of $0.9 million (RMB5,870,267) and interest amount of $19,871 (RMB129,733). In December 1,
2020, CBAK and Jiuzhao reached an agreement that CBAK Power would pay Jiuzhao $76,586 (RMB500,000) by the end of each month from December
2020 to October 2021, and $56,715 (RMB370,267) by November 30, 2021, and CBAK would pay litigation fees of $4,886 (RMB 31,900) to Jiuzhao. As of
December 31, 2020, CBAK Power has accrued $899,162 (RMB5,870,267) material cost and $5,874 (RMB38,346) was frozen by bank. As of the date of
this report, CBAK Power has repaid $306,344 (RMB2,000,000) to Jiuzhao.

F-46

 
 
 
 
 
 
 
 
In November 2020, CBAK Power received notice from Court of Dalian Economic and Technology Development Zone that Dalian Tianda Metal Machinery
Trade  Co.,  Ltd.  (“Tianda”)  filed  a  lawsuit  against  CBAK  Power  for  failure  to  pay  pursuant  to  the  terms  of  the  purchase  contract.  Tianda  sought  a  total
amount  of  $27,365  (RMB178,655)  for  material  cost  and  interest  as  accrued  until  settlement.  In  December  2020,  CBAK  Power  and  Tianda  reached  an
agreement  that  CBAK  Power  would  pay  Tianda  $7,659  (RMB50,000)  by  the  30th  of  each  month  from  November  2020  to  January  2021,  and  $4,389
(RMB28,655)  by  end  of  February  2021,  and  CBAK  Power  would  pay  litigation  fees  of  $297  (RMB1,937)  to  Tianda  by  November  30,  2020.  As  of
December 31, 2020, CBAK Power has accrued $18,358 (RMB119,855) material cost and nil was frozen by bank. Thereafter, CBAK Power fully paid off
the debts to Tianda, and the lawsuit was settled in February 2021.

In December 2020, CBAK Power received notice from Court of Dalian Economic and Technology Development Zone that Shenzhen Haoneng Technology
Co., Ltd. (“Haoneng”) filed a lawsuit against CBAK Power for failure to pay pursuant to the terms of the equipment purchase contract. Haoneng sought a
total amount of $266,182 (RMB1,737,797), including equipment purchase cost of $264,069 (RMB1,724,000) and interest amount of $2,113 (RMB13,797).
As of December 31, 2020, CBAK Power has accrued the equipment purchase cost of $264,069 (RMB 1,724,000).

In December 2020, CBAK Power received notice from Court of Dalian Economic and Technology Development Zone that Haoneng filed another lawsuit
against CBAK Power for failure to pay pursuant to the terms of the purchase contract. Haoneng sought a total amount of $1,571,092 (RMB10,257,030),
including equipment cost of $1,389,578 (RMB9,072,000) and interest amount of $181,514 (RMB1,185,030). As of December 31, 2020, the equipment was
not received by CBAK Power, CBAK Power has included the equipment cost of $1,389,578 (RMB9,072,000) under capital commitments.

In April 2020, CBAK Suzhou received notice from Court of Suzhou Industrial Park that Suzhou Suwangda Plastic Product Co., Ltd (“Suwangda”) filed a
lawsuit  against  CBAK  Suzhou  for  failure  to  pay  pursuant  to  the  terms  of  the  purchase  contract.  Suwangda  sought  contract  amount  of  $13,325
(RMB86,992) and interest as accrued until settlement. As of December 31, 2020, the Company has accrued the material cost of $13,325 (RMB86,992). In
March 2021, CBAK Power, CBAK Suzhou and Suwangda entered into a settlement agreement to settle all the debts by paying $9,670 (RMB63,134) from
CBAK Power to Suwangda. Thereafter, CBAK Power fully paid $9,670 (RMB63,134) and the lawsuit was settled in March 2021. The remaining $3,654
(RMB23,858) was waived by Suwangda.

In June 2020, CBAK Power received notice from Court of Pingyuan County, Shandong province that Shandong Hangewei New Energy Vehicle Control
Co.,  Ltd  (“Hangewei”)  filed  a  lawsuit  against  CBAK  Power  for  failure  to  pay  pursuant  to  the  terms  of  the  purchase  contract.  Hangewei  sought  a  total
amount  of  $16,307  (RMB  106,464)  and  interest  as  accrued  until  settlement.  In  October  2020,  CBAK  Power  and  Hangewei  entered  into  a  settlement
agreement  to  settle  all  the  debts  by  paying  Hangewei  $1,532  (RMB10,000)  and  $12,254  (RMB80,000)  by  the  end  of  October  and  November  2020,
respectively. CBAK Power paid $13,786 (RMB90,000) before December 31, 2020 and the remaining $2,521 (RMB16,464) was waived by Hangewei.

F-47

 
 
 
 
 
 
 
24. Concentrations and Credit Risk

(a) Concentrations

The Company had the following customers that individually comprised 10% or more of net revenue for the years ended December 31, 2019 and 2020 as
follows:

Sales of finished goods and raw materials
Customer A
Customer B
Customer C
Zhengzhou BAK Battery Co., Ltd (note a)

* Comprised less than 10% of net revenue for the respective period.

  $

Year ended
December 31, 
2019
7,222,245     
*     
3,308,638     
3,961,050     

Year ended
December 31,
2020
8,322,504     
3,806,110     
*     
12,770,075     

32.54%  $
* 
14.91%   
17.85%   

22.15%
10.13%

* 

33.99%

The Company had the following customers that individually comprised 10% or more of net accounts receivable (included VAT) as of December 31, 2019
and 2020 as follows:

Customer A
Customer C
Customer D
Customer E
Zhengzhou BAK Battery Co., Ltd (note a)

  $

December 31, 
2019
1,725,293     
1,713,628     
902,309     
830,821     
*     

December 31, 
2020
3,148,737     
*     
*     
*     
15,258,164     

21.93%  $
21.78%   
11.47%   
10.56%   
* 

11.23%

* 
* 
* 

54.42%

* Comprised less than 10% of net accounts receivable for the respective period.

The Company had the following suppliers that individually comprised 10% or more of net purchase for the years ended December 31, 2019 and 2020 as
follows:

Supplier A
Supplier B
Zhengzhou BAK New Energy Vehicle Co., Ltd (note b)
Shenzhen BAK (note c)

* Comprised less than 10% of net purchase for the respective period.

  $

Year ended
December 31, 
2019
*     
2,920,966     
3,812,819     
*      

Year ended
December 31,
2020
12,396,483     
*     
*     
3,884,309     

* 
  $
21.40%   
27.93%   
*  

48.90%

* 
* 

15.32%

The Company had the following suppliers that individually comprised 10% or more of accounts payable as of December 31, 2019 and 2020 as follows:

Supplier A
Supplier C
Supplier D

  $

December 31,
2019
*     
*     
1,126,482     

December 31,
2020
9,272,478     
2,017,814     
*     

47.40%
10.32%

* 

  $

* 
* 
10.10%   

F-48

 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
   
   
   
   
 
 
 
 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
 
 
   
   
   
   
 
 
 
 
 
 
 
 
 
   
   
   
 
Apart from the above, for the years ended December 31, 2019 and 2020, the Company recorded the following transactions:

Purchase of inventories from
BAK Shenzhen (note c)

Sales of finished goods and raw materials to

BAK Shenzhen (note c)
Zhengzhou BAK New Energy Technology Co., Ltd (note b)

December 31,
2019

December 31,
2020

  $

63,950     

- 

526,719     
-     

- 
1,562,637 

Notes: 
a

b

c

Mr. Xiangqian Li, the Company’s former CEO, is a director of Zhengzhou BAK Battery Co., Ltd. Up to the date of this report, Zhengzhou BAK
Battery Co., Ltd. repaid $7,691,611 to the Company.
Mr. Xiangqian Li is a director of Zhengzhou BAK New Energy Vehicle Co., Ltd, which has 29% equity interests in Zhengzhou BAK New Energy
Technology  Co.,  Ltd.  As  of  December  31,  2019  and  2020,  receivable  from  Zhengzhou  BAK  New  Energy  Technology  Co.,  Ltd  were  nil  and
$1,759,050,  respectively,  was  included  in  trade  accounts  and  bills  receivable,  net.  Up  to  the  date  of  this  report,  Zhengzhou  BAK  New  Energy
Technology Co., Ltd repaid $741,353 to the Company.
Mr. Xiangqian Li is a director of Shenzhen BAK and BAK Shenzhen.

(b) Credit Risk

Financial instruments that potentially subject the Company to a significant concentration of credit risk consist primarily of cash and cash equivalents and
pledged  deposits.  As  of  December  31,  2019  and  2020,  substantially  all  of  the  Company’s  cash  and  cash  equivalents  were  held  by  major  financial
institutions located in the PRC, which management believes are of high credit quality.

For  the  credit  risk  related  to  trade  accounts  receivable,  the  Company  performs  ongoing  credit  evaluations  of  its  customers  and,  if  necessary,  maintains
reserves for potential credit losses.

25. Segment Information

The Company used to engage in one business segment, the manufacture, commercialization and distribution of a wide variety of standard and customized
lithium  ion  rechargeable  batteries  for  use  in  a  wide  array  of  applications.  The  Company  manufactured  five  types  of  Li-ion  rechargeable  batteries:
aluminum-case cell, battery pack, cylindrical cell, lithium polymer cell and high-power lithium battery cell. The Company’s products are sold to packing
plants operated by third parties primarily for use in mobile phones and other electronic devices.

F-49

 
 
 
 
 
   
 
 
    
  
 
   
      
  
   
      
  
   
   
 
 
 
 
 
 
 
 
After the disposal of BAK International, the Company focused on producing high-power lithium battery cells. Net revenues from continuing operations for
the years ended December 31, 2019 and 2020 were as follows:

Net revenues by product:

High power lithium batteries used in:
Electric vehicles
Light electric vehicles
Uninterruptable supplies

Raw materials used in lithium batteries
Total

Net revenues by geographic area:

Mainland China
Europe
Korea
Israel
USA
Others
Total

Year ended    

December 31, 
2019

Year ended  
December 31, 
2020

  $

  $

4,509,055    $
16,147     
17,669,146     
22,194,348     
-     
22,194,348    $

259,955 
39,428 
22,748,627 
23,048,010 
14,518,142 
37,566,152 

Year ended    

December 31, 
2019
21,632,637     
-     
-     
118,906     
285,556     
157,249     
22,194,348    $

Year ended  
December 31, 
2020
35,464,245 
1,776,000 
246,453 
- 
3,592 
75,862 
37,566,152 

  $

  $

Substantially all of the Company’s long-lived assets are located in the PRC.

26. CBAK Energy Technology, Inc. (Parent Company)

Under  PRC  regulations,  subsidiaries  in  PRC  (“the  PRC  subsidiaries”)  may  pay  dividends  only  out  of  their  accumulated  profits,  if  any,  determined  in
accordance with PRC GAAP. In addition, the PRC subsidiaries are required to set aside at least 10% of their after tax net profits each year, if any, to fund
the statutory general reserve until the balance of the reserves reaches 50% of their registered capital. The statutory general reserves are not distributable in
the form of cash dividends to the Company and can be used to make up cumulative prior year losses, if any, and may be converted into share capital by the
issue  of  new  shares  to  shareholders  in  proportion  to  their  existing  shareholdings,  or  by  increasing  the  par  value  of  the  shares  currently  held  by  them,
provided that the reserve balance after such issue is not less than 25% of the registered capital. As of December 31, 2019 and 2020, additional transfers of
$56,269,489  and  $164,388,965  were  required  before  the  statutory  general  reserve  reached  50%  of  the  registered  capital  of  the  PRC  subsidiaries.  As  of
December  31,  2019  and  2020,  there  was  $1,230,511  appropriation  from  retained  earnings  and  set  aside  for  statutory  general  reserves  by  the  PRC
subsidiaries. The PRC subsidiaries did not have after tax net profits since its incorporation and therefore no appropriation was made to fund its statutory
general reserve as of December 31, 2019 and 2020.

Schedule I of Article 504 of Regulation SX requires the condensed financial information of the registrant (Parent Company) to be filed when the restricted
net assets of consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal year. For purposes of
this  test,  restricted  net  assets  of  consolidated  subsidiaries  shall  mean  that  amount  of  the  registrant’s  proportionate  share  of  net  assets  of  consolidated
subsidiaries  (after  intercompany  eliminations)  which  as  of  the  end  of  the  most  recent  fiscal  year  may  not  be  transferred  to  the  parent  company  by
subsidiaries in the form of loans, advances or cash dividends without the consent of a third party (i.e., lender, regulatory agency, foreign government, etc.).

F-50

 
 
 
 
 
 
 
 
   
 
   
     
 
   
   
 
   
   
 
  
 
 
 
 
   
 
   
   
   
   
   
 
 
 
 
 
SCHEDULE I – CONDENSED FINANCIAL INFORMATION OF REGISTRANT

CBAK ENERGY TECHNOLOGY, INC.
PARENT COMPANY STATEMENTS OF OPERATIONS
For the years ended December 31, 2019 and 2020
(Unaudited)

REVENUE, net

OPERATING EXPENSES:

Salaries and consulting expenses
General and administrative

Total operating expenses

LOSS FROM OPERATIONS

Finance expenses
Changes in fair value of warrants liability

(LOSS) PROFIT ATTRIBUTABLE TO PARENT COMPANY

EQUITY IN LOSS OF SUBSIDIARIES

Year ended 
December  31, 
2019

Year ended 
December 31, 
2020

  $

-    $

- 

978,942     
439,974     

992,246 
531,449 

(1,418,916)    

(1,523,695)

(1,418,916)    

(1,523,695)

(120,051)    
-     

(429,741)
2,072,000 

(1,538,967)    

118,564 

(9,228,556)    

(7,925,462)

NET LOSS ATTRIBUTABLE TO SHAREHOLDERS

  $ (10,767,523)   $

(7,806,898)

CBAK ENERGY TECHNOLOGY, INC.
PARENT COMPANY BALANCE SHEETS
As of December 31, 2019 and 2020
(Unaudited)

ASSETS

Interests in subsidiaries
Cash and cash equivalents

Total assets

LIABILITIES AND SHAREHOLDERS’ EQUITY

CURRENT LIABILITIES:

Notes payable
Accrued expenses and other payables
Warrants liability

Total current liabilities

SHAREHOLDERS’ EQUITY

Total liabilities and shareholders’ equity

F-51

December 31, 
2019

December 31, 
2020

  $

  $

18,183,266    $
-     
18,183,266    $

66,797,421 
5,107,486 
71,904,907 

  $

2,846,736    $
1,731,251     
-     
4,577,987     

- 
1,722,814 
17,783,000 
19,505,814 

13,605,279     
18,183,266    $

52,399,093 
71,904,907 

  $

 
 
 
 
 
 
   
 
 
   
      
  
   
      
  
   
   
 
   
      
  
   
 
   
      
  
   
 
   
      
  
   
   
 
   
      
  
   
 
   
      
  
   
 
   
      
  
 
 
 
 
   
 
 
      
 
 
   
     
 
   
 
   
      
  
   
      
  
 
   
      
  
   
      
  
   
   
   
 
   
      
  
   
 
CBAK ENERGY TECHNOLOGY, INC.
PARENT COMPANY STATEMENTS OF CASH FLOWS
For the years ended December 31, 2019 and 2020
(Unaudited)

CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss
Adjustments to reconcile net loss to net cash used in operating activities:

Equity in loss of subsidiaries
Share based compensation
Changes in fair value of warrants liability
Change in operating assets and liabilities
Accrued expenses and other payable
Net cash used in operating activities

CASH FLOWS FROM INVESTING ACTIVITIES:

Decrease in interest in subsidiaries

Net cash provided by (used in) investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from issuance of shares
Proceeds from issuance of promissory notes

Net cash provided by financing activities

CHANGE IN CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS, beginning of year

Year ended
December 31,
2019

Year ended
December 31,
2020

  $ (10,767,523)   $

(7,806,898)

9,228,556     
770,113     
-     

7,925,462 
803,931 
(2,072,000)

89,080     
(679,774)    

(8,437)
(1,157,942)

(2,070,226)    
(2,070,226)    

(39,083,154)
(39,083,154)

-     
2,750,000     
2,750,000     

45,348,582 
- 
45,348,582 

-     

5,107,486 

-     

- 

CASH AND CASH EQUIVALENTS, end of year

  $

-    $

5,107,486 

The condensed parent company financial statements have been prepared using the equity method to account for its subsidiaries. Refer to the consolidated
financial statements and notes presented above for additional information and disclosures with respect to these financial statements.

27. Subsequent events

On April 1, 2021, CBAK Power entered into a framework investment agreement with Hangzhou Juzhong Daxin Asset Management Co., Ltd. ("Juzhong
Daxin") for a potential acquisition of Zhejiang Meidu Hitrans Lithium Battery Technology Co., Ltd ("Hitrans"). Juzhong Daxin is the trustee of 85% of
equity interests of Hitrans and has the voting right and right to dividend over the 85% of equity interests. Subject to definitive acquisition agreements to be
entered  into  among  the  parties,  including  shareholders  owning  the  85%  of  equity  interests  of  Hitrans,  CBAK  Power  intends  to  acquire  85%  of  equity
interests  of  Hitrans  in  cash  in  2021.  As  of  date  of  this  report,  CBAK  Power  has  paid  $3.06  million  (RMB20,000,000)  to  Juzhong  Daxin  as  a  security
deposit. Hitrans is an unrelated third party of the Company engaging in researching, manufacturing and trading of raw materials and is one of the major
suppliers of the Company in fiscal 2020.

F-52

 
 
 
 
 
   
 
 
 
     
 
   
      
  
   
   
   
   
      
  
   
   
 
   
      
  
   
      
  
   
   
 
   
      
  
   
      
  
   
   
   
 
   
      
  
   
 
   
      
  
   
 
   
      
  
  
 
 
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

None.

ITEM 9A. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15 under the Exchange Act, our management has carried out an evaluation, with the participation and under the supervision of our
Chief Executive Officer and Interim Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of
December 31, 2020. Disclosure controls and procedures refer to controls and other procedures designed to ensure that information required to be disclosed
in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and
forms of the SEC and that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Interim
Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and
procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of
achieving  the  desired  control  objectives,  and  management  is  required  to  apply  its  judgment  in  evaluating  and  implementing  possible  controls  and
procedures.

Management conducted its evaluation of disclosure controls and procedures under the supervision of our Chief Executive Officer and our Interim Chief
Financial Officer. Based upon, and as of the date of this evaluation, our Chief Executive Officer and Interim Chief Financial Officer concluded that our
disclosure controls and procedures were ineffective as of December 31, 2020.

Management’s Annual Report on Internal Control over Financial Reporting

Management  is  responsible  for  establishing  and  maintaining  adequate  internal  control  over  financial  reporting  for  the  Company.  Internal  control  over
financial reporting refers to the process designed by, or under the supervision of, our Chief Executive Officer and our Interim Chief Financial Officer, and
effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of our financial reporting and
the preparation of financial statements for external purposes in accordance with U.S. GAAP, and includes those policies and procedures that:

● pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;

● provide reasonable  assurance  that  transactions  are  recorded  as  necessary  to  permit  preparation  of  financial  statements  in  accordance  with  U.S.
GAAP, and that our receipts and expenditures are being made only in accordance with the authorization of our management and directors; and

● provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have

a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of
effectiveness  to  future  periods  are  subject  to  the  risk  that  controls  may  become  inadequate  because  of  changes  in  conditions,  or  that  the  degree  of
compliance with the policies or procedures may deteriorate.

Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2020. In making this assessment, management
used the framework set forth in the report entitled Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of
the Treadway Commission, or COSO. The COSO framework summarizes each of the components of a company’s internal control system, including (i) the
control environment, (ii) risk assessment, (iii) control activities, (iv) information and communication, and (v) monitoring.

44

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on this evaluation, our Chief Executive Officer and our Interim Chief Financial Officer concluded that the Company’s internal control over financial
reporting as of December 31, 2020 were not effective because of the following material weaknesses in our internal control over financial reporting has been
identified:

– We did not have appropriate policies and procedures in place to evaluate the proper accounting and disclosures of key documents and agreements.

– We do not have sufficient and skilled accounting personnel with an appropriate level of technical accounting knowledge and experience in the

application of accounting principles generally accepted in the United States commensurate with our financial reporting requirements.

In order to cure the foregoing material weakness, we have taken or are taking the following remediation measures:

– We are in the process of hiring a permanent chief financial officer with significant U.S. GAAP and SEC reporting experience. Ms. Xiangyu Pei

was appointed by the Board of Directors of the Company as the Interim Chief Financial Officer on August 23, 2019.

–

Since September  2016,  we  have  regularly  offered  our  financial  personnel  trainings  on  internal  control  and  risk  management.  Since  November
2016,  we  have  regularly  provided  trainings  to  our  financial  personnel  on  U.S.  GAAP  accounting  guidelines.  We  plan  to  continue  to  provide
trainings  to  our  financial  team  and  our  other  relevant  personnel  on  the  U.S.  GAAP  accounting  guidelines  applicable  to  our  financial reporting
requirements.

We intend to complete the remediation of the material weaknesses discussed above as soon as practicable but we can give no assurance that we will be able
to  do  so.  Designing  and  implementing  an  effective  disclosure  controls  and  procedures  is  a  continuous  effort  that  requires  us  to  anticipate  and  react  to
changes in our business and the economic and regulatory environments and to devote significant resources to maintain a financial reporting system that
adequately satisfies our reporting obligations. The remedial measures that we have taken and intend to take may not fully address the material weakness
that  we  have  identified,  and  material  weaknesses  in  our  disclosure  controls  and  procedures  may  be  identified  in  the  future.  Should  we  discover  such
conditions, we intend to remediate them as soon as practicable. We are committed to taking appropriate steps for remediation, as needed.

Changes in internal control over financial reporting

Except for the matters described above, there were no changes in our internal controls over financial reporting during the fourth quarter of our fiscal year
ended December 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION.

We have no information to disclose that was required to be disclosed in a report on Form 8-K during the fourth quarter of fiscal year 2020, but was not
reported.

45

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

Directors and Executive Officers

The following sets forth the name and position of each of our current executive officers and directors.

PART III

NAME
Yunfei Li
J. Simon Xue
Martha C. Agee
Jianjun He
Guosheng Wang
Xiangyu Pei

AGE
55
67
66
49
49
32

  POSITION
  Chairman of the Board and Chief Executive Officer
  Director
  Director
  Director
  Director

Interim Chief Financial Officer

Yunfei  Li  has  served  as  the  chairman  of  our  board,  our  president  and  chief  executive  officer  since  March  1,  2016.  Mr.  Li  has  more  than  20  years
management experience in industries of real estate development, battery and new energy. Since May 2014, he has been Vice President of the Company’s
subsidiary, CBAK Power in charge of the company’s construction of manufacturing facilities, government relationship and development of new customers.
From May 2010 to May 2014, Mr. Li held management positions of various new energy development and real estate development companies in China.
Prior to that, he was Director of Construction Department, Director of Comprehensive Management Department and Assistant to President of Shenzhen
BAK Battery Co., Ltd., a former subsidiary of the Company, from March 2003 to May 2010. Mr. Li holds a bachelor’s degree in Civil Engineering from
Liao Yuan Vocational Technical College.

J.  Simon  Xue  has  served  as  our  director  since  February  1,  2016.  Dr.  Xue  has  approximately  40  years’  experience  in  nuclear  chemistry,  solid  state
chemistry, superconductivity and materials for Lithium-ion batteries. Within his research career, he has spent 21 years in the research and development of
Lithium-ion battery. Dr. Xue is currently the Senior Director of National Institute for Low-&-Clean Energy in China and a member of National “Thousand
Talent” Plan and a member of Expert Committee for “Chinese Industrial Association of Power Sources.” Prior to that, Dr. Xue was a director of Altair
Nanotechnologies Inc., a Delaware company, between August 2011 and April 2012. From 2010 to 2011, he served as the chief executive officer of Yintong
Energy  Co.,  Ltd.,  a  subsidiary  of  Canon  Investment  Holdings  Ltd.  Dr.  Xue  has  also  held  positions  at  Ultralife,  Duracell,  B&K  Electronics  Co.,  Ltd.,
Valence  Energy-Tech  (Suzhou)  Co.,  A123  Systems  Inc.  and  International  Battery  Inc.  He  enjoys  an  extensive  reputation  in  the  whole  product  chain  of
lithium-ion battery in China, including materials, equipment, cell manufacturing and testing. He has authored or co-authored over 50 scientific articles, 12
patents relevant to battery chemistry and materials and participated, presented and hosted more than 30 battery or material related international conferences.
Dr. Xue completed his Ph.D. program in Solid State Chemistry in McMaster University in 1992.

Martha C. Agee has served as our director since November 15, 2012. Since 1997, Ms. Agee has been a senior lecturer of business law at Hankamer School
of  Business  of  Baylor  University  where  she  teaches  courses  in  the  Legal  Environment  of  Business,  International  Business  Law,  and  Healthcare  Law  &
Ethics  for  graduate  and  undergraduate  students.  Prior  to  that,  Ms.  Agee  practiced  law  from  1988  to  1996.  Ms.  Agee  obtained  her  bachelor’s  degree  in
Accounting in 1976 and Juris Doctorate degree in 1988 from Baylor University.

Jianjun He has served as our director since November 4, 2013. Mr. He has more than 15 years’ experience in accounting and finance and is an associate
member  of  the  Chinese  Institute  of  Certificate  Public  Accounts.  Mr.  He  has  been  the  Managing  Director  of  Jilin  CybernautLvke  Investment  and
Management Co., Ltd., an investment consulting firm in China, since January 1, 2013. From June 30, 2009 to December 31, 2012, Mr. He served as the
Chief Financial Officer of THT Heat Transfer Technology, Inc. (Nasdaq: THTI) (“THT Heat”), a provider of heat exchangers and heat exchange solutions
in China. Mr. He was the Chief Financial Officer of Siping City JuyuanHanyang Plate Heat Exchanger Co. Ltd, a wholly owned subsidiary of THT Heat
from 2007 to December 2012. From 1999 to 2007, Mr. He worked as senior financial officer in Jilin Grain Group, a state-owned enterprise engaged in the
grain processing and trading business. Mr. He graduated from Changchun Taxation College in 1995 with a Bachelor’s degree in Auditing and obtained a
Master’s degree from Jilin University in 2005.

46

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Guosheng Wang has served as our director since August 1, 2014. Since June 2014, Mr. Wang has been in charge of the construction of facilities of the
Company’s subsidiary, CBAK Power and the relocation of assets and equipment of BAK International (Tianjin) Limited (“BAK Tianjin”) to CBAK Power.
Prior to that, Mr. Wang served as vice president of operations of BAK Tianjin since May 2013, where he was managing the Quality Department, Purchase
Department, Equipment Department and HR Department. From May 2010 to May 2013, Mr. Wang served as manager of Equipment Department of BAK
Tianjin. From March 2008 to May 2010, he served as Director of No. 1 Manufacture Department of BAK Tianjin. Mr. Wang began his career working as
an  engineer  at  Harbin  Railway  Transportation  Equipment  Co.,  Ltd  in  1994.  Mr.  Wang  obtained  his  bachelor’s  degree  in  mechanical  manufacturing
engineering and equipment from Lanzhou Jiaotong University in July 1994.

Xiangyu Pei has served as our Interim Chief Financial Officer since August 23, 2019. Prior to that, Ms. Pei has been the secretary of the Company since
2017. She has also served as the financial controller of the Company’s subsidiary, CBAK Power since 2017. She has been responsible for the auditing,
accounting and investor relationship of CBAK Power, as well as assisting in consolidation and financial reporting of the Company. Ms. Pei received a PhD
in World Economics from Jilin University in China.

There are no agreements or understandings for any of our executive officers or director to resign at the request of another person and no officer or director
is acting on behalf of nor will any of them act at the direction of any other person.

Directors are elected until their successors are duly elected and qualified.

Director Qualifications

Directors are responsible for overseeing the Company’s business consistent with their fiduciary duty to shareholders. This significant responsibility requires
highly skilled individuals with various qualities, attributes and professional experience. The Board believes that there are general requirements for service
on the Company’s Board of Directors that are applicable to all directors and that there are other skills and experience that should be represented on the
Board as a whole but not necessarily by each director. The Board and the Nominating and Corporate Governance Committee of the Board consider the
qualifications of directors and director candidates individually and in the broader context of the Board’s overall composition and the Company’s current
and future needs.

Qualifications for All Directors

In identifying and evaluating nominees, the Nominating and Corporate Governance Committee may consult with the other Board members, management,
consultants,  and  other  individuals  likely  to  possess  an  understanding  of  the  Company’s  business  and  knowledge  of  suitable  candidates.  In  making  its
recommendations, the Nominating and Corporate Governance Committee assesses the requisite skills and qualifications of nominees and the composition
of the Board as a whole in the context of the Board’s criteria and needs. In evaluating the suitability of individual Board members, the Nominating and
Corporate  Governance  Committee  may  take  into  account  many  factors,  including  general  understanding  of  marketing,  finance  and  other  disciplines
relevant  to  the  success  of  a  publicly  traded  company  in  today’s  business  environment;  understanding  of  the  Company’s  business  and  technology;  the
international nature of the Company’s operations; educational and professional background; and personal accomplishment. The Nominating and Corporate
Governance  Committee  evaluates  each  individual  in  the  context  of  the  Board  as  a  whole,  with  the  objective  of  recommending  a  group  that  can  best
perpetuate  the  success  of  the  Company’s  business  and  represent  stockholder  interests  through  the  exercise  of  sound  judgment,  using  its  diversity  of
experience. The Nominating and Corporate Governance Committee also ensures that a majority of nominees would be “independent directors” as defined
under the applicable rules of the SEC and The NASDAQ Stock Market LLC.

Qualifications, Attributes, Skills and Experience to be Represented on the Board as a Whole

In  its  assessment  of  each  potential  candidate,  including  those  recommended  by  stockholders,  the  Nominating  and  Corporate  Governance  Committee
considers the nominee’s judgment, integrity, experience, independence, understanding of the Company’s business or other related industries and such other
factors  the  Nominating  and  Corporate  Governance  Committee  determines  are  pertinent  in  light  of  the  current  needs  of  the  Board.  The  Nominating  and
Corporate Governance Committee also takes into account the ability of a Director to devote the time and effort necessary to fulfill his or her responsibilities
to the Company.

47

 
 
 
 
 
 
 
 
 
 
 
 
The Board and the Nominating and Corporate Governance Committee require that each Director be a recognized person of high integrity with a proven
record  of  success  in  his  or  her  field.  Each  Director  must  demonstrate  innovative  thinking,  familiarity  with  and  respect  for  corporate  governance
requirements  and  practices,  an  appreciation  of  multiple  cultures  and  a  commitment  to  sustainability  and  to  dealing  responsibly  with  social  issues.  In
addition to the qualifications required of all Directors, the Board assesses intangible qualities including the individual’s ability to ask difficult questions
and, simultaneously, to work collegially.

The Board has identified particular qualifications, attributes, skills and experience that are important to be represented on the Board as a whole, in light of
the Company’s current needs and business priorities. The Company’s services are performed in various countries and in significant areas of future growth
located outside of the United States. Accordingly, the Board believes that international experience or specific knowledge of key geographic growth areas
and diversity of professional experiences should be represented on the Board. In addition, the Company’s business is multifaceted and involves complex
financial transactions. Therefore, the Board believes that the Board should include some Directors with a high level of financial literacy and some Directors
who possess relevant business experience as a Chief Executive Officer or President. Our business involves complex technologies in a highly specialized
industry. Therefore, the Board believes that extensive knowledge of the Company’s business and industry should be represented on the Board.

The  Board  and  the  Nominating  and  Corporate  Governance  Committee  do  not  have  a  specific  diversity  policy,  but  consider  diversity  of  race,  ethnicity,
gender, age, cultural background and professional experiences in evaluating candidates for Board membership. Diversity is important because a variety of
points of view contribute to a more effective decision-making process.

Summary of Qualifications of Directors

Set forth below is a narrative disclosure that summarizes some of the specific qualifications, attributes, skills and experiences of our directors. For more
detailed information, please refer to the biographical information for each director set forth above.

Mr.  Li,  has  extensive  senior  management  experience  in  the  industry  in  which  we  operate  and  has  held  management  positions  of  various  new  energy
development and real estate development companies in China.

Dr. Xue, Chair of the Compensation Committee, has approximately 40 years’ experience in nuclear chemistry, solid state chemistry, superconductivity and
materials for Lithium-ion batteries. Within his research career, he has spent 21 years in the research and development of Lithium-ion battery.

Ms. Agee, Chair of the Audit Committee, was previously a Certified Public Accountant, worked as Chief Accountant for political sub-division for five and
a  half  years  and  worked  as  Supervisor  of  Accounting  for  a  large  retail  chain  where  the  responsibilities  included  hiring,  training,  and  supervision  of
accounting  staff;  preparation  and  analysis  of  17  monthly  financial  statements  and  quarterly  consolidated  financial  statements;  budgeting,  and  internal
auditing.

Mr. He, Chair of the Nominating and Corporate Governance Committee, has more than 15-year experience in accounting and finance and is an associate
member of the Chinese Institute of Certificate Public Accounts.

Mr. Wang, has served with the Company since 2003 and brings to the Board extensive experience in all aspects of our business and industry and strong
management and technical skills.

Family Relationships

There are no family relationships among our directors or officers.

48

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Involvement in Certain Legal Proceedings

To the best of our knowledge, none of our directors or executive officers has, during the past ten years:

● been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offences);

● had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of

which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;

● been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal
or  state  authority,  permanently  or  temporarily  enjoining,  barring,  suspending  or  otherwise  limiting,  his  involvement  in  any  type  of  business,
securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any
such activity;

● been  found  by  a  court  of  competent  jurisdiction  in  a  civil  action  or  by  the  Securities  and  Exchange  Commission  or  the  Commodity  Futures
Trading  Commission  to  have  violated  a  federal  or  state  securities  or  commodities  law,  and  the  judgment  has  not  been  reversed,  suspended,  or
vacated;

● been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed,
suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or
state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not
limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease- and-
desist  order,  or  removal  or  prohibition  order,  or  any  law  or  regulation  prohibiting  mail  or  wire  fraud  or  fraud  in  connection  with  any  business
entity; or

● been the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self- regulatory organization (as
defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity
Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members
or persons associated with a member.

Board Composition and Committees

Our board of directors is comprised of Yunfei Li, J. Simon Xue, Martha C. Agee, Jianjun He and Guosheng Wang.

J. Simon Xue, Martha Agee and Jianjun He each serves on our board of directors as an “independent director” as defined by as defined by Rule 5605(a)(2)
of  the  NASDAQ  Listing  Rules.  Our  board  of  directors  has  determined  that  Martha  Agee  possesses  the  accounting  or  related  financial  management
experience that qualifies her as financially sophisticated within the meaning of Rule 5605(c)(2)(A) of the NASDAQ Listing Rule and that she is an “audit
committee financial expert” as defined by the rules and regulations of the SEC.

Our board of directors currently has three standing committees which perform various duties on behalf of and report to the board of directors: (i) audit
committee, (ii) compensation committee and (iii) nominating and corporate governance committee. Each of the three standing committees is comprised
entirely of independent directors. From time to time, the board of directors may establish other committees.

Audit Committee

Our Audit Committee consists of three members: Martha C. Agee, J. Simon Xue and Jianjun He. Pursuant to the determination of our Board of Directors,
Ms. Agee serves as the chair of the Audit Committee and as our Audit Committee financial expert as that term is defined by the applicable SEC rules. Each
director who has served or is serving on our Audit Committee was or is “independent” as that term is defined under the NASDAQ listing rules for Audit
Committee members at all times during their service on such Committee.

The Audit  Committee  oversees  our  accounting  and  financial  reporting  processes  and  the  audits  of  the  financial  statements  of  our  Company. The  Audit
Committee is responsible for, among other things:

● the appointment, compensation, retention and oversight of the work of the independent auditor;

● reviewing and pre-approving all auditing services and permissible non-audit services (including the fees and terms thereof) to be performed by the

independent auditor;

● reviewing and approving all proposed related-party transactions;

● discussing the interim and annual financial statements with management and our independent auditors;

● reviewing and discussing with management and the independent auditor (a) the adequacy and effectiveness of the Company’s internal controls, (b)
the  Company’s  internal  audit  procedures,  and  (c)  the  adequacy  and  effectiveness  of  the  Company’s  disclosure  controls  and  procedures,  and
management reports thereon;

● reviewing reported violations of the Company’s code of conduct and business ethics; and

● reviewing and discussing with management and the independent auditor various topics and events that may have significant financial impact on

the Company or that are the subject of discussions between management and the independent auditors.

49

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compensation Committee

Our Compensation Committee consists of three members: Martha C. Agee, J. Simon Xue and Jianjun He, with Mr. Xue serving as chair. Each director who
has  served  or  is  serving  on  our  Compensation  Committee  was  or  is  “independent”  as  that  term  is  defined  under  the  NASDAQ  listing  rules  at  all  times
during their service on such Committee.

The  purpose  of  our  Compensation  Committee  discharge  the  responsibilities  of  the  Company’s  Board  of  Directors  relating  to  compensation  of  the
Company’s executives, to produce an annual report on executive compensation for inclusion in the Company’s proxy statement, if required, and to oversee
and advise the Board on the adoption of policies that govern the Company’s compensation programs, including stock and benefit plans. Our chief executive
officer  may  not  be  present  at  any  Compensation  Committee  meeting  during  which  his  compensation  is  deliberated.  The  Compensation  Committee  is
responsible for, among other things:

● reviewing and approving the compensation structure for corporate officers at the level of corporate vice president and above;

● overseeing an evaluation of the performance of the Company’s executive officers and approve the annual compensation, including salary, bonus,

incentive and equity compensation, for the executive officers;

● reviewing and  approving  chief  executive  officer  goals  and  objectives,  evaluate  chief  executive  officer  performance  in  light  of  these  corporate

objectives, and set chief executive officer compensation consistent with Company philosophy;

● making recommendations to the Board regarding the compensation of board members;

● reviewing and making recommendations concerning long-term incentive compensation plans, including the use of equity-based plans. Except as
otherwise  delegated  by  the  Board  of  Directors,  the  Compensation  Committee  will  act  on  behalf  of  the  Board  of  Directors  as  the  “Committee”
established to administer equity-based and employee benefit plans, and as such will discharge any responsibilities imposed on the Compensation
Committee under those plans, including making and authorizing grants, in accordance with the terms of those plans.

Nominating and Corporate Governance Committee

Our Nominating and Corporate Governance Committee consists of three members: Martha C. Agee, J. Simon Xue and Jianjun He, with Mr. He serving as
chair. Each director who has served or is serving on our Nominating and Corporate Governance Committee was or is “independent” as that term is defined
under the NASDAQ listing standards at all times during their service on such Committee.

The purpose of the Nominating and Corporate Governance Committee is to determine the slate of director nominees for election to the Company’s Board
of Directors, to identify and recommend candidates to fill vacancies occurring between annual shareholder meetings, and to review the Company’s policies
and programs that relate to matters of corporate responsibility, including public issues of significance to the Company and its members. The Nominating
and Corporate Governance Committee is responsible for, among other things:

● annually presenting to the Board a list of individuals recommended for nomination for election to the Board at the annual meeting of stockholders,

and for appointment to the committees of the Board;

● annually reviewing the composition of each committee and present recommendations for committee memberships to the Board as needed; and

● annually  evaluating  and  reporting  to  the  Board  of  Directors  on  the  performance  and  effectiveness  of  the  Board  of  Directors  to  facilitate  the

directors fulfillment of their responsibilities in a manner that serves the interests of the Company’s shareholders.

50

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Code of Business Ethics and Conduct

We have adopted a Code of Business Ethics and Conduct relating to the conduct of our business by our employees, officers and directors. We intend to
maintain  the  highest  standards  of  ethical  business  practices  and  compliance  with  all  laws  and  regulations  applicable  to  our  business,  including  those
relating to doing business outside the United States. A copy of the Code of Business Conduct and Ethics has been filed as Exhibit 14.1 to our Quarterly
Report on Form 10-Q filed on August 22, 2006 and is hereby incorporated by reference into this annual report. The Code of Business Conduct and Ethics is
also available on our website at www.cbak.com.cn. During the fiscal year ended December 31, 2020, there were no amendments to or waivers of our Code
of Business Ethics and Conduct. If we effect an amendment to, or waiver from, a provision of our Code of Business Ethics and Conduct, we intend to
satisfy our disclosure requirements by posting a description of such amendment or waiver on our Internet website at www.cbak.com.cn or via a current
report on Form 8-K.

Delinquent Section 16(a) Reports

Under U.S. securities laws, directors, certain executive officers and persons beneficially owning more than 10% of our Common Stock must report their
initial ownership of the Common Stock, and any changes in that ownership, to the SEC. The SEC has designated specific due dates for these reports. Based
solely  on  our  review  of  copies  of  such  reports  filed  with  the  SEC  and  written  representations  of  our  directors  and  executive  offers,  we  believe  that  all
persons subject to reporting filed the required reports on time in fiscal year 2020, except that one Form 3, covering one transaction, was filed late by Ping
Shen.

ITEM 11. EXECUTIVE COMPENSATION.

Summary Compensation Table

The following table sets forth information concerning all cash and non-cash compensation awarded to, earned by or paid to the named persons for services
rendered in all capacities during the noted periods. No other executive officer received total annual salary and bonus compensation in excess of $100,000.

Name and Principal Position
Yunfei Li,

President, Chief Executive Officer

Period
Year ended December 31, 2019
Year ended December 31, 2020

Salary
($)(1)

Stock
Awards
($)(2)

Option
Awards
($)

128,168     
120,339     

127,000     
120,001     

-     
-     

Total
($)
255,168 
240,340 

(1) The amounts reported in this table have been converted from RMB to U.S. dollars based on the average conversion rate between the U.S. dollar and
RMB for the applicable fiscal year, or $1.00 to RMB6.9073 (fiscal year 2019 exchange rate), $1.00 to RMB6.9032 (fiscal year 2020 exchange rate).

(2) The stock awards consisted of: 1) restricted shares granted on June 30, 2015, which are vested and exercisable in twelve equal quarterly installments
with the first vesting date of June 30, 2015 and with a fair value of $3.24,  2) restricted shares granted on April 19, 2016 with a fair value of $2.68 per
share, which are vested and exercisable under three types of vesting schedules: First, if the number of restricted shares granted is below 3,000, the
shares will vest annually in 2 equal installments over a two-year period with the first vesting on June 30, 2017. Second, if the number of restricted
shares granted is larger than or equal to 3,000 and is below 10,000, the shares will vest annually in 3 equal installments over a three-year period with
the first vesting on June 30, 2017. Third, if the number of restricted shares granted is above or equal to 10,000, the shares will vest semi-annually in 6
equal installments over a three-year period with the first vesting on December 31, 2016, and  3) restricted shares granted on August 23, 2019 with a
fair value of $0.9 per share, which are vested semi-annually in 6 equal installments over a three-year period with the first vesting on September 30,
2019

51

 
 
 
  
 
 
 
 
 
 
 
 
 
 
   
   
   
 
 
 
 
   
   
   
 
 
   
 
   
 
 
 
Summary of Employment Agreements

The  base  salary  shown  in  the  Summary  Compensation  Table  is  described  in  each  named  executive  officer’s  respective  employment  agreement.  The
material terms of those employment agreements are summarized below.

We entered into employment agreements with three-year initial terms with our named executive officers with standard employment agreements. We entered
into  the  employment  agreement  with  Mr.  Yunfei  Li  on  March  1,  2016.  On  August  23,  2019,  the  Board  of  Directors  appointed  Ms.  Xiangyu  Pei  as  the
Interim  Chief  Financial  Officer,  and  we  entered  into  the  employment  agreement  with  Ms.  Xiangyu  Pei  for  a  three-year  term.  Each  of  our  standard
employment agreements is automatically extended by a year at the expiration of the initial term and at the expiration of every one-year extension, until
terminated in accordance with the termination provisions of the agreements, which are described below.

Our standard employment agreement permits us to terminate the executive’s employment for cause, at any time, without notice or remuneration, for certain
acts of the executive, including but not limited to a conviction or plea of guilty to a felony, negligence or dishonesty to our detriment and failure to perform
agreed duties after a reasonable opportunity to cure the failure. An executive may terminate his employment upon one month’s written notice if there is a
material reduction in his authority, duties and responsibilities or if there is a material reduction in his annual salary before the next annual salary review.
Furthermore,  we  may  terminate  the  executive’s  employment  at  any  time  without  cause  by  giving  one  month’s  advance  written  notice  to  the  executive
officer. If we terminate the executive’s employment without cause, the executive will be entitled to a termination payment of up to three months of his or
her then base salary, depending on the length of such executive’s employment with us. Specifically, the executive will receive salary continuation for: (i)
one month following a termination effective prior to the first anniversary of the effective date of the employment agreement; (ii) two months following a
termination effective prior to the second anniversary of the effective date; and (iii) three months following a termination effective prior to or any time after
the  third  anniversary  of  the  effective  date.  The  employment  agreements  provide  that  the  executive  will  not  participate  in  any  severance  plan,  policy,  or
program of the Company.

Our standard employment agreement contains customary non-competition, confidentiality, and non-disclosure covenants. Each executive officer has agreed
to  hold,  both  during  and  after  the  employment  agreement  expires  or  is  earlier  terminated,  in  strict  confidence  and  not  to  use,  except  as  required  in  the
performance of his duties in connection with the employment, any confidential information, technical data, trade secrets and know-how of our company or
the confidential information of any third party, including our affiliated entities and our subsidiaries, received by us. The executive officers have also agreed
to disclose in confidence to us all inventions, designs and trade secrets which they conceive, develop or reduce to practice and to assign all right, title and
interest  in  them  to  us.  In  addition,  each  executive  officer  has  agreed  to  be  bound  by  non-competition  restrictions  set  forth  in  his  or  her  employment
agreement. Specifically, each executive officer has agreed not to, while employed by us and for a period of one year following the termination or expiration
of the employment agreement,

● approach our clients, customers or contacts or other persons or entities, and not to interfere with the business relationship between us and such

persons and/or entities;

● assume employment  with  or  provide  services  as  a  director  for  any  of  our  competitors,  or  engage  in  any  business  which  is  in  direct  or  indirect

competition with our business; or

● solicit the services of any of our employees.

52

 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding Equity Awards at Fiscal Year-End 2020

The following table sets forth the equity awards outstanding at December 31, 2020 for each of our named executive officers.

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END 

Option Awards

Stock Awards

Equity
incentive
plan
awards:
Number of
securities
underlying
unexercised
unearned
options
(#)

Number of
securities
underlying
unexercised
options (#)
exercisable    

Number of
securities
underlying
unexercised
options (#)
 unexercisable    

Number
of shares
or units
of stock
that have
not
vested
(#)

Market
value of
shares or
units of
stock that
have not
vested
(#)

Option
exercise
price 
($)

Option
expiration
date

Equity
incentive
plan
awards:
Number
of
unearned
shares,
units or
other
rights
that have
not vested
(#)

Equity
incentive
plan
awards:
Market
or payout
value of
unearned
shares,
units or
other
rights
that have
not vested
($)

-   

-   

199,999*  

179,999 

Name
Yunfei Li, President,
Chief Executive
Officer

* On June 30, 2015, Mr. Li was granted 30,000 restricted shares of the Company’s common stock, par value $0.001, under the 2015 Equity Incentive
Plan of the Company (the “2015 Plan”). The restricted shares vest over a three-year period in 12 equal quarterly installments with the first vesting date
on  June  30,  2015.  On  April  19,  2016,  pursuant  to  the  2015  Plan,  the  Company  granted  Mr.  Li  an  aggregate  of  150,000  restricted  shares  of  the
Company’s common stock. The restricted shares vest semi-annually in 6 equal installments over a three-year period with the first vesting on December
31, 2016. On August 23, 2019, pursuant to the 2015 Plan, the Company granted Mr. Li an aggregate of 400,000 restricted share units of the Company’s
common stock. The share units vest semi-annually in 6 equal installments over a three-year period with the first vesting on September 30, 2019.

Compensation of Directors

On August 23, 2019, pursuant to the 2015 Plan, each of our independent directors was granted 20,000 restricted share units of the Company’s common
stock. The share units vest semi-annually in 6 equal installments over a three year period with the first vesting on September 30, 2019.

The following table sets forth the total compensation earned by our non-employee directors during our fiscal year ended December 31, 2020:

Name
J. Simon Xue
Martha C. Agee
Jianjun He

Fees 
Earned or
Paid in 
Cash 
($)

Stock
Awards 
($)

Total 
($)

20,000     
20,000     
20,000     

6,000     
6,000     
6,000     

26,000 
26,000 
26,000 

We do not maintain a medical, dental or retirement benefits plan for the directors.

Except  as  disclosed  in  this  annual  report,  we  have  not  compensated,  and  will  not  compensate,  our  non-independent  directors,  Mr.  Yunfei  Li  and  Mr.
Guosheng Wang, for serving as our directors, although they are entitled to reimbursements for reasonable expenses incurred in connection with attending
our board meetings.

The  directors  may  determine  remuneration  to  be  paid  to  the  directors  with  interested  members  of  the  Board  refraining  from  voting.  The  Compensation
Committee will assist the directors in reviewing and approving the compensation structure for the directors.

53

 
 
 
 
 
 
   
 
   
   
   
   
   
   
   
 
   
    
    
    
    
    
 
 
 
 
 
 
 
   
   
 
 
 
   
   
 
   
   
   
 
 
 
 
ITEM  12.  SECURITY  OWNERSHIP  OF  CERTAIN  BENEFICIAL  OWNERS  AND  MANAGEMENT  AND  RELATED  STOCKHOLDER
MATTERS.

Securities Ownership of Certain Beneficial Owners and Management

The following table sets forth information known to us with respect to the beneficial ownership of our Common Stock as of the close of business on April
9,  2021  (the  “Reference  Date”)  for:  (i)  each  person  known  by  us  to  beneficially  own  more  than  5%  of  our  voting  securities,  (ii)  each  named  executive
officer, (iii) each of our directors and nominees, and (iv) all of our executive officers and directors as a group:

Names of Management and Names of Certain Beneficial Owners (1)

Yunfei Li (6) (8) (10)(14)

J. Simon Xue (7) (11)

Martha C. Agee (4) (11)

Jianjun He (4) (11)

Guosheng Wang (5)

Xiangyu Pei (13)

Amount and Nature of
Beneficial Ownership (1)

  Number (2)

    Percent (3)

10,860,039     

12.32%

43,332     

43,332     

43,332     

112,501     

177,983     

* 

* 

* 

* 

* 

All executive officers and directors as a group (6 persons)

11,280,519     

12.79%

Principal Shareholders
Dawei Li (8) (10)
Asia EVK Energy Auto Limited (9) (10)(14)
Ping Shen (12)(14)

*

Denotes less than 1% of the outstanding shares of Common Stock.

6,733,359     
9,702,615     
8,668,983     

7.64%
11.01%
9.84%

(1) The number of shares beneficially owned is determined under SEC rules, and the information is not necessarily indicative of beneficial ownership for
any  other  purpose.  Under  those  rules,  beneficial  ownership  includes  any  shares  as  to  which  the  individual  has  sole  or  shared  voting  power  or
investment power, and also any shares which the individual has the right to acquire within 60 days of the Reference  Date,  through  the  exercise  or
conversion of any stock option, convertible security, warrant or other right (a “Presently Exercisable” security). Including those shares in the table
does not, however, constitute an admission that the named stockholder is a direct or indirect beneficial owner of those shares.

(2) Unless otherwise  indicated,  each  person  or  entity  named  in  the  table  has  sole  voting  power  and  investment  power  (or  shares  that  power  with  that

person’s spouse) with respect to all shares of Common Stock listed as owned by that person or entity.

(3) A  total  of  88,106,019  shares  of  Common  Stock  are  considered  to  be  outstanding  on  the  Reference  Date.  For  each  beneficial  owner  above,  any
Presently Exercisable securities of such beneficial owner have been included in the denominator, pursuant to Rule 13d-3(d)(1) under the Securities
Exchange Act of 1934, as amended, or the Exchange Act.

(4) On June 30, 2015, each of our independent directors then was granted 30,000 restricted shares of the Company’s Common Stock, under the 2015 Plan.

The restricted shares vest over a three-year period in 12 equal quarterly installments with the first vesting date on June 30, 2015.

(5) On June 30, 2015, Mr. Guosheng Wang was granted 50,000 restricted shares of the Company’s Common Stock, under the 2015 Equity Incentive Plan,
or the 2015 Plan. The restricted shares vest over a three-year period in 12 equal quarterly installments with the first vesting date on June 30, 2015. On
April  19,  2016,  Mr.  Wang  was  granted  an  additional  20,000  restricted  shares  under  the  2015  Plan.  Such  shares  vest  semi-annually  in  6  equal
installments  over  a  three-year  period  with  the  first  vesting  on  December  31,  2016.  On  August  23,  2019,  pursuant  to  the  2015  Plan,  the  Company
granted  Mr.  Wang  an  aggregate  of  70,000  restricted  share  units  of  the  Company’s  Common  Stock.  The  share  units  vest  semi-annually  in  6  equal
installments over a three-year period with the first vesting on September 30, 2019.

54

 
 
 
 
 
 
 
 
 
   
 
   
      
  
   
 
   
      
  
   
 
   
      
  
   
 
   
      
  
   
 
   
      
  
   
 
   
      
  
   
 
   
      
  
   
      
  
   
   
   
  
 
 
 
 
 
 
 
 
 
 
(6) On June 30, 2015, Mr. Yunfei Li was granted 30,000 restricted shares of the Company’s Common Stock, under the 2015 Plan. The restricted shares
vest over a three-year period in 12 equal quarterly installments with the first vesting date on June 30, 2015. On April 19, 2016, pursuant to the 2015
Plan,  the  Company  granted  Mr.  Li  an  aggregate  of  150,000  restricted  shares  of  the  Company’s  Common  Stock.  The  restricted  shares  vest  semi-
annually in 6 equal installments over a three-year period with the first vesting on December 31, 2016. On February 17, 2017, we signed a letter of
understanding with each of eight individual investors, including our CEO, Mr. Yunfei Li, whereby these stockholders agreed in principle to subscribe
for  new  shares  of  our  Common  Stock  totaling  $10  million.  The  issue  price  would  be  determined  with  reference  to  the  market  price  prior  to  the
issuance of new shares. In January 2017, the stockholders paid us a total of $2.1 million as refundable deposits, among which, Mr. Yunfei Li agreed
to subscribe new shares totaling $1.12 million and pay a refundable deposit of $0.2 million. In April and May 2017, we received cash of $9.6 million
from these stockholders. On May 31, 2017, we entered into a securities purchase agreement with these investors, pursuant to which we agreed to
issue an aggregate of 6,403,518 shares of Common Stock to these investors, at a purchase price of $1.50 per share, for an aggregate price of $9.6
million, including 746,018 shares were issued to Mr. Yunfei Li, our CEO. On June 22, 2017, we issued the shares to the investors.

On  August  23,  2019,  pursuant  to  the  2015  Plan,  the  Company  granted  Mr.  Li  an  aggregate  of  400,000  restricted  share  units  of  the  Company’s
Common Stock. The share units vest semi-annually in 6 equal installments over a three-year period with the first vesting on September 30, 2019.

(7) On April 19, 2016, pursuant to the 2015 Plan, the Company granted Dr. Xue an aggregate of 30,000 restricted shares of the Company’s Common

Stock. The restricted shares vest semi-annually in 6 equal installments over a three-year period with the first vesting on December 31, 2016.

(8) On January 7, 2019, we entered into a cancellation agreement with Mr. Yunfei Li and Mr. Dawei Li, who loaned an aggregate of approximately $5.2
million (the “First Debt”) to the Company’s subsidiary, CBAK Power. Pursuant to the terms of the cancellation agreement, the creditors agreed to
cancel the First Debt in exchange for an aggregate of 5,098,040 shares of Common Stock of the Company at an exchange price of $1.02 per share.
According to the amount of loan, 3,431,373 and 1,666,667 shares were issued to Mr. Dawei Li and Mr. Yunfei Li, respectively. Upon receipt of the
shares, the creditors released the Company from any claims, demands and other obligations relating to the First Debt.

(9) On April 26, 2019, we entered into a cancellation agreement with Mr. Jun Lang, Ms. Jing Shi and Asia EVK Energy Auto Limited (“Asia EVK”),
who loaned an aggregate of approximately $5.4 million to CBAK Power (the “Second Debt”). Pursuant to the terms of the cancellation agreement,
the creditors agreed to cancel the Second Debt in exchange for an aggregate of 5,205,905 shares of Common Stock of the Company at an exchange
price of $1.1 per share. According to the amount of loan, 300,534, 123,208 and 4,782,163 shares were issued to Mr. Jun Lang, Ms. Jing Shi and Asia
EVK, respectively. Upon receipt of the shares, the creditors released the Company from any claims, demands and other obligations relating to the
Second Debt.

(10) On  July  26,  2019,  we  entered  into  a  cancellation  agreement  with  Mr.  Dawei  Li,  Mr.  Yunfei  Li  and  Asia  EVK,  who  loaned  an  aggregate  of
approximately $7.1 million to CBAK Power (collectively, the “Third Debt” and “Fourth Debt”). Pursuant to the terms of the cancellation agreement,
the creditors agreed to cancel the Third Debt and Fourth Debt in exchange for an aggregate of 7,092,219 shares of Common Stock of the Company at
an exchange price of $1.05 per share. According to the amount of loan, 1,384,717, 2,938,067 and 2,769,435 shares were issued to Mr. Dawei Li, Mr.
Yunfei  Li  and  Asia  EVK,  respectively.  Upon  receipt  of  the  shares,  the  creditors  released  the  Company  from  any  claims,  demands  and  other
obligations relating to the Third Debt and Fourth Debt. 

(11) On August 23, 2019, pursuant to the 2015 Plan, each of our independent directors then was granted 20,000 restricted share units of the Company’s
Common Stock. The share units vest semi-annually in 6 equal installments over a three-year period with the first vesting on September 30, 2019.

(12) On October 14, 2019, we entered into a cancellation agreement with Mr. Shangdong Liu, Mr. Shibin Mao, Ms. Lijuan Wang and Mr. Ping Shen, who
loaned an aggregate of approximately $4.2 million to CBAK Power (the “Fifth Debt”) and the unpaid earnest money of approximately $1.0 million.
Pursuant to the terms of the cancellation agreement, the creditors agreed to cancel the Fifth Debt and convert the unpaid earnest money in exchange
for an aggregate of 8,599,717 shares of Common Stock of the Company at an exchange price of $0.6 per share. According to the amount of loan,
528,053,  3,536,068,  2,267,798  and  2,267,798  shares  were  issued  to  Mr.  Shangdong  Liu,  Mr.  Shibin  Mao,  Ms.  Lijuan  Wang  and  Mr.  Ping  Shen,
respectively. Upon receipt  of  the  shares,  the  creditors  released  the  Company  from  any  claims,  demands  and  other  obligations relating to the Fifth
Debt and the unpaid earnest money.

(13) On April 19, 2016, Ms. Pei was granted 50,000 restricted shares under the 2015 Plan. Such shares vest semi-annually in 6 equal installments over a
three-year period with the first vesting on December 31, 2016. On August 23, 2019, pursuant to the 2015 Plan, the Company granted Ms. Pei an
aggregate of 180,000 restricted share units of the Company’s Common Stock. The share units vest semi-annually in 6 equal installments over a three-
year period with the first vesting on September 30, 2019.

(14) On April 27, 2020, the Company entered into a cancellation agreement with Mr. Yunfei Li, Mr. Ping Shen and Asia EVK (the creditors), who loaned
an aggregate of approximately $4.3 million to CBAK Power (the “Sixth Debt”). Pursuant to the terms of the cancellation agreement, Mr. Yunfei Li,
Mr.  Ping  Shen  and  Asia  EVK  agreed  to  cancel  the  Sixth  Debt  in  exchange  for  2,062,619,  4,714,557  and  2,151,017  shares  of  Common  Stock,
respectively, at an exchange price of $0.48 per share. Upon receipt of the shares, the creditors released the Company from any claims, demands and
other obligations relating to the Sixth Debt. The cancellation agreement contains customary representations and warranties of the creditors.

55

 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Changes in Control

There are no arrangements known to us, including any pledge by any person of our securities, the operation of which may at a subsequent date result in a
change in control of the Company.

Securities Authorized for Issuance Under Equity Compensation Plans

2015 Equity Incentive Plan

The  following  table  sets  forth  certain  information  about  the  securities  authorized  for  issuance  under  the  2015  Plan  as  of  December  31,  2020.  Options
exercisable for all of the securities shown in column (a) below were granted under our 2015 Plan.

Number of
securities
remaining
available for
future
issuance
under equity
compensation
plans
(excluding
securities
reflected in
column
(a)) (c)

Number of
securities to
be issued
upon exercise
of outstanding
options,
warrants and
rights
(a)

Weighted-
average
exercise price
of outstanding
options,
warrants and
rights 
(b)

Equity compensation plans approved by security holders

944,671    $

     1.1     

7,041,852(1)

Equity compensation plans not approved by security holders

-     

Total

944,671    $

1.1     

7,041,852(1)

On June 12, 2015, shareholders of the Company approved the 2015 Plan for employees, directors and consultants of the Company and its affiliates. The
maximum aggregate number of shares that may be issued under the 2015 Plan is ten million (10,000,000).

On June 30, 2015, pursuant to the 2015 Plan, the Company granted an aggregate of 690,000 restricted shares of the Company’s common stock to certain
employees,  officers  and  directors  of  the  Company.  In  accordance  with  the  vesting  schedule  of  the  grant,  the  restricted  shares  will  vest  in  twelve  equal
quarterly installments on the last day of each fiscal quarter beginning on June 30, 2015 and ending on March 31, 2018.

On April 19, 2016, pursuant to the 2015 Plan, the Company granted an aggregate of 500,000 restricted shares of the Company’s common stock to certain
employees, officers and directors of the Company. The restricted shares vest semi-annually in 6 equal installments over a three-year period with the first
vesting on December 31, 2016.

On August 23, 2019, pursuant to the 2015 plan, the Company granted an aggregate of 1,887,000 restricted share units of the Company’s common stock to
certain employees, officers and directors of the Company. There are two types of vesting schedules, (i) the share units will vest semi-annually in 6 equal
installments over a three-year period with the first vesting on September 30, 2019; (ii) the share units will vest annually in 3 equal installments over a three-
year period with the first vesting on March 31, 2021.

On October 23, 2020, pursuant to the Company’s 2015 Plan, the Compensation Committee granted an aggregate of 100,000 restricted share units of the
Company’s common stock to an employee of the Company. The restricted shares will vest semi-annually in six equal installments over a three-year period
with the first vesting on October 30, 2020.

As of December 31, 2020, 2,002,986 vested shares were issued, and 938,837 shares were to be issued upon vesting. As of the date of this annual report,
7,041,852 shares reserved under the 2015 Plan are available for future issuance.

56

 
 
 
 
 
 
 
 
 
   
   
 
 
   
     
     
 
   
 
   
      
      
  
   
      
  
 
   
      
      
  
   
 
 
 
 
 
 
 
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

Transactions with Related Persons

The  Company  borrowed  from  Mr.  Yunfei  Li,  the  Company’s  CEO  to  fund  its  operation.  These  loans  are  unsecured,  free  of  interest  and  repayable  on
demand. The balances were $212,470 and $278,739 as of December 31, 2019 and 2020, respectively.

In  December  2019,  the  Company  obtained  banking  facilities  from  China  Everbright  Bank  Dalian  Friendship  Branch  totaled  RMB39.9  million
(approximately $6.1 million) for a term until November 6, 2020, bearing interest at 5.655% per annum. The facility was secured by 100% equity in CBAK
Power held by BAK Asia and buildings of Hubei BAK Real Estate Co., Ltd., which Mr. Yunfei Li, the Company’s CEO holding 15% equity interest. We
repaid the bank loan of RMB39.9 million (approximately $6.1 million) in December 2020. Mr. Yunfei Li did not receive and is not entitled to receive any
consideration for the above-referenced guarantees. We are not independently obligated to indemnify any of those guarantors for any amounts paid by them
pursuant to any guarantee.

On April 27, 2020, we entered into a cancellation agreement with Mr. Yunfei Li, Asia EVK and Mr. Ping Shen, who loaned an aggregate of approximately
$4.3 million to CBAK Power. Pursuant to the terms of the cancellation agreement, the creditors agreed to cancel the debt in exchange for an aggregate of
8,928,193 shares of common stock of the Company at an exchange price of $0.48 per share. According to the amount of loan, 2,062,619, 2,151,017 and
4,714,557 shares were issued to Mr. Yunfei Li, Asia EVK and Mr. Pin Shen, respectively. Upon receipt of the shares, the creditors released the Company
from any claims, demands and other obligations relating to the debt.

Promoters and Certain Control Persons

We did not have any promoters at any time during the past five fiscal years.

Director Independence

J. Simon Xue, Martha C. Agee and Jianjun He each serves on our board of directors as an “independent director” as defined by Rule 5605(a)(2) of the
NASDAQ Listing Rule.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.

Independent Registered Public Accounting Firm’s Fees and Services

Audit Fees

Centurion  ZD  CPA  &  Co.  has  billed  us  $309,000  and  $202,000  for  the  fiscal  years  ended  December  31,  2020  and  2019,  respectively,  for  professional
services rendered for the audit of our annual financial statements, including reviews of the interim financial statements included in our quarterly reports on
Form 10-Q and assistance with the Securities Act filings.

Audit-Related Fees

We did not engage our principal accountants to provide assurance or related services during the last two fiscal years.

Tax Fees

We  did  not  engage  our  principal  accountants  to  provide  tax  compliance,  tax  advice  or  tax  planning  services  during  the  last  two  fiscal  years  and  three
months transition period.

All Other Fees

We  did  not  engage  our  principal  accountants  to  render  services  to  us  during  the  last  two  fiscal  years  and  three  months  transition  period,  other  than  as
reported above.

Pre-Approval Policies and Procedures

All auditing services and permitted non-audit services (including the fees and terms thereof) to be performed for the Company by our independent auditor
must be approved by the Audit Committee in advance, except non-audit services (other than review and attestation services) if such services fall within
exceptions  established  by  the  SEC.  The  Audit  Committee  will  pre-approve  any  permissible  non-audit  services  to  be  provided  by  the  Company’s
independent auditors on behalf of the Company that do not fall within any exception to the pre-approval requirements established by the SEC. The Audit
Committee may delegate to one or more members the authority to pre-approve permissible non-audit services, but any such delegate or delegates must
present their pre-approval decisions to the Audit Committee at its next meeting. All of our accountants’ services described above were pre-approved by the
Audit Committee or by one or more members under the delegate authority described above.

57

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.

Financial Statements and Schedules

PART IV

The financial statements are set forth under Item 8 of this annual report on Form 10-K. Financial statement schedules have been omitted since they are
either not required, not applicable, or the information is otherwise included.

Exhibit List

(a) List of Documents Filed as a Part of This Report:

(1) Index to Consolidated Financial Statements:

● Report of Centurion ZD CPA & Co., Independent Registered Public Accounting Firm

● Consolidated Balance Sheets as of December 31, 2020 and 2019

● Consolidated Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, 2020 and 2019

● Consolidated Statements of Changes in Stockholders’ Equity for the years ended December 31, 2020 and 2019

● Consolidated Statements of Cash Flows for the years ended December 31, 2020 and 2019

● Notes to Consolidated Financial Statements

(2) Index to Financial Statement Schedules:

All schedules have been omitted because the required information is included in the consolidated financial statements or the notes thereto, or because it is
not required.

(3) Index to Exhibits

See exhibits listed under Part (b) below.

(b) Exhibits:

Exhibit No.

  Description

2.1

3.1

3.2

3.3

3.4

4.1

  Articles of Merger (incorporated by reference to Exhibit 2.1 to the registrant’s Current Report on Form 8- K filed on January 17, 2017)

  Articles of Incorporation of the registrant (incorporated by reference to Exhibit 3.1 to the registrant’s Annual Report on Form 10-K filed

on December 8, 2006)

  By-laws of the registrant (incorporated by reference to Exhibit 3.2 to the registrant’s Annual Report on Form 10-K filed on December 19,

2007)

  Certificate of Change Pursuant to NRS 78.209 filed by the Company on October 22, 2012 (incorporated by reference to Exhibit 3.1 to the

registrant’s Current Report on Form 8-K filed on October 26, 2012)

  Certificate of Amendment to Articles of Incorporation filed by the Company on June 23, 2015 (incorporated by reference to Exhibit 3.1 to

the registrant’s Current Report on Form 8-K filed on June 26, 2015)

  CBAK Energy Technology, Inc. 2015 Equity Incentive Plan (incorporated by reference to Appendix D to the registrant’s Definitive Proxy

Statement on Schedule 14A filed April 24, 2015).

58

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
   
 
   
 
   
 
   
 
   
 
Exhibit No.

  Description

4.2

4.3

4.4

4.5

4.6

  Description of Securities Registered Pursuant to Section 12 of the Exchange Act

Form of Investors Warrant (incorporated by reference to Exhibit 4.1 to the registrant’s Current Report on Form 8-K filed on February 9,
2021)

Form  of  Placement  Agent  Warrant  (incorporated  by  reference  to  Exhibit  4.2  to  the  registrant’s  Current  Report  on  Form  8-K  filed  on
February 9, 2021)

Form of Investors Warrant (incorporated by reference to Exhibit 4.1 to the registrant’s Current Report on Form 8-K filed on December 9,
2020)

Form  of  Placement  Agent  Warrant  (incorporated  by  reference  to  Exhibit  4.2  to  the  registrant’s  Current  Report  on  Form  8-K  filed  on
December 9, 2020)

10.1

  Form of Director and Officer Indemnification Agreement (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on

Form 8-K filed on January 3, 2011)

10.2

  Form of  Restricted  Share  Units  Award  Agreement  Under  2015  Equity  Incentive  Plan  (incorporated  by  reference  to  Exhibit  10.1  to  the

registrant’s Current Report on Form 8-K filed on August 29, 2019)

10.3

  Form of Restricted Stock Award Agreement (incorporated by reference to Exhibit 99.1 to the registrant’s Current Report on Form 8-K filed

on July 6, 2015)

10.4

  Form of Securities Purchase Agreement by and among the Company and the Investors (incorporated by reference to Exhibit 10.1 to the

registrant’s Current Report on Form 8-K filed on February 9, 2021)

10.5

  Form of Registration Rights Agreement by and among the Company and the Investors (incorporated by reference to Exhibit 10.2 to the

registrant’s Current Report on Form 8-K filed on February 9, 2021)

10.6

  Securities Purchase Agreement by and among the Company and the Investors (incorporated by reference to Exhibit 10.1 to the registrant’s

Current Report on Form 8-K filed on December 9, 2020)

14.1

  Code of Business Conduct and Ethics of the registrant (incorporated by reference to Exhibit 14.1 to the registrant’s Quarterly Report on

Form 10-Q filed on August 22, 2006)

  List of subsidiaries of the registrant.

  Consent of Centurion ZD CPA & Co.

  Certifications of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

  Certifications of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

  Certifications of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

  Certifications of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

21.1

23.1

31.1

31.2

32.1

32.2

101.INS

  XBRL Instance Document

101.SCH

  XBRL Taxonomy Extension Schema Document

101.CAL

  XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

  XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

  XBRL Taxonomy Extension Label Linkbase Document

101.PRE

  XBRL Taxonomy Extension Presentation Linkbase Document

ITEM 16. FORM 10-K SUMMARY

None.

59

 
 
 
   
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
 
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

Date: April 13, 2021

SIGNATURES

CBAK ENERGY TECHNOLOGY, INC.

By:

By:

/s/ Yunfei Li
Yunfei Li
Chief Executive Officer

/s/ Xiangyu Pei
Xiangyu Pei
Interim Chief Financial Officer

In accordance with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the
capacities and on the dates indicated.

Signature

/s/ Yunfei Li
Yunfei Li

/s/ Xiangyu Pei
Xiangyu Pei

/s/ Guosheng Wang
Guosheng Wang

/s/ J. Simon Xue
J. Simon Xue

/s/ Martha C. Agee
Martha C. Agee

/s/ Jianjun He
Jianjun He

  Title

  Chairman and Chief Executive Officer
  (Principal Executive Officer)

  Interim Chief Financial Officer
  (Principal Financial and Accounting Officer)

  Director

  Director

  Director

  Director

60

Date

April 13, 2021

April 13, 2021

April 13, 2021

April 13, 2021

April 13, 2021

April 13, 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
   
 
 
 
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
 
 
 
Exhibit 4.2

DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE EXCHANGE ACT

The  following  summary  describes  our  common  stock,  par  value  $0.001  per  share  (the  “Common  Stock”),  of  CBAK  Energy  Technology,  Inc.  (the
“Company,” “we,” “us,” and “our”), which are the only securities of the Company registered pursuant to Section 12 of the Exchange Act.

DESCRIPTION OF COMMON STOCK

The following summary describes the material terms of our Common Stock. This summary does not purport to be complete and is qualified in its entirety
by  reference  to  our  Articles  of  Incorporation,  Certificate  of  Change  Pursuant  to  NRS  78.209,  Certificate  of  Amendment  to  Articles  of  Incorporation,
Articles of Merger and By-laws incorporated by reference as Exhibits 3.1, 3.3, 3.4, 2.1 and 3.2, respectively, to the Annual Report on Form 10-K of which
this Exhibit 4.2 is a part. We encourage you to read the foregoing exhibits and the applicable provisions of the Nevada Revised Statutes, Chapter 78, for a
complete description of our Common Stock.

Authorized Capital Stock

The  Company  is  authorized  to  issue  up  to  500,000,000  shares  of  Common  Stock.  The  Common  Stock  may  be  issued  from  time  to  time  for  such
consideration as may be fixed by the Board of Directors, provided that the consideration fixed is not less than par value.

Voting Rights

Each outstanding share of Common Stock entitles the holder thereof to one vote per share on all matters coming before the stockholders for a vote. Our
articles of incorporation do not permit cumulative voting for the election of directors. Likewise, our articles of incorporation do not vary the size of the vote
necessary for the stockholders to act on various matters from the size of the vote required by Nevada law, which means, unless a different vote is required
by express provisions of Nevada law, an action by the stockholders on a matter other than the election of directors shall be approved if the number of votes
cast in favor of the action exceeds the number of votes cast in opposition to the action. The directors of a Nevada corporation are elected at the annual
meeting of the stockholders by a plurality of the votes cast at the election.

Dividends

The holders of shares of our Common Stock are entitled to dividends out of funds legally available when and as declared by our board of directors. Our
board of directors has never declared a dividend or otherwise authorized any cash or other distribution with respect to the shares of our Common Stock and
does not anticipate declaring a dividend in the foreseeable future. Should we decide in the future to pay dividends, as a holding company, our ability to do
so and meet other obligations depends upon the receipt of dividends or other payments from our operating subsidiaries and other holdings and investments.
In addition, our operating subsidiaries, from time to time, may be subject to restrictions on their ability to make distributions to us, including as a result of
restrictive  covenants  in  loan  agreements,  restrictions  on  the  conversion  of  local  currency  into  dollars  or  other  hard  currency  and  other  regulatory
restrictions.

Liquidation

In  the  event  of  our  liquidation,  dissolution  or  winding  up,  holders  of  our  Common  Stock  are  entitled  to  receive,  ratably,  the  net  assets  available  to
stockholders after payment of all creditors.

Other Rights and Preferences

Our Common Stock has no preemptive or subscription rights, and no redemption, sinking fund, or conversion provisions.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fully Paid and Nonassessable

All  of  the  issued  and  outstanding  shares  of  our  Common  Stock  are  duly  authorized,  validly  issued,  fully  paid  and  non-assessable.  To  the  extent  that
additional shares of our Common Stock are issued, the relative interests of existing stockholders will be diluted.

Anti-takeover Effects of Our Articles of Incorporation and Bylaws

Our articles of incorporation and bylaws contain certain provisions that may have the effect of entrenching our existing board members, delaying, deferring
or preventing a future takeover or change in control of the company unless such takeover or change in control is approved by the board of directors. These
provisions include:

● Special  Meetings  of Stockholders  —  Our  articles  of  incorporation  provide  that  special  meetings  of  the  stockholders  can  only  be  called  by  our
president or any other executive officer, or the board of directors, or any member thereof, the record holder or holders of at least 10% of all shares
entitled to vote at the meeting, and our bylaws provide that a special meeting will be called by the president or secretary at the written request of
our stockholders holding not less than 30% of all the shares issued, outstanding and entitled to vote.

● Advance Notice Procedures — At an annual meeting, our stockholders elect a board of directors and transact such other business as may properly
be brought before the meeting. By contrast, at a special meeting, our stockholders may transact only the business for the purposes specified in the
notice of the meeting unless all of our stockholders entitled to vote are present at the special meeting and consent.

● Contracts and Transactions with Interested Directors — We may enter into a contract or a transaction with an entity in which our  directors  or
officers have a financial or other interest as long as such relationship has been disclosed to, or is known by, our board of directors, or is otherwise
fair to the Company at the time it is authorized or approved.

● Amendment of Bylaws — Our Bylaws may be amended by our board of directors alone.

● Authorized but Unissued Shares  —  Our  board  of  directors  may  cause  us  to  issue  our  authorized  but  unissued  shares  of  Common  Stock  in  the
future  without  stockholders’  approval.  These  additional  shares  may  be  utilized  for  a  variety  of  corporate  purposes,  including  future  public
offerings  to  raise  additional  capital,  corporate  acquisitions  and  employee  benefit  plans.  The  existence  of  authorized  but  unissued  shares  of
Common Stock could render more difficult or discourage an attempt to obtain control of a majority of our Common Stock by means of a proxy
contest, tender offer, merger or otherwise.

Anti-Takeover Effects of Nevada Law

Nevada Business Combination Statute

We are subject to the “business combination” provisions of Sections 78.411 to 78.444 of the Nevada Revised Statutes. In general, such provisions prohibit a
Nevada corporation with at least 200 stockholders from engaging in various “combination” transactions with any interested stockholder for a period of two
years after the date of the transaction in which the person became an interested stockholder, unless the transaction is approved by the board of directors
prior to the date the interested stockholder obtained such status or the combination is approved by the board of directors and thereafter is approved at a
meeting  of  stockholders  by  the  affirmative  vote  of  stockholders  representing  at  least  60%  of  the  outstanding  voting  power  held  by  disinterested
stockholders,  and  extends  beyond  the  expiration  of  the  two-year  period,  unless  (a)  the  combination  was  approved  by  the  board  of  directors  prior  to  the
person becoming an interested stockholder; (b) the transaction by which the person first became an interested stockholder was approved by the board of
directors before the person became an interested stockholder; (c) the combination is later approved by a majority of the voting power held by disinterested
stockholders; or (d) if the consideration to be paid by the interested stockholder is at least equal to the highest of: (i) the highest price per share paid by the
interested  stockholder  within  the  two  years  immediately  preceding  the  date  of  the  announcement  of  the  combination  or  in  the  transaction  in  which  it
became an interested stockholder, whichever is higher, or (ii) the market value per share of common stock on the date of announcement of the combination
and the date the interested stockholder acquired the shares, whichever is higher.

2

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A “combination” is generally defined to include mergers or consolidations or any sale, lease, exchange, mortgage, pledge, transfer, or other disposition, in
one transaction or a series of transactions, with an “interested stockholder” or any affiliate or associate of an interested stockholder having: (a) an aggregate
market value equal to more than 5% of the aggregate market value of the assets of the corporation, (b) an aggregate market value equal to more than 5% of
the  aggregate  market  value  of  all  outstanding  voting  shares  of  the  corporation,  and  (c)  more  than  10%  of  the  earning  power  or  net  income  of  the
corporation.

An “interested stockholder” is generally defined to mean a beneficial owner of at least 10% of the outstanding voting power or an affiliate or associate of
the corporation that has been a 10% beneficial owner within the preceding 2 years. The statutes could prohibit or delay mergers or other takeover or change
in  control  attempts  and,  accordingly,  may  discourage  attempts  to  acquire  our  company  even  though  such  a  transaction  may  offer  our  stockholders  the
opportunity to sell their stock at a price above the prevailing market price.

Nevada Acquisition of Controlling Interest Statute

Nevada’s Acquisition of Controlling Interest Statute (NRS Sections 78.378-78.3793) applies only to Nevada corporations with at least 200 stockholders,
including  at  least  100  stockholders  of  record  who  are  Nevada  residents,  which  conduct  business  directly  or  indirectly  in  Nevada  and  whose  articles  of
incorporation or bylaws in effect 10 days following the acquisition of a controlling interest by an acquiror do not prohibit its application. As of the date of
this prospectus, we do not believe we have 100 stockholders of record who are residents of Nevada, although there can be no assurance that in the future
the acquisition of controlling interest statutes will not apply to us.

Nevada’s Acquisition of Controlling Interest Statute, prohibits an acquiror, under certain circumstances, from voting shares of a target corporation’s stock
after  crossing  certain  threshold  ownership  percentages,  unless  the  acquiror  obtains  the  approval  of  the  target  corporation’s  stockholders.  The  statute
specifies three thresholds that constitute a controlling interest: (a) at least one-fifth but less than one-third; (b) at least one-third but less than a majority; and
(c)  a  majority  or  more,  of  the  outstanding  voting  power.  Once  an  acquiror  crosses  one  of  these  thresholds,  shares  which  it  acquired  in  the  transaction
exceeding the threshold (or within ninety days preceding the date thereof) become “control shares” which could be deprived of the right to vote until a
majority of the disinterested stockholders restore that right.

A special stockholders meeting may be called at the request of the acquiror to consider the voting rights of the acquiror’s shares. If the acquiror requests a
special meeting and gives an undertaking to pay the expenses of said meeting, then the meeting must take place no earlier than 30 days (unless the acquiror
requests that the meeting be held sooner) and no more than 50 days (unless the acquiror agrees to a later date) after the delivery by the acquiror to the
corporation of an information statement which sets forth the range of voting power that the acquiror has acquired or proposes to acquire and certain other
information concerning the acquiror and the proposed control share acquisition.

If no such request for a stockholders meeting is made, consideration of the voting rights of the acquiror’s shares must be taken at the next special or annual
stockholders meeting. If the stockholders fail to restore voting rights to the acquiror, or if the acquiror fails to timely deliver an information statement to the
corporation, then the corporation may, if so provided in its articles of incorporation or bylaws, call certain of the acquiror’s shares for redemption at the
average price paid for the control shares by the acquiror.

In the event the stockholders restore full voting rights to a holder of control shares that owns a majority of the voting stock, then all other stockholders who
do not vote in favor of restoring voting rights to the control shares may demand payment for the “fair value” of their shares as determined by a court in
dissenters rights proceeding pursuant to Chapter 92A of the Nevada Revised Statutes.

Listing

Our Common Stock is listed on Nasdaq Capital Market under the symbol “CBAT.”

Transfer Agent and Registrar

Our transfer agent and registrar is Securities Transfer Corporation, 2901 N Dallas Parkway, Suite 380, Plano, Texas 75093.

 3

 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIST OF SUBSIDIARIES

Name of Subsidiary
China BAK Asia Holdings Limited
Dalian CBAK Trading Co., Ltd.
Dalian CBAK Power Battery Co., Ltd.
Dalian CBAK Energy Technology Co., Ltd.
CBAK New Energy (Suzhou) Co., Ltd.
BAK Asia Investments Limited
CBAK New Energy (Nanjing) Co., Ltd
Nanjing Daxin New Energy Automobile Industry Co., Ltd
Nanjing CBAK New Energy Technology Co., Ltd

Exhibit 21.1

Percentage of
Ownership  

100%
100%
100%
100%
90%
100%
100%
100%
100%

Jurisdiction of
Incorporation or
Organization
Hong Kong
PRC
PRC
PRC
PRC
Hong Kong
PRC
PRC
PRC

 
  
 
 
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
Exhibit 23.1

中正達會計師事務所
Centurion ZD CPA & Co.
Certified Public Accountants (Practising)

Unit 1304, 13/F, Two Harbourfront, 22 Tak Fung Street, Hunghom, Hong Kong.
香港 紅磡 德豐街22號 海濱廣場二期 13樓1304室
Tel 電話: (852) 2126 2388 Fax 傳真: (852) 2122 9078
Email 電郵: info@czdcpa.com

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We  hereby  consent  to  the  incorporation  by  reference  in  the  Registration  Statements  on  Form  S-3  (No.  333-250893,  and  No.  333-253349)  and  the
Registration Statements on Form S-8 (No. 333-137747, No. 333-153649, No. 333-153650 and No. 333-205218) of CBAK Energy Technology, Inc. (the
“Company”) of our report dated April 13, 2021, relating to the Company’s consolidated financial statements (which report expresses an unqualified opinion
with an emphasis paragraph on the substantial doubt about the Company’s ability to continue as a going concern), which appears in this Annual Report on
Form 10-K.

/s/ Centurion ZD CPA & Co.
Centurion ZD CPA & Co.

Hong Kong, China
April 13, 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I, Yunfei Li, certify that:

1.

I have reviewed this annual report on Form 10-K of CBAK Energy Technology, Inc.;

CERTIFICATIONS

Exhibit 31.1

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the

financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;

b) Designed such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial  reporting  to  be  designed  under  our
supervision,  to  provide  reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial  statements  for
external purposes in accordance with generally accepted accounting principles;

c) Evaluated  the  effectiveness  of  the  registrant’s  disclosure  controls  and  procedures  and  presented  in  this  report  our  conclusions  about  the

effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal  quarter  (the  registrant’s  fourth  fiscal  quarter  in  the  case  of  an  annual  report)  that  has  materially  affected,  or  is  reasonably  likely  to
materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the

registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All  significant  deficiencies  and  material  weaknesses  in  the  design  or  operation  of  internal  control  over  financial  reporting  which  are

reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud,  whether  or  not  material,  that  involves  management  or  other  employees  who  have  a  significant  role  in  the  registrant’s  internal

control over financial reporting.

Date: April 13, 2021

/s/ Yunfei Li
Yunfei Li
Chief Executive Officer
(Principal Executive Officer)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I, Xiangyu Pei, certify that:

1.

I have reviewed this annual report on Form 10-K of CBAK Energy Technology, Inc.;

CERTIFICATIONS

Exhibit 31.2

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the

financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;

b) Designed such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial  reporting  to  be  designed  under  our
supervision,  to  provide  reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial  statements  for
external purposes in accordance with generally accepted accounting principles;

c) Evaluated  the  effectiveness  of  the  registrant’s  disclosure  controls  and  procedures  and  presented  in  this  report  our  conclusions  about  the

effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal  quarter  (the  registrant’s  fourth  fiscal  quarter  in  the  case  of  an  annual  report)  that  has  materially  affected,  or  is  reasonably  likely  to
materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the

registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All  significant  deficiencies  and  material  weaknesses  in  the  design  or  operation  of  internal  control  over  financial  reporting  which  are

reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any  fraud,  whether  or  not  material,  that  involves  management  or  other  employees  who  have  a  significant  role  in  the  registrant’s  internal

control over financial reporting.

Date: April 13, 2021

/s/ Xiangyu Pei
Xiangyu Pei
Interim Chief Financial Officer
(Principal Financial and Accounting Officer)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 32.1

The undersigned, Yunfei Li, the Chief Executive Officer of CBAK Energy Technology, Inc. (the “Company”), DOES HEREBY CERTIFY that:

1. The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the “Report”), fully complies with the requirements

of Section 13(a) of the Securities Exchange Act of 1934; and

2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

IN WITNESS WHEREOF, the undersigned has executed this statement this 13th day of April, 2021.

/s/ Yunfei Li
Yunfei Li
Chief Executive Officer
(Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to CBAK Energy Technology, Inc. and will be retained by CBAK
Energy Technology, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

The forgoing certification is being furnished to the Securities and Exchange Commission pursuant to § 18 U.S.C. Section 1350. It is not being filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company,
whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 
 
 
 
 
 
 
 
 
 
 
 
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 32.2

The  undersigned,  Xiangyu  Pei,  the  Interim  Chief  Financial  Officer  of  CBAK  Energy  Technology,  Inc.  (the  “Company”),  DOES  HEREBY

CERTIFY that:

1. The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the “Report”), fully complies with the requirements

of Section 13(a) of the Securities Exchange Act of 1934; and

2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

IN WITNESS WHEREOF, the undersigned has executed this statement this 13th day of April, 2021.

/s/ Xiangyu Pei
Xiangyu Pei
Interim Chief Financial Officer
(Principal Financial and Accounting Officer)

A signed original of this written statement required by Section 906 has been provided to CBAK Energy Technology, Inc. and will be retained by CBAK
Energy Technology, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

The forgoing certification is being furnished to the Securities and Exchange Commission pursuant to § 18 U.S.C. Section 1350. It is not being filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company,
whether made before or after the date hereof, regardless of any general incorporation language in such filing.